data_2md9_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2md9 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.02 133.66 56.3 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.556 0.617 . . . . 0.0 109.819 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -139.54 117.25 11.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.48 87.92 Favored Pre-proline 0 C--O 1.24 0.593 0 O-C-N 124.048 0.843 . . . . 0.0 109.106 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.94 144.37 87.84 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.205 2.603 . . . . 0.0 110.042 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 p -124.69 -11.57 7.23 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -108.89 133.36 53.02 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.33 -39.11 2.96 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.56 -50.45 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.356 0.98 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -58.41 -41.28 84.61 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.824 2.049 . . . . 0.0 108.633 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -64.28 -35.13 79.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.37 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -77.05 -35.43 56.79 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.949 -1.095 . . . . 0.0 111.688 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.22 -37.68 72.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.602 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.54 80.63 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.67 -47.21 73.17 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.6 mt -57.27 -38.45 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.569 0.747 . . . . 0.0 109.955 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -64.75 -42.8 94.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -57.73 -41.95 82.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -69.38 -22.04 63.75 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.02 -1.05 . . . . 0.0 113.723 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.92 -41.88 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.864 0.756 . . . . 0.0 110.632 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -83.77 -22.84 31.74 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.736 1.214 . . . . 0.0 112.733 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.2 35.02 69.98 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.93 173.9 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -130.41 148.67 52.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.487 1.115 . . . . 0.0 108.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 53.16 1.41 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.082 0.849 . . . . 0.0 113.521 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.0 mm -91.12 121.4 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.96 26.74 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 122.623 1.124 . . . . 0.0 112.339 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.04 -24.16 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 O-C-N 121.687 -0.89 . . . . 0.0 111.93 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.14 22.18 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.582 2.353 . . . . 0.0 113.371 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.94 116.17 8.29 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.62 110.84 12.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -40.02 -46.26 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.95 2.1 . . . . 0.0 113.908 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -68.09 -32.94 73.62 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.716 -0.615 . . . . 0.0 112.152 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.48 -32.09 69.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.194 0.906 . . . . 0.0 109.394 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -70.43 -20.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.67 7.88 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.545 1.069 . . . . 0.0 112.212 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.56 160.77 40.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.444 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 20.5 p80 -148.2 177.74 9.15 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.6 1.16 . . . . 0.0 108.212 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.32 -52.38 12.85 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.126 0.97 . . . . 0.0 112.995 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -47.72 73.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.914 1.233 . . . . 0.0 110.504 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 63.3 mmtt -62.56 -43.15 99.52 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.196 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.79 79.85 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.243 1.417 . . . . 0.0 110.996 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 74.7 mtm -68.81 -37.28 79.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.71 71.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.703 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.36 -52.69 52.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.06 69.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.518 1.054 . . . . 0.0 112.085 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -78.02 -32.8 51.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.183 0.992 . . . . 0.0 111.348 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.89 -40.08 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.065 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -37.97 82.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.813 1.188 . . . . 0.0 109.219 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -76.0 -31.77 59.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.26 -47.96 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.572 0.749 . . . . 0.0 111.869 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -94.48 0.49 55.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.741 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 55.66 37.44 28.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.737 1.215 . . . . 0.0 109.56 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.56 136.72 36.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.38 132.92 44.59 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.839 1.255 . . . . 0.0 110.029 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.2 tp -130.07 86.11 55.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 123.97 0.908 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.76 153.68 77.12 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.673 1.582 . . . . 0.0 110.453 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.5 -30.12 62.62 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.543 0.737 . . . . 0.0 110.463 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -53.03 -30.69 37.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.117 0.967 . . . . 0.0 111.94 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.08 -46.3 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.431 1.092 . . . . 0.0 108.842 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -46.55 82.89 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.598 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -36.57 58.51 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.289 -0.882 . . . . 0.0 111.42 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.53 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.596 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.55 73.1 62.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 124.361 1.064 . . . . 0.0 109.151 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.16 54.25 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.378 3.385 . . . . 0.0 110.804 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 147.62 41.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.178 0.899 . . . . 0.0 110.572 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 mm -57.77 -44.46 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 124.98 1.312 . . . . 0.0 108.617 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -55.83 -47.75 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.854 0.297 . . . . 0.0 110.986 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.85 -52.57 64.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.05 -41.28 97.97 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 108.235 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.7 92.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.027 0.83 . . . . 0.0 110.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -74.61 -40.88 61.29 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.958 0.503 . . . . 0.0 111.182 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -63.23 -42.72 99.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.43 -46.34 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.55 -49.7 67.11 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 t -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.278 0.361 . . . . 0.0 111.376 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mtt85 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.228 179.292 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -47.35 129.88 13.12 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.326 1.051 . . . . 0.0 113.107 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.43 117.46 3.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 156.89 73.91 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 124.039 0.837 . . . . 0.0 109.484 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.99 164.49 24.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.336 2.024 . . . . 0.0 112.766 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -134.18 -12.13 2.49 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.929 1.292 . . . . 0.0 112.259 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.34 144.68 35.55 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.02 -38.51 37.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.319 1.048 . . . . 0.0 112.179 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.29 -55.41 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.514 1.126 . . . . 0.0 110.457 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.69 -36.79 57.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 109.601 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -61.06 -46.97 88.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.743 0.817 . . . . 0.0 111.163 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -60.08 -49.44 77.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.536 0.607 . . . . 0.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.73 -42.1 97.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.915 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.01 69.99 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.527 0.603 . . . . 0.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -71.27 -46.78 60.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.3 mt -59.32 -35.09 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 121.525 -0.735 . . . . 0.0 109.701 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -62.28 -42.27 99.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.273 -0.892 . . . . 0.0 109.25 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.78 -33.82 76.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 109.191 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.34 -26.38 63.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.088 -1.008 . . . . 0.0 112.271 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.03 -55.41 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 118.276 0.489 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.82 -17.22 60.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.034 0.934 . . . . 0.0 113.24 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.57 21.66 72.83 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.244 0.926 . . . . 0.0 111.651 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.87 174.31 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -143.85 109.09 5.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.85 39.98 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.744 1.164 . . . . 0.0 113.052 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.6 mm -77.78 124.84 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.099 1.449 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.39 169.93 16.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.442 1.496 . . . . 0.0 110.788 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.81 -26.57 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.109 -1.23 . . . . 0.0 112.971 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.93 1.75 43.01 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.771 1.628 . . . . 0.0 112.97 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -69.49 127.29 32.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.285 0.564 . . . . 0.0 109.872 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -78.95 114.46 17.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.942 1.297 . . . . 0.0 110.871 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -44.01 -49.65 8.6 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.641 1.176 . . . . 0.0 113.627 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -76.44 -27.69 56.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.06 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.23 -30.17 67.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.092 1.315 . . . . 0.0 109.784 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.93 -13.68 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.61 -0.94 30.64 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.729 1.157 . . . . 0.0 112.627 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 133.36 33.93 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.71 175.11 5.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.94 -49.5 15.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.288 1.035 . . . . 0.0 112.019 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.31 -47.23 82.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.46 0.304 . . . . 0.0 110.575 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -64.75 -35.26 80.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.675 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.9 84.77 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.278 0.945 . . . . 0.0 109.261 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.3 mtm -69.57 -37.22 76.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.74 81.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.685 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.07 -49.73 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.993 1.27 . . . . 0.0 107.69 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.07 64.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.98 0.912 . . . . 0.0 111.15 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.63 85.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.682 0.793 . . . . 0.0 110.537 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.48 -38.98 48.04 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.461 0.573 . . . . 0.0 110.458 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 t -62.31 -47.32 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.438 1.095 . . . . 0.0 109.274 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.56 89.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.507 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.92 -31.79 59.3 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.93 -48.42 12.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.772 0.829 . . . . 0.0 110.751 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -91.12 -3.09 57.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.936 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 52.41 43.74 30.61 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.306 1.442 . . . . 0.0 110.316 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.33 129.61 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.1 134.45 51.86 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.204 1.186 . . . . 0.0 114.204 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.74 84.25 61.0 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.56 153.33 76.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.693 1.595 . . . . 0.0 109.729 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -27.74 63.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.652 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -59.62 -26.87 65.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.917 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.34 -48.2 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -50.09 61.79 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.444 1.497 . . . . 0.0 111.25 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -30.24 39.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.967 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.16 -27.13 59.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.586 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -141.42 68.5 26.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.334 1.454 . . . . 0.0 110.626 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.36 57.36 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.38 3.387 . . . . 0.0 114.012 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.64 147.25 37.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -54.65 -47.99 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 124.73 1.212 . . . . 0.0 107.879 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -52.24 -42.76 63.89 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.82 72.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.33 -40.17 64.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.69 68.54 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.094 -0.955 . . . . 0.0 108.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.21 -38.34 78.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.19 -51.9 61.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.823 0.849 . . . . 0.0 109.009 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.7 -39.67 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.24 77.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.364 1.066 . . . . 0.0 113.353 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 t -64.82 -28.93 69.9 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.831 0.707 . . . . 0.0 110.281 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 . . . . . 0 C--O 1.218 -0.555 0 CA-C-N 118.583 0.629 . . . . 0.0 109.861 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -55.34 133.44 49.62 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.81 1.244 . . . . 0.0 112.118 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.18 117.03 9.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.82 158.46 69.4 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 124.079 0.862 . . . . 0.0 109.425 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.91 139.66 75.25 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.611 1.541 . . . . 0.0 110.471 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -111.13 -10.45 14.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.654 1.182 . . . . 0.0 111.319 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -121.59 152.87 38.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.48 1.036 . . . . 0.0 109.238 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.7 -36.41 67.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.239 0.616 . . . . 0.0 111.496 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.95 -49.79 70.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.81 -35.87 77.6 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.473 0.709 . . . . 0.0 110.041 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 t -65.59 -49.07 70.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -54.41 -56.52 17.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.773 0.829 . . . . 0.0 110.208 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.12 -42.36 90.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.991 -1.004 . . . . 0.0 113.274 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.48 66.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 123.87 0.731 . . . . 0.0 109.981 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -72.46 -37.73 68.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.7 mm -59.14 -38.73 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -67.46 -41.1 85.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.737 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.06 -35.1 77.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.018 0.826 . . . . 0.0 109.165 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -71.0 -43.19 68.5 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.064 -1.023 . . . . 0.0 111.269 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.56 -54.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.63 0.772 . . . . 0.0 111.371 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.7 -26.73 66.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 111.731 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.3 59.8 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.938 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.36 174.22 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.945 1.298 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t -132.32 135.11 45.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.73 60.79 0.84 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.22 0.914 . . . . 0.0 112.973 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.84 121.75 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.25 163.46 31.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 118.831 0.741 . . . . 0.0 111.5 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.2 pt -65.12 -22.18 30.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.309 1.044 . . . . 0.0 110.937 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.95 21.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.62 1.968 . . . . 0.0 113.834 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.63 128.48 35.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.319 0.963 . . . . 0.0 110.433 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -75.83 118.31 18.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.148 0.979 . . . . 0.0 109.423 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -48.92 -40.47 30.16 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.689 1.195 . . . . 0.0 111.792 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -72.34 -28.99 63.39 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 112.608 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.401 ' C ' ' H ' ' A' ' 42' ' ' GLY . 10.5 tp-100 -69.47 -33.0 72.26 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -75.86 29.64 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 126.199 1.8 . . . . 0.0 109.301 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . 70.08 10.04 64.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 119.223 -2.173 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.51 151.93 47.19 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.483 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.0 p80 -143.42 172.58 12.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.36 -53.96 6.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.99 1.316 . . . . 0.0 112.823 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tp -55.52 -47.32 76.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.694 0.679 . . . . 0.0 111.827 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 72.6 mmtt -59.94 -42.69 94.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.138 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.56 90.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.136 0.974 . . . . 0.0 109.257 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -61.44 -37.99 85.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.513 0.725 . . . . 0.0 109.772 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -28.9 68.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.171 0.588 . . . . 0.0 110.769 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -72.54 -48.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -29.99 59.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.14 -53.54 36.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 122.106 0.955 . . . . 0.0 108.815 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -65.27 -38.42 90.23 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.812 1.645 . . . . 0.0 109.824 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.09 -46.1 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 -38.92 87.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 118.693 0.678 . . . . 0.0 110.72 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -76.53 -31.9 57.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.28 -44.7 11.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.384 0.538 . . . . 0.0 112.13 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -93.14 -0.78 56.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.816 0.446 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 52.93 37.94 25.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.222 1.409 . . . . 0.0 110.984 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.1 129.7 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.413 0.625 . . . . 0.0 112.396 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.69 117.81 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.5 tp -111.4 88.77 9.43 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.57 157.13 63.2 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.974 1.782 . . . . 0.0 110.786 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -27.37 68.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.578 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -54.77 -28.83 51.69 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 110.89 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.87 -43.38 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.909 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -47.91 83.72 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.126 0.571 . . . . 0.0 111.054 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -33.16 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.2 -31.9 58.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.813 0.278 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -140.49 74.12 28.95 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.891 0.876 . . . . 0.0 109.153 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.87 53.28 3.23 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.373 3.382 . . . . 0.0 113.306 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.65 147.8 48.72 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.808 1.185 . . . . 0.0 110.612 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.31 -43.4 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -57.77 -47.33 82.84 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.51 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.03 97.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.0 -42.83 62.85 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.59 91.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 109.933 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.92 -44.96 72.05 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.477 0.58 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.34 -42.38 98.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.37 -37.65 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.9 -46.09 89.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.683 0.674 . . . . 0.0 110.213 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -29.54 70.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.464 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 . . . . . 0 N--CA 1.469 0.505 0 CA-C-N 119.096 0.862 . . . . 0.0 112.821 -179.693 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.82 138.23 57.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.494 1.517 . . . . 0.0 109.438 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.9 t -147.55 119.24 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.61 160.39 44.21 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.277 1.031 . . . . 0.0 109.535 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.62 152.08 58.31 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.103 2.535 . . . . 0.0 114.223 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -123.01 -18.49 6.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.282 2.233 . . . . 0.0 112.595 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.46 148.72 40.47 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.19 62.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.727 1.211 . . . . 0.0 110.547 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.45 -47.51 83.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.39 -31.28 71.92 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.598 0.759 . . . . 0.0 110.004 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -52.21 53.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.757 0.823 . . . . 0.0 110.231 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -57.54 -52.75 64.12 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.7 -42.09 83.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.653 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -33.4 65.42 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.79 0.436 . . . . 0.0 111.687 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.61 -48.69 66.08 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.068 0.461 . . . . 0.0 109.896 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.75 -34.82 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.089 0.956 . . . . 0.0 110.123 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -67.25 -43.71 81.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 119.033 0.833 . . . . 0.0 110.691 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.43 -44.78 76.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.783 0.833 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -60.06 -30.46 69.22 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.701 1.2 . . . . 0.0 113.084 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.35 -49.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.708 0.685 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -69.16 -23.04 63.9 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.51 1.124 . . . . 0.0 112.102 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 34.6 66.99 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.733 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.08 173.92 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -138.34 127.17 23.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.78 32.9 0.97 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 124.235 0.922 . . . . 0.0 111.006 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.25 127.76 31.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 -169.32 24.24 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.47 1.509 . . . . 0.0 110.64 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.236 1.815 . . . . 0.0 113.378 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.412 HD11 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.69 0.78 22.63 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -176.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.04 122.31 14.04 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.986 1.714 . . . . 0.0 110.843 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -75.66 103.07 5.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -39.89 -48.56 2.33 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 113.766 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.63 -30.69 63.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.24 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.34 -32.17 72.09 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.406 1.003 . . . . 0.0 109.659 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.37 -7.58 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 125.338 1.455 . . . . 0.0 110.493 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.16 3.0 41.84 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.552 1.073 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 151.5 52.28 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -142.34 176.93 8.62 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.269 -1.136 . . . . 0.0 108.21 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.44 -53.05 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.211 1.404 . . . . 0.0 112.33 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.21 -46.23 86.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.904 0.32 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.56 -42.49 98.92 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.786 -0.571 . . . . 0.0 110.042 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.42 67.66 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.058 0.943 . . . . 0.0 109.94 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mmt -67.85 -38.77 83.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 109.484 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.74 70.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.025 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -76.26 -50.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.67 -36.14 34.35 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 112.756 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.55 63.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.816 0.817 . . . . 0.0 111.517 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -72.51 -33.63 67.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 122.193 0.997 . . . . 0.0 110.741 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.33 -46.27 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 C-N-CA 124.682 1.193 . . . . 0.0 108.892 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -61.67 -41.56 97.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -75.15 -29.19 60.41 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.428 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -87.08 -49.09 7.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.818 0.735 . . . . 0.0 112.615 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -90.89 -2.36 57.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.514 0.726 . . . . 0.0 110.74 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 53.69 38.7 28.99 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.855 0.752 . . . . 0.0 110.176 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.01 120.54 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.183 0.993 . . . . 0.0 111.695 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.42 111.07 7.29 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.73 85.35 3.86 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 122.962 0.505 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 154.67 69.88 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.488 2.792 . . . . 0.0 111.878 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -27.31 64.12 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.582 1.553 . . . . 0.0 110.016 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -53.18 -32.93 50.41 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.305 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.31 -46.49 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -43.59 72.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.908 0.483 . . . . 0.0 111.924 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -30.54 40.31 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 119.068 -0.492 . . . . 0.0 111.34 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.99 73.83 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.97 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -140.78 76.87 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 110.472 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.02 59.37 5.19 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.621 2.881 . . . . 0.0 114.057 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 148.52 38.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.347 0.976 . . . . 0.0 110.442 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 mm -60.48 -40.95 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -56.03 -45.32 79.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.202 0.456 . . . . 0.0 110.926 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.9 95.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.15 0.98 . . . . 0.0 113.465 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.18 -38.91 68.99 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.77 -51.39 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.652 0.66 . . . . 0.0 109.598 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -69.26 -33.09 72.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.962 0.801 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -67.05 -51.63 52.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.661 0.743 . . . . 0.0 109.071 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.7 -35.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -37.4 87.12 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.202 0.91 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -71.05 -15.86 62.57 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.517 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.307 1.043 . . . . 0.0 113.059 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -38.77 131.66 1.3 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.119 2.168 . . . . 0.0 114.54 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.5 t -144.44 116.95 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.17 162.19 56.92 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.77 147.4 41.0 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.57 2.18 . . . . 0.0 112.029 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -121.89 -1.58 9.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.016 1.326 . . . . 0.0 112.042 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.32 150.51 52.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.77 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.529 0.732 . . . . 0.0 111.243 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.52 -49.61 81.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.78 -35.72 69.02 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -49.46 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 110.609 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -55.31 -50.08 70.51 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.871 0.468 . . . . 0.0 110.452 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.89 -42.08 98.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.889 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.05 67.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 123.694 0.621 . . . . 0.0 110.561 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.72 -40.04 76.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.466 0.576 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.75 -38.19 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -62.32 -38.86 91.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.75 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -59.82 -39.15 84.09 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 118.611 0.641 . . . . 0.0 110.119 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.598 HH21 ' NE2' ' A' ' 54' ' ' GLN . 67.3 mtm-85 -68.74 -44.33 74.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.789 1.177 . . . . 0.0 113.93 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.05 -43.28 58.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 122.231 0.213 . . . . 0.0 111.132 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.49 -21.83 38.43 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 122.574 0.35 . . . . 0.0 111.316 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.81 35.71 90.06 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.454 -1.192 . . . . 0.0 111.56 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.47 175.13 10.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 t -132.11 150.06 52.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.39 52.06 1.26 Allowed Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.735 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.63 130.18 41.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.67 19.87 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 126.711 2.101 . . . . 0.0 109.773 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.6 pt -83.03 -22.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -1.13 19.22 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.3 119.08 26.19 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 122.834 1.302 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.41 124.02 20.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.095 1.758 . . . . 0.0 111.19 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -48.04 -46.41 33.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.998 1.719 . . . . 0.0 110.633 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.52 -31.38 69.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.541 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -71.41 -34.52 70.43 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -70.86 -31.13 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.37 -11.67 4.08 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.008 0.822 . . . . 0.0 113.825 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.89 159.74 27.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.353 1.076 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -147.56 178.86 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.445 1.498 . . . . 0.0 108.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.51 -53.33 7.12 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.076 1.351 . . . . 0.0 113.304 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tp -56.03 -49.0 74.91 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.276 0.944 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.55 -44.44 96.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.349 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.42 63.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.634 0.774 . . . . 0.0 110.46 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.5 mtm -66.05 -37.47 85.92 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -40.44 88.18 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.9 -52.73 57.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -28.62 63.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.448 1.099 . . . . 0.0 112.845 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.38 -49.83 31.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.843 0.747 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.598 ' NE2' HH21 ' A' ' 25' ' ' ARG . 0.7 OUTLIER -65.57 -36.38 83.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.706 0.402 . . . . 0.0 110.04 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.51 -40.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -40.32 86.96 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 119.218 0.917 . . . . 0.0 109.799 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.25 7.4 ptm180 -77.09 -33.42 56.99 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -80.68 -39.76 26.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -101.54 -1.36 33.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.791 0.436 . . . . 0.0 110.66 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 56.02 38.85 30.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.735 1.214 . . . . 0.0 110.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 133.13 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 O-C-N 121.654 -0.653 . . . . 0.0 112.629 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.14 141.67 58.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.339 1.855 . . . . 0.0 112.817 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.7 tp -128.75 96.61 29.27 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 109.912 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.95 153.49 68.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.621 2.214 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.86 68.11 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.49 1.516 . . . . 0.0 110.13 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -52.92 -27.56 19.33 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.023 0.929 . . . . 0.0 110.082 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.438 HG23 ' CZ ' ' A' ' 80' ' ' TYR . 46.2 t -88.02 -49.11 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.69 1.196 . . . . 0.0 109.534 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -45.18 85.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -24.17 45.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.986 0.914 . . . . 0.0 112.518 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.49 -39.31 22.64 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.488 0.586 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.24 77.21 30.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 O-C-N 124.168 0.918 . . . . 0.0 110.893 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.04 57.75 2.71 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.894 3.729 . . . . 0.0 113.228 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -141.73 149.77 40.92 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 121.245 1.839 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.1 -40.24 76.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -57.05 -46.66 82.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.909 0.777 . . . . 0.0 111.192 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.45 86.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.72 -42.65 63.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.3 70.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.96 0.904 . . . . 0.0 109.802 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.83 -39.0 76.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.367 0.53 . . . . 0.0 111.639 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CZ ' HG23 ' A' ' 67' ' ' VAL . 34.3 t80 -64.2 -46.93 81.72 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.85 -41.53 77.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.23 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.01 90.41 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.643 1.11 . . . . 0.0 112.268 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -63.93 -20.89 66.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.713 0.688 . . . . 0.0 110.873 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 . . . . . 0 C--O 1.235 0.335 0 C-N-CA 124.034 0.933 . . . . 0.0 110.164 178.563 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.38 137.25 19.01 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.592 1.557 . . . . 0.0 110.997 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.1 t -142.03 118.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.91 162.18 31.94 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.458 0.703 . . . . 0.0 110.567 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.13 154.64 69.5 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.015 1.81 . . . . 0.0 109.231 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -129.73 -12.9 4.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -121.09 153.18 37.79 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -23.47 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.94 -49.84 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.552 1.523 . . . . 0.0 108.64 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -55.14 -45.3 75.63 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.406 1.882 . . . . 0.0 108.689 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.2 t -56.6 -37.92 71.31 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.031 2.132 . . . . 0.0 110.71 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.2 mmpt? -78.02 -45.44 23.67 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.67 -41.18 94.54 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.77 72.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.493 1.121 . . . . 0.0 109.858 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.21 -43.02 74.95 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.23 0.468 . . . . 0.0 110.501 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.86 -37.45 80.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.453 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -61.88 -44.57 96.54 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.902 0.774 . . . . 0.0 110.759 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -52.15 -47.13 65.59 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.536 1.134 . . . . 0.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -59.91 -16.15 27.3 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.85 -43.02 4.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.057 0.943 . . . . 0.0 111.821 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.02 -26.25 60.33 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 121.76 -0.587 . . . . 0.0 110.672 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.18 50.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 118.379 0.536 . . . . 0.0 111.809 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.48 169.62 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -138.03 111.4 8.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 108.063 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.91 69.58 0.44 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.021 1.296 . . . . 0.0 110.677 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.45 122.04 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.364 1.466 . . . . 0.0 109.544 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.54 161.05 44.24 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.19 0.905 . . . . 0.0 110.849 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.5 -21.29 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 121.469 -1.018 . . . . 0.0 112.581 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -4.77 17.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.87 2.068 . . . . 0.0 112.836 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -71.91 122.56 21.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.675 0.67 . . . . 0.0 109.627 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -70.62 114.32 8.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.286 1.435 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -42.86 -42.07 3.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.863 1.665 . . . . 0.0 114.341 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -75.43 -27.41 58.96 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.431 -0.793 . . . . 0.0 111.965 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.0 -28.41 64.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.097 0.862 . . . . 0.0 109.325 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.77 29.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.836 2.054 . . . . 0.0 109.118 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.88 -0.87 49.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 119.786 -1.821 . . . . 0.0 113.834 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.29 157.0 49.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 119.032 1.416 . . . . 0.0 110.811 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -143.49 173.95 11.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.09 -30.07 24.37 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.71 -52.23 22.29 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -55.44 -41.38 72.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 109.832 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.99 64.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.561 0.745 . . . . 0.0 111.74 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.91 -38.33 61.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.305 1.042 . . . . 0.0 110.004 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.3 75.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.41 0.284 . . . . 0.0 110.252 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -76.62 -45.83 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.84 -34.08 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.35 1.06 . . . . 0.0 112.35 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.14 82.56 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.558 0.694 . . . . 0.0 109.854 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -67.97 -42.74 80.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.294 1.037 . . . . 0.0 110.164 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -62.46 -47.83 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 123.731 0.813 . . . . 0.0 109.502 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.24 90.4 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.024 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -75.74 -33.04 60.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.6 -49.28 8.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.543 0.611 . . . . 0.0 111.041 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -88.2 1.92 53.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.393 0.677 . . . . 0.0 111.502 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 51.73 38.9 24.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.984 1.314 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.55 128.4 7.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 O-C-N 121.233 -0.917 . . . . 0.0 112.408 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.34 122.07 15.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.64 88.65 14.0 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.86 160.31 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.268 1.312 . . . . 0.0 110.99 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.91 -26.0 58.37 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.307 1.443 . . . . 0.0 108.559 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -51.88 -44.47 63.73 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.22 1.008 . . . . 0.0 111.718 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 t -77.69 -40.88 28.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.45 0.7 . . . . 0.0 109.633 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -42.14 98.62 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.603 0.761 . . . . 0.0 110.718 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -41.54 23.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.47 78.92 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.496 -0.882 . . . . 0.0 112.54 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -143.08 74.95 17.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.156 0.982 . . . . 0.0 111.319 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 59.85 2.46 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.879 3.719 . . . . 0.0 113.302 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.01 147.59 37.14 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.285 -1.509 . . . . 0.0 109.829 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.03 -44.38 94.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -57.11 -44.89 83.69 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.029 0.831 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.79 93.49 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.005 0.522 . . . . 0.0 111.895 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.4 -44.43 71.43 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.35 65.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.719 0.808 . . . . 0.0 110.923 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -72.34 -34.53 68.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.978 0.808 . . . . 0.0 112.457 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -68.38 -52.51 32.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.257 0.623 . . . . 0.0 110.357 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.79 -44.54 85.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.172 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.97 77.21 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -75.81 -26.17 57.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.357 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.401 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.8 137.6 31.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.049 2.14 . . . . 0.0 111.205 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -144.85 117.52 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.01 152.86 82.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.49 150.46 75.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.85 2.367 . . . . 0.0 110.475 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 p -127.1 -17.78 4.74 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -102.4 142.28 33.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -22.42 0.91 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.598 1.559 . . . . 0.0 115.089 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.43 -48.81 19.51 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.021 0 CA-C-N 119.25 0.932 . . . . 0.0 109.376 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.23 -45.82 72.41 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.875 2.07 . . . . 0.0 110.14 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 t -59.19 -38.76 80.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.526 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -70.66 -38.85 73.85 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.128 0.422 . . . . 0.0 111.829 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.09 -40.06 86.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 -34.51 73.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 123.843 0.714 . . . . 0.0 109.482 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -63.86 -49.39 72.95 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 118.397 0.544 . . . . 0.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.1 -37.87 80.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.923 0.489 . . . . 0.0 110.053 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -64.03 -42.34 97.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.229 -0.92 . . . . 0.0 109.974 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -62.39 -32.36 73.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.047 0.939 . . . . 0.0 109.808 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.73 -43.03 26.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.172 -0.955 . . . . 0.0 111.37 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.65 -55.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.3 mt -68.47 -30.22 69.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.236 0.614 . . . . 0.0 112.082 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.85 43.34 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 123.664 0.649 . . . . 0.0 111.81 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.21 175.58 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.989 1.715 . . . . 0.0 108.144 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -138.57 139.72 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 107.758 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.74 38.76 2.31 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.38 0.514 . . . . 0.0 112.925 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -81.69 122.28 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.81 -178.39 30.76 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.578 1.561 . . . . 0.0 110.831 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 pt -74.09 -26.72 21.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 O-C-N 121.403 -1.057 . . . . 0.0 113.179 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -3.5 23.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.711 2.004 . . . . 0.0 113.95 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.04 116.58 8.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.61 127.69 33.45 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -48.97 -45.64 42.38 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.499 1.12 . . . . 0.0 111.288 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.98 -38.66 91.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.467 0.707 . . . . 0.0 110.879 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -66.81 -20.74 66.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.772 1.229 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.39 7.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 120.98 -1.075 . . . . 0.0 108.118 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.94 0.64 87.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 119.631 -1.918 . . . . 0.0 113.676 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.45 139.51 30.61 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.422 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 24.5 p80 -121.99 175.19 6.45 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.161 -1.199 . . . . 0.0 108.434 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.053 0.941 . . . . 0.0 112.94 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.172 0.442 . . . . 0.0 111.907 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.422 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 16.6 mmtp -64.64 -42.38 95.51 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.0 79.02 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.832 1.253 . . . . 0.0 111.265 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.4 mmt -55.65 -42.83 75.61 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.819 0.848 . . . . 0.0 110.193 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.59 -38.6 91.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.838 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.25 -48.49 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.54 -28.25 59.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.514 0.726 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -50.56 47.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.927 0.785 . . . . 0.0 110.081 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -68.27 -36.53 79.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.05 0.929 . . . . 0.0 110.328 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -67.3 -45.67 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -40.16 86.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.021 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -75.87 -31.22 59.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -84.97 -48.24 9.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.551 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -87.07 -1.63 58.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 52.33 39.01 26.47 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 111.089 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.9 138.26 14.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.55 125.08 28.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.975 0.893 . . . . 0.0 110.172 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tt -113.82 91.87 23.19 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.42 155.32 70.66 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.424 1.416 . . . . 0.0 110.935 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.15 -28.83 19.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.126 1.37 . . . . 0.0 111.686 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.68 -44.35 66.17 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.554 0.742 . . . . 0.0 112.236 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -80.84 -37.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -44.56 95.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.208 0.603 . . . . 0.0 110.491 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -40.8 26.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.561 1.545 . . . . 0.0 110.934 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.01 71.75 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.992 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -134.25 70.65 73.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.66 0.784 . . . . 0.0 110.161 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.12 59.35 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.562 3.508 . . . . 0.0 111.908 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.96 147.9 37.73 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.878 1.672 . . . . 0.0 109.396 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.45 -42.79 85.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.78 -49.07 66.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.869 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.27 -40.4 90.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.05 -38.5 66.48 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.28 69.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.385 0.538 . . . . 0.0 110.208 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.13 -39.38 72.03 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.239 0.337 . . . . 0.0 111.795 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -63.75 -47.37 81.29 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 110.018 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.21 -37.38 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.95 -46.74 88.44 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.632 1.105 . . . . 0.0 112.082 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -63.41 -17.38 62.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.28 0.491 . . . . 0.0 110.467 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 . . . . . 0 C--N 1.342 0.277 0 O-C-N 120.953 -1.092 . . . . 0.0 112.05 178.882 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.36 135.42 27.01 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -147.92 117.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 162.18 14.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.378 1.071 . . . . 0.0 110.228 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.15 151.02 84.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.382 2.054 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 -6.02 3.62 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.965 0.906 . . . . 0.0 111.995 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -117.38 140.09 50.02 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.15 -33.81 41.98 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.82 -38.12 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.847 0.749 . . . . 0.0 109.667 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.9 -38.76 92.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -61.93 -46.65 88.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.598 1.159 . . . . 0.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -56.56 -58.13 9.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.893 0.877 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.76 -36.35 83.59 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.017 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.17 63.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.424 0.689 . . . . 0.0 110.764 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.15 -48.39 23.86 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -54.39 -41.42 53.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.126 1.371 . . . . 0.0 111.151 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -61.97 -42.22 98.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.729 0.812 . . . . 0.0 111.558 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.64 -46.05 87.95 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.5 mmm-85 -62.27 -23.92 66.97 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.929 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -92.4 -55.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 119.929 1.241 . . . . 0.0 109.445 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.36 -23.87 66.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.82 33.75 57.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.99 174.11 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.8 p -134.7 132.08 38.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.307 1.443 . . . . 0.0 107.698 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.71 45.74 0.95 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 123.966 0.793 . . . . 0.0 113.21 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.2 121.89 27.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.86 35.68 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.3 0.952 . . . . 0.0 111.029 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.5 pt -81.69 -21.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 120.45 -1.618 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.82 1.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.137 1.775 . . . . 0.0 113.418 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.66 122.44 15.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.931 1.348 . . . . 0.0 111.828 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -81.02 108.34 14.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -44.88 -45.15 10.14 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.974 1.709 . . . . 0.0 113.718 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -73.73 -27.83 61.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.537 -0.727 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.37 -30.25 69.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.2 mt -77.37 6.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 126.484 1.914 . . . . 0.0 109.984 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 3.35 79.84 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 119.659 -1.901 . . . . 0.0 112.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.58 157.98 47.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 107.817 -2.113 . . . . 0.0 107.817 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.439 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 18.6 p80 -147.06 178.59 8.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.61 -54.63 5.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.913 1.285 . . . . 0.0 112.247 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.04 -45.8 75.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 64.8 mmtt -64.41 -44.07 92.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -40.09 68.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.309 1.044 . . . . 0.0 111.459 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 mtm -65.68 -35.47 80.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.524 0.33 . . . . 0.0 111.168 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.95 78.49 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.949 0.9 . . . . 0.0 111.612 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.01 -41.68 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.74 70.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.484 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.76 48.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.59 -38.59 85.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.93 -46.36 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -40.93 90.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.52 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -29.37 58.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.83 -48.44 8.76 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.23 2.16 52.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 111.505 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 55.85 31.83 18.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.264 0.626 . . . . 0.0 111.877 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.87 128.99 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 123.317 0.647 . . . . 0.0 112.601 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.54 124.98 25.54 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.6 tp -112.22 87.63 9.39 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.05 156.81 64.42 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.753 0.969 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -27.54 65.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.261 1.024 . . . . 0.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.77 -29.08 62.28 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.961 0.8 . . . . 0.0 111.079 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.4 t -86.64 -43.5 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -49.06 79.24 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 123.055 0.542 . . . . 0.0 111.159 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -29.12 61.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.62 -29.91 27.33 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.635 0.652 . . . . 0.0 112.085 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -138.58 68.02 44.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 109.213 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.78 57.95 4.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.56 2.84 . . . . 0.0 114.88 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.16 148.21 37.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.383 0.992 . . . . 0.0 110.558 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -56.28 -44.08 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -52.31 -49.66 63.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.894 0.77 . . . . 0.0 111.42 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.18 99.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.05 -43.09 62.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.262 1.425 . . . . 0.0 108.516 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.82 88.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -73.31 -37.12 66.3 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.253 0.621 . . . . 0.0 111.493 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -65.51 -41.11 93.52 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.16 -43.6 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.69 90.64 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -15.86 63.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.328 0.651 . . . . 0.0 112.23 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 . . . . . 0 N--CA 1.462 0.151 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 178.224 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -42.95 124.5 3.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.4 1.88 . . . . 0.0 114.967 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.0 t -146.86 116.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.04 161.62 15.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.109 1.763 . . . . 0.0 112.672 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.06 148.47 93.1 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.625 2.883 . . . . 0.0 112.65 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 p -114.66 -21.14 10.38 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.255 1.422 . . . . 0.0 113.656 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -109.97 162.86 14.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.377 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -34.28 77.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.837 1.655 . . . . 0.0 110.612 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.1 -50.99 28.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.75 -43.4 76.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 126.342 1.857 . . . . 0.0 109.427 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -65.52 -32.96 74.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.328 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -68.45 -48.7 63.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.786 1.176 . . . . 0.0 108.896 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.65 -41.86 82.31 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.086 0.955 . . . . 0.0 110.918 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.02 67.84 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.207 1.003 . . . . 0.0 111.95 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -77.42 -37.35 51.96 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 118.937 0.79 . . . . 0.0 110.127 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.89 -40.17 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.518 -0.739 . . . . 0.0 109.76 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -59.41 -39.21 82.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.302 0.641 . . . . 0.0 111.874 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -63.69 -32.84 74.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.495 0.718 . . . . 0.0 110.902 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -68.01 -35.7 78.73 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.817 -1.177 . . . . 0.0 111.484 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.22 -54.83 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.27 0.628 . . . . 0.0 110.838 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.18 -24.83 57.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.4 21.67 69.3 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.426 1.012 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 m -105.15 175.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.505 1.122 . . . . 0.0 110.458 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 t -139.32 112.75 8.28 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.35 62.8 0.34 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 123.202 0.429 . . . . 0.0 112.435 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.7 mm -86.63 137.83 20.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.83 177.19 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 124.89 1.233 . . . . 0.0 111.741 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 pt -78.87 -22.42 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 121.082 -1.246 . . . . 0.0 113.41 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 0.78 22.58 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.251 34.9 p30 -76.11 129.56 36.98 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 123.192 1.472 . . . . 0.0 112.706 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -74.1 111.59 9.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.849 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -43.46 -45.94 6.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.737 1.615 . . . . 0.0 112.604 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -66.99 -37.02 83.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -67.62 -31.45 71.48 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.652 0.781 . . . . 0.0 109.98 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mt -71.98 -6.26 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.286 1.034 . . . . 0.0 109.27 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.39 10.24 27.78 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 126.024 1.774 . . . . 0.0 112.908 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.9 159.31 47.46 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.878 1.339 . . . . 0.0 110.111 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.421 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 20.1 p80 -146.86 178.07 8.62 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.344 1.458 . . . . 0.0 107.906 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.57 -54.75 5.77 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.633 1.173 . . . . 0.0 112.739 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -54.95 -50.54 68.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.857 0.863 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 32.2 mmtp -61.86 -39.31 91.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.893 -1.051 . . . . 0.0 111.149 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.96 96.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.497 1.044 . . . . 0.0 108.847 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.4 mtm -66.69 -37.45 84.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.942 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.31 92.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.221 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.65 -45.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.691 1.132 . . . . 0.0 108.057 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.32 -32.74 57.35 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.938 0.895 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.03 83.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.213 0.461 . . . . 0.0 111.064 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -77.74 -43.33 31.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 122.002 0.906 . . . . 0.0 108.885 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.78 -46.46 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 124.049 0.94 . . . . 0.0 109.605 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -60.61 -41.08 94.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.778 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -75.53 -32.39 60.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -82.51 -45.99 13.99 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 123.219 0.607 . . . . 0.0 111.873 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -93.96 -3.01 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.899 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 53.82 46.97 24.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.754 1.221 . . . . 0.0 108.761 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.08 126.97 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 48.0 tt0 -73.04 115.0 11.84 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.66 88.54 16.47 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.81 153.85 63.9 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.05 1.167 . . . . 0.0 109.725 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.84 -26.36 9.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.855 2.062 . . . . 0.0 110.35 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.29 -44.35 64.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.616 1.166 . . . . 0.0 110.641 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.5 t -77.66 -45.72 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.566 0.747 . . . . 0.0 109.085 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -42.62 74.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.453 0.701 . . . . 0.0 110.716 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -37.45 28.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.281 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.44 98.81 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.336 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -137.64 83.38 25.05 Favored Pre-proline 0 N--CA 1.448 -0.56 0 O-C-N 124.396 1.06 . . . . 0.0 109.222 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 60.77 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.164 2.576 . . . . 0.0 110.95 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.18 148.66 38.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.972 1.715 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mm -57.17 -43.01 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.83 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.55 -48.99 76.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.864 0.756 . . . . 0.0 111.587 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.69 -41.45 86.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.148 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.4 -42.25 62.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.26 76.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.703 1.201 . . . . 0.0 110.849 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -37.88 64.94 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.894 0.77 . . . . 0.0 110.311 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.31 -48.08 79.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.535 0.607 . . . . 0.0 110.929 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 t -69.7 -40.82 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.11 86.57 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 118.998 0.817 . . . . 0.0 112.528 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 t -73.16 -13.93 61.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.231 0.469 . . . . 0.0 110.118 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 . . . . . 0 C--O 1.225 -0.201 0 CA-C-N 119.542 1.064 . . . . 0.0 109.684 177.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -48.11 125.47 9.24 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.806 2.442 . . . . 0.0 110.48 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.2 t -135.22 117.39 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 152.89 72.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.056 0.942 . . . . 0.0 111.458 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.49 151.57 84.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.951 2.434 . . . . 0.0 111.081 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -129.2 -13.87 4.4 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.719 1.208 . . . . 0.0 111.229 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -90.08 152.09 21.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.28 70.78 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.899 0.48 . . . . 0.0 110.162 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -78.28 -51.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.734 1.614 . . . . 0.0 110.833 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.37 -37.96 68.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.132 0.573 . . . . 0.0 110.089 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 t -59.97 -52.29 66.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 123.843 0.714 . . . . 0.0 109.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.4 mmpt? -56.5 -49.2 75.4 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.75 -38.8 92.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 117.486 -1.245 . . . . 0.0 111.075 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.15 -30.09 70.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.76 0.709 . . . . 0.0 110.174 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.98 -44.08 97.01 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -63.52 -39.23 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.689 1.196 . . . . 0.0 109.586 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -55.46 -43.85 75.86 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.868 0.758 . . . . 0.0 109.967 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.4 -32.28 72.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.745 0.702 . . . . 0.0 110.643 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -76.22 -16.36 59.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.486 -1.384 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.04 -36.23 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.641 0.776 . . . . 0.0 110.078 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.19 -42.13 12.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.971 1.308 . . . . 0.0 111.537 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.75 40.32 7.24 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.394 -1.226 . . . . 0.0 110.948 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.253 3.4 m -128.24 177.22 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.664 1.232 . . . . 0.0 108.686 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.3 t -143.59 108.26 4.88 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 119.981 -1.7 . . . . 0.0 108.233 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.97 41.93 0.15 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.453 1.501 . . . . 0.0 114.167 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.5 mm -76.42 145.38 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 120.193 1.997 . . . . 0.0 108.507 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.03 175.5 15.88 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.389 1.947 . . . . 0.0 110.079 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 pt -75.63 -30.83 22.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -0.52 36.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.523 1.129 . . . . 0.0 113.382 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.53 116.59 10.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -67.45 117.57 9.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.94 -45.58 15.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.542 1.537 . . . . 0.0 111.893 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -70.67 -29.77 66.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.45 0.7 . . . . 0.0 112.53 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -76.91 -30.29 56.08 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.51 -0.744 . . . . 0.0 110.39 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.3 mt -70.72 -31.05 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.264 0.484 . . . . 0.0 110.389 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.58 -2.45 2.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.907 1.242 . . . . 0.0 111.651 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.7 157.83 53.59 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -136.66 172.96 12.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.83 -45.92 20.5 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.336 0.654 . . . . 0.0 112.47 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.03 -49.29 78.46 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.517 0.598 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -60.64 -38.83 86.1 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.395 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -35.23 62.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.844 1.202 . . . . 0.0 111.006 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.6 mtm -73.85 -42.06 61.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.55 74.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.082 1.353 . . . . 0.0 111.327 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.9 -53.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.98 -36.28 65.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.081 0.952 . . . . 0.0 112.316 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.21 -52.49 65.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.692 0.797 . . . . 0.0 111.565 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -75.72 -33.27 60.3 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.635 -0.666 . . . . 0.0 111.799 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.99 -44.09 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.658 1.183 . . . . 0.0 108.909 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -41.08 88.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.611 0.641 . . . . 0.0 110.261 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.69 -34.44 60.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.89 -48.16 13.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.802 0.689 . . . . 0.0 111.585 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -91.34 3.18 55.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.165 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 48.8 38.81 12.67 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.269 1.428 . . . . 0.0 110.445 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.46 117.65 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 123.678 0.791 . . . . 0.0 110.14 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -64.12 140.01 58.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 tt -120.38 84.54 35.44 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.85 144.81 94.16 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.3 14.81 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.885 1.274 . . . . 0.0 110.462 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -53.28 -35.11 59.73 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 t -87.97 -44.24 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 119.121 0.873 . . . . 0.0 109.135 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -51.63 63.29 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 123.536 0.734 . . . . 0.0 110.796 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -71.57 -37.91 70.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.295 0.638 . . . . 0.0 111.573 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.6 84.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.75 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.86 78.6 29.82 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.861 1.264 . . . . 0.0 108.653 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 55.39 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.846 3.031 . . . . 0.0 111.043 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.25 147.16 47.41 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.194 0.906 . . . . 0.0 110.098 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.17 -39.3 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.31 -51.2 60.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 111.867 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.31 97.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.695 1.598 . . . . 0.0 114.212 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.1 -40.4 65.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.847 1.259 . . . . 0.0 108.417 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -51.75 68.22 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 119.028 0.831 . . . . 0.0 109.385 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.77 -38.5 89.23 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.497 0.319 . . . . 0.0 111.622 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.93 -51.97 48.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.246 1.018 . . . . 0.0 110.377 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.42 -41.84 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 123.346 0.404 . . . . 0.0 110.165 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.18 78.67 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -70.9 -24.91 62.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.68 0.218 . . . . 0.0 110.568 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.461 0.12 0 O-C-N 120.687 -1.258 . . . . 0.0 108.694 178.59 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -52.01 123.33 10.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 0.0 111.638 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -138.37 117.26 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 160.07 44.08 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.356 1.462 . . . . 0.0 110.101 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.33 145.16 99.18 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.887 3.058 . . . . 0.0 113.353 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -116.65 -11.67 10.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 0.0 112.391 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -125.3 145.4 50.03 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.33 -29.31 9.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.372 1.069 . . . . 0.0 112.863 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.47 -53.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.673 0.749 . . . . 0.0 109.58 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -55.85 -42.96 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.605 1.962 . . . . 0.0 109.272 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -66.08 -31.82 72.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.424 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -72.31 -40.37 67.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.038 1.29 . . . . 0.0 109.761 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -69.07 -39.07 79.3 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.079 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 -33.83 70.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.487 1.117 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -69.55 -40.79 76.62 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 117.999 0.363 . . . . 0.0 111.171 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.18 -36.39 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -62.49 -35.64 80.0 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.652 -0.655 . . . . 0.0 109.659 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.54 -39.9 88.82 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.59 -0.694 . . . . 0.0 109.624 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -65.84 -38.81 89.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.37 -44.57 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.0 mt -85.91 -24.03 26.77 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.055 0.542 . . . . 0.0 112.128 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.29 31.15 59.61 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.268 -0.74 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.27 171.33 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.7 p -143.04 138.22 29.8 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.954 1.252 . . . . 0.0 111.521 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.34 42.6 1.05 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.978 1.275 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.49 121.55 28.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.786 0.834 . . . . 0.0 109.68 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -90.97 169.31 33.48 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.67 1.129 . . . . 0.0 110.67 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.3 pt -71.28 -25.94 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.099 -1.236 . . . . 0.0 111.973 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 1.03 32.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.069 2.147 . . . . 0.0 112.724 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 33' ' ' GLY . 10.8 m-20 -65.68 116.73 7.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.15 0.98 . . . . 0.0 108.559 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -74.78 112.83 11.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -43.08 -52.46 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.503 1.521 . . . . 0.0 112.471 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.74 -33.02 72.28 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.319 -0.863 . . . . 0.0 111.666 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -68.65 -23.09 64.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.117 0.967 . . . . 0.0 110.461 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.2 mt -84.25 14.01 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 125.339 1.456 . . . . 0.0 109.157 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 9.6 70.21 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 119.368 -2.083 . . . . 0.0 113.721 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 170.51 54.31 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 118.306 1.053 . . . . 0.0 112.047 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -155.08 176.7 12.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 108.03 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.92 -46.09 60.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.558 0.743 . . . . 0.0 112.563 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.26 -49.1 72.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.122 0.874 . . . . 0.0 109.401 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -59.38 -46.58 88.28 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.38 62.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.052 0.842 . . . . 0.0 113.048 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.1 mtm -75.63 -39.79 57.28 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 109.776 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.086 1.354 . . . . 0.0 111.574 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.71 -53.56 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.89 61.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.356 1.463 . . . . 0.0 113.779 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.32 -50.63 59.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.493 1.042 . . . . 0.0 108.646 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.05 -31.96 56.58 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 121.984 0.897 . . . . 0.0 110.992 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.63 -42.58 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -42.1 98.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.311 0.96 . . . . 0.0 109.573 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -74.18 -30.02 62.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.188 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.89 -49.55 10.88 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.822 0.737 . . . . 0.0 110.379 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.84 -1.56 57.89 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 55.68 40.89 30.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.991 1.317 . . . . 0.0 109.804 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.38 130.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.76 128.25 34.96 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.132 0.573 . . . . 0.0 109.548 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.75 86.7 13.39 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.41 141.75 52.22 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.713 1.608 . . . . 0.0 109.735 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -27.33 16.84 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.742 1.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -53.9 -32.25 52.75 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.057 0.844 . . . . 0.0 111.577 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -86.81 -46.54 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -47.73 72.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.509 1.124 . . . . 0.0 111.488 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.94 -36.46 62.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.149 0.58 . . . . 0.0 111.003 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -33.11 67.58 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.224 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -141.36 74.43 24.17 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.385 1.474 . . . . 0.0 109.366 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.98 56.49 3.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 125.062 3.841 . . . . 0.0 113.894 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.45 148.35 42.62 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.883 -1.136 . . . . 0.0 111.773 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -56.7 -42.96 78.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -54.99 -49.89 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.163 0.438 . . . . 0.0 110.892 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.48 97.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.24 -40.86 70.79 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.41 79.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.441 0.564 . . . . 0.0 110.206 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.25 -40.48 67.65 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.923 0.489 . . . . 0.0 111.728 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.27 -43.82 96.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.2 t -74.03 -35.89 42.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.866 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -35.59 71.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.248 0.931 . . . . 0.0 112.73 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 t -82.31 -18.64 41.56 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.216 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 . . . . . 0 N--CA 1.468 0.46 0 CA-C-N 119.742 1.155 . . . . 0.0 109.506 179.227 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -50.48 133.88 24.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.957 2.103 . . . . 0.0 112.791 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.55 118.98 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.46 157.59 77.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.251 1.02 . . . . 0.0 111.614 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 155.3 71.38 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.484 2.789 . . . . 0.0 112.926 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.3 t -130.78 -20.22 2.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.466 1.107 . . . . 0.0 112.419 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -98.72 143.72 28.77 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.99 -27.1 12.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.02 0.928 . . . . 0.0 113.49 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.95 -46.64 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 120.388 1.449 . . . . 0.0 109.186 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.82 -35.27 68.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.21 1.404 . . . . 0.0 110.471 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -63.2 -49.09 75.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -57.42 -48.64 78.59 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.36 -41.68 94.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.664 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.67 -34.6 73.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.725 0.641 . . . . 0.0 109.93 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -66.41 -50.59 62.93 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.55 -37.38 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.286 1.034 . . . . 0.0 110.339 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -62.43 -44.8 95.54 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.718 0.69 . . . . 0.0 111.204 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.35 -32.86 70.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.227 0.611 . . . . 0.0 111.538 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -67.69 -43.02 81.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.523 0.601 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.7 -52.05 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 123.646 0.778 . . . . 0.0 111.864 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.88 -25.63 62.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.636 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.53 57.94 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.12 174.64 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.648 1.179 . . . . 0.0 110.023 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -144.07 114.45 7.52 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.36 27.17 0.52 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.727 1.156 . . . . 0.0 112.36 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.13 125.48 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.687 1.243 . . . . 0.0 110.819 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 175.76 22.42 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.367 1.461 . . . . 0.0 112.051 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.28 -28.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 121.098 -1.237 . . . . 0.0 112.193 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.61 2.28 28.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.465 1.906 . . . . 0.0 112.53 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.19 122.84 17.59 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.21 119.43 25.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.513 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -46.79 -46.44 20.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.236 1.814 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -74.75 -31.36 61.78 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.647 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -63.62 -36.97 85.57 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.8 mt -72.13 6.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 125.455 1.502 . . . . 0.0 109.809 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.61 3.72 80.61 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 119.543 -1.973 . . . . 0.0 111.309 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.87 145.8 49.03 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 120.081 1.941 . . . . 0.0 108.933 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -139.49 -179.39 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.297 1.039 . . . . 0.0 109.127 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.61 -53.04 12.31 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.918 1.287 . . . . 0.0 112.224 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -49.17 72.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.142 0.577 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -61.93 -44.75 96.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.842 -0.537 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.4 83.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.486 1.114 . . . . 0.0 110.217 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.85 -41.29 91.1 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.592 0.757 . . . . 0.0 109.5 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.5 75.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.179 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.9 -51.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 120.56 1.527 . . . . 0.0 107.33 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.88 -33.01 61.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.132 0.973 . . . . 0.0 113.027 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.95 75.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.265 0.626 . . . . 0.0 110.695 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -76.49 -34.18 58.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.705 0.765 . . . . 0.0 111.495 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.54 -44.98 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -39.03 84.41 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.535 0.607 . . . . 0.0 110.122 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -76.15 -31.79 58.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.12 -47.42 8.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.86 0.464 . . . . 0.0 111.783 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -90.09 0.71 57.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.749 0.419 . . . . 0.0 110.571 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 52.74 36.51 21.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.477 1.111 . . . . 0.0 111.441 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.75 123.0 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.235 0.54 . . . . 0.0 112.13 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.91 110.34 2.85 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.905 -1.122 . . . . 0.0 108.452 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 tp -100.34 93.14 2.5 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.049 1.34 . . . . 0.0 110.941 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.0 145.18 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.707 3.605 . . . . 0.0 111.096 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -29.37 9.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.709 2.404 . . . . 0.0 111.428 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -52.97 -26.66 15.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.5 -50.05 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.799 1.64 . . . . 0.0 109.212 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -46.57 63.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.005 0.922 . . . . 0.0 110.718 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -30.7 38.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.368 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.0 -30.95 58.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.948 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.38 69.25 13.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 111.394 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.37 60.43 3.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.787 3.658 . . . . 0.0 112.998 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.2 147.12 36.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.901 -1.125 . . . . 0.0 109.045 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 mm -56.9 -47.51 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 C-N-CA 124.11 0.964 . . . . 0.0 108.662 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.87 -47.37 80.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.635 0.584 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.43 81.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.2 -41.47 85.75 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.718 1.607 . . . . 0.0 108.716 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.82 99.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.512 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.6 -46.59 58.79 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 118.571 0.623 . . . . 0.0 110.403 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -58.9 -42.35 89.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.3 t -73.49 -41.33 56.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.122 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.04 82.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.677 1.126 . . . . 0.0 112.334 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -70.74 -29.35 65.58 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.546 0.612 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 . . . . . 0 CA--C 1.517 -0.3 0 O-C-N 120.94 -1.1 . . . . 0.0 111.792 -178.993 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -56.34 128.72 37.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.268 1.827 . . . . 0.0 114.07 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.96 117.61 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.11 163.41 17.44 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.297 1.439 . . . . 0.0 110.786 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.9 148.89 82.96 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.236 1.957 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 p -130.43 -12.15 3.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.2 143.66 40.0 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -28.38 6.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.873 1.269 . . . . 0.0 114.229 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.49 -40.76 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 119.525 1.057 . . . . 0.0 109.442 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -56.36 -39.02 72.2 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.089 0.556 . . . . 0.0 110.305 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.5 t -63.1 -49.11 75.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.852 0.72 . . . . 0.0 109.587 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -54.89 -52.29 63.34 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.678 0.672 . . . . 0.0 110.369 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -64.51 -41.63 96.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.253 -0.88 . . . . 0.0 112.716 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.78 74.55 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.5 -45.75 71.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.5 -41.85 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -61.14 -41.97 97.7 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 121.11 -0.994 . . . . 0.0 109.905 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.7 -45.13 95.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.476 0.58 . . . . 0.0 111.403 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -70.75 -39.85 73.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.577 1.081 . . . . 0.0 112.902 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.01 -55.88 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -74.96 -28.32 60.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.06 19.6 60.74 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.124 1.821 . . . . 0.0 113.093 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.07 174.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.15 1.38 . . . . 0.0 108.462 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 t -145.36 132.04 19.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.661 0.664 . . . . 0.0 112.409 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.21 0.88 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.0 mm -78.25 128.47 38.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.22 161.08 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.118 0.843 . . . . 0.0 112.66 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.55 -21.35 26.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.934 1.294 . . . . 0.0 111.193 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -3.89 18.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.175 2.19 . . . . 0.0 114.301 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 131.09 39.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.556 1.071 . . . . 0.0 111.003 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.28 119.95 23.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -40.97 -46.26 2.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.879 2.071 . . . . 0.0 114.403 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -67.84 -32.3 72.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 112.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.14 -32.04 68.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.635 0.652 . . . . 0.0 109.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -71.23 -9.93 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.445 1.098 . . . . 0.0 110.397 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.26 1.91 23.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 124.367 0.984 . . . . 0.0 111.864 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 152.51 52.1 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -143.43 179.86 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.51 -49.27 36.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.222 0.919 . . . . 0.0 111.974 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.68 -48.32 81.47 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -59.85 -43.43 94.64 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.057 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.58 77.71 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.68 0.792 . . . . 0.0 110.009 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.74 -39.56 94.6 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.26 77.88 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.059 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.2 -50.73 55.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.47 -32.65 65.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.098 0.959 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.87 99.46 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.042 0.537 . . . . 0.0 110.485 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -78.4 -40.95 34.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 121.473 0.654 . . . . 0.0 111.252 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -64.28 -46.13 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 O-C-N 121.621 -0.674 . . . . 0.0 110.727 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -37.16 85.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.849 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -76.04 -30.22 58.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -89.71 -48.69 7.11 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.95 -3.8 59.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 109.783 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 50.98 45.17 28.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.766 2.026 . . . . 0.0 110.342 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.38 128.7 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.472 0.709 . . . . 0.0 110.286 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.86 125.63 25.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -116.19 79.67 8.86 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -66.6 150.35 83.89 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.423 2.082 . . . . 0.0 112.951 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -26.59 64.67 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.592 1.557 . . . . 0.0 109.933 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -53.32 -41.97 66.23 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.327 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -37.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -49.67 -51.1 40.57 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.505 1.122 . . . . 0.0 109.545 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -36.53 69.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.944 0.898 . . . . 0.0 111.484 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -37.17 85.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.508 0.505 . . . . 0.0 111.476 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -138.56 75.34 38.22 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 107.962 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.66 64.26 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.37 2.714 . . . . 0.0 112.147 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.09 147.09 36.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.673 1.124 . . . . 0.0 110.226 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -55.82 -49.8 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 108.735 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -52.82 -48.12 67.19 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.091 0.556 . . . . 0.0 111.142 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.65 73.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.185 0.994 . . . . 0.0 113.281 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.1 -43.43 78.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.938 1.695 . . . . 0.0 108.864 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.24 74.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -68.8 -42.64 77.03 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.422 1.089 . . . . 0.0 111.769 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -63.96 -43.24 96.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.685 0.794 . . . . 0.0 109.737 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.06 -36.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.546 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -49.0 72.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.881 0.473 . . . . 0.0 110.486 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -65.22 -28.11 69.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -45.29 120.5 2.5 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.75 1.62 . . . . 0.0 110.943 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.42 119.73 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 159.94 5.52 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.52 1.528 . . . . 0.0 111.513 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.82 152.74 77.03 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.646 2.231 . . . . 0.0 111.034 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -127.01 -14.08 5.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -118.6 145.08 45.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.52 54.32 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 122.84 0.456 . . . . 0.0 111.763 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.9 -45.0 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.73 -42.13 96.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -49.34 76.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.206 0.941 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -56.99 -54.48 46.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.876 0.87 . . . . 0.0 110.907 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.93 -37.58 87.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.21 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.46 72.37 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.069 0.849 . . . . 0.0 109.755 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.86 -48.16 80.23 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.27 -38.83 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -67.37 -44.98 77.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.062 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -55.38 -42.1 73.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.821 0.848 . . . . 0.0 110.295 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -71.62 -41.88 68.33 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.298 -0.876 . . . . 0.0 112.839 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -71.51 -45.16 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.601 0.76 . . . . 0.0 110.997 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.43 -32.15 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.92 0.888 . . . . 0.0 110.707 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.32 26.07 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.04 171.91 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.566 1.546 . . . . 0.0 108.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -143.92 127.94 17.5 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.39 40.1 0.6 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.396 1.95 . . . . 0.0 110.961 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.2 mm -77.64 126.24 37.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.842 0.857 . . . . 0.0 109.219 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.09 -179.07 38.72 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 121.807 0.671 . . . . 0.0 111.71 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 -28.27 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.245 0.618 . . . . 0.0 111.687 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.54 -4.1 20.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.421 1.489 . . . . 0.0 113.921 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.62 123.19 17.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.21 115.33 17.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.221 0.608 . . . . 0.0 110.833 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -44.75 -46.5 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.502 1.121 . . . . 0.0 113.256 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -67.46 -29.78 69.32 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.19 -31.19 34.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mt -71.08 -21.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.172 0.442 . . . . 0.0 110.051 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.69 -5.21 5.48 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.74 1.162 . . . . 0.0 113.479 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.98 157.98 53.22 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -146.18 176.93 9.37 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.31 6.6 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.157 1.783 . . . . 0.0 112.39 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -37.2 76.98 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -76.1 -37.93 57.53 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 120.215 -1.553 . . . . 0.0 110.984 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.46 72.87 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.415 1.486 . . . . 0.0 112.71 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -44.23 96.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.75 72.17 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.722 1.209 . . . . 0.0 110.741 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.45 -53.15 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.09 71.31 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.914 0.486 . . . . 0.0 110.952 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.93 72.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.061 0.846 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -72.38 -31.45 65.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.017 0.913 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.37 -42.78 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -40.61 87.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 121.758 -0.589 . . . . 0.0 110.086 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -33.73 59.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.12 -39.61 14.43 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -97.8 0.93 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 50.97 37.78 18.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.305 1.042 . . . . 0.0 110.437 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.48 129.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.403 0.681 . . . . 0.0 112.785 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -80.82 116.61 20.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.65 92.76 6.41 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 127.197 2.199 . . . . 0.0 105.345 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.3 152.25 82.67 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.988 1.792 . . . . 0.0 110.524 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -28.84 22.23 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.701 1.6 . . . . 0.0 110.276 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -52.28 -39.58 60.64 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.505 1.122 . . . . 0.0 112.133 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.64 -38.92 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -50.68 72.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.972 0.909 . . . . 0.0 110.808 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.35 56.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.628 1.571 . . . . 0.0 109.882 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.53 70.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.572 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.36 73.99 35.76 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.185 1.394 . . . . 0.0 108.596 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.96 62.0 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.423 3.415 . . . . 0.0 109.869 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.61 146.95 36.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.19 -42.35 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -54.75 -42.89 72.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.061 0.846 . . . . 0.0 111.318 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.12 -44.47 88.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.16 -38.76 66.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.367 1.467 . . . . 0.0 108.077 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.32 69.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.562 0.745 . . . . 0.0 109.348 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.02 -38.93 79.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.241 0.473 . . . . 0.0 111.243 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 -48.27 81.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.21 -40.24 65.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 O-C-N 123.825 0.703 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.26 76.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.753 1.161 . . . . 0.0 114.034 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -73.36 -24.41 60.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.322 0.249 . . . . 0.0 111.323 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 123.094 0.557 . . . . 0.0 109.732 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.41 130.69 47.42 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.202 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.3 t -145.22 117.52 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.91 160.67 19.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.869 1.268 . . . . 0.0 111.236 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.73 160.81 11.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.654 2.903 . . . . 0.0 114.222 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -127.96 -38.16 1.86 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.04 -1.891 . . . . 0.0 112.294 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -89.48 163.7 15.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.18 71.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.773 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.32 -49.96 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.235 0.614 . . . . 0.0 109.558 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -54.33 -41.58 69.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.863 0.865 . . . . 0.0 109.139 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -54.5 -37.7 65.6 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.607 1.563 . . . . 0.0 110.758 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -76.93 -57.29 3.93 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 120.17 1.35 . . . . 0.0 111.302 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -53.31 -41.96 66.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.518 1.127 . . . . 0.0 113.101 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.42 69.19 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 123.57 0.544 . . . . 0.0 110.378 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -77.74 -34.93 52.36 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.215 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.36 -36.04 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -62.91 -33.98 76.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.956 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -63.59 -37.84 88.85 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -68.88 -15.97 63.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.11 -54.45 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 119.201 0.909 . . . . 0.0 110.355 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.55 -27.43 64.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.822 0.849 . . . . 0.0 111.983 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.49 39.02 51.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.48 174.56 12.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.918 1.287 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -134.89 138.24 43.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.0 1.32 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.03 64.04 0.95 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.587 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.18 141.37 14.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.3 -173.14 18.57 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 125.393 1.473 . . . . 0.0 111.025 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 pt -84.92 -28.85 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.24 1.96 24.31 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -81.49 123.51 28.68 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.403 1.097 . . . . 0.0 110.8 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -69.93 122.52 19.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.585 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.58 -46.82 39.72 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.314 1.846 . . . . 0.0 111.98 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.36 -31.65 69.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.181 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -67.96 -33.06 73.94 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.14 0.882 . . . . 0.0 109.046 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.03 -11.64 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.834 0.854 . . . . 0.0 108.812 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.85 3.64 26.55 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.209 1.862 . . . . 0.0 114.206 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.98 152.91 48.32 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.297 1.549 . . . . 0.0 111.827 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -138.31 175.56 9.46 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.464 1.506 . . . . 0.0 108.144 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.26 -49.23 34.31 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.931 0.892 . . . . 0.0 112.92 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.17 -51.11 67.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.568 1.077 . . . . 0.0 109.411 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -59.41 -48.09 82.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.01 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.17 68.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.687 1.595 . . . . 0.0 110.542 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmt -66.09 -39.36 89.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.859 0.864 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.201 -0.905 . . . . 0.0 110.802 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 t -67.71 -50.78 57.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.01 -32.05 63.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.85 63.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.554 0.615 . . . . 0.0 109.366 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.44 -40.04 77.46 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.883 0.473 . . . . 0.0 111.184 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -63.64 -49.23 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -39.98 91.74 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.306 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -30.95 59.73 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -83.88 -48.22 10.25 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.029 0.831 . . . . 0.0 110.449 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -87.42 -3.58 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.592 0.557 . . . . 0.0 110.742 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 59.02 38.02 24.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.52 1.055 . . . . 0.0 111.515 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.68 126.92 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.101 -0.999 . . . . 0.0 112.681 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.87 142.0 58.58 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.97 78.61 74.61 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.74 152.99 79.48 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.734 1.623 . . . . 0.0 111.173 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -28.43 47.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.905 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -54.27 -33.53 58.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.488 1.115 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.8 t -88.17 -51.78 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -48.9 35.62 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.454 1.902 . . . . 0.0 111.41 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.85 40.63 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.643 -0.66 . . . . 0.0 112.296 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.85 79.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.223 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -138.33 79.63 30.19 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.519 1.128 . . . . 0.0 108.528 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.74 55.26 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 124.635 3.556 . . . . 0.0 112.651 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 147.8 38.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.549 1.068 . . . . 0.0 110.906 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 mm -54.94 -44.97 75.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.527 1.131 . . . . 0.0 108.749 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -54.19 -39.3 66.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.638 0.654 . . . . 0.0 111.913 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.32 27.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.675 -0.641 . . . . 0.0 112.204 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.4 -40.58 93.6 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 126.51 1.924 . . . . 0.0 109.726 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.37 -51.29 68.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.913 0.778 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.0 -35.7 64.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.081 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.07 -41.11 91.2 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.4 -43.12 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -47.11 85.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.717 0.807 . . . . 0.0 112.539 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -63.49 -19.31 64.64 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.348 -0.845 . . . . 0.0 111.386 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.3 mtt-85 . . . . . 0 CA--C 1.521 -0.149 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.536 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.31 123.12 11.92 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.463 0.705 . . . . 0.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.08 117.05 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 162.36 25.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.471 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.25 137.32 78.12 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.528 2.152 . . . . 0.0 110.755 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 p -106.05 -23.53 12.61 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.258 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -107.32 146.72 31.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.9 57.99 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -69.4 -44.66 79.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.36 -36.39 80.07 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.504 0.721 . . . . 0.0 109.422 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -56.99 -52.43 65.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 109.512 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -56.53 -54.75 42.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.723 0.409 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.95 -47.85 81.7 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.769 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.99 -32.92 62.09 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.54 -38.91 67.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.3 -34.98 66.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 119.257 0.935 . . . . 0.0 109.98 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -62.62 -42.97 99.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 122.026 -0.421 . . . . 0.0 109.919 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -32.06 70.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.135 0.974 . . . . 0.0 111.559 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.39 -40.42 57.99 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.882 0.873 . . . . 0.0 109.982 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.34 -55.71 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 119.109 0.868 . . . . 0.0 109.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.72 -35.94 82.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.018 0.927 . . . . 0.0 111.095 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.1 15.24 70.09 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.216 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 169.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.4 t -136.05 146.33 46.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.24 0.927 . . . . 0.0 108.876 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.79 38.0 3.77 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.906 1.717 . . . . 0.0 111.324 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mm -72.22 128.16 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.345 1.073 . . . . 0.0 109.493 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.45 175.96 23.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.965 1.269 . . . . 0.0 111.005 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 pt -70.8 -23.8 24.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.921 1.689 . . . . 0.0 112.73 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.35 0.2 21.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.872 1.669 . . . . 0.0 113.792 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.77 115.62 14.56 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.4 122.97 22.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 122.829 0.452 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -45.98 -45.08 15.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.939 1.296 . . . . 0.0 113.352 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.43 -32.63 62.71 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -72.26 -31.09 65.47 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.004 0.922 . . . . 0.0 111.59 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 mt -70.65 -21.23 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.14 -4.55 6.37 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 118.664 -1.076 . . . . 0.0 111.548 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.18 162.91 48.85 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.017 1.408 . . . . 0.0 109.821 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -152.32 174.55 13.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.52 -50.91 12.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.242 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.04 -46.06 79.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.702 0.228 . . . . 0.0 110.941 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -67.82 -37.89 82.53 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.02 72.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.014 0.926 . . . . 0.0 110.167 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -42.93 89.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.024 0.53 . . . . 0.0 109.856 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.34 69.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.648 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -72.02 -51.55 30.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.56 -34.33 64.66 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.231 0.612 . . . . 0.0 111.66 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.22 86.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.775 0.83 . . . . 0.0 110.713 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -77.77 -39.82 42.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.855 0.862 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.0 -47.21 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -35.39 80.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.535 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -76.68 -33.44 58.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -89.18 -48.77 7.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.375 0.534 . . . . 0.0 111.768 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -85.13 -3.0 58.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.981 0.512 . . . . 0.0 109.994 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 54.38 35.2 22.49 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.246 1.019 . . . . 0.0 110.395 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.75 131.61 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.3 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -70.46 140.93 52.06 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.723 0.773 . . . . 0.0 111.64 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 tp -127.15 93.09 42.38 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 127.507 2.323 . . . . 0.0 105.683 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -73.19 152.75 50.88 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.072 1.848 . . . . 0.0 109.094 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -26.85 51.38 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.755 0.822 . . . . 0.0 110.95 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -54.26 -36.55 63.71 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.956 0.903 . . . . 0.0 112.908 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -85.87 -40.19 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -49.96 75.04 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.963 1.305 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -39.06 64.7 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.663 0.785 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.13 71.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 119.034 -1.066 . . . . 0.0 112.655 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -137.08 67.79 55.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.533 0.733 . . . . 0.0 111.628 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.18 50.37 1.52 Allowed 'Trans proline' 0 CA--C 1.54 0.821 1 C-N-CA 126.394 4.73 . . . . 0.0 114.92 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.91 147.05 44.02 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.6 mm -56.82 -46.23 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 126.984 2.113 . . . . 0.0 108.099 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -54.11 -41.63 68.54 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.898 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.35 -46.12 67.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.07 -36.84 75.23 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.449 1.1 . . . . 0.0 108.758 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.83 -51.54 61.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.43 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -66.32 -37.76 86.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.552 1.069 . . . . 0.0 110.496 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -63.97 -53.84 43.81 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.66 0.784 . . . . 0.0 109.324 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.96 -40.83 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.9 79.88 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.536 1.134 . . . . 0.0 113.296 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 t -73.49 -25.0 60.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.258 0.481 . . . . 0.0 110.093 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.343 0.286 0 CA-C-O 117.96 -1.019 . . . . 0.0 113.031 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 C--O 1.224 -0.27 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.57 122.44 14.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.78 0.718 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.61 115.99 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.02 159.23 77.71 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 124.633 1.173 . . . . 0.0 110.558 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.86 129.36 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.466 3.444 . . . . 0.0 110.89 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -101.51 -21.34 14.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.671 1.188 . . . . 0.0 109.887 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.52 148.69 30.79 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -23.83 67.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.108 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.48 -44.38 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.277 1.853 . . . . 0.0 107.542 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.84 -40.89 81.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -58.07 -51.2 70.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.555 1.142 . . . . 0.0 109.724 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.28 -52.7 64.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.196 0.598 . . . . 0.0 111.558 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.79 -42.87 99.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.868 0.758 . . . . 0.0 111.352 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.04 -33.42 72.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.78 -47.39 78.29 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.67 -34.85 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.468 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -59.81 -40.91 90.01 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 119.7 1.137 . . . . 0.0 109.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.94 -39.77 94.0 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.04 -32.04 72.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.351 -0.843 . . . . 0.0 112.066 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.57 -53.41 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.695 0.68 . . . . 0.0 109.855 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.3 mt -75.62 -25.57 57.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.18 66.99 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.496 1.522 . . . . 0.0 112.229 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -94.91 175.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 t -144.83 119.35 9.7 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.889 0.876 . . . . 0.0 109.329 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.5 0.84 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 124.668 1.128 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.1 mm -90.72 125.06 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 126.347 1.859 . . . . 0.0 107.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.03 164.98 25.15 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.6 pt -67.94 -28.09 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.771 -0.841 . . . . 0.0 111.49 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.451 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.68 -3.48 32.94 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.218 2.207 . . . . 0.0 116.147 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -82.46 121.56 26.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.207 1.367 . . . . 0.0 108.823 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.33 127.64 33.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.576 0.35 . . . . 0.0 110.713 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -48.21 -44.22 32.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.479 1.912 . . . . 0.0 111.665 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -69.36 -38.11 77.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.69 -28.16 65.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.028 -0.51 . . . . 0.0 110.781 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.8 mt -71.03 -17.76 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.661 0.784 . . . . 0.0 109.206 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.46 2.69 8.15 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.935 1.255 . . . . 0.0 112.79 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 164.62 53.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . 0.4 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.1 p80 -146.77 174.92 11.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.6 6.34 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.214 1.405 . . . . 0.0 112.779 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -43.76 94.84 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 43.7 mmtt -66.17 -38.89 89.17 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.715 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.64 74.68 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.5 0.72 . . . . 0.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -64.03 -40.49 96.44 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 122.86 0.464 . . . . 0.0 110.276 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.61 92.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.182 0.446 . . . . 0.0 110.234 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.42 -52.96 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.56 -31.13 63.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.6 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.1 69.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.912 0.778 . . . . 0.0 111.374 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.66 -42.7 61.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.264 0.625 . . . . 0.0 109.343 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.85 -33.91 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 120.672 -1.268 . . . . 0.0 108.195 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.65 -42.42 91.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.392 0.996 . . . . 0.0 109.18 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -75.27 -31.75 60.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -74.48 -48.92 24.44 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -94.13 0.14 55.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.15 37.85 27.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.46 1.504 . . . . 0.0 109.851 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.41 124.9 15.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -67.37 130.74 44.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.565 -0.71 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 tt -118.03 87.99 30.22 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 159.2 54.15 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.475 2.116 . . . . 0.0 112.168 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -40.93 51.07 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.724 2.01 . . . . 0.0 109.785 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -53.46 -32.18 48.9 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.393 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -87.28 -47.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 119.982 1.264 . . . . 0.0 109.328 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -47.31 76.5 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.554 0.742 . . . . 0.0 111.749 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -31.74 43.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.974 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -39.38 71.1 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.67 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -137.47 78.31 38.48 Favored Pre-proline 0 N--CA 1.453 -0.312 0 O-C-N 124.271 0.982 . . . . 0.0 109.39 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 52.69 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.707 2.938 . . . . 0.0 111.756 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.85 147.78 48.39 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 120.224 1.375 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.4 mm -58.12 -40.68 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -53.8 -46.21 71.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.229 0.468 . . . . 0.0 110.682 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.42 -51.42 44.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.09 -38.12 89.92 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 125.005 1.322 . . . . 0.0 109.86 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.49 94.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.978 0.808 . . . . 0.0 109.385 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -74.54 -44.87 49.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 111.395 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 67' ' ' VAL . 27.7 t80 -62.22 -44.07 97.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.25 -43.2 50.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.508 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.05 98.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 t -67.73 -29.9 69.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.777 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 . . . . . 0 CA--C 1.515 -0.369 0 CA-C-N 119.074 0.852 . . . . 0.0 109.407 -179.734 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.86 0.362 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -46.08 132.61 9.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.396 2.678 . . . . 0.0 113.174 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.5 t -140.05 117.62 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.25 158.23 38.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.116 0.885 . . . . 0.0 110.02 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.51 149.74 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.49 2.793 . . . . 0.0 112.023 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -123.61 -21.58 5.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.589 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -102.87 141.11 36.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.96 -18.66 0.82 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.713 1.205 . . . . 0.0 113.881 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.78 -54.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.636 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.77 -42.77 58.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.893 2.077 . . . . 0.0 110.103 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 t -60.86 -44.88 96.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.837 0.711 . . . . 0.0 110.78 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -61.25 -45.37 94.8 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.636 -1.29 . . . . 0.0 110.756 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.89 -38.45 88.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.121 0.873 . . . . 0.0 111.452 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.48 75.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.1 -37.53 75.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.4 -40.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -60.45 -41.11 93.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.72 -38.88 72.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.547 0.612 . . . . 0.0 109.858 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -68.45 -32.85 73.17 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.31 -46.25 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 123.022 1.391 . . . . 0.0 111.729 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.14 -33.2 71.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.357 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.13 38.82 54.44 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.64 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.015 1.726 . . . . 0.0 107.108 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 p -136.72 138.85 41.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 110.71 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.15 66.64 1.51 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.21 1.386 . . . . 0.0 112.186 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.7 mm -83.89 129.5 37.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.52 167.58 28.75 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.029 0.831 . . . . 0.0 111.326 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.62 -24.55 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.987 0.915 . . . . 0.0 112.553 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -0.26 21.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.454 1.501 . . . . 0.0 114.911 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.03 122.8 26.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 118.868 0.758 . . . . 0.0 109.557 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -67.23 123.73 21.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.331 1.052 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -46.36 -45.95 18.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.429 1.892 . . . . 0.0 112.876 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -70.72 -24.07 62.57 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.752 -1.218 . . . . 0.0 112.224 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -74.28 -37.14 63.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.46 29.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 125.965 1.706 . . . . 0.0 109.981 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.32 5.37 34.94 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.159 -2.213 . . . . 0.0 113.936 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.64 142.19 43.47 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 108.135 -1.986 . . . . 0.0 108.135 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -132.81 173.18 11.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.847 0.823 . . . . 0.0 108.886 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.62 -47.48 28.94 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.347 0.659 . . . . 0.0 111.628 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -48.26 73.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.91 0.323 . . . . 0.0 110.587 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.97 -39.59 90.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.86 80.53 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.163 0.985 . . . . 0.0 110.427 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.78 -37.9 87.57 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.56 75.23 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.222 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.08 -53.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.65 69.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.064 0.946 . . . . 0.0 112.231 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.19 -47.48 67.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.651 0.739 . . . . 0.0 109.904 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -67.16 -39.98 86.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 109.987 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 t -64.59 -47.46 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 121.35 -0.844 . . . . 0.0 108.775 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.22 -37.65 86.16 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.529 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -75.85 -32.26 59.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.48 -48.14 8.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.36 0.33 57.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.352 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 49.93 43.09 25.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.596 1.089 . . . . 0.0 109.199 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.1 128.43 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 123.365 0.666 . . . . 0.0 110.657 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -69.45 120.72 15.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -114.76 78.71 5.33 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.42 158.15 42.26 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.23 1.287 . . . . 0.0 111.503 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.72 -26.86 67.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.344 1.058 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -52.97 -41.59 64.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.262 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.29 -37.23 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-N 119.719 1.145 . . . . 0.0 109.021 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.3 -50.08 60.05 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.445 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -30.7 56.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.16 -31.43 49.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.119 0.872 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -134.68 72.76 68.75 Favored Pre-proline 0 N--CA 1.449 -0.52 0 C-N-CA 125.468 1.507 . . . . 0.0 107.898 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.18 53.28 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 113.093 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.62 147.38 46.88 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 120.311 1.414 . . . . 0.0 110.455 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.12 -44.08 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.86 -46.68 74.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.576 0.35 . . . . 0.0 111.404 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.17 85.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.301 1.04 . . . . 0.0 113.233 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -42.97 84.91 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 125.345 1.458 . . . . 0.0 107.246 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.46 97.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.749 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -76.24 -36.72 58.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.201 1.364 . . . . 0.0 111.159 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -60.99 -51.46 69.17 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.63 -47.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.692 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.13 -51.79 60.79 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.801 1.182 . . . . 0.0 113.304 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -64.41 -22.41 66.95 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 119.125 0.875 . . . . 0.0 112.98 -179.619 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -47.33 131.03 13.48 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.105 0.962 . . . . 0.0 113.274 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.62 116.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 102.468 -3.16 . . . . 0.0 102.468 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.01 161.19 65.08 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.615 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.58 72.96 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.682 1.588 . . . . 0.0 110.056 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 p -132.24 -13.95 3.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.477 0.311 . . . . 0.0 111.283 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 141.95 28.53 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -28.14 8.04 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -44.78 19.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 119.086 0.857 . . . . 0.0 109.154 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -51.94 -42.51 62.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.269 1.027 . . . . 0.0 109.983 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -54.26 -50.54 66.98 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.331 1.019 . . . . 0.0 110.431 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.29 -50.12 75.22 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 111.7 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.25 -41.66 85.26 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 119.99 -1.694 . . . . 0.0 112.724 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.61 71.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 124.531 1.144 . . . . 0.0 111.024 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.7 -47.87 43.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.108 0.867 . . . . 0.0 111.23 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.01 -37.89 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.055 0.542 . . . . 0.0 109.743 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.68 -39.69 85.36 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.212 -0.93 . . . . 0.0 111.012 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -57.27 -43.18 82.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.276 0.63 . . . . 0.0 110.646 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -64.11 -31.73 73.04 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.726 0.81 . . . . 0.0 112.591 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.66 -44.44 15.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.899 0.772 . . . . 0.0 111.715 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.27 -24.09 40.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.114 0.966 . . . . 0.0 112.728 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.79 23.93 68.42 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.901 1.239 . . . . 0.0 111.936 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.0 175.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.467 1.633 . . . . 0.0 106.599 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 t -141.76 143.48 33.51 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.001 1.273 . . . . 0.0 107.859 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 69.15 1.41 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.27 121.79 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.3 169.13 45.29 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 118.45 0.568 . . . . 0.0 112.67 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 pt -68.54 -24.08 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 120.948 -1.325 . . . . 0.0 111.466 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -3.37 24.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.12 2.568 . . . . 0.0 113.117 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.44 124.23 23.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -77.32 117.33 18.72 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.963 1.305 . . . . 0.0 108.777 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.09 -48.05 11.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.893 1.677 . . . . 0.0 113.223 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -71.08 -33.64 70.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.876 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -67.95 -29.54 68.62 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.9 mt -72.01 -3.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.985 0.914 . . . . 0.0 109.389 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.84 -0.56 33.96 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.033 1.778 . . . . 0.0 111.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.57 160.81 46.71 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 118.618 1.209 . . . . 0.0 110.64 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -151.18 179.2 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.184 1.394 . . . . 0.0 108.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.26 -50.71 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.133 1.373 . . . . 0.0 113.251 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -46.51 86.93 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.449 0.568 . . . . 0.0 110.324 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -63.48 -39.2 93.83 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 121.205 -0.934 . . . . 0.0 110.798 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -42.39 69.61 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.662 0.665 . . . . 0.0 109.268 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 mmt -65.98 -41.52 91.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.164 0.586 . . . . 0.0 109.768 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.28 83.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 118.377 -0.82 . . . . 0.0 112.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.2 -52.3 25.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.83 -31.59 39.84 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.59 72.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.593 0.633 . . . . 0.0 111.447 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.09 -37.35 61.58 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.574 0.702 . . . . 0.0 110.921 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -64.63 -47.37 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 121.082 -1.011 . . . . 0.0 108.961 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -40.7 90.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.344 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -75.27 -29.1 60.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.65 -48.09 8.16 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.607 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.29 -3.7 58.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 51.49 39.17 24.01 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.268 1.827 . . . . 0.0 110.886 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.25 132.31 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.748 0.785 . . . . 0.0 112.085 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -71.53 115.66 10.96 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.15 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -110.19 83.72 3.26 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.3 157.79 58.29 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.669 2.246 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -33.49 54.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.436 1.494 . . . . 0.0 110.522 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -30.85 47.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.146 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.92 -46.85 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -49.72 60.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.277 1.431 . . . . 0.0 110.926 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -31.01 38.75 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.641 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.94 -37.11 83.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.076 0.853 . . . . 0.0 110.502 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -141.76 79.31 16.91 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.263 1.025 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 52.56 3.58 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.951 3.101 . . . . 0.0 113.189 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 147.21 49.21 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.887 -1.133 . . . . 0.0 109.535 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.47 -48.21 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -52.32 -47.82 65.79 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.623 0.577 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.47 98.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.27 -41.48 63.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.62 73.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.255 1.022 . . . . 0.0 109.315 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.42 -38.63 77.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.787 1.176 . . . . 0.0 111.552 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -67.16 -46.13 74.95 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.094 0.558 . . . . 0.0 110.627 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.78 -42.79 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.155 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.99 84.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.86 0.754 . . . . 0.0 112.804 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -61.98 -32.71 73.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.349 0.522 . . . . 0.0 109.64 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 . . . . . 0 C--N 1.343 0.293 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.699 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.87 123.91 4.86 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.131 1.372 . . . . 0.0 114.138 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -146.33 117.6 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.81 172.41 4.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.329 1.051 . . . . 0.0 112.008 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.14 146.46 70.35 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.02 2.48 . . . . 0.0 111.111 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -118.82 -13.51 9.53 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.607 0.763 . . . . 0.0 111.733 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -120.31 147.11 45.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.29 -26.14 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.663 -1.636 . . . . 0.0 113.502 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.73 -55.1 17.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 120.496 1.498 . . . . 0.0 107.792 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.54 -44.08 65.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.618 1.967 . . . . 0.0 109.728 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -40.32 85.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.305 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.37 -50.74 71.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 119.325 0.966 . . . . 0.0 110.237 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.45 -41.94 98.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.413 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.21 -36.16 68.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.977 0.911 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.29 -49.94 15.67 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 118.973 0.806 . . . . 0.0 110.409 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.0 mt -51.39 -40.94 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -64.95 -45.83 84.11 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.319 1.448 . . . . 0.0 110.223 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -59.33 -37.12 77.0 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.369 0.668 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -70.57 -29.08 65.42 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.49 -55.73 7.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.764 0.826 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.9 mt -74.51 -20.51 59.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.631 1.172 . . . . 0.0 113.523 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 32.93 68.49 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.034 0.834 . . . . 0.0 111.847 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.14 175.21 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.4 1.88 . . . . 0.0 109.634 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -139.25 127.77 23.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.028 0.931 . . . . 0.0 112.945 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 69.27 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mm -87.02 123.39 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 107.383 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.5 174.32 44.82 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 pt -80.76 -26.83 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 118.725 1.263 . . . . 0.0 110.628 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -96.71 4.84 51.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.013 2.525 . . . . 0.0 113.877 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -62.99 123.35 18.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.651 1.581 . . . . 0.0 113.107 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.73 105.3 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.226 -1.546 . . . . 0.0 107.09 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -41.74 -47.55 4.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 113.237 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -69.62 -33.19 72.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.277 0.944 . . . . 0.0 108.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -71.29 -15.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.016 0.926 . . . . 0.0 109.587 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.16 -6.86 23.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.078 1.799 . . . . 0.0 112.541 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.76 157.77 33.91 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.675 1.237 . . . . 0.0 110.276 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -143.33 171.45 14.1 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.04 -48.68 11.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.321 1.048 . . . . 0.0 112.475 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -46.04 82.91 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.762 -0.586 . . . . 0.0 110.657 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -66.05 -42.17 89.85 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 121.444 -0.785 . . . . 0.0 110.036 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.35 -43.71 67.94 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.303 1.041 . . . . 0.0 110.187 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.5 mtm -63.72 -30.41 71.51 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.657 0.383 . . . . 0.0 111.811 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.52 -35.39 68.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.62 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.29 -48.28 86.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.82 64.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.139 0.976 . . . . 0.0 111.337 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.84 87.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.144 0.884 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -73.25 -36.15 66.36 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.63 0.729 . . . . 0.0 110.385 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.04 -45.18 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' HIS . . . . . 0.467 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 1.2 t-80 -61.02 -36.73 80.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.477 -0.765 . . . . 0.0 111.489 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -76.79 -32.07 57.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -89.63 -44.86 9.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.04 0.924 . . . . 0.0 112.17 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -90.25 -0.62 57.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.883 1.273 . . . . 0.0 109.897 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 49.2 42.04 20.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.206 1.402 . . . . 0.0 111.002 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.39 139.86 13.51 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 O-C-N 120.847 -1.158 . . . . 0.0 111.883 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 30.6 tt0 -66.8 143.77 56.7 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.193 -0.317 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.33 82.42 57.91 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.79 149.24 72.71 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.819 1.68 . . . . 0.0 111.147 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.8 -27.43 41.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 125.088 1.355 . . . . 0.0 111.294 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -53.19 -36.49 61.01 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.682 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.57 -47.27 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -48.9 47.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.007 1.723 . . . . 0.0 111.531 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -29.72 37.99 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.082 0.953 . . . . 0.0 112.848 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.69 -31.89 59.9 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.256 0.347 . . . . 0.0 111.336 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -134.58 74.52 65.37 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.88 56.32 3.55 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.346 3.364 . . . . 0.0 112.687 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.98 147.43 36.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.846 1.203 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -54.81 -49.26 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 108.876 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -52.38 -50.51 62.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.21 96.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.59 -44.58 56.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.048 1.339 . . . . 0.0 107.559 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.42 66.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.258 1.023 . . . . 0.0 109.678 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.33 -40.25 74.27 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.322 0.389 . . . . 0.0 111.099 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.55 -48.13 82.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.636 0.774 . . . . 0.0 110.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.24 -38.46 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.733 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.71 74.04 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.258 0.935 . . . . 0.0 111.426 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -63.51 -32.35 73.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.626 0.194 . . . . 0.0 111.379 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.3 p -158.29 -11.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -90.71 73.61 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.57 1.85 11.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.02 156.51 30.07 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.277 0.49 . . . . 0.0 111.252 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -74.06 172.18 12.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.157 0.983 . . . . 0.0 108.424 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.02 133.66 56.3 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.556 0.617 . . . . 0.0 109.819 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -139.54 117.25 11.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.48 87.92 Favored Pre-proline 0 C--O 1.24 0.593 0 O-C-N 124.048 0.843 . . . . 0.0 109.106 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.94 144.37 87.84 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.205 2.603 . . . . 0.0 110.042 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 p -124.69 -11.57 7.23 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -108.89 133.36 53.02 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.33 -39.11 2.96 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.56 -50.45 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.356 0.98 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -58.41 -41.28 84.61 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.824 2.049 . . . . 0.0 108.633 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -64.28 -35.13 79.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.37 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -77.05 -35.43 56.79 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.949 -1.095 . . . . 0.0 111.688 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.22 -37.68 72.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.602 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.54 80.63 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.67 -47.21 73.17 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.6 mt -57.27 -38.45 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.569 0.747 . . . . 0.0 109.955 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -64.75 -42.8 94.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -57.73 -41.95 82.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -69.38 -22.04 63.75 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.02 -1.05 . . . . 0.0 113.723 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.92 -41.88 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.864 0.756 . . . . 0.0 110.632 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -83.77 -22.84 31.74 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.736 1.214 . . . . 0.0 112.733 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.2 35.02 69.98 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.93 173.9 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -130.41 148.67 52.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.487 1.115 . . . . 0.0 108.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 53.16 1.41 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.082 0.849 . . . . 0.0 113.521 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.0 mm -91.12 121.4 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.96 26.74 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 122.623 1.124 . . . . 0.0 112.339 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.04 -24.16 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 O-C-N 121.687 -0.89 . . . . 0.0 111.93 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.14 22.18 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.582 2.353 . . . . 0.0 113.371 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -67.94 116.17 8.29 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.62 110.84 12.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -40.02 -46.26 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.95 2.1 . . . . 0.0 113.908 -178.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -68.09 -32.94 73.62 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.716 -0.615 . . . . 0.0 112.152 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.48 -32.09 69.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.194 0.906 . . . . 0.0 109.394 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.2 mt -70.43 -20.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.67 7.88 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.545 1.069 . . . . 0.0 112.212 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.56 160.77 40.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.444 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 20.5 p80 -148.2 177.74 9.15 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.6 1.16 . . . . 0.0 108.212 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.32 -52.38 12.85 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.126 0.97 . . . . 0.0 112.995 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -47.72 73.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.914 1.233 . . . . 0.0 110.504 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.444 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 63.3 mmtt -62.56 -43.15 99.52 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.196 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.16 -41.79 79.85 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.243 1.417 . . . . 0.0 110.996 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 74.7 mtm -68.81 -37.28 79.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.71 71.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.703 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.36 -52.69 52.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.06 69.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.518 1.054 . . . . 0.0 112.085 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -78.02 -32.8 51.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.183 0.992 . . . . 0.0 111.348 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 59.3 t -71.89 -40.08 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.065 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -37.97 82.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.813 1.188 . . . . 0.0 109.219 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -76.0 -31.77 59.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.26 -47.96 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.572 0.749 . . . . 0.0 111.869 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 16.8 m-85 -94.48 0.49 55.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.741 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 55.66 37.44 28.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.737 1.215 . . . . 0.0 109.56 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.56 136.72 36.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.38 132.92 44.59 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.839 1.255 . . . . 0.0 110.029 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.2 tp -130.07 86.11 55.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 123.97 0.908 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.76 153.68 77.12 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.673 1.582 . . . . 0.0 110.453 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.5 -30.12 62.62 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.543 0.737 . . . . 0.0 110.463 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -53.03 -30.69 37.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.117 0.967 . . . . 0.0 111.94 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.08 -46.3 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.431 1.092 . . . . 0.0 108.842 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.24 -46.55 82.89 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.598 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -36.57 58.51 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.289 -0.882 . . . . 0.0 111.42 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.53 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.596 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.55 73.1 62.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 124.361 1.064 . . . . 0.0 109.151 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.16 54.25 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.378 3.385 . . . . 0.0 110.804 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 147.62 41.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.178 0.899 . . . . 0.0 110.572 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 mm -57.77 -44.46 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 124.98 1.312 . . . . 0.0 108.617 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -55.83 -47.75 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.854 0.297 . . . . 0.0 110.986 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.85 -52.57 64.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.05 -41.28 97.97 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 108.235 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.7 92.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.027 0.83 . . . . 0.0 110.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -74.61 -40.88 61.29 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.958 0.503 . . . . 0.0 111.182 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -63.23 -42.72 99.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -71.43 -46.34 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.55 -49.7 67.11 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 t -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.278 0.361 . . . . 0.0 111.376 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mtt85 -87.66 -35.96 17.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.228 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 p -69.12 -19.6 64.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -60.08 162.1 6.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.265 1.031 . . . . 0.0 111.068 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -73.55 95.01 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.057 1.343 . . . . 0.0 112.558 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.91 171.52 14.64 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -137.92 67.58 1.42 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -57.18 -34.3 68.33 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.51 1.124 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t60 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 127.576 2.35 . . . . 0.0 110.203 178.568 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 N--CA 1.472 0.212 0 N-CA-C 109.815 -0.879 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.63 150.65 23.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -81.5 176.31 9.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.422 1.889 . . . . 0.0 109.007 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 62.84 14.64 7.56 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.536 1.135 . . . . 0.0 110.774 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 153.69 36.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.143 1.377 . . . . 0.0 110.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.25 174.52 5.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -47.35 129.88 13.12 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.326 1.051 . . . . 0.0 113.107 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.43 117.46 3.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 156.89 73.91 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 124.039 0.837 . . . . 0.0 109.484 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.99 164.49 24.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.336 2.024 . . . . 0.0 112.766 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -134.18 -12.13 2.49 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.929 1.292 . . . . 0.0 112.259 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.34 144.68 35.55 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.02 -38.51 37.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.319 1.048 . . . . 0.0 112.179 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.29 -55.41 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.514 1.126 . . . . 0.0 110.457 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.69 -36.79 57.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 109.601 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -61.06 -46.97 88.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.743 0.817 . . . . 0.0 111.163 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -60.08 -49.44 77.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.536 0.607 . . . . 0.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.73 -42.1 97.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.915 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.01 69.99 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.527 0.603 . . . . 0.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -71.27 -46.78 60.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.3 mt -59.32 -35.09 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 121.525 -0.735 . . . . 0.0 109.701 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -62.28 -42.27 99.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.273 -0.892 . . . . 0.0 109.25 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.78 -33.82 76.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 109.191 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.34 -26.38 63.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.088 -1.008 . . . . 0.0 112.271 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.03 -55.41 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 118.276 0.489 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.82 -17.22 60.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.034 0.934 . . . . 0.0 113.24 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.57 21.66 72.83 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.244 0.926 . . . . 0.0 111.651 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 32.3 m -94.87 174.31 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 -179.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -143.85 109.09 5.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.85 39.98 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.744 1.164 . . . . 0.0 113.052 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 36.6 mm -77.78 124.84 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.099 1.449 . . . . 0.0 110.396 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.39 169.93 16.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.442 1.496 . . . . 0.0 110.788 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.81 -26.57 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.109 -1.23 . . . . 0.0 112.971 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -99.93 1.75 43.01 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.771 1.628 . . . . 0.0 112.97 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -69.49 127.29 32.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.285 0.564 . . . . 0.0 109.872 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -78.95 114.46 17.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.942 1.297 . . . . 0.0 110.871 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -44.01 -49.65 8.6 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.641 1.176 . . . . 0.0 113.627 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -76.44 -27.69 56.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.06 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.23 -30.17 67.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.092 1.315 . . . . 0.0 109.784 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.93 -13.68 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.61 -0.94 30.64 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.729 1.157 . . . . 0.0 112.627 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 133.36 33.93 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.71 175.11 5.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.94 -49.5 15.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.288 1.035 . . . . 0.0 112.019 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.31 -47.23 82.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.46 0.304 . . . . 0.0 110.575 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -64.75 -35.26 80.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.675 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.9 84.77 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.278 0.945 . . . . 0.0 109.261 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.3 mtm -69.57 -37.22 76.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.74 81.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.685 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.07 -49.73 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.993 1.27 . . . . 0.0 107.69 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.07 64.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.98 0.912 . . . . 0.0 111.15 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.63 85.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.682 0.793 . . . . 0.0 110.537 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.48 -38.98 48.04 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.461 0.573 . . . . 0.0 110.458 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 t -62.31 -47.32 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.438 1.095 . . . . 0.0 109.274 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.56 89.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.507 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.92 -31.79 59.3 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.93 -48.42 12.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.772 0.829 . . . . 0.0 110.751 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -91.12 -3.09 57.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.936 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 52.41 43.74 30.61 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.306 1.442 . . . . 0.0 110.316 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.33 129.61 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.1 134.45 51.86 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.204 1.186 . . . . 0.0 114.204 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.74 84.25 61.0 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.56 153.33 76.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.693 1.595 . . . . 0.0 109.729 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -27.74 63.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.652 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -59.62 -26.87 65.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.917 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.34 -48.2 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -50.09 61.79 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.444 1.497 . . . . 0.0 111.25 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -30.24 39.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.967 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.16 -27.13 59.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.586 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -141.42 68.5 26.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.334 1.454 . . . . 0.0 110.626 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.36 57.36 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.38 3.387 . . . . 0.0 114.012 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.64 147.25 37.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -54.65 -47.99 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 124.73 1.212 . . . . 0.0 107.879 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -52.24 -42.76 63.89 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.82 72.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.33 -40.17 64.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.69 68.54 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.094 -0.955 . . . . 0.0 108.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.21 -38.34 78.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.19 -51.9 61.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.823 0.849 . . . . 0.0 109.009 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.7 -39.67 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.24 77.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.364 1.066 . . . . 0.0 113.353 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 t -64.82 -28.93 69.9 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.831 0.707 . . . . 0.0 110.281 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -80.46 -31.74 37.31 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 118.583 0.629 . . . . 0.0 109.861 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -72.8 14.44 0.27 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 0.0 111.067 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -118.09 82.92 1.92 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.75 92.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 0.0 112.633 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -112.53 143.24 44.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.654 1.582 . . . . 0.0 109.168 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -90.35 -7.63 52.77 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.204 1.002 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -71.77 89.44 1.04 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.716 1.207 . . . . 0.0 109.839 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m80 . . . . . 0 C--O 1.247 0.972 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.347 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.476 0.465 0 N-CA-C 110.887 -0.467 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.18 -169.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.493 1.917 . . . . 0.0 110.518 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.43 69.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.238 1.015 . . . . 0.0 110.588 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.42 -21.11 30.87 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.932 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.03 158.89 30.28 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.018 1.327 . . . . 0.0 110.199 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -92.4 178.81 5.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.446 1.499 . . . . 0.0 109.415 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -55.34 133.44 49.62 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.81 1.244 . . . . 0.0 112.118 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.18 117.03 9.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.82 158.46 69.4 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 124.079 0.862 . . . . 0.0 109.425 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.91 139.66 75.25 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.611 1.541 . . . . 0.0 110.471 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -111.13 -10.45 14.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.654 1.182 . . . . 0.0 111.319 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -121.59 152.87 38.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.48 1.036 . . . . 0.0 109.238 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.7 -36.41 67.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.239 0.616 . . . . 0.0 111.496 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.95 -49.79 70.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.81 -35.87 77.6 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.473 0.709 . . . . 0.0 110.041 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 t -65.59 -49.07 70.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -54.41 -56.52 17.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.773 0.829 . . . . 0.0 110.208 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.12 -42.36 90.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.991 -1.004 . . . . 0.0 113.274 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.48 66.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 123.87 0.731 . . . . 0.0 109.981 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -72.46 -37.73 68.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.7 mm -59.14 -38.73 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -67.46 -41.1 85.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.737 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.06 -35.1 77.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.018 0.826 . . . . 0.0 109.165 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -71.0 -43.19 68.5 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.064 -1.023 . . . . 0.0 111.269 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.56 -54.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.63 0.772 . . . . 0.0 111.371 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.7 -26.73 66.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 111.731 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.3 59.8 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.938 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.36 174.22 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.945 1.298 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t -132.32 135.11 45.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.73 60.79 0.84 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.22 0.914 . . . . 0.0 112.973 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -90.84 121.75 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.25 163.46 31.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 118.831 0.741 . . . . 0.0 111.5 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.2 pt -65.12 -22.18 30.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.309 1.044 . . . . 0.0 110.937 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.95 21.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.62 1.968 . . . . 0.0 113.834 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.63 128.48 35.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.319 0.963 . . . . 0.0 110.433 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -75.83 118.31 18.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.148 0.979 . . . . 0.0 109.423 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -48.92 -40.47 30.16 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.689 1.195 . . . . 0.0 111.792 178.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -72.34 -28.99 63.39 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 112.608 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.401 ' C ' ' H ' ' A' ' 42' ' ' GLY . 10.5 tp-100 -69.47 -33.0 72.26 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.2 mt -75.86 29.64 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 126.199 1.8 . . . . 0.0 109.301 179.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 40' ' ' GLN . . . 70.08 10.04 64.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 119.223 -2.173 . . . . 0.0 112.563 -179.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.51 151.93 47.19 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.483 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.0 p80 -143.42 172.58 12.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.36 -53.96 6.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.99 1.316 . . . . 0.0 112.823 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tp -55.52 -47.32 76.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.694 0.679 . . . . 0.0 111.827 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 72.6 mmtt -59.94 -42.69 94.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.138 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.56 90.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.136 0.974 . . . . 0.0 109.257 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.4 mtm -61.44 -37.99 85.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.513 0.725 . . . . 0.0 109.772 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -28.9 68.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.171 0.588 . . . . 0.0 110.769 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.8 t -72.54 -48.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -29.99 59.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.14 -53.54 36.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 122.106 0.955 . . . . 0.0 108.815 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -65.27 -38.42 90.23 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.812 1.645 . . . . 0.0 109.824 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.09 -46.1 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 -38.92 87.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 118.693 0.678 . . . . 0.0 110.72 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -76.53 -31.9 57.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.28 -44.7 11.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.384 0.538 . . . . 0.0 112.13 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -93.14 -0.78 56.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.816 0.446 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 52.93 37.94 25.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.222 1.409 . . . . 0.0 110.984 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.1 129.7 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.413 0.625 . . . . 0.0 112.396 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.69 117.81 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.5 tp -111.4 88.77 9.43 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.57 157.13 63.2 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.974 1.782 . . . . 0.0 110.786 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.14 -27.37 68.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.578 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -54.77 -28.83 51.69 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 110.89 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.87 -43.38 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.909 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -47.91 83.72 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.126 0.571 . . . . 0.0 111.054 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -33.16 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.2 -31.9 58.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.813 0.278 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -140.49 74.12 28.95 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.891 0.876 . . . . 0.0 109.153 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.87 53.28 3.23 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.373 3.382 . . . . 0.0 113.306 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.65 147.8 48.72 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.808 1.185 . . . . 0.0 110.612 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.31 -43.4 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -57.77 -47.33 82.84 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.51 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.03 97.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.0 -42.83 62.85 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.59 91.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 109.933 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.92 -44.96 72.05 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.477 0.58 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.34 -42.38 98.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.37 -37.65 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.9 -46.09 89.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.683 0.674 . . . . 0.0 110.213 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -29.54 70.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.464 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -85.98 -28.57 24.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.096 0.862 . . . . 0.0 112.821 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -32.98 71.58 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.036 1.335 . . . . 0.0 108.106 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -85.86 141.38 29.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -124.5 177.29 5.99 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.878 1.271 . . . . 0.0 107.959 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -129.02 3.56 5.29 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.477 -0.764 . . . . 0.0 110.706 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -103.17 149.35 24.73 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -100.67 67.63 1.28 Allowed 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 . . . . . 0 C--O 1.255 1.343 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.525 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.528 0.2 0 N-CA-C 114.242 0.824 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.77 159.39 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.6 0.76 . . . . 0.0 110.128 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 t -163.44 176.31 9.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.471 2.308 . . . . 0.0 106.065 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -124.97 7.96 8.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.883 1.673 . . . . 0.0 109.943 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.2 8.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.687 1.595 . . . . 0.0 113.927 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -77.12 166.67 22.96 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.776 1.23 . . . . 0.0 110.705 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.82 138.23 57.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.494 1.517 . . . . 0.0 109.438 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.9 t -147.55 119.24 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.61 160.39 44.21 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.277 1.031 . . . . 0.0 109.535 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.62 152.08 58.31 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.103 2.535 . . . . 0.0 114.223 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -123.01 -18.49 6.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.282 2.233 . . . . 0.0 112.595 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.46 148.72 40.47 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.19 62.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.727 1.211 . . . . 0.0 110.547 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.45 -47.51 83.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.39 -31.28 71.92 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.598 0.759 . . . . 0.0 110.004 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -52.21 53.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.757 0.823 . . . . 0.0 110.231 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -57.54 -52.75 64.12 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.7 -42.09 83.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.653 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -33.4 65.42 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.79 0.436 . . . . 0.0 111.687 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.61 -48.69 66.08 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.068 0.461 . . . . 0.0 109.896 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.75 -34.82 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.089 0.956 . . . . 0.0 110.123 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -67.25 -43.71 81.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 119.033 0.833 . . . . 0.0 110.691 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.43 -44.78 76.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.783 0.833 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -60.06 -30.46 69.22 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.701 1.2 . . . . 0.0 113.084 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.35 -49.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.708 0.685 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -69.16 -23.04 63.9 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.51 1.124 . . . . 0.0 112.102 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 34.6 66.99 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.733 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.08 173.92 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -138.34 127.17 23.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.78 32.9 0.97 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 124.235 0.922 . . . . 0.0 111.006 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.25 127.76 31.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 -169.32 24.24 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.47 1.509 . . . . 0.0 110.64 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.236 1.815 . . . . 0.0 113.378 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.412 HD11 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.69 0.78 22.63 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -176.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -60.04 122.31 14.04 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.986 1.714 . . . . 0.0 110.843 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -75.66 103.07 5.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -39.89 -48.56 2.33 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 113.766 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.63 -30.69 63.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.24 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.34 -32.17 72.09 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.406 1.003 . . . . 0.0 109.659 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 mt -71.37 -7.58 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 125.338 1.455 . . . . 0.0 110.493 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.16 3.0 41.84 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.552 1.073 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 151.5 52.28 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -142.34 176.93 8.62 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.269 -1.136 . . . . 0.0 108.21 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.44 -53.05 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.211 1.404 . . . . 0.0 112.33 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.21 -46.23 86.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.904 0.32 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.1 mmtp -61.56 -42.49 98.92 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.786 -0.571 . . . . 0.0 110.042 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.42 67.66 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.058 0.943 . . . . 0.0 109.94 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mmt -67.85 -38.77 83.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 109.484 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.74 70.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.025 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 t -76.26 -50.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 178.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.67 -36.14 34.35 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 112.756 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.55 63.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.816 0.817 . . . . 0.0 111.517 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -72.51 -33.63 67.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 122.193 0.997 . . . . 0.0 110.741 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.33 -46.27 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 C-N-CA 124.682 1.193 . . . . 0.0 108.892 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -61.67 -41.56 97.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -75.15 -29.19 60.41 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.428 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -87.08 -49.09 7.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.818 0.735 . . . . 0.0 112.615 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -90.89 -2.36 57.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.514 0.726 . . . . 0.0 110.74 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 53.69 38.7 28.99 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.855 0.752 . . . . 0.0 110.176 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.6 p -124.01 120.54 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.183 0.993 . . . . 0.0 111.695 -177.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.42 111.07 7.29 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.73 85.35 3.86 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 122.962 0.505 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 154.67 69.88 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.488 2.792 . . . . 0.0 111.878 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -27.31 64.12 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.582 1.553 . . . . 0.0 110.016 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -53.18 -32.93 50.41 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.305 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.31 -46.49 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -43.59 72.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.908 0.483 . . . . 0.0 111.924 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -30.54 40.31 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 119.068 -0.492 . . . . 0.0 111.34 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.99 73.83 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.97 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -140.78 76.87 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 110.472 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.02 59.37 5.19 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.621 2.881 . . . . 0.0 114.057 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 148.52 38.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.347 0.976 . . . . 0.0 110.442 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 mm -60.48 -40.95 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -56.03 -45.32 79.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.202 0.456 . . . . 0.0 110.926 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.9 95.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.15 0.98 . . . . 0.0 113.465 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.18 -38.91 68.99 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.77 -51.39 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.652 0.66 . . . . 0.0 109.598 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -69.26 -33.09 72.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.962 0.801 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -67.05 -51.63 52.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.661 0.743 . . . . 0.0 109.071 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.7 -35.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -37.4 87.12 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.202 0.91 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -71.05 -15.86 62.57 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.517 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -102.65 -32.7 9.75 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.307 1.043 . . . . 0.0 113.059 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 t -87.52 19.56 3.29 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.743 2.417 . . . . 0.0 112.612 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -55.03 136.99 47.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.279 1.399 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -68.4 148.65 50.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -59.83 118.33 6.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -133.11 50.64 2.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 108.607 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -133.8 168.55 18.52 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 109.742 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 179.444 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 CA-C-O 118.649 -0.646 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.83 163.45 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.531 1.06 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.1 p -121.94 58.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.267 1.027 . . . . 0.0 109.912 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 7.75 0.36 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.554 2.342 . . . . 0.0 115.048 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.92 129.1 14.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.193 2.197 . . . . 0.0 114.328 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.65 159.35 33.17 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -38.77 131.66 1.3 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.119 2.168 . . . . 0.0 114.54 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.5 t -144.44 116.95 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.17 162.19 56.92 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.77 147.4 41.0 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.57 2.18 . . . . 0.0 112.029 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -121.89 -1.58 9.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.016 1.326 . . . . 0.0 112.042 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.32 150.51 52.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.77 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.529 0.732 . . . . 0.0 111.243 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.52 -49.61 81.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.78 -35.72 69.02 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -49.46 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 110.609 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -55.31 -50.08 70.51 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.871 0.468 . . . . 0.0 110.452 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.89 -42.08 98.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.889 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.05 67.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 123.694 0.621 . . . . 0.0 110.561 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.72 -40.04 76.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.466 0.576 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.75 -38.19 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -62.32 -38.86 91.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.75 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -59.82 -39.15 84.09 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 118.611 0.641 . . . . 0.0 110.119 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.598 HH21 ' NE2' ' A' ' 54' ' ' GLN . 67.3 mtm-85 -68.74 -44.33 74.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.789 1.177 . . . . 0.0 113.93 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.05 -43.28 58.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 122.231 0.213 . . . . 0.0 111.132 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.49 -21.83 38.43 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 122.574 0.35 . . . . 0.0 111.316 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.81 35.71 90.06 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.454 -1.192 . . . . 0.0 111.56 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.47 175.13 10.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 t -132.11 150.06 52.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.39 52.06 1.26 Allowed Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.735 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.63 130.18 41.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.67 19.87 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 126.711 2.101 . . . . 0.0 109.773 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.6 pt -83.03 -22.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.97 -1.13 19.22 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.3 119.08 26.19 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 122.834 1.302 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.41 124.02 20.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.095 1.758 . . . . 0.0 111.19 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -48.04 -46.41 33.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.998 1.719 . . . . 0.0 110.633 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.52 -31.38 69.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.541 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -71.41 -34.52 70.43 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -70.86 -31.13 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.37 -11.67 4.08 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.008 0.822 . . . . 0.0 113.825 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.89 159.74 27.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.353 1.076 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -147.56 178.86 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.445 1.498 . . . . 0.0 108.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.51 -53.33 7.12 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.076 1.351 . . . . 0.0 113.304 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tp -56.03 -49.0 74.91 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.276 0.944 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.55 -44.44 96.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.349 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.12 -39.42 63.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.634 0.774 . . . . 0.0 110.46 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.5 mtm -66.05 -37.47 85.92 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -40.44 88.18 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.9 -52.73 57.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -28.62 63.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.448 1.099 . . . . 0.0 112.845 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.38 -49.83 31.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.843 0.747 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.598 ' NE2' HH21 ' A' ' 25' ' ' ARG . 0.7 OUTLIER -65.57 -36.38 83.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.706 0.402 . . . . 0.0 110.04 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.51 -40.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.57 -40.32 86.96 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 119.218 0.917 . . . . 0.0 109.799 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.25 7.4 ptm180 -77.09 -33.42 56.99 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -80.68 -39.76 26.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -101.54 -1.36 33.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.791 0.436 . . . . 0.0 110.66 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 56.02 38.85 30.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.735 1.214 . . . . 0.0 110.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 p -148.85 133.13 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 O-C-N 121.654 -0.653 . . . . 0.0 112.629 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.14 141.67 58.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.339 1.855 . . . . 0.0 112.817 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.7 tp -128.75 96.61 29.27 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 109.912 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.95 153.49 68.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.621 2.214 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.86 68.11 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.49 1.516 . . . . 0.0 110.13 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -52.92 -27.56 19.33 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.023 0.929 . . . . 0.0 110.082 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.438 HG23 ' CZ ' ' A' ' 80' ' ' TYR . 46.2 t -88.02 -49.11 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.69 1.196 . . . . 0.0 109.534 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.46 -45.18 85.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -24.17 45.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.986 0.914 . . . . 0.0 112.518 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.49 -39.31 22.64 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.488 0.586 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.24 77.21 30.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 O-C-N 124.168 0.918 . . . . 0.0 110.893 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.04 57.75 2.71 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.894 3.729 . . . . 0.0 113.228 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -141.73 149.77 40.92 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 121.245 1.839 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.1 -40.24 76.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -57.05 -46.66 82.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.909 0.777 . . . . 0.0 111.192 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.45 86.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.72 -42.65 63.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.3 70.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.96 0.904 . . . . 0.0 109.802 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.83 -39.0 76.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.367 0.53 . . . . 0.0 111.639 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.438 ' CZ ' HG23 ' A' ' 67' ' ' VAL . 34.3 t80 -64.2 -46.93 81.72 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.85 -41.53 77.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.23 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.01 90.41 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.643 1.11 . . . . 0.0 112.268 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -63.93 -20.89 66.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.713 0.688 . . . . 0.0 110.873 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -92.29 -38.18 12.22 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.034 0.933 . . . . 0.0 110.164 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.5 m -74.26 -20.64 60.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.508 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -93.97 108.29 20.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -128.55 -160.13 1.0 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.915 2.086 . . . . 0.0 106.394 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.36 -74.96 0.59 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -147.98 133.76 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -80.05 99.44 7.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 . . . . . 0 C--O 1.247 0.969 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.655 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.48 0.702 0 CA-C-O 119.256 -0.393 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.3 158.68 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.202 1.401 . . . . 0.0 111.716 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 97.28 3.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -80.42 -21.86 41.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.178 0.991 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.31 120.08 11.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.789 1.236 . . . . 0.0 110.609 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -62.08 151.02 36.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.679 1.592 . . . . 0.0 108.87 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -50.38 137.25 19.01 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.592 1.557 . . . . 0.0 110.997 179.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.1 t -142.03 118.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.91 162.18 31.94 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.458 0.703 . . . . 0.0 110.567 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.13 154.64 69.5 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.015 1.81 . . . . 0.0 109.231 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -129.73 -12.9 4.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -121.09 153.18 37.79 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -23.47 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.94 -49.84 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.552 1.523 . . . . 0.0 108.64 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -55.14 -45.3 75.63 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.406 1.882 . . . . 0.0 108.689 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.2 t -56.6 -37.92 71.31 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.031 2.132 . . . . 0.0 110.71 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.569 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.2 mmpt? -78.02 -45.44 23.67 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.67 -41.18 94.54 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.77 72.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.493 1.121 . . . . 0.0 109.858 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.21 -43.02 74.95 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.23 0.468 . . . . 0.0 110.501 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.86 -37.45 80.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.453 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -61.88 -44.57 96.54 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.902 0.774 . . . . 0.0 110.759 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -52.15 -47.13 65.59 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.536 1.134 . . . . 0.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -59.91 -16.15 27.3 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.85 -43.02 4.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.057 0.943 . . . . 0.0 111.821 -179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.02 -26.25 60.33 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 121.76 -0.587 . . . . 0.0 110.672 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.18 50.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 118.379 0.536 . . . . 0.0 111.809 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.48 169.62 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -138.03 111.4 8.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 108.063 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.91 69.58 0.44 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.021 1.296 . . . . 0.0 110.677 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.45 122.04 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.364 1.466 . . . . 0.0 109.544 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.54 161.05 44.24 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.19 0.905 . . . . 0.0 110.849 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 5.9 pt -69.5 -21.29 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 121.469 -1.018 . . . . 0.0 112.581 -178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -4.77 17.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.87 2.068 . . . . 0.0 112.836 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -71.91 122.56 21.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.675 0.67 . . . . 0.0 109.627 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -70.62 114.32 8.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.286 1.435 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -42.86 -42.07 3.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.863 1.665 . . . . 0.0 114.341 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -75.43 -27.41 58.96 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.431 -0.793 . . . . 0.0 111.965 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.0 -28.41 64.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.097 0.862 . . . . 0.0 109.325 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.77 29.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.836 2.054 . . . . 0.0 109.118 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.88 -0.87 49.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 119.786 -1.821 . . . . 0.0 113.834 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.29 157.0 49.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 119.032 1.416 . . . . 0.0 110.811 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -143.49 173.95 11.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.09 -30.07 24.37 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.71 -52.23 22.29 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.4 mmtp -55.44 -41.38 72.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 109.832 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.99 64.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.561 0.745 . . . . 0.0 111.74 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.91 -38.33 61.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.305 1.042 . . . . 0.0 110.004 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.3 75.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.41 0.284 . . . . 0.0 110.252 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 11.6 t -76.62 -45.83 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.84 -34.08 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.35 1.06 . . . . 0.0 112.35 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.14 82.56 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.558 0.694 . . . . 0.0 109.854 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -67.97 -42.74 80.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.294 1.037 . . . . 0.0 110.164 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -62.46 -47.83 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 123.731 0.813 . . . . 0.0 109.502 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.24 90.4 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.024 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -75.74 -33.04 60.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.6 -49.28 8.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.543 0.611 . . . . 0.0 111.041 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -88.2 1.92 53.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.393 0.677 . . . . 0.0 111.502 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 51.73 38.9 24.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.984 1.314 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.55 128.4 7.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 O-C-N 121.233 -0.917 . . . . 0.0 112.408 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.34 122.07 15.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.64 88.65 14.0 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.86 160.31 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.268 1.312 . . . . 0.0 110.99 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.91 -26.0 58.37 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.307 1.443 . . . . 0.0 108.559 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -51.88 -44.47 63.73 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.22 1.008 . . . . 0.0 111.718 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 t -77.69 -40.88 28.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.45 0.7 . . . . 0.0 109.633 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -42.14 98.62 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.603 0.761 . . . . 0.0 110.718 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -41.54 23.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.47 78.92 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.496 -0.882 . . . . 0.0 112.54 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -143.08 74.95 17.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.156 0.982 . . . . 0.0 111.319 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 59.85 2.46 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.879 3.719 . . . . 0.0 113.302 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.01 147.59 37.14 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.285 -1.509 . . . . 0.0 109.829 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.6 mm -60.03 -44.38 94.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -57.11 -44.89 83.69 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.029 0.831 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.79 93.49 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.005 0.522 . . . . 0.0 111.895 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.4 -44.43 71.43 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.35 65.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.719 0.808 . . . . 0.0 110.923 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -72.34 -34.53 68.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.978 0.808 . . . . 0.0 112.457 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -68.38 -52.51 32.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.257 0.623 . . . . 0.0 110.357 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.79 -44.54 85.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.172 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.97 77.21 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -75.81 -26.17 57.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.357 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -74.98 -51.11 14.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 p -83.06 29.46 0.47 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.351 1.46 . . . . 0.0 109.835 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -63.91 159.37 19.92 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.129 0.877 . . . . 0.0 109.037 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -139.46 121.26 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 41.37 72.01 0.18 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.118 1.767 . . . . 0.0 112.902 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -150.8 93.39 1.94 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -121.48 27.81 8.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.003 1.721 . . . . 0.0 111.52 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.6 m170 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 117.123 -1.418 . . . . 0.0 110.155 179.858 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.476 0.458 0 N-CA-C 111.384 -0.275 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.58 161.49 21.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.129 0.971 . . . . 0.0 108.953 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 m -67.57 149.85 49.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 59.26 13.9 3.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 113.032 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.19 129.29 20.96 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.4 156.9 36.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.355 1.462 . . . . 0.0 109.348 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 9.6 t80 -52.8 137.6 31.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.049 2.14 . . . . 0.0 111.205 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -144.85 117.52 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.01 152.86 82.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.49 150.46 75.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.85 2.367 . . . . 0.0 110.475 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 p -127.1 -17.78 4.74 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -102.4 142.28 33.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -22.42 0.91 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.598 1.559 . . . . 0.0 115.089 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.43 -48.81 19.51 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.021 0 CA-C-N 119.25 0.932 . . . . 0.0 109.376 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.23 -45.82 72.41 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.875 2.07 . . . . 0.0 110.14 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 t -59.19 -38.76 80.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.526 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -70.66 -38.85 73.85 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.128 0.422 . . . . 0.0 111.829 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.09 -40.06 86.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 -34.51 73.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 123.843 0.714 . . . . 0.0 109.482 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -63.86 -49.39 72.95 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 118.397 0.544 . . . . 0.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.1 -37.87 80.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.923 0.489 . . . . 0.0 110.053 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -64.03 -42.34 97.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.229 -0.92 . . . . 0.0 109.974 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -62.39 -32.36 73.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.047 0.939 . . . . 0.0 109.808 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.73 -43.03 26.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.172 -0.955 . . . . 0.0 111.37 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.65 -55.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.3 mt -68.47 -30.22 69.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.236 0.614 . . . . 0.0 112.082 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.85 43.34 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 123.664 0.649 . . . . 0.0 111.81 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.21 175.58 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.989 1.715 . . . . 0.0 108.144 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -138.57 139.72 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 107.758 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.74 38.76 2.31 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.38 0.514 . . . . 0.0 112.925 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.4 mm -81.69 122.28 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.81 -178.39 30.76 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.578 1.561 . . . . 0.0 110.831 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 pt -74.09 -26.72 21.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 O-C-N 121.403 -1.057 . . . . 0.0 113.179 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.03 -3.5 23.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.711 2.004 . . . . 0.0 113.95 -178.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -68.04 116.58 8.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.61 127.69 33.45 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -48.97 -45.64 42.38 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.499 1.12 . . . . 0.0 111.288 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.98 -38.66 91.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.467 0.707 . . . . 0.0 110.879 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -66.81 -20.74 66.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.772 1.229 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.3 mt -89.39 7.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 120.98 -1.075 . . . . 0.0 108.118 178.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.94 0.64 87.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 119.631 -1.918 . . . . 0.0 113.676 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.45 139.51 30.61 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.422 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 24.5 p80 -121.99 175.19 6.45 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.161 -1.199 . . . . 0.0 108.434 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.053 0.941 . . . . 0.0 112.94 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.172 0.442 . . . . 0.0 111.907 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.422 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 16.6 mmtp -64.64 -42.38 95.51 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.0 79.02 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.832 1.253 . . . . 0.0 111.265 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.4 mmt -55.65 -42.83 75.61 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.819 0.848 . . . . 0.0 110.193 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.59 -38.6 91.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.838 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.25 -48.49 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.54 -28.25 59.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.514 0.726 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -50.56 47.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.927 0.785 . . . . 0.0 110.081 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -68.27 -36.53 79.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.05 0.929 . . . . 0.0 110.328 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -67.3 -45.67 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -40.16 86.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.021 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -75.87 -31.22 59.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -84.97 -48.24 9.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.551 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -87.07 -1.63 58.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 52.33 39.01 26.47 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 111.089 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.9 138.26 14.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.55 125.08 28.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.975 0.893 . . . . 0.0 110.172 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tt -113.82 91.87 23.19 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.42 155.32 70.66 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.424 1.416 . . . . 0.0 110.935 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.15 -28.83 19.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.126 1.37 . . . . 0.0 111.686 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.68 -44.35 66.17 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.554 0.742 . . . . 0.0 112.236 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -80.84 -37.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -44.56 95.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.208 0.603 . . . . 0.0 110.491 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -40.8 26.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.561 1.545 . . . . 0.0 110.934 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.01 71.75 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.992 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -134.25 70.65 73.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.66 0.784 . . . . 0.0 110.161 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.12 59.35 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.562 3.508 . . . . 0.0 111.908 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.96 147.9 37.73 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.878 1.672 . . . . 0.0 109.396 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.45 -42.79 85.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.78 -49.07 66.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.869 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.27 -40.4 90.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.05 -38.5 66.48 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.28 69.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.385 0.538 . . . . 0.0 110.208 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.13 -39.38 72.03 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.239 0.337 . . . . 0.0 111.795 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -63.75 -47.37 81.29 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 110.018 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.21 -37.38 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.95 -46.74 88.44 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.632 1.105 . . . . 0.0 112.082 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -63.41 -17.38 62.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.28 0.491 . . . . 0.0 110.467 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -98.58 -29.23 13.18 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.953 -1.092 . . . . 0.0 112.05 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.9 p -77.2 -4.68 45.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.988 0.813 . . . . 0.0 110.868 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -114.32 173.54 6.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.195 2.598 . . . . 0.0 108.735 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -107.65 172.52 6.79 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.192 0.997 . . . . 0.0 108.731 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -147.35 5.72 0.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.383 0.673 . . . . 0.0 112.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -149.2 102.85 3.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -153.18 116.26 4.58 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 . . . . . 0 C--O 1.252 1.186 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.162 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 CA--C 1.532 0.403 0 N-CA-C 112.664 0.217 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.76 161.89 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 129.27 3.028 . . . . 0.0 115.666 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 m -91.85 89.18 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.7 5.77 2.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 0.0 112.552 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 155.84 37.21 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 120.77 -1.206 . . . . 0.0 112.112 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -82.5 171.23 14.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -51.36 135.42 27.01 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -178.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -147.92 117.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 162.18 14.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.378 1.071 . . . . 0.0 110.228 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.15 151.02 84.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.382 2.054 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 -6.02 3.62 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.965 0.906 . . . . 0.0 111.995 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -117.38 140.09 50.02 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.15 -33.81 41.98 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.82 -38.12 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.847 0.749 . . . . 0.0 109.667 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.9 -38.76 92.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -61.93 -46.65 88.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.598 1.159 . . . . 0.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -56.56 -58.13 9.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.893 0.877 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.76 -36.35 83.59 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.017 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.17 63.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.424 0.689 . . . . 0.0 110.764 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.15 -48.39 23.86 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -54.39 -41.42 53.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.126 1.371 . . . . 0.0 111.151 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -61.97 -42.22 98.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.729 0.812 . . . . 0.0 111.558 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.64 -46.05 87.95 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.5 mmm-85 -62.27 -23.92 66.97 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.929 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -92.4 -55.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 119.929 1.241 . . . . 0.0 109.445 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.36 -23.87 66.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.82 33.75 57.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.99 174.11 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.8 p -134.7 132.08 38.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.307 1.443 . . . . 0.0 107.698 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.71 45.74 0.95 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 123.966 0.793 . . . . 0.0 113.21 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.2 121.89 27.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.86 35.68 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.3 0.952 . . . . 0.0 111.029 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.5 pt -81.69 -21.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 120.45 -1.618 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.82 1.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.137 1.775 . . . . 0.0 113.418 -178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.66 122.44 15.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.931 1.348 . . . . 0.0 111.828 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -81.02 108.34 14.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -44.88 -45.15 10.14 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.974 1.709 . . . . 0.0 113.718 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -73.73 -27.83 61.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.537 -0.727 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.37 -30.25 69.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 16.2 mt -77.37 6.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 126.484 1.914 . . . . 0.0 109.984 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 3.35 79.84 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 119.659 -1.901 . . . . 0.0 112.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.58 157.98 47.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 107.817 -2.113 . . . . 0.0 107.817 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.439 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 18.6 p80 -147.06 178.59 8.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.61 -54.63 5.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.913 1.285 . . . . 0.0 112.247 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.04 -45.8 75.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.439 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 64.8 mmtt -64.41 -44.07 92.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -40.09 68.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.309 1.044 . . . . 0.0 111.459 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 mtm -65.68 -35.47 80.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.524 0.33 . . . . 0.0 111.168 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.95 78.49 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.949 0.9 . . . . 0.0 111.612 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.01 -41.68 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.74 70.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.484 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.76 48.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.59 -38.59 85.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.93 -46.36 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -40.93 90.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.52 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -29.37 58.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.83 -48.44 8.76 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -96.23 2.16 52.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 111.505 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 55.85 31.83 18.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.264 0.626 . . . . 0.0 111.877 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.8 p -133.87 128.99 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 123.317 0.647 . . . . 0.0 112.601 -177.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.54 124.98 25.54 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.6 tp -112.22 87.63 9.39 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.05 156.81 64.42 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.753 0.969 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -27.54 65.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.261 1.024 . . . . 0.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.77 -29.08 62.28 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.961 0.8 . . . . 0.0 111.079 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 49.4 t -86.64 -43.5 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -49.06 79.24 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 123.055 0.542 . . . . 0.0 111.159 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -29.12 61.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.62 -29.91 27.33 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.635 0.652 . . . . 0.0 112.085 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -138.58 68.02 44.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 109.213 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.78 57.95 4.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.56 2.84 . . . . 0.0 114.88 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.16 148.21 37.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.383 0.992 . . . . 0.0 110.558 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -56.28 -44.08 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -52.31 -49.66 63.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.894 0.77 . . . . 0.0 111.42 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.18 99.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.05 -43.09 62.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.262 1.425 . . . . 0.0 108.516 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.82 88.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -73.31 -37.12 66.3 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.253 0.621 . . . . 0.0 111.493 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -65.51 -41.11 93.52 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.16 -43.6 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.69 90.64 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -15.86 63.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.328 0.651 . . . . 0.0 112.23 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -101.07 -31.92 10.84 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.9 t -67.61 4.3 1.12 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.85 2.46 . . . . 0.0 111.51 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -137.1 82.26 1.92 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -75.76 -47.76 24.6 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -77.33 -172.59 2.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.214 1.006 . . . . 0.0 109.315 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -112.97 -6.69 13.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.975 0.91 . . . . 0.0 112.487 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -124.25 156.16 37.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.192 1.397 . . . . 0.0 108.569 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 117.347 -1.311 . . . . 0.0 107.773 179.459 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 N--CA 1.479 0.619 0 CA-C-O 119.73 -0.196 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.35 174.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.847 1.259 . . . . 0.0 110.498 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 m -114.09 143.28 45.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.528 1.531 . . . . 0.0 107.151 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -123.88 8.54 8.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.438 0.695 . . . . 0.0 111.568 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.13 165.85 15.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.564 1.146 . . . . 0.0 111.141 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -76.27 170.66 15.91 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -42.95 124.5 3.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.4 1.88 . . . . 0.0 114.967 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.0 t -146.86 116.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.04 161.62 15.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.109 1.763 . . . . 0.0 112.672 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.06 148.47 93.1 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.625 2.883 . . . . 0.0 112.65 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 p -114.66 -21.14 10.38 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.255 1.422 . . . . 0.0 113.656 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -109.97 162.86 14.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.377 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -34.28 77.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.837 1.655 . . . . 0.0 110.612 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.1 -50.99 28.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.75 -43.4 76.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 126.342 1.857 . . . . 0.0 109.427 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -65.52 -32.96 74.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.328 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -68.45 -48.7 63.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.786 1.176 . . . . 0.0 108.896 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.65 -41.86 82.31 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.086 0.955 . . . . 0.0 110.918 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.02 67.84 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.207 1.003 . . . . 0.0 111.95 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -77.42 -37.35 51.96 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 118.937 0.79 . . . . 0.0 110.127 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.89 -40.17 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.518 -0.739 . . . . 0.0 109.76 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -59.41 -39.21 82.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.302 0.641 . . . . 0.0 111.874 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -63.69 -32.84 74.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.495 0.718 . . . . 0.0 110.902 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -68.01 -35.7 78.73 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.817 -1.177 . . . . 0.0 111.484 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.22 -54.83 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.27 0.628 . . . . 0.0 110.838 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.18 -24.83 57.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.4 21.67 69.3 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.426 1.012 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 m -105.15 175.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.505 1.122 . . . . 0.0 110.458 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 t -139.32 112.75 8.28 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.35 62.8 0.34 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 123.202 0.429 . . . . 0.0 112.435 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.7 mm -86.63 137.83 20.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.83 177.19 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 124.89 1.233 . . . . 0.0 111.741 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 pt -78.87 -22.42 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 121.082 -1.246 . . . . 0.0 113.41 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.72 0.78 22.58 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -178.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.251 34.9 p30 -76.11 129.56 36.98 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 123.192 1.472 . . . . 0.0 112.706 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -74.1 111.59 9.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.849 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -43.46 -45.94 6.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.737 1.615 . . . . 0.0 112.604 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -66.99 -37.02 83.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -67.62 -31.45 71.48 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.652 0.781 . . . . 0.0 109.98 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mt -71.98 -6.26 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.286 1.034 . . . . 0.0 109.27 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.39 10.24 27.78 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 126.024 1.774 . . . . 0.0 112.908 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.9 159.31 47.46 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.878 1.339 . . . . 0.0 110.111 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.421 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 20.1 p80 -146.86 178.07 8.62 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.344 1.458 . . . . 0.0 107.906 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.57 -54.75 5.77 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.633 1.173 . . . . 0.0 112.739 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -54.95 -50.54 68.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.857 0.863 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.421 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 32.2 mmtp -61.86 -39.31 91.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.893 -1.051 . . . . 0.0 111.149 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.96 96.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.497 1.044 . . . . 0.0 108.847 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.4 mtm -66.69 -37.45 84.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.942 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.31 92.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.221 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -72.65 -45.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.691 1.132 . . . . 0.0 108.057 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.32 -32.74 57.35 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.938 0.895 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.03 83.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.213 0.461 . . . . 0.0 111.064 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -77.74 -43.33 31.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 122.002 0.906 . . . . 0.0 108.885 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.78 -46.46 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 124.049 0.94 . . . . 0.0 109.605 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.423 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -60.61 -41.08 94.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.778 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -75.53 -32.39 60.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -82.51 -45.99 13.99 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 123.219 0.607 . . . . 0.0 111.873 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -93.96 -3.01 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.899 -179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 53.82 46.97 24.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.754 1.221 . . . . 0.0 108.761 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.6 p -140.08 126.97 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.423 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 48.0 tt0 -73.04 115.0 11.84 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.66 88.54 16.47 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.81 153.85 63.9 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.05 1.167 . . . . 0.0 109.725 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.84 -26.36 9.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.855 2.062 . . . . 0.0 110.35 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.29 -44.35 64.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.616 1.166 . . . . 0.0 110.641 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 56.5 t -77.66 -45.72 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.566 0.747 . . . . 0.0 109.085 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -42.62 74.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.453 0.701 . . . . 0.0 110.716 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -37.45 28.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.281 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.44 98.81 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.336 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -137.64 83.38 25.05 Favored Pre-proline 0 N--CA 1.448 -0.56 0 O-C-N 124.396 1.06 . . . . 0.0 109.222 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 60.77 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.164 2.576 . . . . 0.0 110.95 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.18 148.66 38.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.972 1.715 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mm -57.17 -43.01 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.83 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.55 -48.99 76.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.864 0.756 . . . . 0.0 111.587 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.69 -41.45 86.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.148 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.4 -42.25 62.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.26 76.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.703 1.201 . . . . 0.0 110.849 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -37.88 64.94 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.894 0.77 . . . . 0.0 110.311 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.8 t80 -63.31 -48.08 79.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.535 0.607 . . . . 0.0 110.929 -178.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 28.8 t -69.7 -40.82 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.11 86.57 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 118.998 0.817 . . . . 0.0 112.528 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 t -73.16 -13.93 61.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.231 0.469 . . . . 0.0 110.118 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -97.75 -39.74 8.9 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 119.542 1.064 . . . . 0.0 109.684 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.2 t -68.29 -39.95 81.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.793 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -97.8 108.47 21.19 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.613 0.765 . . . . 0.0 109.874 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -80.58 104.22 10.96 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -94.91 107.11 19.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.674 0.789 . . . . 0.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.94 170.96 15.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.419 1.088 . . . . 0.0 108.271 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -131.05 62.49 1.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.15 1.38 . . . . 0.0 108.452 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 C--O 1.251 1.161 0 N-CA-C 103.226 -2.879 . . . . 0.0 103.226 178.845 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 N--CA 1.48 0.715 0 CA-C-O 120.927 0.303 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.17 -33.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 122.539 1.162 . . . . 0.0 109.795 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 141.82 57.09 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 131.226 3.811 . . . . 0.0 107.097 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 66.62 3.0 2.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.166 1.386 . . . . 0.0 113.57 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.75 126.29 13.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -58.48 146.14 36.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.357 2.263 . . . . 0.0 110.784 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -48.11 125.47 9.24 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.806 2.442 . . . . 0.0 110.48 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.2 t -135.22 117.39 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 152.89 72.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.056 0.942 . . . . 0.0 111.458 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.49 151.57 84.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.951 2.434 . . . . 0.0 111.081 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -129.2 -13.87 4.4 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.719 1.208 . . . . 0.0 111.229 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -90.08 152.09 21.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.28 70.78 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.899 0.48 . . . . 0.0 110.162 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -78.28 -51.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.734 1.614 . . . . 0.0 110.833 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -55.37 -37.96 68.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.132 0.573 . . . . 0.0 110.089 -178.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 t -59.97 -52.29 66.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 123.843 0.714 . . . . 0.0 109.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.4 mmpt? -56.5 -49.2 75.4 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.75 -38.8 92.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 117.486 -1.245 . . . . 0.0 111.075 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.15 -30.09 70.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.76 0.709 . . . . 0.0 110.174 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.98 -44.08 97.01 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -63.52 -39.23 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.689 1.196 . . . . 0.0 109.586 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -55.46 -43.85 75.86 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.868 0.758 . . . . 0.0 109.967 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.4 -32.28 72.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.745 0.702 . . . . 0.0 110.643 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -76.22 -16.36 59.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.486 -1.384 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.04 -36.23 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.641 0.776 . . . . 0.0 110.078 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.19 -42.13 12.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.971 1.308 . . . . 0.0 111.537 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.75 40.32 7.24 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.394 -1.226 . . . . 0.0 110.948 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.253 3.4 m -128.24 177.22 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.664 1.232 . . . . 0.0 108.686 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.3 t -143.59 108.26 4.88 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 119.981 -1.7 . . . . 0.0 108.233 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.97 41.93 0.15 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.453 1.501 . . . . 0.0 114.167 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 39.5 mm -76.42 145.38 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 120.193 1.997 . . . . 0.0 108.507 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.03 175.5 15.88 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.389 1.947 . . . . 0.0 110.079 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 pt -75.63 -30.83 22.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -101.13 -0.52 36.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.523 1.129 . . . . 0.0 113.382 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -69.53 116.59 10.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -67.45 117.57 9.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.94 -45.58 15.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.542 1.537 . . . . 0.0 111.893 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -70.67 -29.77 66.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.45 0.7 . . . . 0.0 112.53 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -76.91 -30.29 56.08 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.51 -0.744 . . . . 0.0 110.39 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.3 mt -70.72 -31.05 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.264 0.484 . . . . 0.0 110.389 -178.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.58 -2.45 2.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.907 1.242 . . . . 0.0 111.651 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.7 157.83 53.59 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -136.66 172.96 12.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.83 -45.92 20.5 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.336 0.654 . . . . 0.0 112.47 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.03 -49.29 78.46 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.517 0.598 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -60.64 -38.83 86.1 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.395 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -35.23 62.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.844 1.202 . . . . 0.0 111.006 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.6 mtm -73.85 -42.06 61.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.55 74.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.082 1.353 . . . . 0.0 111.327 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.9 -53.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.98 -36.28 65.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.081 0.952 . . . . 0.0 112.316 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.21 -52.49 65.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.692 0.797 . . . . 0.0 111.565 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -75.72 -33.27 60.3 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.635 -0.666 . . . . 0.0 111.799 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.99 -44.09 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.658 1.183 . . . . 0.0 108.909 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -41.08 88.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.611 0.641 . . . . 0.0 110.261 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.69 -34.44 60.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.89 -48.16 13.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.802 0.689 . . . . 0.0 111.585 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -91.34 3.18 55.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.165 -179.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 48.8 38.81 12.67 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.269 1.428 . . . . 0.0 110.445 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.46 117.65 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 123.678 0.791 . . . . 0.0 110.14 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -64.12 140.01 58.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 tt -120.38 84.54 35.44 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.85 144.81 94.16 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.3 14.81 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.885 1.274 . . . . 0.0 110.462 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -53.28 -35.11 59.73 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 t -87.97 -44.24 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 119.121 0.873 . . . . 0.0 109.135 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -51.63 63.29 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 123.536 0.734 . . . . 0.0 110.796 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -71.57 -37.91 70.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.295 0.638 . . . . 0.0 111.573 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.6 84.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.75 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.86 78.6 29.82 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.861 1.264 . . . . 0.0 108.653 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 55.39 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.846 3.031 . . . . 0.0 111.043 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.25 147.16 47.41 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.194 0.906 . . . . 0.0 110.098 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.5 mm -61.17 -39.3 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.31 -51.2 60.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 111.867 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.31 97.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.695 1.598 . . . . 0.0 114.212 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.1 -40.4 65.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.847 1.259 . . . . 0.0 108.417 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -51.75 68.22 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 119.028 0.831 . . . . 0.0 109.385 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.77 -38.5 89.23 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.497 0.319 . . . . 0.0 111.622 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.93 -51.97 48.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.246 1.018 . . . . 0.0 110.377 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.9 t -66.42 -41.84 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 123.346 0.404 . . . . 0.0 110.165 -179.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.18 78.67 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -70.9 -24.91 62.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.68 0.218 . . . . 0.0 110.568 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -77.09 -40.73 44.96 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.687 -1.258 . . . . 0.0 108.694 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -78.41 3.43 15.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.285 1.034 . . . . 0.0 112.308 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -49.17 116.31 1.64 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.981 2.113 . . . . 0.0 111.942 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.29 65.1 1.16 Allowed 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -78.65 76.15 5.15 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.239 1.415 . . . . 0.0 107.737 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -154.16 -69.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -78.17 -5.39 51.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.26 1.824 . . . . 0.0 112.229 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.113 0 C-N-CA 127.322 2.249 . . . . 0.0 107.263 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 110.325 -0.683 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.07 162.01 34.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 123.319 0.648 . . . . 0.0 109.264 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -85.66 62.22 7.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 55.26 10.6 0.46 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.91 2.484 . . . . 0.0 113.998 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.46 -10.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 129.032 2.933 . . . . 0.0 118.182 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.33 144.36 54.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -52.01 123.33 10.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 0.0 111.638 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -138.37 117.26 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 160.07 44.08 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.356 1.462 . . . . 0.0 110.101 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.33 145.16 99.18 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.887 3.058 . . . . 0.0 113.353 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -116.65 -11.67 10.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 0.0 112.391 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -125.3 145.4 50.03 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.33 -29.31 9.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.372 1.069 . . . . 0.0 112.863 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.47 -53.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.673 0.749 . . . . 0.0 109.58 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -55.85 -42.96 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.605 1.962 . . . . 0.0 109.272 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -66.08 -31.82 72.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.424 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -72.31 -40.37 67.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.038 1.29 . . . . 0.0 109.761 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -69.07 -39.07 79.3 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.079 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 -33.83 70.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.487 1.117 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -69.55 -40.79 76.62 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 117.999 0.363 . . . . 0.0 111.171 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.18 -36.39 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -62.49 -35.64 80.0 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.652 -0.655 . . . . 0.0 109.659 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.54 -39.9 88.82 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.59 -0.694 . . . . 0.0 109.624 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -65.84 -38.81 89.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.8 t -81.37 -44.57 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.0 mt -85.91 -24.03 26.77 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.055 0.542 . . . . 0.0 112.128 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.29 31.15 59.61 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.268 -0.74 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.27 171.33 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.7 p -143.04 138.22 29.8 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.954 1.252 . . . . 0.0 111.521 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.34 42.6 1.05 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.978 1.275 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.49 121.55 28.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.786 0.834 . . . . 0.0 109.68 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -90.97 169.31 33.48 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.67 1.129 . . . . 0.0 110.67 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.3 pt -71.28 -25.94 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.099 -1.236 . . . . 0.0 111.973 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.28 1.03 32.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.069 2.147 . . . . 0.0 112.724 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 33' ' ' GLY . 10.8 m-20 -65.68 116.73 7.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.15 0.98 . . . . 0.0 108.559 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -74.78 112.83 11.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -43.08 -52.46 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.503 1.521 . . . . 0.0 112.471 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.74 -33.02 72.28 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.319 -0.863 . . . . 0.0 111.666 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -68.65 -23.09 64.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.117 0.967 . . . . 0.0 110.461 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 15.2 mt -84.25 14.01 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 125.339 1.456 . . . . 0.0 109.157 179.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 9.6 70.21 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 119.368 -2.083 . . . . 0.0 113.721 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 170.51 54.31 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 118.306 1.053 . . . . 0.0 112.047 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -155.08 176.7 12.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 108.03 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.92 -46.09 60.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.558 0.743 . . . . 0.0 112.563 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.26 -49.1 72.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.122 0.874 . . . . 0.0 109.401 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -59.38 -46.58 88.28 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.38 62.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.052 0.842 . . . . 0.0 113.048 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.1 mtm -75.63 -39.79 57.28 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 109.776 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.086 1.354 . . . . 0.0 111.574 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 97.8 t -68.71 -53.56 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.89 61.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.356 1.463 . . . . 0.0 113.779 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.32 -50.63 59.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.493 1.042 . . . . 0.0 108.646 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.05 -31.96 56.58 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 121.984 0.897 . . . . 0.0 110.992 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.63 -42.58 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -42.1 98.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.311 0.96 . . . . 0.0 109.573 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -74.18 -30.02 62.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.188 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.89 -49.55 10.88 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.822 0.737 . . . . 0.0 110.379 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.84 -1.56 57.89 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 55.68 40.89 30.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.991 1.317 . . . . 0.0 109.804 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 2.5 p -150.38 130.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.76 128.25 34.96 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.132 0.573 . . . . 0.0 109.548 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.75 86.7 13.39 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.41 141.75 52.22 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.713 1.608 . . . . 0.0 109.735 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -27.33 16.84 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.742 1.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -53.9 -32.25 52.75 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.057 0.844 . . . . 0.0 111.577 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 59.4 t -86.81 -46.54 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.58 -47.73 72.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.509 1.124 . . . . 0.0 111.488 -179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.94 -36.46 62.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.149 0.58 . . . . 0.0 111.003 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -33.11 67.58 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.224 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -141.36 74.43 24.17 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.385 1.474 . . . . 0.0 109.366 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.98 56.49 3.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 125.062 3.841 . . . . 0.0 113.894 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.45 148.35 42.62 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.883 -1.136 . . . . 0.0 111.773 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -56.7 -42.96 78.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -54.99 -49.89 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.163 0.438 . . . . 0.0 110.892 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.48 97.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.24 -40.86 70.79 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.41 79.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.441 0.564 . . . . 0.0 110.206 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.25 -40.48 67.65 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.923 0.489 . . . . 0.0 111.728 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -63.27 -43.82 96.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 74.2 t -74.03 -35.89 42.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.866 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -35.59 71.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.248 0.931 . . . . 0.0 112.73 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 t -82.31 -18.64 41.56 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.216 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -93.23 -47.83 6.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.742 1.155 . . . . 0.0 109.506 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -83.81 34.93 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.989 2.116 . . . . 0.0 107.357 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -64.39 172.54 2.5 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.876 1.67 . . . . 0.0 110.673 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.21 -34.26 0.17 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -74.09 69.32 1.48 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.881 1.272 . . . . 0.0 111.993 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -70.09 110.76 5.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -129.78 90.23 2.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.663 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 N--CA 1.476 0.492 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.36 152.32 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.685 1.194 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -105.53 38.97 1.85 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.7 1.2 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.5 1.48 1.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.224 1.41 . . . . 0.0 114.451 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.68 123.29 48.92 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.332 1.453 . . . . 0.0 109.998 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -68.63 165.27 19.65 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.801 0.688 . . . . 0.0 109.679 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -50.48 133.88 24.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.957 2.103 . . . . 0.0 112.791 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.55 118.98 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.46 157.59 77.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.251 1.02 . . . . 0.0 111.614 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 155.3 71.38 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.484 2.789 . . . . 0.0 112.926 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.3 t -130.78 -20.22 2.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.466 1.107 . . . . 0.0 112.419 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -98.72 143.72 28.77 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.99 -27.1 12.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.02 0.928 . . . . 0.0 113.49 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.95 -46.64 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 120.388 1.449 . . . . 0.0 109.186 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -56.82 -35.27 68.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.21 1.404 . . . . 0.0 110.471 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -63.2 -49.09 75.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -57.42 -48.64 78.59 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.36 -41.68 94.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.664 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.67 -34.6 73.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.725 0.641 . . . . 0.0 109.93 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -66.41 -50.59 62.93 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.55 -37.38 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.286 1.034 . . . . 0.0 110.339 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -62.43 -44.8 95.54 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.718 0.69 . . . . 0.0 111.204 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.35 -32.86 70.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.227 0.611 . . . . 0.0 111.538 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -67.69 -43.02 81.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.523 0.601 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.7 -52.05 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 123.646 0.778 . . . . 0.0 111.864 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.88 -25.63 62.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.636 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.53 57.94 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.12 174.64 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.648 1.179 . . . . 0.0 110.023 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -144.07 114.45 7.52 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.36 27.17 0.52 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.727 1.156 . . . . 0.0 112.36 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.13 125.48 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.687 1.243 . . . . 0.0 110.819 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 175.76 22.42 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.367 1.461 . . . . 0.0 112.051 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.28 -28.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 121.098 -1.237 . . . . 0.0 112.193 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -105.61 2.28 28.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.465 1.906 . . . . 0.0 112.53 -178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.19 122.84 17.59 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.21 119.43 25.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.513 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -46.79 -46.44 20.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.236 1.814 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -74.75 -31.36 61.78 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.647 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -63.62 -36.97 85.57 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.8 mt -72.13 6.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 125.455 1.502 . . . . 0.0 109.809 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.61 3.72 80.61 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 119.543 -1.973 . . . . 0.0 111.309 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.87 145.8 49.03 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 120.081 1.941 . . . . 0.0 108.933 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -139.49 -179.39 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.297 1.039 . . . . 0.0 109.127 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.61 -53.04 12.31 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.918 1.287 . . . . 0.0 112.224 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -49.17 72.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.142 0.577 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 54.8 mmtt -61.93 -44.75 96.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.842 -0.537 . . . . 0.0 109.877 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.4 83.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.486 1.114 . . . . 0.0 110.217 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.85 -41.29 91.1 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.592 0.757 . . . . 0.0 109.5 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.5 75.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.179 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 t -69.9 -51.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 120.56 1.527 . . . . 0.0 107.33 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.88 -33.01 61.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.132 0.973 . . . . 0.0 113.027 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.95 75.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.265 0.626 . . . . 0.0 110.695 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -76.49 -34.18 58.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.705 0.765 . . . . 0.0 111.495 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.54 -44.98 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -39.03 84.41 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.535 0.607 . . . . 0.0 110.122 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -76.15 -31.79 58.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.12 -47.42 8.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.86 0.464 . . . . 0.0 111.783 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -90.09 0.71 57.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.749 0.419 . . . . 0.0 110.571 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 52.74 36.51 21.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.477 1.111 . . . . 0.0 111.441 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.75 123.0 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.235 0.54 . . . . 0.0 112.13 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.91 110.34 2.85 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.905 -1.122 . . . . 0.0 108.452 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 tp -100.34 93.14 2.5 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.049 1.34 . . . . 0.0 110.941 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.0 145.18 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.707 3.605 . . . . 0.0 111.096 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -29.37 9.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.709 2.404 . . . . 0.0 111.428 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -52.97 -26.66 15.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 48.4 t -87.5 -50.05 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.799 1.64 . . . . 0.0 109.212 178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -46.57 63.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.005 0.922 . . . . 0.0 110.718 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -30.7 38.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.368 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.0 -30.95 58.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.948 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.38 69.25 13.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 111.394 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.37 60.43 3.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.787 3.658 . . . . 0.0 112.998 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.2 147.12 36.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.901 -1.125 . . . . 0.0 109.045 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 mm -56.9 -47.51 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 C-N-CA 124.11 0.964 . . . . 0.0 108.662 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.87 -47.37 80.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.635 0.584 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.43 81.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.2 -41.47 85.75 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.718 1.607 . . . . 0.0 108.716 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.82 99.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.512 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.6 -46.59 58.79 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 118.571 0.623 . . . . 0.0 110.403 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -58.9 -42.35 89.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.3 t -73.49 -41.33 56.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.122 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.04 82.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.677 1.126 . . . . 0.0 112.334 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -70.74 -29.35 65.58 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.546 0.612 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -86.32 -36.8 19.07 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.94 -1.1 . . . . 0.0 111.792 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.2 m -76.47 -4.13 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 111.631 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.55 153.22 44.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 121.169 -0.957 . . . . 0.0 111.762 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 53.76 67.44 1.0 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.753 2.421 . . . . 0.0 115.826 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -134.51 162.15 33.06 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.703 1.601 . . . . 0.0 107.244 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -136.8 84.88 2.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.561 0.696 . . . . 0.0 109.277 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -76.2 32.43 0.12 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.608 0.763 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.245 0.821 0 C-N-CA 125.598 1.559 . . . . 0.0 107.166 179.66 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 N--CA 1.48 0.699 0 CA-C-O 119.378 -0.342 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 168.71 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 111.351 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.01 114.43 2.11 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.141 1.777 . . . . 0.0 106.503 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -149.09 64.03 1.04 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.411 0.624 . . . . 0.0 110.582 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.38 156.4 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -70.78 159.2 34.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.17 1.388 . . . . 0.0 111.628 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -56.34 128.72 37.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.268 1.827 . . . . 0.0 114.07 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.96 117.61 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.11 163.41 17.44 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.297 1.439 . . . . 0.0 110.786 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.9 148.89 82.96 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.236 1.957 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 p -130.43 -12.15 3.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.2 143.66 40.0 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -28.38 6.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.873 1.269 . . . . 0.0 114.229 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.49 -40.76 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 119.525 1.057 . . . . 0.0 109.442 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -56.36 -39.02 72.2 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.089 0.556 . . . . 0.0 110.305 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.5 t -63.1 -49.11 75.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.852 0.72 . . . . 0.0 109.587 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -54.89 -52.29 63.34 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.678 0.672 . . . . 0.0 110.369 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -64.51 -41.63 96.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.253 -0.88 . . . . 0.0 112.716 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.78 74.55 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.5 -45.75 71.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.5 -41.85 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -61.14 -41.97 97.7 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 121.11 -0.994 . . . . 0.0 109.905 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.7 -45.13 95.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.476 0.58 . . . . 0.0 111.403 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -70.75 -39.85 73.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.577 1.081 . . . . 0.0 112.902 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.01 -55.88 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -74.96 -28.32 60.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.06 19.6 60.74 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.124 1.821 . . . . 0.0 113.093 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.07 174.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.15 1.38 . . . . 0.0 108.462 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 t -145.36 132.04 19.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.661 0.664 . . . . 0.0 112.409 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.21 0.88 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.0 mm -78.25 128.47 38.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.22 161.08 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.118 0.843 . . . . 0.0 112.66 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.55 -21.35 26.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.934 1.294 . . . . 0.0 111.193 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.9 -3.89 18.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.175 2.19 . . . . 0.0 114.301 -179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -75.8 131.09 39.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.556 1.071 . . . . 0.0 111.003 -177.665 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -80.28 119.95 23.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -40.97 -46.26 2.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.879 2.071 . . . . 0.0 114.403 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -67.84 -32.3 72.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 112.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.14 -32.04 68.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.635 0.652 . . . . 0.0 109.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 28.4 mt -71.23 -9.93 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.445 1.098 . . . . 0.0 110.397 -179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.26 1.91 23.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 124.367 0.984 . . . . 0.0 111.864 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 152.51 52.1 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -143.43 179.86 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.51 -49.27 36.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.222 0.919 . . . . 0.0 111.974 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.68 -48.32 81.47 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -59.85 -43.43 94.64 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.057 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.58 77.71 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.68 0.792 . . . . 0.0 110.009 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.74 -39.56 94.6 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.26 77.88 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.059 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.2 -50.73 55.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.47 -32.65 65.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.098 0.959 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.87 99.46 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.042 0.537 . . . . 0.0 110.485 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -78.4 -40.95 34.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 121.473 0.654 . . . . 0.0 111.252 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -64.28 -46.13 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 O-C-N 121.621 -0.674 . . . . 0.0 110.727 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -37.16 85.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.849 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -76.04 -30.22 58.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -89.71 -48.69 7.11 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.95 -3.8 59.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 109.783 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 50.98 45.17 28.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.766 2.026 . . . . 0.0 110.342 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -144.38 128.7 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.472 0.709 . . . . 0.0 110.286 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.86 125.63 25.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -116.19 79.67 8.86 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -66.6 150.35 83.89 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.423 2.082 . . . . 0.0 112.951 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -26.59 64.67 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.592 1.557 . . . . 0.0 109.933 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -53.32 -41.97 66.23 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.327 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -37.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -49.67 -51.1 40.57 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.505 1.122 . . . . 0.0 109.545 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -36.53 69.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.944 0.898 . . . . 0.0 111.484 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -37.17 85.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.508 0.505 . . . . 0.0 111.476 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -138.56 75.34 38.22 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 107.962 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -76.66 64.26 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.37 2.714 . . . . 0.0 112.147 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.09 147.09 36.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.673 1.124 . . . . 0.0 110.226 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -55.82 -49.8 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 108.735 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -52.82 -48.12 67.19 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.091 0.556 . . . . 0.0 111.142 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.65 73.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.185 0.994 . . . . 0.0 113.281 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.1 -43.43 78.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.938 1.695 . . . . 0.0 108.864 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.24 74.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -68.8 -42.64 77.03 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.422 1.089 . . . . 0.0 111.769 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -63.96 -43.24 96.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.685 0.794 . . . . 0.0 109.737 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -74.06 -36.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.546 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -49.0 72.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.881 0.473 . . . . 0.0 110.486 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -65.22 -28.11 69.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.44 -7.58 31.32 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.7 t -126.16 38.49 4.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.263 1.825 . . . . 0.0 108.227 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -53.0 116.87 2.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.631 1.172 . . . . 0.0 110.081 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -85.08 -5.95 59.33 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.611 1.165 . . . . 0.0 110.988 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -85.59 152.36 23.2 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -66.09 119.86 12.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -130.31 145.41 51.77 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 116.812 -1.566 . . . . 0.0 112.032 -179.842 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 CA-C-O 119.003 -0.499 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.6 171.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.854 1.262 . . . . 0.0 109.76 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.7 m -79.65 75.1 6.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.05 1.34 . . . . 0.0 107.989 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.19 -7.19 45.05 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.659 -0.651 . . . . 0.0 111.115 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 178.45 6.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.396 1.878 . . . . 0.0 109.367 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -121.62 155.28 35.42 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -45.29 120.5 2.5 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.75 1.62 . . . . 0.0 110.943 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.42 119.73 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 159.94 5.52 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.52 1.528 . . . . 0.0 111.513 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.82 152.74 77.03 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.646 2.231 . . . . 0.0 111.034 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -127.01 -14.08 5.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 23.2 t30 -118.6 145.08 45.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.52 54.32 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 122.84 0.456 . . . . 0.0 111.763 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.9 -45.0 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -60.73 -42.13 96.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -49.34 76.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.206 0.941 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -56.99 -54.48 46.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.876 0.87 . . . . 0.0 110.907 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.93 -37.58 87.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.21 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.46 72.37 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.069 0.849 . . . . 0.0 109.755 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.86 -48.16 80.23 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.27 -38.83 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -67.37 -44.98 77.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.062 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -55.38 -42.1 73.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.821 0.848 . . . . 0.0 110.295 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -71.62 -41.88 68.33 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.298 -0.876 . . . . 0.0 112.839 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -71.51 -45.16 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.601 0.76 . . . . 0.0 110.997 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.43 -32.15 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.92 0.888 . . . . 0.0 110.707 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.32 26.07 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.04 171.91 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.566 1.546 . . . . 0.0 108.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -143.92 127.94 17.5 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.39 40.1 0.6 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.396 1.95 . . . . 0.0 110.961 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.2 mm -77.64 126.24 37.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.842 0.857 . . . . 0.0 109.219 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.09 -179.07 38.72 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 121.807 0.671 . . . . 0.0 111.71 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 -28.27 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.245 0.618 . . . . 0.0 111.687 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.54 -4.1 20.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.421 1.489 . . . . 0.0 113.921 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.62 123.19 17.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.21 115.33 17.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.221 0.608 . . . . 0.0 110.833 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.0 t80 -44.75 -46.5 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.502 1.121 . . . . 0.0 113.256 -179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -67.46 -29.78 69.32 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.19 -31.19 34.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.2 mt -71.08 -21.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.172 0.442 . . . . 0.0 110.051 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.69 -5.21 5.48 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.74 1.162 . . . . 0.0 113.479 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.98 157.98 53.22 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -146.18 176.93 9.37 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.31 6.6 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.157 1.783 . . . . 0.0 112.39 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -37.2 76.98 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -76.1 -37.93 57.53 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 120.215 -1.553 . . . . 0.0 110.984 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.46 72.87 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.415 1.486 . . . . 0.0 112.71 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -44.23 96.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.75 72.17 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.722 1.209 . . . . 0.0 110.741 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.45 -53.15 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.09 71.31 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.914 0.486 . . . . 0.0 110.952 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.93 72.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.061 0.846 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -72.38 -31.45 65.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.017 0.913 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.37 -42.78 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -40.61 87.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 121.758 -0.589 . . . . 0.0 110.086 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -33.73 59.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.12 -39.61 14.43 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -97.8 0.93 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 50.97 37.78 18.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.305 1.042 . . . . 0.0 110.437 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.1 p -138.48 129.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.403 0.681 . . . . 0.0 112.785 -178.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -80.82 116.61 20.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.65 92.76 6.41 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 127.197 2.199 . . . . 0.0 105.345 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.3 152.25 82.67 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.988 1.792 . . . . 0.0 110.524 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -28.84 22.23 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.701 1.6 . . . . 0.0 110.276 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -52.28 -39.58 60.64 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.505 1.122 . . . . 0.0 112.133 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.64 -38.92 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -50.68 72.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.972 0.909 . . . . 0.0 110.808 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.35 56.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.628 1.571 . . . . 0.0 109.882 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.53 70.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.572 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.36 73.99 35.76 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.185 1.394 . . . . 0.0 108.596 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.96 62.0 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.423 3.415 . . . . 0.0 109.869 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.61 146.95 36.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.19 -42.35 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -54.75 -42.89 72.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.061 0.846 . . . . 0.0 111.318 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.12 -44.47 88.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.16 -38.76 66.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.367 1.467 . . . . 0.0 108.077 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.32 69.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.562 0.745 . . . . 0.0 109.348 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.02 -38.93 79.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.241 0.473 . . . . 0.0 111.243 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 -48.27 81.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.3 t -72.21 -40.24 65.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 O-C-N 123.825 0.703 . . . . 0.0 110.033 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.26 76.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.753 1.161 . . . . 0.0 114.034 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -73.36 -24.41 60.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.322 0.249 . . . . 0.0 111.323 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -87.95 -44.94 10.65 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.094 0.557 . . . . 0.0 109.732 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -83.1 38.73 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.88 146.67 45.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.937 -1.102 . . . . 0.0 112.635 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -75.6 9.45 2.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.673 2.389 . . . . 0.0 111.033 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -54.59 110.07 0.59 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.932 2.493 . . . . 0.0 109.145 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.9 m80 43.23 65.03 1.04 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.944 1.698 . . . . 0.0 111.247 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -148.08 165.9 29.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.752 1.221 . . . . 0.0 108.58 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 C--O 1.242 0.675 0 C-N-CA 125.42 1.488 . . . . 0.0 108.352 -179.82 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.479 0.626 0 CA-C-O 118.61 -0.662 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.31 166.04 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.58 1.082 . . . . 0.0 110.421 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -159.32 166.48 31.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.22 31.21 5.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 127.664 2.386 . . . . 0.0 106.752 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.18 159.92 30.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.84 1.656 . . . . 0.0 110.722 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.91 154.24 19.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.499 1.919 . . . . 0.0 111.658 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.41 130.69 47.42 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.202 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.3 t -145.22 117.52 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.91 160.67 19.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.869 1.268 . . . . 0.0 111.236 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.73 160.81 11.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.654 2.903 . . . . 0.0 114.222 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -127.96 -38.16 1.86 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.04 -1.891 . . . . 0.0 112.294 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -89.48 163.7 15.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.18 71.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.773 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.32 -49.96 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.235 0.614 . . . . 0.0 109.558 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -54.33 -41.58 69.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.863 0.865 . . . . 0.0 109.139 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -54.5 -37.7 65.6 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.607 1.563 . . . . 0.0 110.758 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -76.93 -57.29 3.93 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 120.17 1.35 . . . . 0.0 111.302 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -53.31 -41.96 66.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.518 1.127 . . . . 0.0 113.101 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.42 69.19 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 123.57 0.544 . . . . 0.0 110.378 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -77.74 -34.93 52.36 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.215 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.36 -36.04 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -62.91 -33.98 76.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.956 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -63.59 -37.84 88.85 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -68.88 -15.97 63.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -104.11 -54.45 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 119.201 0.909 . . . . 0.0 110.355 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.55 -27.43 64.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.822 0.849 . . . . 0.0 111.983 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.49 39.02 51.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.48 174.56 12.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.918 1.287 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -134.89 138.24 43.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.0 1.32 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.03 64.04 0.95 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.587 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.18 141.37 14.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.3 -173.14 18.57 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 125.393 1.473 . . . . 0.0 111.025 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 pt -84.92 -28.85 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.24 1.96 24.31 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -81.49 123.51 28.68 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.403 1.097 . . . . 0.0 110.8 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -69.93 122.52 19.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.585 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.58 -46.82 39.72 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.314 1.846 . . . . 0.0 111.98 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.36 -31.65 69.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.181 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -67.96 -33.06 73.94 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.14 0.882 . . . . 0.0 109.046 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.03 -11.64 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.834 0.854 . . . . 0.0 108.812 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.85 3.64 26.55 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.209 1.862 . . . . 0.0 114.206 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.98 152.91 48.32 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.297 1.549 . . . . 0.0 111.827 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -138.31 175.56 9.46 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.464 1.506 . . . . 0.0 108.144 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.26 -49.23 34.31 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.931 0.892 . . . . 0.0 112.92 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.17 -51.11 67.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.568 1.077 . . . . 0.0 109.411 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.6 mmtt -59.41 -48.09 82.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.01 -179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.17 68.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.687 1.595 . . . . 0.0 110.542 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmt -66.09 -39.36 89.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.859 0.864 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.201 -0.905 . . . . 0.0 110.802 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.7 t -67.71 -50.78 57.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.01 -32.05 63.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.85 63.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.554 0.615 . . . . 0.0 109.366 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.44 -40.04 77.46 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.883 0.473 . . . . 0.0 111.184 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -63.64 -49.23 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -39.98 91.74 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.306 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -30.95 59.73 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -83.88 -48.22 10.25 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.029 0.831 . . . . 0.0 110.449 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -87.42 -3.58 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.592 0.557 . . . . 0.0 110.742 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 59.02 38.02 24.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.52 1.055 . . . . 0.0 111.515 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.68 126.92 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.101 -0.999 . . . . 0.0 112.681 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.87 142.0 58.58 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.97 78.61 74.61 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.74 152.99 79.48 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.734 1.623 . . . . 0.0 111.173 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -28.43 47.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.905 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -54.27 -33.53 58.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.488 1.115 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 88.8 t -88.17 -51.78 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 107.902 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -48.9 35.62 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.454 1.902 . . . . 0.0 111.41 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.85 40.63 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.643 -0.66 . . . . 0.0 112.296 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.85 79.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.223 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -138.33 79.63 30.19 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.519 1.128 . . . . 0.0 108.528 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.74 55.26 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 124.635 3.556 . . . . 0.0 112.651 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 147.8 38.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.549 1.068 . . . . 0.0 110.906 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 mm -54.94 -44.97 75.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.527 1.131 . . . . 0.0 108.749 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -54.19 -39.3 66.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.638 0.654 . . . . 0.0 111.913 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.32 27.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.675 -0.641 . . . . 0.0 112.204 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.4 -40.58 93.6 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 126.51 1.924 . . . . 0.0 109.726 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.37 -51.29 68.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.913 0.778 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.0 -35.7 64.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.081 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 13.9 t80 -66.07 -41.11 91.2 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.4 -43.12 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -47.11 85.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.717 0.807 . . . . 0.0 112.539 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -63.49 -19.31 64.64 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.348 -0.845 . . . . 0.0 111.386 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.3 mtt-85 -100.74 -25.51 14.11 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.5 p -60.8 -35.6 76.9 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.514 0.597 . . . . 0.0 110.479 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -63.36 121.35 13.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.175 1.39 . . . . 0.0 108.578 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -68.68 139.54 55.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -142.73 127.51 18.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.722 0.809 . . . . 0.0 109.475 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -74.0 99.84 3.4 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.575 1.179 . . . . 0.0 108.898 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -139.0 97.21 3.26 Favored 'General case' 0 C--N 1.321 -0.643 1 N-CA-C 100.036 -4.061 . . . . 0.0 100.036 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.367 -1.302 . . . . 0.0 108.244 -179.338 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.476 0.485 0 CA-C-O 118.619 -0.659 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 t -57.97 153.96 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -138.63 157.69 45.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -138.31 43.95 2.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.953 0.882 . . . . 0.0 110.089 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.33 164.24 12.49 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.461 1.504 . . . . 0.0 111.284 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -86.6 179.54 6.79 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.31 123.12 11.92 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.463 0.705 . . . . 0.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.08 117.05 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 162.36 25.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.471 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.25 137.32 78.12 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.528 2.152 . . . . 0.0 110.755 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 p -106.05 -23.53 12.61 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.258 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -107.32 146.72 31.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.9 57.99 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -69.4 -44.66 79.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.36 -36.39 80.07 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.504 0.721 . . . . 0.0 109.422 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -56.99 -52.43 65.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 109.512 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -56.53 -54.75 42.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.723 0.409 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.95 -47.85 81.7 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.769 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.99 -32.92 62.09 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.54 -38.91 67.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.3 -34.98 66.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 119.257 0.935 . . . . 0.0 109.98 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -62.62 -42.97 99.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 122.026 -0.421 . . . . 0.0 109.919 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -32.06 70.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.135 0.974 . . . . 0.0 111.559 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.39 -40.42 57.99 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.882 0.873 . . . . 0.0 109.982 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.34 -55.71 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 119.109 0.868 . . . . 0.0 109.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.72 -35.94 82.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.018 0.927 . . . . 0.0 111.095 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.1 15.24 70.09 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.216 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 169.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.4 t -136.05 146.33 46.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.24 0.927 . . . . 0.0 108.876 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.79 38.0 3.77 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.906 1.717 . . . . 0.0 111.324 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 20.1 mm -72.22 128.16 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.345 1.073 . . . . 0.0 109.493 179.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.45 175.96 23.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.965 1.269 . . . . 0.0 111.005 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 18.2 pt -70.8 -23.8 24.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.921 1.689 . . . . 0.0 112.73 -179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.35 0.2 21.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.872 1.669 . . . . 0.0 113.792 179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.77 115.62 14.56 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.4 122.97 22.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 122.829 0.452 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -45.98 -45.08 15.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.939 1.296 . . . . 0.0 113.352 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.43 -32.63 62.71 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -72.26 -31.09 65.47 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.004 0.922 . . . . 0.0 111.59 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.4 mt -70.65 -21.23 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.14 -4.55 6.37 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 118.664 -1.076 . . . . 0.0 111.548 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.18 162.91 48.85 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.017 1.408 . . . . 0.0 109.821 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -152.32 174.55 13.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.52 -50.91 12.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.242 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.04 -46.06 79.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.702 0.228 . . . . 0.0 110.941 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -67.82 -37.89 82.53 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.02 72.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.014 0.926 . . . . 0.0 110.167 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -42.93 89.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.024 0.53 . . . . 0.0 109.856 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.34 69.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.648 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -72.02 -51.55 30.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.56 -34.33 64.66 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.231 0.612 . . . . 0.0 111.66 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.22 86.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.775 0.83 . . . . 0.0 110.713 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -77.77 -39.82 42.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.855 0.862 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.0 -47.21 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -35.39 80.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.535 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -76.68 -33.44 58.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -89.18 -48.77 7.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.375 0.534 . . . . 0.0 111.768 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.8 m-85 -85.13 -3.0 58.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.981 0.512 . . . . 0.0 109.994 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 54.38 35.2 22.49 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.246 1.019 . . . . 0.0 110.395 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -141.75 131.61 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.3 -176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -70.46 140.93 52.06 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.723 0.773 . . . . 0.0 111.64 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 tp -127.15 93.09 42.38 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 127.507 2.323 . . . . 0.0 105.683 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -73.19 152.75 50.88 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.072 1.848 . . . . 0.0 109.094 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.1 -26.85 51.38 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.755 0.822 . . . . 0.0 110.95 179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -54.26 -36.55 63.71 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.956 0.903 . . . . 0.0 112.908 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -85.87 -40.19 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -49.96 75.04 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.963 1.305 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -39.06 64.7 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.663 0.785 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.13 71.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 119.034 -1.066 . . . . 0.0 112.655 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -137.08 67.79 55.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.533 0.733 . . . . 0.0 111.628 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.18 50.37 1.52 Allowed 'Trans proline' 0 CA--C 1.54 0.821 1 C-N-CA 126.394 4.73 . . . . 0.0 114.92 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.91 147.05 44.02 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.6 mm -56.82 -46.23 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 126.984 2.113 . . . . 0.0 108.099 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -54.11 -41.63 68.54 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.898 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.35 -46.12 67.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.07 -36.84 75.23 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.449 1.1 . . . . 0.0 108.758 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.83 -51.54 61.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.43 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -66.32 -37.76 86.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.552 1.069 . . . . 0.0 110.496 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -63.97 -53.84 43.81 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.66 0.784 . . . . 0.0 109.324 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.96 -40.83 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.9 79.88 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.536 1.134 . . . . 0.0 113.296 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 t -73.49 -25.0 60.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.258 0.481 . . . . 0.0 110.093 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -15.89 29.89 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.96 -1.019 . . . . 0.0 113.031 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 p -75.75 -4.81 42.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 110.02 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.77 141.52 32.36 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.161 1.384 . . . . 0.0 109.404 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -165.76 140.5 4.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -88.06 93.67 9.56 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.76 160.08 20.92 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -161.24 168.21 24.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.159 0.984 . . . . 0.0 109.689 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.243 0 C-N-CA 127.514 2.326 . . . . 0.0 105.65 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.541 0.868 0 N-CA-C 113.747 0.634 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.16 168.99 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.762 2.425 . . . . 0.0 111.456 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -128.14 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -64.88 4.39 0.44 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.82 -5.88 40.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.704 2.002 . . . . 0.0 112.836 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -60.92 145.99 48.33 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.57 122.44 14.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.78 0.718 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.61 115.99 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.02 159.23 77.71 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 124.633 1.173 . . . . 0.0 110.558 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.86 129.36 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.466 3.444 . . . . 0.0 110.89 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -101.51 -21.34 14.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.671 1.188 . . . . 0.0 109.887 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -109.52 148.69 30.79 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -23.83 67.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.108 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.48 -44.38 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.277 1.853 . . . . 0.0 107.542 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.84 -40.89 81.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -58.07 -51.2 70.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.555 1.142 . . . . 0.0 109.724 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.28 -52.7 64.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.196 0.598 . . . . 0.0 111.558 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.79 -42.87 99.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.868 0.758 . . . . 0.0 111.352 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.04 -33.42 72.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.78 -47.39 78.29 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.67 -34.85 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.468 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -59.81 -40.91 90.01 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 119.7 1.137 . . . . 0.0 109.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.94 -39.77 94.0 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.04 -32.04 72.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.351 -0.843 . . . . 0.0 112.066 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.57 -53.41 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.695 0.68 . . . . 0.0 109.855 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.3 mt -75.62 -25.57 57.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.18 66.99 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.496 1.522 . . . . 0.0 112.229 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.3 m -94.91 175.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 111.8 -178.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 t -144.83 119.35 9.7 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.889 0.876 . . . . 0.0 109.329 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.5 0.84 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 124.668 1.128 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 27.1 mm -90.72 125.06 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 126.347 1.859 . . . . 0.0 107.874 178.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.03 164.98 25.15 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.6 pt -67.94 -28.09 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.771 -0.841 . . . . 0.0 111.49 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.451 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.68 -3.48 32.94 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.218 2.207 . . . . 0.0 116.147 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -82.46 121.56 26.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.207 1.367 . . . . 0.0 108.823 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.33 127.64 33.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.576 0.35 . . . . 0.0 110.713 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -48.21 -44.22 32.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.479 1.912 . . . . 0.0 111.665 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -69.36 -38.11 77.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.69 -28.16 65.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.028 -0.51 . . . . 0.0 110.781 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.8 mt -71.03 -17.76 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.661 0.784 . . . . 0.0 109.206 179.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.46 2.69 8.15 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.935 1.255 . . . . 0.0 112.79 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 164.62 53.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . 0.4 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.1 p80 -146.77 174.92 11.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.6 6.34 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.214 1.405 . . . . 0.0 112.779 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -43.76 94.84 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 43.7 mmtt -66.17 -38.89 89.17 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.715 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.64 74.68 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.5 0.72 . . . . 0.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -64.03 -40.49 96.44 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 122.86 0.464 . . . . 0.0 110.276 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.61 92.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.182 0.446 . . . . 0.0 110.234 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.42 -52.96 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.56 -31.13 63.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.6 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.1 69.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.912 0.778 . . . . 0.0 111.374 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.66 -42.7 61.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.264 0.625 . . . . 0.0 109.343 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.85 -33.91 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 120.672 -1.268 . . . . 0.0 108.195 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.65 -42.42 91.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.392 0.996 . . . . 0.0 109.18 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -75.27 -31.75 60.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -74.48 -48.92 24.44 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -94.13 0.14 55.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.15 37.85 27.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.46 1.504 . . . . 0.0 109.851 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.7 p -141.41 124.9 15.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -67.37 130.74 44.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.565 -0.71 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 tt -118.03 87.99 30.22 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 159.2 54.15 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.475 2.116 . . . . 0.0 112.168 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -40.93 51.07 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.724 2.01 . . . . 0.0 109.785 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -53.46 -32.18 48.9 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.393 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG23 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -87.28 -47.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 119.982 1.264 . . . . 0.0 109.328 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -47.31 76.5 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.554 0.742 . . . . 0.0 111.749 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -31.74 43.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.974 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -39.38 71.1 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.67 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -137.47 78.31 38.48 Favored Pre-proline 0 N--CA 1.453 -0.312 0 O-C-N 124.271 0.982 . . . . 0.0 109.39 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 52.69 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.707 2.938 . . . . 0.0 111.756 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.85 147.78 48.39 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 120.224 1.375 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.4 mm -58.12 -40.68 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -53.8 -46.21 71.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.229 0.468 . . . . 0.0 110.682 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.42 -51.42 44.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.09 -38.12 89.92 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 125.005 1.322 . . . . 0.0 109.86 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.49 94.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.978 0.808 . . . . 0.0 109.385 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -74.54 -44.87 49.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 111.395 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CE2' HG23 ' A' ' 67' ' ' VAL . 27.7 t80 -62.22 -44.07 97.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.25 -43.2 50.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.508 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.05 98.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 t -67.73 -29.9 69.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.777 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -83.21 -43.99 15.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.074 0.852 . . . . 0.0 109.407 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 t -77.94 36.49 0.22 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.873 1.669 . . . . 0.0 109.395 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -69.11 133.21 47.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.129 -0.982 . . . . 0.0 109.649 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -67.69 121.57 16.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.26 150.73 13.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.643 0.735 . . . . 0.0 110.953 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -74.03 153.61 39.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -136.59 144.32 44.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.851 2.46 . . . . 0.0 105.414 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.644 2.378 . . . . 0.0 106.028 -178.669 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.477 0.535 0 N-CA-C 110.518 -0.608 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t 58.05 75.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 123.974 1.845 . . . . 0.0 108.719 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -130.96 36.9 3.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.517 -2.129 . . . . 0.0 110.164 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.25 -22.51 60.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.79 -0.569 . . . . 0.0 112.346 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 148.49 50.94 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -75.51 161.72 28.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.838 1.255 . . . . 0.0 110.709 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -46.08 132.61 9.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.396 2.678 . . . . 0.0 113.174 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.5 t -140.05 117.62 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.25 158.23 38.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.116 0.885 . . . . 0.0 110.02 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.51 149.74 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.49 2.793 . . . . 0.0 112.023 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -123.61 -21.58 5.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.589 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -102.87 141.11 36.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.96 -18.66 0.82 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.713 1.205 . . . . 0.0 113.881 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.78 -54.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.636 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.77 -42.77 58.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.893 2.077 . . . . 0.0 110.103 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 t -60.86 -44.88 96.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.837 0.711 . . . . 0.0 110.78 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -61.25 -45.37 94.8 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.636 -1.29 . . . . 0.0 110.756 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.89 -38.45 88.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.121 0.873 . . . . 0.0 111.452 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.48 75.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.1 -37.53 75.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.4 -40.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -60.45 -41.11 93.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.72 -38.88 72.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.547 0.612 . . . . 0.0 109.858 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -68.45 -32.85 73.17 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -86.31 -46.25 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 123.022 1.391 . . . . 0.0 111.729 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.14 -33.2 71.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.357 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.13 38.82 54.44 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.64 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.015 1.726 . . . . 0.0 107.108 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 p -136.72 138.85 41.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 110.71 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.15 66.64 1.51 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.21 1.386 . . . . 0.0 112.186 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.7 mm -83.89 129.5 37.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.52 167.58 28.75 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.029 0.831 . . . . 0.0 111.326 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.62 -24.55 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.987 0.915 . . . . 0.0 112.553 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -0.26 21.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.454 1.501 . . . . 0.0 114.911 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.03 122.8 26.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 118.868 0.758 . . . . 0.0 109.557 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -67.23 123.73 21.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.331 1.052 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -46.36 -45.95 18.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.429 1.892 . . . . 0.0 112.876 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -70.72 -24.07 62.57 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.752 -1.218 . . . . 0.0 112.224 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -74.28 -37.14 63.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.46 29.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 125.965 1.706 . . . . 0.0 109.981 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.32 5.37 34.94 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.159 -2.213 . . . . 0.0 113.936 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.64 142.19 43.47 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 108.135 -1.986 . . . . 0.0 108.135 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -132.81 173.18 11.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.847 0.823 . . . . 0.0 108.886 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.62 -47.48 28.94 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.347 0.659 . . . . 0.0 111.628 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -48.26 73.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.91 0.323 . . . . 0.0 110.587 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.97 -39.59 90.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.86 80.53 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.163 0.985 . . . . 0.0 110.427 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.78 -37.9 87.57 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.56 75.23 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.222 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 70.9 t -63.08 -53.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.65 69.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.064 0.946 . . . . 0.0 112.231 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.19 -47.48 67.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.651 0.739 . . . . 0.0 109.904 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.6 mm100 -67.16 -39.98 86.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 109.987 -179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 t -64.59 -47.46 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 121.35 -0.844 . . . . 0.0 108.775 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.22 -37.65 86.16 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.529 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -75.85 -32.26 59.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.48 -48.14 8.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -92.36 0.33 57.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.352 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 49.93 43.09 25.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.596 1.089 . . . . 0.0 109.199 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.2 p -136.1 128.43 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 123.365 0.666 . . . . 0.0 110.657 -178.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -69.45 120.72 15.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -114.76 78.71 5.33 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.42 158.15 42.26 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.23 1.287 . . . . 0.0 111.503 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.72 -26.86 67.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.344 1.058 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -52.97 -41.59 64.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.262 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.29 -37.23 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-N 119.719 1.145 . . . . 0.0 109.021 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.3 -50.08 60.05 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.445 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -30.7 56.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.16 -31.43 49.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.119 0.872 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -134.68 72.76 68.75 Favored Pre-proline 0 N--CA 1.449 -0.52 0 C-N-CA 125.468 1.507 . . . . 0.0 107.898 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.18 53.28 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 113.093 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.62 147.38 46.88 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 120.311 1.414 . . . . 0.0 110.455 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.12 -44.08 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.86 -46.68 74.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.576 0.35 . . . . 0.0 111.404 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.17 85.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.301 1.04 . . . . 0.0 113.233 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -42.97 84.91 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 125.345 1.458 . . . . 0.0 107.246 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.46 97.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.749 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -76.24 -36.72 58.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.201 1.364 . . . . 0.0 111.159 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -60.99 -51.46 69.17 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 77.4 t -68.63 -47.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.692 -178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.13 -51.79 60.79 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.801 1.182 . . . . 0.0 113.304 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -64.41 -22.41 66.95 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -100.58 -24.07 14.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.125 0.875 . . . . 0.0 112.98 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.8 t -73.15 -23.6 60.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.38 116.34 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -56.42 149.84 16.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.778 0.831 . . . . 0.0 108.94 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . 0.401 ' CE1' ' HB2' ' A' ' 90' ' ' HIS . 18.4 p80 -140.26 30.41 1.97 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.598 0.759 . . . . 0.0 111.757 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 p80 46.06 33.97 1.88 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.674 2.79 . . . . 0.0 115.748 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.401 ' HB2' ' CE1' ' A' ' 88' ' ' HIS . 48.6 t-80 -51.99 113.72 1.09 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.253 1.24 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.412 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 CA-C-O 118.247 -0.814 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -60.3 140.97 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 119.622 1.101 . . . . 0.0 109.813 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.9 p -84.12 149.79 25.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -130.83 17.48 5.18 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.242 1.017 . . . . 0.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 -10.49 22.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.596 1.558 . . . . 0.0 113.505 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -67.6 142.07 56.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -47.33 131.03 13.48 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.105 0.962 . . . . 0.0 113.274 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.62 116.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 102.468 -3.16 . . . . 0.0 102.468 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.01 161.19 65.08 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.615 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.58 72.96 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.682 1.588 . . . . 0.0 110.056 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 p -132.24 -13.95 3.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.477 0.311 . . . . 0.0 111.283 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 141.95 28.53 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -28.14 8.04 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -44.78 19.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 119.086 0.857 . . . . 0.0 109.154 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -51.94 -42.51 62.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.269 1.027 . . . . 0.0 109.983 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -54.26 -50.54 66.98 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.331 1.019 . . . . 0.0 110.431 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.29 -50.12 75.22 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 111.7 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.25 -41.66 85.26 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 119.99 -1.694 . . . . 0.0 112.724 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.61 71.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 124.531 1.144 . . . . 0.0 111.024 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.7 -47.87 43.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.108 0.867 . . . . 0.0 111.23 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.01 -37.89 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.055 0.542 . . . . 0.0 109.743 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.68 -39.69 85.36 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.212 -0.93 . . . . 0.0 111.012 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -57.27 -43.18 82.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.276 0.63 . . . . 0.0 110.646 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -64.11 -31.73 73.04 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.726 0.81 . . . . 0.0 112.591 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.66 -44.44 15.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.899 0.772 . . . . 0.0 111.715 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.27 -24.09 40.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.114 0.966 . . . . 0.0 112.728 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.79 23.93 68.42 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.901 1.239 . . . . 0.0 111.936 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.0 175.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.467 1.633 . . . . 0.0 106.599 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 t -141.76 143.48 33.51 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.001 1.273 . . . . 0.0 107.859 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 69.15 1.41 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 49.7 mm -91.27 121.79 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.3 169.13 45.29 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 118.45 0.568 . . . . 0.0 112.67 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 pt -68.54 -24.08 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 120.948 -1.325 . . . . 0.0 111.466 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -103.89 -3.37 24.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.12 2.568 . . . . 0.0 113.117 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.44 124.23 23.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -77.32 117.33 18.72 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.963 1.305 . . . . 0.0 108.777 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.09 -48.05 11.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.893 1.677 . . . . 0.0 113.223 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -71.08 -33.64 70.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.876 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -67.95 -29.54 68.62 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 30.9 mt -72.01 -3.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.985 0.914 . . . . 0.0 109.389 178.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.84 -0.56 33.96 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.033 1.778 . . . . 0.0 111.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.57 160.81 46.71 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 118.618 1.209 . . . . 0.0 110.64 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -151.18 179.2 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.184 1.394 . . . . 0.0 108.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.26 -50.71 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.133 1.373 . . . . 0.0 113.251 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -46.51 86.93 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.449 0.568 . . . . 0.0 110.324 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.7 mmtp -63.48 -39.2 93.83 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 121.205 -0.934 . . . . 0.0 110.798 -179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -42.39 69.61 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.662 0.665 . . . . 0.0 109.268 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 mmt -65.98 -41.52 91.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.164 0.586 . . . . 0.0 109.768 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.28 83.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 118.377 -0.82 . . . . 0.0 112.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 t -72.2 -52.3 25.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.83 -31.59 39.84 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.59 72.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.593 0.633 . . . . 0.0 111.447 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.09 -37.35 61.58 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.574 0.702 . . . . 0.0 110.921 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -64.63 -47.37 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 121.082 -1.011 . . . . 0.0 108.961 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -40.7 90.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.344 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -75.27 -29.1 60.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.65 -48.09 8.16 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.607 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.29 -3.7 58.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 51.49 39.17 24.01 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.268 1.827 . . . . 0.0 110.886 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 p -141.25 132.31 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.748 0.785 . . . . 0.0 112.085 -177.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -71.53 115.66 10.96 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.15 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -110.19 83.72 3.26 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.3 157.79 58.29 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.669 2.246 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -33.49 54.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.436 1.494 . . . . 0.0 110.522 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -30.85 47.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.146 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.92 -46.85 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -49.72 60.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.277 1.431 . . . . 0.0 110.926 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -31.01 38.75 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.641 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.94 -37.11 83.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.076 0.853 . . . . 0.0 110.502 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -141.76 79.31 16.91 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.263 1.025 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 52.56 3.58 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.951 3.101 . . . . 0.0 113.189 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 147.21 49.21 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.887 -1.133 . . . . 0.0 109.535 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.47 -48.21 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -52.32 -47.82 65.79 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.623 0.577 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.47 98.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.27 -41.48 63.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.62 73.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.255 1.022 . . . . 0.0 109.315 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.42 -38.63 77.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.787 1.176 . . . . 0.0 111.552 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -67.16 -46.13 74.95 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.094 0.558 . . . . 0.0 110.627 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 78.0 t -73.78 -42.79 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.155 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.99 84.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.86 0.754 . . . . 0.0 112.804 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -61.98 -32.71 73.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.349 0.522 . . . . 0.0 109.64 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -75.25 -37.93 60.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -33.5 64.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.299 1.04 . . . . 0.0 109.69 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -60.22 107.69 0.68 Allowed 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -117.95 32.84 5.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.865 2.066 . . . . 0.0 110.591 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -59.42 105.3 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.018 0.927 . . . . 0.0 110.555 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -139.02 41.62 2.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.34 1.856 . . . . 0.0 107.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -140.18 -15.44 0.99 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.055 0.942 . . . . 0.0 113.346 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.6 m80 . . . . . 0 C--O 1.246 0.886 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 179.1 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 113.798 0.653 . . . . 0.0 113.798 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.91 161.44 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.25 1.024 . . . . 0.0 112.07 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -146.81 119.0 8.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.928 1.691 . . . . 0.0 107.445 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.18 19.18 20.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.21 2.604 . . . . 0.0 109.006 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.16 164.31 25.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.884 1.273 . . . . 0.0 109.785 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -120.59 160.26 23.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 108.469 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.87 123.91 4.86 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.131 1.372 . . . . 0.0 114.138 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -146.33 117.6 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.81 172.41 4.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.329 1.051 . . . . 0.0 112.008 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.14 146.46 70.35 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.02 2.48 . . . . 0.0 111.111 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -118.82 -13.51 9.53 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.607 0.763 . . . . 0.0 111.733 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -120.31 147.11 45.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.29 -26.14 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.663 -1.636 . . . . 0.0 113.502 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.73 -55.1 17.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 120.496 1.498 . . . . 0.0 107.792 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.54 -44.08 65.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.618 1.967 . . . . 0.0 109.728 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -40.32 85.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.305 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.37 -50.74 71.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 119.325 0.966 . . . . 0.0 110.237 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.45 -41.94 98.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.413 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.21 -36.16 68.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.977 0.911 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.29 -49.94 15.67 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 118.973 0.806 . . . . 0.0 110.409 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.0 mt -51.39 -40.94 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 8.2 m0 -64.95 -45.83 84.11 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.319 1.448 . . . . 0.0 110.223 178.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -59.33 -37.12 77.0 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.369 0.668 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -70.57 -29.08 65.42 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.49 -55.73 7.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.764 0.826 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.9 mt -74.51 -20.51 59.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.631 1.172 . . . . 0.0 113.523 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 32.93 68.49 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.034 0.834 . . . . 0.0 111.847 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.14 175.21 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.4 1.88 . . . . 0.0 109.634 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -139.25 127.77 23.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.028 0.931 . . . . 0.0 112.945 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 69.27 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mm -87.02 123.39 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 107.383 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.5 174.32 44.82 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 pt -80.76 -26.83 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 118.725 1.263 . . . . 0.0 110.628 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.535 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -96.71 4.84 51.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.013 2.525 . . . . 0.0 113.877 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -62.99 123.35 18.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.651 1.581 . . . . 0.0 113.107 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.73 105.3 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.226 -1.546 . . . . 0.0 107.09 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 92.5 t80 -41.74 -47.55 4.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 113.237 -179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -69.62 -33.19 72.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.277 0.944 . . . . 0.0 108.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 31.2 mt -71.29 -15.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.016 0.926 . . . . 0.0 109.587 -179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.16 -6.86 23.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.078 1.799 . . . . 0.0 112.541 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.76 157.77 33.91 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.675 1.237 . . . . 0.0 110.276 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -143.33 171.45 14.1 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.04 -48.68 11.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.321 1.048 . . . . 0.0 112.475 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -46.04 82.91 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.762 -0.586 . . . . 0.0 110.657 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -66.05 -42.17 89.85 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 121.444 -0.785 . . . . 0.0 110.036 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.35 -43.71 67.94 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.303 1.041 . . . . 0.0 110.187 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.5 mtm -63.72 -30.41 71.51 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.657 0.383 . . . . 0.0 111.811 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.52 -35.39 68.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.62 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.29 -48.28 86.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.82 64.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.139 0.976 . . . . 0.0 111.337 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.84 87.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.144 0.884 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -73.25 -36.15 66.36 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.63 0.729 . . . . 0.0 110.385 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.04 -45.18 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' HIS . . . . . 0.467 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 1.2 t-80 -61.02 -36.73 80.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.477 -0.765 . . . . 0.0 111.489 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -76.79 -32.07 57.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -89.63 -44.86 9.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.04 0.924 . . . . 0.0 112.17 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -90.25 -0.62 57.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.883 1.273 . . . . 0.0 109.897 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 49.2 42.04 20.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.206 1.402 . . . . 0.0 111.002 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.39 139.86 13.51 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 O-C-N 120.847 -1.158 . . . . 0.0 111.883 -177.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.467 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 30.6 tt0 -66.8 143.77 56.7 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.193 -0.317 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.33 82.42 57.91 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.79 149.24 72.71 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.819 1.68 . . . . 0.0 111.147 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.8 -27.43 41.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 125.088 1.355 . . . . 0.0 111.294 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -53.19 -36.49 61.01 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.682 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.57 -47.27 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -48.9 47.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.007 1.723 . . . . 0.0 111.531 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -29.72 37.99 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.082 0.953 . . . . 0.0 112.848 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.69 -31.89 59.9 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.256 0.347 . . . . 0.0 111.336 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -134.58 74.52 65.37 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.88 56.32 3.55 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.346 3.364 . . . . 0.0 112.687 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.98 147.43 36.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.846 1.203 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -54.81 -49.26 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 108.876 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -52.38 -50.51 62.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.21 96.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.59 -44.58 56.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.048 1.339 . . . . 0.0 107.559 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.42 66.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.258 1.023 . . . . 0.0 109.678 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.33 -40.25 74.27 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.322 0.389 . . . . 0.0 111.099 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.55 -48.13 82.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.636 0.774 . . . . 0.0 110.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 71.3 t -72.24 -38.46 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.733 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.71 74.04 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.258 0.935 . . . . 0.0 111.426 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -63.51 -32.35 73.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.626 0.194 . . . . 0.0 111.379 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -75.8 -29.62 58.76 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.3 p -82.4 -10.75 58.93 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.88 86.25 2.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.027 0.931 . . . . 0.0 110.377 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -73.02 164.28 26.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.98 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -147.62 158.1 43.85 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.309 1.044 . . . . 0.0 109.841 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -74.79 46.01 0.27 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.507 2.323 . . . . 0.0 110.696 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -73.14 -11.05 60.39 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 120.278 -1.514 . . . . 0.0 112.796 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -179.65 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.02 133.66 56.3 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.556 0.617 . . . . 0.0 109.819 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -139.54 117.25 11.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.48 87.92 Favored Pre-proline 0 C--O 1.24 0.593 0 O-C-N 124.048 0.843 . . . . 0.0 109.106 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.94 144.37 87.84 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.205 2.603 . . . . 0.0 110.042 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 p -124.69 -11.57 7.23 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -108.89 133.36 53.02 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.33 -39.11 2.96 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.56 -50.45 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.356 0.98 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -58.41 -41.28 84.61 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.824 2.049 . . . . 0.0 108.633 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -64.28 -35.13 79.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.37 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -77.05 -35.43 56.79 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.949 -1.095 . . . . 0.0 111.688 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.22 -37.68 72.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.602 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.54 80.63 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.67 -47.21 73.17 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.6 mt -57.27 -38.45 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.569 0.747 . . . . 0.0 109.955 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -64.75 -42.8 94.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -57.73 -41.95 82.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -69.38 -22.04 63.75 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.02 -1.05 . . . . 0.0 113.723 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.92 -41.88 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.864 0.756 . . . . 0.0 110.632 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -83.77 -22.84 31.74 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.736 1.214 . . . . 0.0 112.733 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.2 35.02 69.98 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.93 173.9 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -130.41 148.67 52.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.487 1.115 . . . . 0.0 108.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 53.16 1.41 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.082 0.849 . . . . 0.0 113.521 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.0 mm -91.12 121.4 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.96 26.74 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 122.623 1.124 . . . . 0.0 112.339 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.04 -24.16 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 O-C-N 121.687 -0.89 . . . . 0.0 111.93 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.6 -0.14 22.18 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.582 2.353 . . . . 0.0 113.371 -179.227 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.767 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -67.94 116.17 8.29 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.62 110.84 12.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.681 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.3 t80 -40.02 -46.26 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.95 2.1 . . . . 0.0 113.908 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -68.09 -32.94 73.62 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.716 -0.615 . . . . 0.0 112.152 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.48 -32.09 69.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.194 0.906 . . . . 0.0 109.394 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 36' ' ' ASP . 23.2 mt -70.43 -20.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.67 7.88 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.545 1.069 . . . . 0.0 112.212 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.56 160.77 40.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.44 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 20.5 p80 -148.2 177.74 9.15 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.6 1.16 . . . . 0.0 108.212 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.32 -52.38 12.85 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.126 0.97 . . . . 0.0 112.995 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -47.72 73.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.914 1.233 . . . . 0.0 110.504 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 63.3 mmtt -62.56 -43.15 99.52 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.196 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -57.16 -41.79 79.85 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.243 1.417 . . . . 0.0 110.996 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 74.7 mtm -68.81 -37.28 79.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.71 71.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.703 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.36 -52.69 52.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.06 69.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.518 1.054 . . . . 0.0 112.085 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -78.02 -32.8 51.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.183 0.992 . . . . 0.0 111.348 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 59' ' ' TYR . 59.3 t -71.89 -40.08 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.065 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -37.97 82.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.813 1.188 . . . . 0.0 109.219 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -76.0 -31.77 59.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.26 -47.96 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.572 0.749 . . . . 0.0 111.869 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HG11 ' A' ' 81' ' ' VAL . 16.8 m-85 -94.48 0.49 55.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.741 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 55.66 37.44 28.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.737 1.215 . . . . 0.0 109.56 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 81' ' ' VAL . 9.4 p -140.56 136.72 36.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.38 132.92 44.59 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.839 1.255 . . . . 0.0 110.029 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.2 tp -130.07 86.11 55.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 123.97 0.908 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.76 153.68 77.12 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.673 1.582 . . . . 0.0 110.453 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.5 -30.12 62.62 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.543 0.737 . . . . 0.0 110.463 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -53.03 -30.69 37.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.117 0.967 . . . . 0.0 111.94 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.08 -46.3 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.431 1.092 . . . . 0.0 108.842 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -57.24 -46.55 82.89 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.598 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -36.57 58.51 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.289 -0.882 . . . . 0.0 111.42 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.53 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.596 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.55 73.1 62.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 124.361 1.064 . . . . 0.0 109.151 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.16 54.25 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.378 3.385 . . . . 0.0 110.804 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 147.62 41.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.178 0.899 . . . . 0.0 110.572 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 mm -57.77 -44.46 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 124.98 1.312 . . . . 0.0 108.617 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -55.83 -47.75 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.854 0.297 . . . . 0.0 110.986 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.85 -52.57 64.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.05 -41.28 97.97 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 108.235 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.7 92.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.027 0.83 . . . . 0.0 110.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -74.61 -40.88 61.29 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.958 0.503 . . . . 0.0 111.182 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -63.23 -42.72 99.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 61' ' ' VAL . 55.8 t -71.43 -46.34 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.55 -49.7 67.11 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 t -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.278 0.361 . . . . 0.0 111.376 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mtt85 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.228 179.292 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -47.35 129.88 13.12 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.326 1.051 . . . . 0.0 113.107 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.43 117.46 3.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 156.89 73.91 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 124.039 0.837 . . . . 0.0 109.484 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.99 164.49 24.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.336 2.024 . . . . 0.0 112.766 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -134.18 -12.13 2.49 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.929 1.292 . . . . 0.0 112.259 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.34 144.68 35.55 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.02 -38.51 37.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.319 1.048 . . . . 0.0 112.179 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.29 -55.41 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.514 1.126 . . . . 0.0 110.457 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.69 -36.79 57.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 109.601 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -61.06 -46.97 88.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.743 0.817 . . . . 0.0 111.163 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -60.08 -49.44 77.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.536 0.607 . . . . 0.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.73 -42.1 97.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.915 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.01 69.99 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.527 0.603 . . . . 0.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -71.27 -46.78 60.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.3 mt -59.32 -35.09 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 121.525 -0.735 . . . . 0.0 109.701 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -62.28 -42.27 99.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.273 -0.892 . . . . 0.0 109.25 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.78 -33.82 76.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 109.191 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.34 -26.38 63.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.088 -1.008 . . . . 0.0 112.271 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.03 -55.41 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 118.276 0.489 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.82 -17.22 60.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.034 0.934 . . . . 0.0 113.24 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.57 21.66 72.83 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.244 0.926 . . . . 0.0 111.651 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 32' ' ' ILE . 32.3 m -94.87 174.31 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -143.85 109.09 5.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.85 39.98 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.744 1.164 . . . . 0.0 113.052 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 29' ' ' VAL . 36.6 mm -77.78 124.84 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.099 1.449 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.39 169.93 16.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.442 1.496 . . . . 0.0 110.788 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.81 -26.57 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.109 -1.23 . . . . 0.0 112.971 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.464 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.93 1.75 43.01 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.771 1.628 . . . . 0.0 112.97 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -69.49 127.29 32.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.285 0.564 . . . . 0.0 109.872 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -78.95 114.46 17.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.942 1.297 . . . . 0.0 110.871 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -44.01 -49.65 8.6 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.641 1.176 . . . . 0.0 113.627 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -76.44 -27.69 56.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.06 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.23 -30.17 67.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.092 1.315 . . . . 0.0 109.784 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.93 -13.68 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.61 -0.94 30.64 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.729 1.157 . . . . 0.0 112.627 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 133.36 33.93 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.71 175.11 5.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.94 -49.5 15.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.288 1.035 . . . . 0.0 112.019 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.31 -47.23 82.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.46 0.304 . . . . 0.0 110.575 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -64.75 -35.26 80.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.675 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.9 84.77 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.278 0.945 . . . . 0.0 109.261 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.3 mtm -69.57 -37.22 76.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.74 81.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.685 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.07 -49.73 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.993 1.27 . . . . 0.0 107.69 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.07 64.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.98 0.912 . . . . 0.0 111.15 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.63 85.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.682 0.793 . . . . 0.0 110.537 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.48 -38.98 48.04 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.461 0.573 . . . . 0.0 110.458 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 t -62.31 -47.32 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.438 1.095 . . . . 0.0 109.274 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.56 89.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.507 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.92 -31.79 59.3 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.93 -48.42 12.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.772 0.829 . . . . 0.0 110.751 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -91.12 -3.09 57.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.936 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 52.41 43.74 30.61 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.306 1.442 . . . . 0.0 110.316 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.33 129.61 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.1 134.45 51.86 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.204 1.186 . . . . 0.0 114.204 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.74 84.25 61.0 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.56 153.33 76.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.693 1.595 . . . . 0.0 109.729 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -27.74 63.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.652 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -59.62 -26.87 65.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.917 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.34 -48.2 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -50.09 61.79 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.444 1.497 . . . . 0.0 111.25 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -30.24 39.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.967 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.16 -27.13 59.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.586 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -141.42 68.5 26.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.334 1.454 . . . . 0.0 110.626 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.36 57.36 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.38 3.387 . . . . 0.0 114.012 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.64 147.25 37.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -54.65 -47.99 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 124.73 1.212 . . . . 0.0 107.879 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -52.24 -42.76 63.89 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.82 72.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.33 -40.17 64.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.69 68.54 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.094 -0.955 . . . . 0.0 108.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.21 -38.34 78.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.19 -51.9 61.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.823 0.849 . . . . 0.0 109.009 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.7 -39.67 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.24 77.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.364 1.066 . . . . 0.0 113.353 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 t -64.82 -28.93 69.9 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.831 0.707 . . . . 0.0 110.281 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 . . . . . 0 C--O 1.218 -0.555 0 CA-C-N 118.583 0.629 . . . . 0.0 109.861 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -55.34 133.44 49.62 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.81 1.244 . . . . 0.0 112.118 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.18 117.03 9.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.82 158.46 69.4 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 124.079 0.862 . . . . 0.0 109.425 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.91 139.66 75.25 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.611 1.541 . . . . 0.0 110.471 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -111.13 -10.45 14.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.654 1.182 . . . . 0.0 111.319 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -121.59 152.87 38.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.48 1.036 . . . . 0.0 109.238 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.7 -36.41 67.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.239 0.616 . . . . 0.0 111.496 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.95 -49.79 70.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.81 -35.87 77.6 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.473 0.709 . . . . 0.0 110.041 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 t -65.59 -49.07 70.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -54.41 -56.52 17.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.773 0.829 . . . . 0.0 110.208 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.12 -42.36 90.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.991 -1.004 . . . . 0.0 113.274 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.48 66.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 123.87 0.731 . . . . 0.0 109.981 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -72.46 -37.73 68.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.7 mm -59.14 -38.73 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -67.46 -41.1 85.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.737 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.06 -35.1 77.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.018 0.826 . . . . 0.0 109.165 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -71.0 -43.19 68.5 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.064 -1.023 . . . . 0.0 111.269 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.56 -54.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.63 0.772 . . . . 0.0 111.371 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.7 -26.73 66.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 111.731 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.3 59.8 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.938 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.36 174.22 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.945 1.298 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t -132.32 135.11 45.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.73 60.79 0.84 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.22 0.914 . . . . 0.0 112.973 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.44 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -90.84 121.75 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.25 163.46 31.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 118.831 0.741 . . . . 0.0 111.5 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.2 pt -65.12 -22.18 30.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.309 1.044 . . . . 0.0 110.937 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.95 21.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.62 1.968 . . . . 0.0 113.834 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.63 128.48 35.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.319 0.963 . . . . 0.0 110.433 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -75.83 118.31 18.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.148 0.979 . . . . 0.0 109.423 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' ILE . 87.5 t80 -48.92 -40.47 30.16 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.689 1.195 . . . . 0.0 111.792 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -72.34 -28.99 63.39 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 112.608 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -69.47 -33.0 72.26 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 32' ' ' ILE . 12.2 mt -75.86 29.64 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 126.199 1.8 . . . . 0.0 109.301 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 10.04 64.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 119.223 -2.173 . . . . 0.0 112.563 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.51 151.93 47.19 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.504 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.0 p80 -143.42 172.58 12.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.36 -53.96 6.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.99 1.316 . . . . 0.0 112.823 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tp -55.52 -47.32 76.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.694 0.679 . . . . 0.0 111.827 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 72.6 mmtt -59.94 -42.69 94.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.138 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.56 90.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.136 0.974 . . . . 0.0 109.257 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.45 ' HG2' HD23 ' A' ' 65' ' ' LEU . 63.4 mtm -61.44 -37.99 85.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.513 0.725 . . . . 0.0 109.772 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -28.9 68.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.171 0.588 . . . . 0.0 110.769 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.8 t -72.54 -48.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -29.99 59.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.14 -53.54 36.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 122.106 0.955 . . . . 0.0 108.815 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -65.27 -38.42 90.23 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.812 1.645 . . . . 0.0 109.824 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.09 -46.1 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 -38.92 87.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 118.693 0.678 . . . . 0.0 110.72 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -76.53 -31.9 57.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.28 -44.7 11.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.384 0.538 . . . . 0.0 112.13 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -93.14 -0.78 56.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.816 0.446 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 52.93 37.94 25.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.222 1.409 . . . . 0.0 110.984 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.1 129.7 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.413 0.625 . . . . 0.0 112.396 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.69 117.81 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.5 tp -111.4 88.77 9.43 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.57 157.13 63.2 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.974 1.782 . . . . 0.0 110.786 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.2 OUTLIER -61.14 -27.37 68.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.578 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -54.77 -28.83 51.69 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 110.89 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.87 -43.38 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.909 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -47.91 83.72 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.126 0.571 . . . . 0.0 111.054 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -33.16 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.2 -31.9 58.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.813 0.278 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -140.49 74.12 28.95 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.891 0.876 . . . . 0.0 109.153 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.87 53.28 3.23 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.373 3.382 . . . . 0.0 113.306 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.65 147.8 48.72 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.808 1.185 . . . . 0.0 110.612 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.31 -43.4 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -57.77 -47.33 82.84 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.51 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.03 97.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.0 -42.83 62.85 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.59 91.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 109.933 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.92 -44.96 72.05 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.477 0.58 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.34 -42.38 98.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.37 -37.65 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.9 -46.09 89.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.683 0.674 . . . . 0.0 110.213 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -29.54 70.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.464 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 . . . . . 0 N--CA 1.469 0.505 0 CA-C-N 119.096 0.862 . . . . 0.0 112.821 -179.693 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.491 ' HA ' HD21 ' A' ' 35' ' ' LEU . 2.5 t80 -58.82 138.23 57.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.494 1.517 . . . . 0.0 109.438 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.9 t -147.55 119.24 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.61 160.39 44.21 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.277 1.031 . . . . 0.0 109.535 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.62 152.08 58.31 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.103 2.535 . . . . 0.0 114.223 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -123.01 -18.49 6.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.282 2.233 . . . . 0.0 112.595 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.46 148.72 40.47 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.19 62.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.727 1.211 . . . . 0.0 110.547 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.45 -47.51 83.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.39 -31.28 71.92 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.598 0.759 . . . . 0.0 110.004 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -52.21 53.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.757 0.823 . . . . 0.0 110.231 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -57.54 -52.75 64.12 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.7 -42.09 83.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.653 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -33.4 65.42 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.79 0.436 . . . . 0.0 111.687 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.61 -48.69 66.08 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.068 0.461 . . . . 0.0 109.896 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.75 -34.82 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.089 0.956 . . . . 0.0 110.123 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -67.25 -43.71 81.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 119.033 0.833 . . . . 0.0 110.691 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.43 -44.78 76.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.783 0.833 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -60.06 -30.46 69.22 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.701 1.2 . . . . 0.0 113.084 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.35 -49.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.708 0.685 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -69.16 -23.04 63.9 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.51 1.124 . . . . 0.0 112.102 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 34.6 66.99 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.733 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.08 173.92 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -138.34 127.17 23.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.78 32.9 0.97 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 124.235 0.922 . . . . 0.0 111.006 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.25 127.76 31.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 -169.32 24.24 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.47 1.509 . . . . 0.0 110.64 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.236 1.815 . . . . 0.0 113.378 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.596 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.69 0.78 22.63 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -176.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' HD11 ' A' ' 41' ' ' ILE . 7.7 p-10 -60.04 122.31 14.04 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.986 1.714 . . . . 0.0 110.843 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -75.66 103.07 5.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -39.89 -48.56 2.33 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 113.766 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.63 -30.69 63.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.24 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.34 -32.17 72.09 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.406 1.003 . . . . 0.0 109.659 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' A' ' 36' ' ' ASP . 23.4 mt -71.37 -7.58 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 125.338 1.455 . . . . 0.0 110.493 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.16 3.0 41.84 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.552 1.073 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 151.5 52.28 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -142.34 176.93 8.62 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.269 -1.136 . . . . 0.0 108.21 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.44 -53.05 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.211 1.404 . . . . 0.0 112.33 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.21 -46.23 86.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.904 0.32 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.1 mmtp -61.56 -42.49 98.92 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.786 -0.571 . . . . 0.0 110.042 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.42 67.66 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.058 0.943 . . . . 0.0 109.94 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mmt -67.85 -38.77 83.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 109.484 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.74 70.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.025 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.5 t -76.26 -50.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.67 -36.14 34.35 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 112.756 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.55 63.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.816 0.817 . . . . 0.0 111.517 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -72.51 -33.63 67.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 122.193 0.997 . . . . 0.0 110.741 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.33 -46.27 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 C-N-CA 124.682 1.193 . . . . 0.0 108.892 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -61.67 -41.56 97.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -75.15 -29.19 60.41 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.428 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -87.08 -49.09 7.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.818 0.735 . . . . 0.0 112.615 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 61' ' ' VAL . 17.4 m-85 -90.89 -2.36 57.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.514 0.726 . . . . 0.0 110.74 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 53.69 38.7 28.99 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.855 0.752 . . . . 0.0 110.176 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.6 p -124.01 120.54 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.183 0.993 . . . . 0.0 111.695 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.42 111.07 7.29 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.73 85.35 3.86 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 122.962 0.505 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 154.67 69.88 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.488 2.792 . . . . 0.0 111.878 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -27.31 64.12 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.582 1.553 . . . . 0.0 110.016 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -53.18 -32.93 50.41 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.305 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.31 -46.49 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -43.59 72.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.908 0.483 . . . . 0.0 111.924 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -30.54 40.31 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 119.068 -0.492 . . . . 0.0 111.34 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.99 73.83 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.97 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -140.78 76.87 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 110.472 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.02 59.37 5.19 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.621 2.881 . . . . 0.0 114.057 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 148.52 38.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.347 0.976 . . . . 0.0 110.442 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 mm -60.48 -40.95 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -56.03 -45.32 79.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.202 0.456 . . . . 0.0 110.926 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.9 95.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.15 0.98 . . . . 0.0 113.465 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.18 -38.91 68.99 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.77 -51.39 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.652 0.66 . . . . 0.0 109.598 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -69.26 -33.09 72.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.962 0.801 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 83' ' ' THR . 84.8 t80 -67.05 -51.63 52.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.661 0.743 . . . . 0.0 109.071 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.7 -35.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -37.4 87.12 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.202 0.91 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 80' ' ' TYR . 1.2 t -71.05 -15.86 62.57 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.517 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.307 1.043 . . . . 0.0 113.059 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HA ' HD21 ' A' ' 35' ' ' LEU . 80.2 t80 -38.77 131.66 1.3 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.119 2.168 . . . . 0.0 114.54 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.5 t -144.44 116.95 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.17 162.19 56.92 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.77 147.4 41.0 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.57 2.18 . . . . 0.0 112.029 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -121.89 -1.58 9.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.016 1.326 . . . . 0.0 112.042 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.32 150.51 52.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.77 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.529 0.732 . . . . 0.0 111.243 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.52 -49.61 81.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.78 -35.72 69.02 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -49.46 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 110.609 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -55.31 -50.08 70.51 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.871 0.468 . . . . 0.0 110.452 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.89 -42.08 98.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.889 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.05 67.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 123.694 0.621 . . . . 0.0 110.561 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.72 -40.04 76.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.466 0.576 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.75 -38.19 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -62.32 -38.86 91.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.75 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -59.82 -39.15 84.09 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 118.611 0.641 . . . . 0.0 110.119 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.3 mtm-85 -68.74 -44.33 74.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.789 1.177 . . . . 0.0 113.93 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.05 -43.28 58.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 122.231 0.213 . . . . 0.0 111.132 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.49 -21.83 38.43 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 122.574 0.35 . . . . 0.0 111.316 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.81 35.71 90.06 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.454 -1.192 . . . . 0.0 111.56 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.47 175.13 10.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 t -132.11 150.06 52.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.39 52.06 1.26 Allowed Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.735 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.63 130.18 41.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.67 19.87 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 126.711 2.101 . . . . 0.0 109.773 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.6 pt -83.03 -22.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.97 -1.13 19.22 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.3 119.08 26.19 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 122.834 1.302 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.41 124.02 20.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.095 1.758 . . . . 0.0 111.19 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -48.04 -46.41 33.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.998 1.719 . . . . 0.0 110.633 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.52 -31.38 69.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.541 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -71.41 -34.52 70.43 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -70.86 -31.13 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.37 -11.67 4.08 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.008 0.822 . . . . 0.0 113.825 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.89 159.74 27.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.353 1.076 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -147.56 178.86 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.445 1.498 . . . . 0.0 108.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.51 -53.33 7.12 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.076 1.351 . . . . 0.0 113.304 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tp -56.03 -49.0 74.91 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.276 0.944 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.55 -44.44 96.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.349 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -53.12 -39.42 63.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.634 0.774 . . . . 0.0 110.46 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.5 mtm -66.05 -37.47 85.92 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -40.44 88.18 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.9 -52.73 57.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -28.62 63.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.448 1.099 . . . . 0.0 112.845 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.38 -49.83 31.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.843 0.747 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -65.57 -36.38 83.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.706 0.402 . . . . 0.0 110.04 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.51 -40.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -59.57 -40.32 86.96 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 119.218 0.917 . . . . 0.0 109.799 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.25 7.4 ptm180 -77.09 -33.42 56.99 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -80.68 -39.76 26.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -101.54 -1.36 33.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.791 0.436 . . . . 0.0 110.66 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 56.02 38.85 30.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.735 1.214 . . . . 0.0 110.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' HIS . 11.8 p -148.85 133.13 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 O-C-N 121.654 -0.653 . . . . 0.0 112.629 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.14 141.67 58.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.339 1.855 . . . . 0.0 112.817 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.7 tp -128.75 96.61 29.27 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 109.912 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.95 153.49 68.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.621 2.214 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.86 68.11 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.49 1.516 . . . . 0.0 110.13 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -52.92 -27.56 19.33 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.023 0.929 . . . . 0.0 110.082 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 46.2 t -88.02 -49.11 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.69 1.196 . . . . 0.0 109.534 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -57.46 -45.18 85.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -24.17 45.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.986 0.914 . . . . 0.0 112.518 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.49 -39.31 22.64 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.488 0.586 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.24 77.21 30.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 O-C-N 124.168 0.918 . . . . 0.0 110.893 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.04 57.75 2.71 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.894 3.729 . . . . 0.0 113.228 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -141.73 149.77 40.92 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 121.245 1.839 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.1 -40.24 76.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -57.05 -46.66 82.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.909 0.777 . . . . 0.0 111.192 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.45 86.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.72 -42.65 63.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.3 70.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.96 0.904 . . . . 0.0 109.802 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.83 -39.0 76.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.367 0.53 . . . . 0.0 111.639 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 34.3 t80 -64.2 -46.93 81.72 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.85 -41.53 77.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.23 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.01 90.41 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.643 1.11 . . . . 0.0 112.268 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -63.93 -20.89 66.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.713 0.688 . . . . 0.0 110.873 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 . . . . . 0 C--O 1.235 0.335 0 C-N-CA 124.034 0.933 . . . . 0.0 110.164 178.563 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HA ' HD21 ' A' ' 35' ' ' LEU . 12.3 t80 -50.38 137.25 19.01 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.592 1.557 . . . . 0.0 110.997 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.1 t -142.03 118.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.91 162.18 31.94 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.458 0.703 . . . . 0.0 110.567 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.13 154.64 69.5 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.015 1.81 . . . . 0.0 109.231 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -129.73 -12.9 4.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -121.09 153.18 37.79 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -23.47 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.94 -49.84 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.552 1.523 . . . . 0.0 108.64 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -55.14 -45.3 75.63 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.406 1.882 . . . . 0.0 108.689 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.2 t -56.6 -37.92 71.31 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.031 2.132 . . . . 0.0 110.71 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.2 mmpt? -78.02 -45.44 23.67 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.67 -41.18 94.54 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.77 72.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.493 1.121 . . . . 0.0 109.858 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.21 -43.02 74.95 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.23 0.468 . . . . 0.0 110.501 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.86 -37.45 80.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.453 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -61.88 -44.57 96.54 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.902 0.774 . . . . 0.0 110.759 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -52.15 -47.13 65.59 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.536 1.134 . . . . 0.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -59.91 -16.15 27.3 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 51' ' ' VAL . 4.7 t -111.85 -43.02 4.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.057 0.943 . . . . 0.0 111.821 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.02 -26.25 60.33 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 121.76 -0.587 . . . . 0.0 110.672 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.18 50.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 118.379 0.536 . . . . 0.0 111.809 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.48 169.62 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -138.03 111.4 8.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 108.063 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.91 69.58 0.44 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.021 1.296 . . . . 0.0 110.677 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.45 122.04 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.364 1.466 . . . . 0.0 109.544 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.54 161.05 44.24 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.19 0.905 . . . . 0.0 110.849 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 5.9 pt -69.5 -21.29 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 121.469 -1.018 . . . . 0.0 112.581 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.6 -4.77 17.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.87 2.068 . . . . 0.0 112.836 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -71.91 122.56 21.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.675 0.67 . . . . 0.0 109.627 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -70.62 114.32 8.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.286 1.435 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -42.86 -42.07 3.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.863 1.665 . . . . 0.0 114.341 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -75.43 -27.41 58.96 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.431 -0.793 . . . . 0.0 111.965 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.0 -28.41 64.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.097 0.862 . . . . 0.0 109.325 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.77 29.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.836 2.054 . . . . 0.0 109.118 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.88 -0.87 49.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 119.786 -1.821 . . . . 0.0 113.834 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.29 157.0 49.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 119.032 1.416 . . . . 0.0 110.811 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -143.49 173.95 11.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.09 -30.07 24.37 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.71 -52.23 22.29 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.4 mmtp -55.44 -41.38 72.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 109.832 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.99 64.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.561 0.745 . . . . 0.0 111.74 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.91 -38.33 61.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.305 1.042 . . . . 0.0 110.004 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.3 75.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.41 0.284 . . . . 0.0 110.252 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 HG21 ' A' ' 26' ' ' VAL . 11.6 t -76.62 -45.83 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.84 -34.08 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.35 1.06 . . . . 0.0 112.35 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.14 82.56 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.558 0.694 . . . . 0.0 109.854 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -67.97 -42.74 80.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.294 1.037 . . . . 0.0 110.164 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -62.46 -47.83 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 123.731 0.813 . . . . 0.0 109.502 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.24 90.4 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.024 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -75.74 -33.04 60.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.6 -49.28 8.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.543 0.611 . . . . 0.0 111.041 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -88.2 1.92 53.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.393 0.677 . . . . 0.0 111.502 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 51.73 38.9 24.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.984 1.314 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.55 128.4 7.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 O-C-N 121.233 -0.917 . . . . 0.0 112.408 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.34 122.07 15.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.64 88.65 14.0 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.86 160.31 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.268 1.312 . . . . 0.0 110.99 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.91 -26.0 58.37 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.307 1.443 . . . . 0.0 108.559 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -51.88 -44.47 63.73 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.22 1.008 . . . . 0.0 111.718 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 t -77.69 -40.88 28.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.45 0.7 . . . . 0.0 109.633 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -42.14 98.62 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.603 0.761 . . . . 0.0 110.718 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -41.54 23.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.47 78.92 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.496 -0.882 . . . . 0.0 112.54 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -143.08 74.95 17.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.156 0.982 . . . . 0.0 111.319 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 59.85 2.46 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.879 3.719 . . . . 0.0 113.302 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.01 147.59 37.14 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.285 -1.509 . . . . 0.0 109.829 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 34' ' ' ILE . 21.6 mm -60.03 -44.38 94.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -57.11 -44.89 83.69 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.029 0.831 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.79 93.49 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.005 0.522 . . . . 0.0 111.895 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.4 -44.43 71.43 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.35 65.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.719 0.808 . . . . 0.0 110.923 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -72.34 -34.53 68.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.978 0.808 . . . . 0.0 112.457 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -68.38 -52.51 32.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.257 0.623 . . . . 0.0 110.357 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.79 -44.54 85.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.172 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.97 77.21 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -75.81 -26.17 57.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.357 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.401 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' HA ' HD21 ' A' ' 35' ' ' LEU . 9.6 t80 -52.8 137.6 31.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.049 2.14 . . . . 0.0 111.205 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -144.85 117.52 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.01 152.86 82.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.49 150.46 75.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.85 2.367 . . . . 0.0 110.475 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 p -127.1 -17.78 4.74 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -102.4 142.28 33.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -22.42 0.91 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.598 1.559 . . . . 0.0 115.089 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.43 -48.81 19.51 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.021 0 CA-C-N 119.25 0.932 . . . . 0.0 109.376 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.23 -45.82 72.41 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.875 2.07 . . . . 0.0 110.14 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 t -59.19 -38.76 80.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.526 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -70.66 -38.85 73.85 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.128 0.422 . . . . 0.0 111.829 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.09 -40.06 86.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 -34.51 73.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 123.843 0.714 . . . . 0.0 109.482 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -63.86 -49.39 72.95 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 118.397 0.544 . . . . 0.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.1 -37.87 80.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.923 0.489 . . . . 0.0 110.053 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -64.03 -42.34 97.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.229 -0.92 . . . . 0.0 109.974 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -62.39 -32.36 73.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.047 0.939 . . . . 0.0 109.808 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.73 -43.03 26.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.172 -0.955 . . . . 0.0 111.37 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.65 -55.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.3 mt -68.47 -30.22 69.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.236 0.614 . . . . 0.0 112.082 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.85 43.34 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 123.664 0.649 . . . . 0.0 111.81 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.21 175.58 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.989 1.715 . . . . 0.0 108.144 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -138.57 139.72 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 107.758 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.74 38.76 2.31 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.38 0.514 . . . . 0.0 112.925 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.528 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -81.69 122.28 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.81 -178.39 30.76 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.578 1.561 . . . . 0.0 110.831 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 pt -74.09 -26.72 21.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 O-C-N 121.403 -1.057 . . . . 0.0 113.179 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.03 -3.5 23.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.711 2.004 . . . . 0.0 113.95 -178.344 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.0 m-20 -68.04 116.58 8.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -73.61 127.69 33.45 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.6 t80 -48.97 -45.64 42.38 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.499 1.12 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.98 -38.66 91.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.467 0.707 . . . . 0.0 110.879 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -66.81 -20.74 66.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.772 1.229 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 32' ' ' ILE . 11.3 mt -89.39 7.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 120.98 -1.075 . . . . 0.0 108.118 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.94 0.64 87.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 119.631 -1.918 . . . . 0.0 113.676 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.45 139.51 30.61 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.425 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 24.5 p80 -121.99 175.19 6.45 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.161 -1.199 . . . . 0.0 108.434 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.053 0.941 . . . . 0.0 112.94 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.172 0.442 . . . . 0.0 111.907 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 16.6 mmtp -64.64 -42.38 95.51 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.0 79.02 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.832 1.253 . . . . 0.0 111.265 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.4 mmt -55.65 -42.83 75.61 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.819 0.848 . . . . 0.0 110.193 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.59 -38.6 91.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.838 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.25 -48.49 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.54 -28.25 59.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.514 0.726 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -50.56 47.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.927 0.785 . . . . 0.0 110.081 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -68.27 -36.53 79.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.05 0.929 . . . . 0.0 110.328 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -67.3 -45.67 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -40.16 86.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.021 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -75.87 -31.22 59.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -84.97 -48.24 9.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.551 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -87.07 -1.63 58.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 52.33 39.01 26.47 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 111.089 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.9 138.26 14.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.55 125.08 28.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.975 0.893 . . . . 0.0 110.172 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tt -113.82 91.87 23.19 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.42 155.32 70.66 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.424 1.416 . . . . 0.0 110.935 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.15 -28.83 19.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.126 1.37 . . . . 0.0 111.686 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.68 -44.35 66.17 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.554 0.742 . . . . 0.0 112.236 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 80' ' ' TYR . 48.4 t -80.84 -37.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -44.56 95.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.208 0.603 . . . . 0.0 110.491 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -40.8 26.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.561 1.545 . . . . 0.0 110.934 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.01 71.75 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.992 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -134.25 70.65 73.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.66 0.784 . . . . 0.0 110.161 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.12 59.35 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.562 3.508 . . . . 0.0 111.908 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.96 147.9 37.73 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.878 1.672 . . . . 0.0 109.396 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.45 -42.79 85.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.78 -49.07 66.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.869 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.27 -40.4 90.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.05 -38.5 66.48 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.28 69.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.385 0.538 . . . . 0.0 110.208 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.13 -39.38 72.03 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.239 0.337 . . . . 0.0 111.795 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 67' ' ' VAL . 48.6 t80 -63.75 -47.37 81.29 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 110.018 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.21 -37.38 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.95 -46.74 88.44 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.632 1.105 . . . . 0.0 112.082 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -63.41 -17.38 62.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.28 0.491 . . . . 0.0 110.467 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 . . . . . 0 C--N 1.342 0.277 0 O-C-N 120.953 -1.092 . . . . 0.0 112.05 178.882 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.489 ' HA ' HD21 ' A' ' 35' ' ' LEU . 38.6 t80 -51.36 135.42 27.01 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -147.92 117.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 162.18 14.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.378 1.071 . . . . 0.0 110.228 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.15 151.02 84.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.382 2.054 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 -6.02 3.62 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.965 0.906 . . . . 0.0 111.995 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -117.38 140.09 50.02 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.15 -33.81 41.98 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.82 -38.12 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.847 0.749 . . . . 0.0 109.667 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.9 -38.76 92.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -61.93 -46.65 88.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.598 1.159 . . . . 0.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -56.56 -58.13 9.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.893 0.877 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.76 -36.35 83.59 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.017 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.17 63.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.424 0.689 . . . . 0.0 110.764 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.15 -48.39 23.86 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -54.39 -41.42 53.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.126 1.371 . . . . 0.0 111.151 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -61.97 -42.22 98.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.729 0.812 . . . . 0.0 111.558 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.64 -46.05 87.95 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.5 mmm-85 -62.27 -23.92 66.97 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.929 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -92.4 -55.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 119.929 1.241 . . . . 0.0 109.445 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.36 -23.87 66.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.82 33.75 57.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.99 174.11 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.8 p -134.7 132.08 38.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.307 1.443 . . . . 0.0 107.698 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.71 45.74 0.95 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 123.966 0.793 . . . . 0.0 113.21 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.2 121.89 27.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.86 35.68 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.3 0.952 . . . . 0.0 111.029 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.5 pt -81.69 -21.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 120.45 -1.618 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.82 1.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.137 1.775 . . . . 0.0 113.418 -178.521 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.66 122.44 15.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.931 1.348 . . . . 0.0 111.828 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -81.02 108.34 14.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.1 t80 -44.88 -45.15 10.14 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.974 1.709 . . . . 0.0 113.718 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -73.73 -27.83 61.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.537 -0.727 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.37 -30.25 69.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 38' ' ' PHE . 16.2 mt -77.37 6.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 126.484 1.914 . . . . 0.0 109.984 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 3.35 79.84 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 119.659 -1.901 . . . . 0.0 112.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.58 157.98 47.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 107.817 -2.113 . . . . 0.0 107.817 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.451 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 18.6 p80 -147.06 178.59 8.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.61 -54.63 5.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.913 1.285 . . . . 0.0 112.247 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.04 -45.8 75.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 64.8 mmtt -64.41 -44.07 92.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -40.09 68.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.309 1.044 . . . . 0.0 111.459 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 mtm -65.68 -35.47 80.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.524 0.33 . . . . 0.0 111.168 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.95 78.49 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.949 0.9 . . . . 0.0 111.612 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.01 -41.68 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.74 70.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.484 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.76 48.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.59 -38.59 85.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.93 -46.36 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -40.93 90.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.52 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -29.37 58.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.83 -48.44 8.76 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 61' ' ' VAL . 53.1 m-85 -96.23 2.16 52.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 111.505 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 55.85 31.83 18.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.264 0.626 . . . . 0.0 111.877 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.8 p -133.87 128.99 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 123.317 0.647 . . . . 0.0 112.601 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.54 124.98 25.54 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.6 tp -112.22 87.63 9.39 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.05 156.81 64.42 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.753 0.969 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -27.54 65.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.261 1.024 . . . . 0.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.77 -29.08 62.28 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.961 0.8 . . . . 0.0 111.079 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 80' ' ' TYR . 49.4 t -86.64 -43.5 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -49.06 79.24 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 123.055 0.542 . . . . 0.0 111.159 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -29.12 61.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.62 -29.91 27.33 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.635 0.652 . . . . 0.0 112.085 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -138.58 68.02 44.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 109.213 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.78 57.95 4.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.56 2.84 . . . . 0.0 114.88 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.16 148.21 37.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.383 0.992 . . . . 0.0 110.558 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -56.28 -44.08 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -52.31 -49.66 63.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.894 0.77 . . . . 0.0 111.42 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.18 99.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.05 -43.09 62.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.262 1.425 . . . . 0.0 108.516 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.82 88.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -73.31 -37.12 66.3 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.253 0.621 . . . . 0.0 111.493 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 67' ' ' VAL . 17.3 t80 -65.51 -41.11 93.52 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.16 -43.6 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.69 90.64 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -15.86 63.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.328 0.651 . . . . 0.0 112.23 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 . . . . . 0 N--CA 1.462 0.151 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 178.224 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -42.95 124.5 3.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.4 1.88 . . . . 0.0 114.967 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.0 t -146.86 116.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.04 161.62 15.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.109 1.763 . . . . 0.0 112.672 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.06 148.47 93.1 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.625 2.883 . . . . 0.0 112.65 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 p -114.66 -21.14 10.38 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.255 1.422 . . . . 0.0 113.656 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -109.97 162.86 14.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.377 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -34.28 77.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.837 1.655 . . . . 0.0 110.612 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.1 -50.99 28.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.75 -43.4 76.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 126.342 1.857 . . . . 0.0 109.427 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -65.52 -32.96 74.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.328 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -68.45 -48.7 63.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.786 1.176 . . . . 0.0 108.896 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.65 -41.86 82.31 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.086 0.955 . . . . 0.0 110.918 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.02 67.84 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.207 1.003 . . . . 0.0 111.95 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -77.42 -37.35 51.96 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 118.937 0.79 . . . . 0.0 110.127 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.89 -40.17 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.518 -0.739 . . . . 0.0 109.76 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -59.41 -39.21 82.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.302 0.641 . . . . 0.0 111.874 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -63.69 -32.84 74.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.495 0.718 . . . . 0.0 110.902 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -68.01 -35.7 78.73 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.817 -1.177 . . . . 0.0 111.484 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.22 -54.83 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.27 0.628 . . . . 0.0 110.838 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.18 -24.83 57.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.4 21.67 69.3 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.426 1.012 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 m -105.15 175.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.505 1.122 . . . . 0.0 110.458 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 t -139.32 112.75 8.28 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.35 62.8 0.34 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 123.202 0.429 . . . . 0.0 112.435 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.7 mm -86.63 137.83 20.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.83 177.19 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 124.89 1.233 . . . . 0.0 111.741 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 pt -78.87 -22.42 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 121.082 -1.246 . . . . 0.0 113.41 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.72 0.78 22.58 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.251 34.9 p30 -76.11 129.56 36.98 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 123.192 1.472 . . . . 0.0 112.706 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -74.1 111.59 9.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.849 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' HD12 ' A' ' 41' ' ' ILE . 85.4 t80 -43.46 -45.94 6.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.737 1.615 . . . . 0.0 112.604 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -66.99 -37.02 83.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -67.62 -31.45 71.48 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.652 0.781 . . . . 0.0 109.98 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 38' ' ' PHE . 24.2 mt -71.98 -6.26 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.286 1.034 . . . . 0.0 109.27 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.39 10.24 27.78 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 126.024 1.774 . . . . 0.0 112.908 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.9 159.31 47.46 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.878 1.339 . . . . 0.0 110.111 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' HIS . . . . . 0.436 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 20.1 p80 -146.86 178.07 8.62 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.344 1.458 . . . . 0.0 107.906 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.57 -54.75 5.77 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.633 1.173 . . . . 0.0 112.739 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -54.95 -50.54 68.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.857 0.863 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.2 mmtp -61.86 -39.31 91.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.893 -1.051 . . . . 0.0 111.149 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.96 96.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.497 1.044 . . . . 0.0 108.847 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.4 mtm -66.69 -37.45 84.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.942 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.31 92.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.221 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.9 t -72.65 -45.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.691 1.132 . . . . 0.0 108.057 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.32 -32.74 57.35 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.938 0.895 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.03 83.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.213 0.461 . . . . 0.0 111.064 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -77.74 -43.33 31.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 122.002 0.906 . . . . 0.0 108.885 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.78 -46.46 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 124.049 0.94 . . . . 0.0 109.605 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -60.61 -41.08 94.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.778 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -75.53 -32.39 60.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -82.51 -45.99 13.99 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 123.219 0.607 . . . . 0.0 111.873 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB2' HG12 ' A' ' 61' ' ' VAL . 71.9 m-85 -93.96 -3.01 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.899 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 53.82 46.97 24.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.754 1.221 . . . . 0.0 108.761 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 59' ' ' TYR . 8.6 p -140.08 126.97 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 48.0 tt0 -73.04 115.0 11.84 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.66 88.54 16.47 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.81 153.85 63.9 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.05 1.167 . . . . 0.0 109.725 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.84 -26.36 9.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.855 2.062 . . . . 0.0 110.35 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.29 -44.35 64.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.616 1.166 . . . . 0.0 110.641 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 56.5 t -77.66 -45.72 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.566 0.747 . . . . 0.0 109.085 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -42.62 74.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.453 0.701 . . . . 0.0 110.716 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -37.45 28.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.281 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.44 98.81 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.336 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -137.64 83.38 25.05 Favored Pre-proline 0 N--CA 1.448 -0.56 0 O-C-N 124.396 1.06 . . . . 0.0 109.222 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 60.77 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.164 2.576 . . . . 0.0 110.95 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.18 148.66 38.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.972 1.715 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mm -57.17 -43.01 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.83 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.55 -48.99 76.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.864 0.756 . . . . 0.0 111.587 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.69 -41.45 86.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.148 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.4 -42.25 62.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.26 76.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.703 1.201 . . . . 0.0 110.849 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -37.88 64.94 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.894 0.77 . . . . 0.0 110.311 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 43.8 t80 -63.31 -48.08 79.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.535 0.607 . . . . 0.0 110.929 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.432 HG13 HG11 ' A' ' 61' ' ' VAL . 28.8 t -69.7 -40.82 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.11 86.57 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 118.998 0.817 . . . . 0.0 112.528 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 t -73.16 -13.93 61.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.231 0.469 . . . . 0.0 110.118 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 . . . . . 0 C--O 1.225 -0.201 0 CA-C-N 119.542 1.064 . . . . 0.0 109.684 177.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -48.11 125.47 9.24 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.806 2.442 . . . . 0.0 110.48 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.2 t -135.22 117.39 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 152.89 72.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.056 0.942 . . . . 0.0 111.458 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.49 151.57 84.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.951 2.434 . . . . 0.0 111.081 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -129.2 -13.87 4.4 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.719 1.208 . . . . 0.0 111.229 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 25.0 t-20 -90.08 152.09 21.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.28 70.78 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.899 0.48 . . . . 0.0 110.162 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -78.28 -51.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.734 1.614 . . . . 0.0 110.833 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 2.1 mt-10 -55.37 -37.96 68.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.132 0.573 . . . . 0.0 110.089 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 t -59.97 -52.29 66.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 123.843 0.714 . . . . 0.0 109.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.4 mmpt? -56.5 -49.2 75.4 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.75 -38.8 92.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 117.486 -1.245 . . . . 0.0 111.075 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.15 -30.09 70.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.76 0.709 . . . . 0.0 110.174 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.98 -44.08 97.01 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -63.52 -39.23 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.689 1.196 . . . . 0.0 109.586 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -55.46 -43.85 75.86 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.868 0.758 . . . . 0.0 109.967 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.4 -32.28 72.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.745 0.702 . . . . 0.0 110.643 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -76.22 -16.36 59.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.486 -1.384 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.04 -36.23 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.641 0.776 . . . . 0.0 110.078 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.19 -42.13 12.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.971 1.308 . . . . 0.0 111.537 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.75 40.32 7.24 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.394 -1.226 . . . . 0.0 110.948 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.253 3.4 m -128.24 177.22 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.664 1.232 . . . . 0.0 108.686 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.3 t -143.59 108.26 4.88 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 119.981 -1.7 . . . . 0.0 108.233 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.97 41.93 0.15 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.453 1.501 . . . . 0.0 114.167 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 41' ' ' ILE . 39.5 mm -76.42 145.38 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 120.193 1.997 . . . . 0.0 108.507 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.03 175.5 15.88 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.389 1.947 . . . . 0.0 110.079 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 pt -75.63 -30.83 22.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.433 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -101.13 -0.52 36.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.523 1.129 . . . . 0.0 113.382 -178.368 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.2 m-20 -69.53 116.59 10.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -67.45 117.57 9.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 84.3 t80 -45.94 -45.58 15.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.542 1.537 . . . . 0.0 111.893 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -70.67 -29.77 66.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.45 0.7 . . . . 0.0 112.53 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -76.91 -30.29 56.08 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.51 -0.744 . . . . 0.0 110.39 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 32' ' ' ILE . 32.3 mt -70.72 -31.05 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.264 0.484 . . . . 0.0 110.389 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.58 -2.45 2.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.907 1.242 . . . . 0.0 111.651 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.7 157.83 53.59 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -136.66 172.96 12.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.83 -45.92 20.5 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.336 0.654 . . . . 0.0 112.47 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.03 -49.29 78.46 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.517 0.598 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -60.64 -38.83 86.1 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.395 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -35.23 62.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.844 1.202 . . . . 0.0 111.006 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.6 mtm -73.85 -42.06 61.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.55 74.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.082 1.353 . . . . 0.0 111.327 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.9 -53.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.98 -36.28 65.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.081 0.952 . . . . 0.0 112.316 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.21 -52.49 65.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.692 0.797 . . . . 0.0 111.565 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -75.72 -33.27 60.3 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.635 -0.666 . . . . 0.0 111.799 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.99 -44.09 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.658 1.183 . . . . 0.0 108.909 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -41.08 88.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.611 0.641 . . . . 0.0 110.261 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.69 -34.44 60.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.89 -48.16 13.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.802 0.689 . . . . 0.0 111.585 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CB ' HG12 ' A' ' 61' ' ' VAL . 23.7 m-85 -91.34 3.18 55.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.165 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 48.8 38.81 12.67 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.269 1.428 . . . . 0.0 110.445 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 81' ' ' VAL . 7.3 p -143.46 117.65 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 123.678 0.791 . . . . 0.0 110.14 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -64.12 140.01 58.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 tt -120.38 84.54 35.44 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.85 144.81 94.16 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.3 14.81 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.885 1.274 . . . . 0.0 110.462 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -53.28 -35.11 59.73 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 t -87.97 -44.24 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 119.121 0.873 . . . . 0.0 109.135 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -51.63 63.29 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 123.536 0.734 . . . . 0.0 110.796 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -71.57 -37.91 70.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.295 0.638 . . . . 0.0 111.573 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.6 84.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.75 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.86 78.6 29.82 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.861 1.264 . . . . 0.0 108.653 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 55.39 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.846 3.031 . . . . 0.0 111.043 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.25 147.16 47.41 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.194 0.906 . . . . 0.0 110.098 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 74' ' ' ILE . 4.5 mm -61.17 -39.3 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.31 -51.2 60.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 111.867 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.31 97.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.695 1.598 . . . . 0.0 114.212 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.1 -40.4 65.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.847 1.259 . . . . 0.0 108.417 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -51.75 68.22 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 119.028 0.831 . . . . 0.0 109.385 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.77 -38.5 89.23 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.497 0.319 . . . . 0.0 111.622 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.93 -51.97 48.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.246 1.018 . . . . 0.0 110.377 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.633 HG13 HG11 ' A' ' 61' ' ' VAL . 70.9 t -66.42 -41.84 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 123.346 0.404 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.18 78.67 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -70.9 -24.91 62.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.68 0.218 . . . . 0.0 110.568 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.461 0.12 0 O-C-N 120.687 -1.258 . . . . 0.0 108.694 178.59 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -52.01 123.33 10.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 0.0 111.638 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -138.37 117.26 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 160.07 44.08 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.356 1.462 . . . . 0.0 110.101 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.33 145.16 99.18 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.887 3.058 . . . . 0.0 113.353 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -116.65 -11.67 10.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 0.0 112.391 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -125.3 145.4 50.03 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.33 -29.31 9.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.372 1.069 . . . . 0.0 112.863 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.47 -53.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.673 0.749 . . . . 0.0 109.58 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -55.85 -42.96 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.605 1.962 . . . . 0.0 109.272 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -66.08 -31.82 72.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.424 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -72.31 -40.37 67.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.038 1.29 . . . . 0.0 109.761 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -69.07 -39.07 79.3 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.079 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 -33.83 70.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.487 1.117 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -69.55 -40.79 76.62 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 117.999 0.363 . . . . 0.0 111.171 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.18 -36.39 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -62.49 -35.64 80.0 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.652 -0.655 . . . . 0.0 109.659 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.54 -39.9 88.82 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.59 -0.694 . . . . 0.0 109.624 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -65.84 -38.81 89.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 51' ' ' VAL . 48.8 t -81.37 -44.57 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.0 mt -85.91 -24.03 26.77 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.055 0.542 . . . . 0.0 112.128 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.29 31.15 59.61 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.268 -0.74 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.27 171.33 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.7 p -143.04 138.22 29.8 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.954 1.252 . . . . 0.0 111.521 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.34 42.6 1.05 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.978 1.275 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.49 121.55 28.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.786 0.834 . . . . 0.0 109.68 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -90.97 169.31 33.48 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.67 1.129 . . . . 0.0 110.67 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.3 pt -71.28 -25.94 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.099 -1.236 . . . . 0.0 111.973 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.28 1.03 32.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.069 2.147 . . . . 0.0 112.724 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.676 ' HB3' HD11 ' A' ' 41' ' ' ILE . 10.8 m-20 -65.68 116.73 7.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.15 0.98 . . . . 0.0 108.559 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -74.78 112.83 11.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.0 t80 -43.08 -52.46 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.503 1.521 . . . . 0.0 112.471 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.74 -33.02 72.28 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.319 -0.863 . . . . 0.0 111.666 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -68.65 -23.09 64.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.117 0.967 . . . . 0.0 110.461 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 36' ' ' ASP . 15.2 mt -84.25 14.01 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 125.339 1.456 . . . . 0.0 109.157 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 9.6 70.21 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 119.368 -2.083 . . . . 0.0 113.721 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 170.51 54.31 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 118.306 1.053 . . . . 0.0 112.047 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -155.08 176.7 12.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 108.03 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.92 -46.09 60.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.558 0.743 . . . . 0.0 112.563 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.26 -49.1 72.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.122 0.874 . . . . 0.0 109.401 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -59.38 -46.58 88.28 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.38 62.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.052 0.842 . . . . 0.0 113.048 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.1 mtm -75.63 -39.79 57.28 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 109.776 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.086 1.354 . . . . 0.0 111.574 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 26' ' ' VAL . 97.8 t -68.71 -53.56 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.89 61.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.356 1.463 . . . . 0.0 113.779 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.32 -50.63 59.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.493 1.042 . . . . 0.0 108.646 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.05 -31.96 56.58 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 121.984 0.897 . . . . 0.0 110.992 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.63 -42.58 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -42.1 98.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.311 0.96 . . . . 0.0 109.573 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -74.18 -30.02 62.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.188 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.89 -49.55 10.88 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.822 0.737 . . . . 0.0 110.379 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.84 -1.56 57.89 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 55.68 40.89 30.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.991 1.317 . . . . 0.0 109.804 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.585 HG11 HG13 ' A' ' 81' ' ' VAL . 2.5 p -150.38 130.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.76 128.25 34.96 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.132 0.573 . . . . 0.0 109.548 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.75 86.7 13.39 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.41 141.75 52.22 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.713 1.608 . . . . 0.0 109.735 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -27.33 16.84 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.742 1.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -53.9 -32.25 52.75 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.057 0.844 . . . . 0.0 111.577 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 80' ' ' TYR . 59.4 t -86.81 -46.54 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -54.58 -47.73 72.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.509 1.124 . . . . 0.0 111.488 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.94 -36.46 62.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.149 0.58 . . . . 0.0 111.003 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -33.11 67.58 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.224 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -141.36 74.43 24.17 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.385 1.474 . . . . 0.0 109.366 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.98 56.49 3.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 125.062 3.841 . . . . 0.0 113.894 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.45 148.35 42.62 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.883 -1.136 . . . . 0.0 111.773 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -56.7 -42.96 78.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -54.99 -49.89 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.163 0.438 . . . . 0.0 110.892 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.48 97.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.24 -40.86 70.79 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.41 79.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.441 0.564 . . . . 0.0 110.206 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.25 -40.48 67.65 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.923 0.489 . . . . 0.0 111.728 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' CE1' HG21 ' A' ' 67' ' ' VAL . 61.2 t80 -63.27 -43.82 96.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.585 HG13 HG11 ' A' ' 61' ' ' VAL . 74.2 t -74.03 -35.89 42.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.866 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -35.59 71.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.248 0.931 . . . . 0.0 112.73 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 t -82.31 -18.64 41.56 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.216 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 . . . . . 0 N--CA 1.468 0.46 0 CA-C-N 119.742 1.155 . . . . 0.0 109.506 179.227 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . 0.433 ' HA ' HD21 ' A' ' 35' ' ' LEU . 5.9 t80 -50.48 133.88 24.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.957 2.103 . . . . 0.0 112.791 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.55 118.98 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.46 157.59 77.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.251 1.02 . . . . 0.0 111.614 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 155.3 71.38 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.484 2.789 . . . . 0.0 112.926 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.3 t -130.78 -20.22 2.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.466 1.107 . . . . 0.0 112.419 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 7.4 t-20 -98.72 143.72 28.77 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.99 -27.1 12.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.02 0.928 . . . . 0.0 113.49 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.95 -46.64 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 120.388 1.449 . . . . 0.0 109.186 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 3.9 mt-10 -56.82 -35.27 68.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.21 1.404 . . . . 0.0 110.471 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -63.2 -49.09 75.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -57.42 -48.64 78.59 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.36 -41.68 94.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.664 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.67 -34.6 73.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.725 0.641 . . . . 0.0 109.93 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -66.41 -50.59 62.93 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.55 -37.38 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.286 1.034 . . . . 0.0 110.339 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -62.43 -44.8 95.54 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.718 0.69 . . . . 0.0 111.204 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.35 -32.86 70.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.227 0.611 . . . . 0.0 111.538 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -67.69 -43.02 81.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.523 0.601 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.7 -52.05 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 123.646 0.778 . . . . 0.0 111.864 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.88 -25.63 62.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.636 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.53 57.94 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.12 174.64 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.648 1.179 . . . . 0.0 110.023 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -144.07 114.45 7.52 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.36 27.17 0.52 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.727 1.156 . . . . 0.0 112.36 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.13 125.48 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.687 1.243 . . . . 0.0 110.819 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 175.76 22.42 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.367 1.461 . . . . 0.0 112.051 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.28 -28.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 121.098 -1.237 . . . . 0.0 112.193 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.61 2.28 28.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.465 1.906 . . . . 0.0 112.53 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.19 122.84 17.59 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.21 119.43 25.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.513 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -46.79 -46.44 20.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.236 1.814 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -74.75 -31.36 61.78 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.647 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -63.62 -36.97 85.57 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.8 mt -72.13 6.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 125.455 1.502 . . . . 0.0 109.809 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.61 3.72 80.61 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 119.543 -1.973 . . . . 0.0 111.309 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.87 145.8 49.03 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 120.081 1.941 . . . . 0.0 108.933 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -139.49 -179.39 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.297 1.039 . . . . 0.0 109.127 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.61 -53.04 12.31 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.918 1.287 . . . . 0.0 112.224 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -49.17 72.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.142 0.577 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 54.8 mmtt -61.93 -44.75 96.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.842 -0.537 . . . . 0.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.4 83.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.486 1.114 . . . . 0.0 110.217 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.85 -41.29 91.1 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.592 0.757 . . . . 0.0 109.5 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.5 75.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.179 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 4.5 t -69.9 -51.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 120.56 1.527 . . . . 0.0 107.33 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.88 -33.01 61.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.132 0.973 . . . . 0.0 113.027 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.95 75.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.265 0.626 . . . . 0.0 110.695 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -76.49 -34.18 58.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.705 0.765 . . . . 0.0 111.495 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.54 -44.98 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -39.03 84.41 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.535 0.607 . . . . 0.0 110.122 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -76.15 -31.79 58.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.12 -47.42 8.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.86 0.464 . . . . 0.0 111.783 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -90.09 0.71 57.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.749 0.419 . . . . 0.0 110.571 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 52.74 36.51 21.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.477 1.111 . . . . 0.0 111.441 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.75 123.0 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.235 0.54 . . . . 0.0 112.13 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.91 110.34 2.85 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.905 -1.122 . . . . 0.0 108.452 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 tp -100.34 93.14 2.5 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.049 1.34 . . . . 0.0 110.941 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.0 145.18 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.707 3.605 . . . . 0.0 111.096 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -29.37 9.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.709 2.404 . . . . 0.0 111.428 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -52.97 -26.66 15.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 48.4 t -87.5 -50.05 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.799 1.64 . . . . 0.0 109.212 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -46.57 63.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.005 0.922 . . . . 0.0 110.718 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -30.7 38.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.368 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.0 -30.95 58.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.948 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.38 69.25 13.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 111.394 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.37 60.43 3.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.787 3.658 . . . . 0.0 112.998 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.2 147.12 36.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.901 -1.125 . . . . 0.0 109.045 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 mm -56.9 -47.51 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 C-N-CA 124.11 0.964 . . . . 0.0 108.662 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.87 -47.37 80.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.635 0.584 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.43 81.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.2 -41.47 85.75 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.718 1.607 . . . . 0.0 108.716 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.82 99.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.512 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.6 -46.59 58.79 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 118.571 0.623 . . . . 0.0 110.403 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.578 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 22.1 t80 -58.9 -42.35 89.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.3 t -73.49 -41.33 56.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.122 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.04 82.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.677 1.126 . . . . 0.0 112.334 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -70.74 -29.35 65.58 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.546 0.612 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 . . . . . 0 CA--C 1.517 -0.3 0 O-C-N 120.94 -1.1 . . . . 0.0 111.792 -178.993 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -56.34 128.72 37.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.268 1.827 . . . . 0.0 114.07 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.96 117.61 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.11 163.41 17.44 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.297 1.439 . . . . 0.0 110.786 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.9 148.89 82.96 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.236 1.957 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 p -130.43 -12.15 3.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.2 143.66 40.0 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -28.38 6.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.873 1.269 . . . . 0.0 114.229 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.49 -40.76 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 119.525 1.057 . . . . 0.0 109.442 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -56.36 -39.02 72.2 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.089 0.556 . . . . 0.0 110.305 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.5 t -63.1 -49.11 75.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.852 0.72 . . . . 0.0 109.587 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -54.89 -52.29 63.34 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.678 0.672 . . . . 0.0 110.369 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -64.51 -41.63 96.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.253 -0.88 . . . . 0.0 112.716 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.78 74.55 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.5 -45.75 71.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.5 -41.85 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -61.14 -41.97 97.7 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 121.11 -0.994 . . . . 0.0 109.905 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.7 -45.13 95.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.476 0.58 . . . . 0.0 111.403 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -70.75 -39.85 73.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.577 1.081 . . . . 0.0 112.902 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.01 -55.88 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -74.96 -28.32 60.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.06 19.6 60.74 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.124 1.821 . . . . 0.0 113.093 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.07 174.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.15 1.38 . . . . 0.0 108.462 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 t -145.36 132.04 19.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.661 0.664 . . . . 0.0 112.409 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.21 0.88 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.0 mm -78.25 128.47 38.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.22 161.08 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.118 0.843 . . . . 0.0 112.66 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.55 -21.35 26.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.934 1.294 . . . . 0.0 111.193 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.9 -3.89 18.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.175 2.19 . . . . 0.0 114.301 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -75.8 131.09 39.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.556 1.071 . . . . 0.0 111.003 -177.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 5.3 m120 -80.28 119.95 23.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 41' ' ' ILE . 82.7 t80 -40.97 -46.26 2.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.879 2.071 . . . . 0.0 114.403 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -67.84 -32.3 72.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 112.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.14 -32.04 68.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.635 0.652 . . . . 0.0 109.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 38' ' ' PHE . 28.4 mt -71.23 -9.93 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.445 1.098 . . . . 0.0 110.397 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.26 1.91 23.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 124.367 0.984 . . . . 0.0 111.864 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 152.51 52.1 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -143.43 179.86 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.51 -49.27 36.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.222 0.919 . . . . 0.0 111.974 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.68 -48.32 81.47 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -59.85 -43.43 94.64 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.057 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.58 77.71 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.68 0.792 . . . . 0.0 110.009 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.74 -39.56 94.6 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.26 77.88 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.059 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.2 -50.73 55.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.47 -32.65 65.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.098 0.959 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.87 99.46 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.042 0.537 . . . . 0.0 110.485 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -78.4 -40.95 34.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 121.473 0.654 . . . . 0.0 111.252 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -64.28 -46.13 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 O-C-N 121.621 -0.674 . . . . 0.0 110.727 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -37.16 85.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.849 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -76.04 -30.22 58.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -89.71 -48.69 7.11 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.95 -3.8 59.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 109.783 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 50.98 45.17 28.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.766 2.026 . . . . 0.0 110.342 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.487 HG11 HG13 ' A' ' 81' ' ' VAL . 12.6 p -144.38 128.7 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.472 0.709 . . . . 0.0 110.286 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.86 125.63 25.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -116.19 79.67 8.86 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -66.6 150.35 83.89 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.423 2.082 . . . . 0.0 112.951 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -26.59 64.67 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.592 1.557 . . . . 0.0 109.933 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -53.32 -41.97 66.23 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.327 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -37.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -49.67 -51.1 40.57 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.505 1.122 . . . . 0.0 109.545 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -36.53 69.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.944 0.898 . . . . 0.0 111.484 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -37.17 85.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.508 0.505 . . . . 0.0 111.476 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -138.56 75.34 38.22 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 107.962 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 74.3 Cg_endo -76.66 64.26 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.37 2.714 . . . . 0.0 112.147 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.09 147.09 36.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.673 1.124 . . . . 0.0 110.226 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -55.82 -49.8 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 108.735 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -52.82 -48.12 67.19 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.091 0.556 . . . . 0.0 111.142 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.65 73.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.185 0.994 . . . . 0.0 113.281 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.1 -43.43 78.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.938 1.695 . . . . 0.0 108.864 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.24 74.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -68.8 -42.64 77.03 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.422 1.089 . . . . 0.0 111.769 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -63.96 -43.24 96.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.685 0.794 . . . . 0.0 109.737 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 61' ' ' VAL . 94.9 t -74.06 -36.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.546 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -49.0 72.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.881 0.473 . . . . 0.0 110.486 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -65.22 -28.11 69.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -45.29 120.5 2.5 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.75 1.62 . . . . 0.0 110.943 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.42 119.73 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 159.94 5.52 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.52 1.528 . . . . 0.0 111.513 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.82 152.74 77.03 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.646 2.231 . . . . 0.0 111.034 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -127.01 -14.08 5.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 23.2 t30 -118.6 145.08 45.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.52 54.32 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 122.84 0.456 . . . . 0.0 111.763 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.9 -45.0 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 7.2 mt-10 -60.73 -42.13 96.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -49.34 76.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.206 0.941 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -56.99 -54.48 46.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.876 0.87 . . . . 0.0 110.907 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.93 -37.58 87.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.21 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.46 72.37 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.069 0.849 . . . . 0.0 109.755 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.86 -48.16 80.23 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.27 -38.83 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -67.37 -44.98 77.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.062 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -55.38 -42.1 73.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.821 0.848 . . . . 0.0 110.295 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -71.62 -41.88 68.33 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.298 -0.876 . . . . 0.0 112.839 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -71.51 -45.16 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.601 0.76 . . . . 0.0 110.997 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.43 -32.15 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.92 0.888 . . . . 0.0 110.707 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.32 26.07 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.04 171.91 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.566 1.546 . . . . 0.0 108.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -143.92 127.94 17.5 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.39 40.1 0.6 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.396 1.95 . . . . 0.0 110.961 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.2 mm -77.64 126.24 37.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.842 0.857 . . . . 0.0 109.219 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.09 -179.07 38.72 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 121.807 0.671 . . . . 0.0 111.71 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 -28.27 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.245 0.618 . . . . 0.0 111.687 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.54 -4.1 20.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.421 1.489 . . . . 0.0 113.921 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.655 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -61.62 123.19 17.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.21 115.33 17.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.221 0.608 . . . . 0.0 110.833 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' HA ' HD12 ' A' ' 41' ' ' ILE . 73.0 t80 -44.75 -46.5 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.502 1.121 . . . . 0.0 113.256 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -67.46 -29.78 69.32 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.19 -31.19 34.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 36' ' ' ASP . 24.2 mt -71.08 -21.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.172 0.442 . . . . 0.0 110.051 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.69 -5.21 5.48 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.74 1.162 . . . . 0.0 113.479 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.98 157.98 53.22 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -146.18 176.93 9.37 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.31 6.6 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.157 1.783 . . . . 0.0 112.39 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -37.2 76.98 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -76.1 -37.93 57.53 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 120.215 -1.553 . . . . 0.0 110.984 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.46 72.87 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.415 1.486 . . . . 0.0 112.71 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -44.23 96.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.75 72.17 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.722 1.209 . . . . 0.0 110.741 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.45 -53.15 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.09 71.31 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.914 0.486 . . . . 0.0 110.952 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.93 72.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.061 0.846 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -72.38 -31.45 65.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.017 0.913 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.37 -42.78 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -40.61 87.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 121.758 -0.589 . . . . 0.0 110.086 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -33.73 59.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.12 -39.61 14.43 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' HG12 ' A' ' 61' ' ' VAL . 14.1 m-85 -97.8 0.93 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 50.97 37.78 18.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.305 1.042 . . . . 0.0 110.437 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG11 HG13 ' A' ' 81' ' ' VAL . 14.1 p -138.48 129.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.403 0.681 . . . . 0.0 112.785 -178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -80.82 116.61 20.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.65 92.76 6.41 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 127.197 2.199 . . . . 0.0 105.345 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.3 152.25 82.67 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.988 1.792 . . . . 0.0 110.524 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -28.84 22.23 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.701 1.6 . . . . 0.0 110.276 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -52.28 -39.58 60.64 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.505 1.122 . . . . 0.0 112.133 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.64 -38.92 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -50.68 72.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.972 0.909 . . . . 0.0 110.808 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.35 56.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.628 1.571 . . . . 0.0 109.882 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.53 70.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.572 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.36 73.99 35.76 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.185 1.394 . . . . 0.0 108.596 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.96 62.0 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.423 3.415 . . . . 0.0 109.869 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.61 146.95 36.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.19 -42.35 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -54.75 -42.89 72.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.061 0.846 . . . . 0.0 111.318 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.12 -44.47 88.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.16 -38.76 66.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.367 1.467 . . . . 0.0 108.077 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.32 69.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.562 0.745 . . . . 0.0 109.348 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.02 -38.93 79.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.241 0.473 . . . . 0.0 111.243 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 -48.27 81.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.449 HG13 HG11 ' A' ' 61' ' ' VAL . 54.3 t -72.21 -40.24 65.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 O-C-N 123.825 0.703 . . . . 0.0 110.033 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.26 76.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.753 1.161 . . . . 0.0 114.034 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -73.36 -24.41 60.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.322 0.249 . . . . 0.0 111.323 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 123.094 0.557 . . . . 0.0 109.732 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.41 130.69 47.42 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.202 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.3 t -145.22 117.52 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.91 160.67 19.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.869 1.268 . . . . 0.0 111.236 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.73 160.81 11.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.654 2.903 . . . . 0.0 114.222 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -127.96 -38.16 1.86 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.04 -1.891 . . . . 0.0 112.294 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 1.4 t-20 -89.48 163.7 15.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.18 71.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.773 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.32 -49.96 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.235 0.614 . . . . 0.0 109.558 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 12.0 mt-10 -54.33 -41.58 69.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.863 0.865 . . . . 0.0 109.139 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -54.5 -37.7 65.6 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.607 1.563 . . . . 0.0 110.758 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -76.93 -57.29 3.93 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 120.17 1.35 . . . . 0.0 111.302 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -53.31 -41.96 66.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.518 1.127 . . . . 0.0 113.101 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.42 69.19 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 123.57 0.544 . . . . 0.0 110.378 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -77.74 -34.93 52.36 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.215 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.36 -36.04 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -62.91 -33.98 76.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.956 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -63.59 -37.84 88.85 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -68.88 -15.97 63.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.563 HG21 HG22 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -104.11 -54.45 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 119.201 0.909 . . . . 0.0 110.355 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.55 -27.43 64.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.822 0.849 . . . . 0.0 111.983 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.49 39.02 51.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.48 174.56 12.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.918 1.287 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -134.89 138.24 43.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.0 1.32 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.03 64.04 0.95 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.587 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.18 141.37 14.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.3 -173.14 18.57 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 125.393 1.473 . . . . 0.0 111.025 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 pt -84.92 -28.85 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.24 1.96 24.31 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -81.49 123.51 28.68 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.403 1.097 . . . . 0.0 110.8 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -69.93 122.52 19.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.585 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.58 -46.82 39.72 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.314 1.846 . . . . 0.0 111.98 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.36 -31.65 69.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.181 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -67.96 -33.06 73.94 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.14 0.882 . . . . 0.0 109.046 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.03 -11.64 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.834 0.854 . . . . 0.0 108.812 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.85 3.64 26.55 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.209 1.862 . . . . 0.0 114.206 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.98 152.91 48.32 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.297 1.549 . . . . 0.0 111.827 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -138.31 175.56 9.46 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.464 1.506 . . . . 0.0 108.144 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.26 -49.23 34.31 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.931 0.892 . . . . 0.0 112.92 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.17 -51.11 67.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.568 1.077 . . . . 0.0 109.411 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mmtt -59.41 -48.09 82.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.01 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.17 68.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.687 1.595 . . . . 0.0 110.542 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmt -66.09 -39.36 89.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.859 0.864 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.201 -0.905 . . . . 0.0 110.802 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 26' ' ' VAL . 1.7 t -67.71 -50.78 57.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.01 -32.05 63.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.85 63.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.554 0.615 . . . . 0.0 109.366 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.44 -40.04 77.46 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.883 0.473 . . . . 0.0 111.184 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -63.64 -49.23 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -39.98 91.74 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.306 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -30.95 59.73 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -83.88 -48.22 10.25 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.029 0.831 . . . . 0.0 110.449 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -87.42 -3.58 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.592 0.557 . . . . 0.0 110.742 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 59.02 38.02 24.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.52 1.055 . . . . 0.0 111.515 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.68 126.92 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.101 -0.999 . . . . 0.0 112.681 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.87 142.0 58.58 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.97 78.61 74.61 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.74 152.99 79.48 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.734 1.623 . . . . 0.0 111.173 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -28.43 47.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.905 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -54.27 -33.53 58.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.488 1.115 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -88.17 -51.78 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 107.902 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -48.9 35.62 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.454 1.902 . . . . 0.0 111.41 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.85 40.63 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.643 -0.66 . . . . 0.0 112.296 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.85 79.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.223 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -138.33 79.63 30.19 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.519 1.128 . . . . 0.0 108.528 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.74 55.26 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 124.635 3.556 . . . . 0.0 112.651 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 147.8 38.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.549 1.068 . . . . 0.0 110.906 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 mm -54.94 -44.97 75.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.527 1.131 . . . . 0.0 108.749 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -54.19 -39.3 66.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.638 0.654 . . . . 0.0 111.913 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.32 27.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.675 -0.641 . . . . 0.0 112.204 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.4 -40.58 93.6 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 126.51 1.924 . . . . 0.0 109.726 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.37 -51.29 68.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.913 0.778 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.0 -35.7 64.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.081 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 67' ' ' VAL . 13.9 t80 -66.07 -41.11 91.2 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.4 -43.12 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -47.11 85.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.717 0.807 . . . . 0.0 112.539 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -63.49 -19.31 64.64 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.348 -0.845 . . . . 0.0 111.386 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.3 mtt-85 . . . . . 0 CA--C 1.521 -0.149 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.536 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.31 123.12 11.92 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.463 0.705 . . . . 0.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.08 117.05 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 162.36 25.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.471 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.25 137.32 78.12 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.528 2.152 . . . . 0.0 110.755 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 p -106.05 -23.53 12.61 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.258 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -107.32 146.72 31.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.9 57.99 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -69.4 -44.66 79.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.36 -36.39 80.07 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.504 0.721 . . . . 0.0 109.422 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -56.99 -52.43 65.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 109.512 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -56.53 -54.75 42.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.723 0.409 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.95 -47.85 81.7 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.769 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.99 -32.92 62.09 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.54 -38.91 67.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.3 -34.98 66.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 119.257 0.935 . . . . 0.0 109.98 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -62.62 -42.97 99.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 122.026 -0.421 . . . . 0.0 109.919 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -32.06 70.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.135 0.974 . . . . 0.0 111.559 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.39 -40.42 57.99 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.882 0.873 . . . . 0.0 109.982 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.34 -55.71 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 119.109 0.868 . . . . 0.0 109.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.72 -35.94 82.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.018 0.927 . . . . 0.0 111.095 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.1 15.24 70.09 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.216 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 169.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.4 t -136.05 146.33 46.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.24 0.927 . . . . 0.0 108.876 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.79 38.0 3.77 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.906 1.717 . . . . 0.0 111.324 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 41' ' ' ILE . 20.1 mm -72.22 128.16 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.345 1.073 . . . . 0.0 109.493 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.45 175.96 23.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.965 1.269 . . . . 0.0 111.005 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.411 HG13 HD13 ' A' ' 35' ' ' LEU . 18.2 pt -70.8 -23.8 24.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.921 1.689 . . . . 0.0 112.73 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -108.35 0.2 21.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.872 1.669 . . . . 0.0 113.792 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.77 115.62 14.56 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.4 122.97 22.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 122.829 0.452 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -45.98 -45.08 15.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.939 1.296 . . . . 0.0 113.352 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.43 -32.63 62.71 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -72.26 -31.09 65.47 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.004 0.922 . . . . 0.0 111.59 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 HD12 ' A' ' 32' ' ' ILE . 23.4 mt -70.65 -21.23 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.14 -4.55 6.37 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 118.664 -1.076 . . . . 0.0 111.548 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.18 162.91 48.85 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.017 1.408 . . . . 0.0 109.821 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -152.32 174.55 13.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.52 -50.91 12.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.242 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.04 -46.06 79.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.702 0.228 . . . . 0.0 110.941 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -67.82 -37.89 82.53 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.02 72.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.014 0.926 . . . . 0.0 110.167 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -58.66 -42.93 89.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.024 0.53 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.34 69.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.648 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -72.02 -51.55 30.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.56 -34.33 64.66 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.231 0.612 . . . . 0.0 111.66 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.22 86.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.775 0.83 . . . . 0.0 110.713 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -77.77 -39.82 42.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.855 0.862 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.0 -47.21 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -35.39 80.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.535 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -76.68 -33.44 58.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -89.18 -48.77 7.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.375 0.534 . . . . 0.0 111.768 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' HB2' HG12 ' A' ' 61' ' ' VAL . 39.8 m-85 -85.13 -3.0 58.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.981 0.512 . . . . 0.0 109.994 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 54.38 35.2 22.49 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.246 1.019 . . . . 0.0 110.395 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.3 p -141.75 131.61 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.3 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -70.46 140.93 52.06 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.723 0.773 . . . . 0.0 111.64 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 tp -127.15 93.09 42.38 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 127.507 2.323 . . . . 0.0 105.683 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -73.19 152.75 50.88 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.072 1.848 . . . . 0.0 109.094 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.1 -26.85 51.38 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.755 0.822 . . . . 0.0 110.95 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -54.26 -36.55 63.71 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.956 0.903 . . . . 0.0 112.908 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -85.87 -40.19 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -49.96 75.04 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.963 1.305 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -39.06 64.7 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.663 0.785 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.13 71.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 119.034 -1.066 . . . . 0.0 112.655 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -137.08 67.79 55.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.533 0.733 . . . . 0.0 111.628 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.18 50.37 1.52 Allowed 'Trans proline' 0 CA--C 1.54 0.821 1 C-N-CA 126.394 4.73 . . . . 0.0 114.92 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.91 147.05 44.02 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.6 mm -56.82 -46.23 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 126.984 2.113 . . . . 0.0 108.099 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -54.11 -41.63 68.54 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.898 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.35 -46.12 67.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.07 -36.84 75.23 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.449 1.1 . . . . 0.0 108.758 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.83 -51.54 61.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.43 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -66.32 -37.76 86.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.552 1.069 . . . . 0.0 110.496 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -63.97 -53.84 43.81 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.66 0.784 . . . . 0.0 109.324 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.96 -40.83 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.9 79.88 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.536 1.134 . . . . 0.0 113.296 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 t -73.49 -25.0 60.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.258 0.481 . . . . 0.0 110.093 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.343 0.286 0 CA-C-O 117.96 -1.019 . . . . 0.0 113.031 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 C--O 1.224 -0.27 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.57 122.44 14.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.78 0.718 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.61 115.99 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.02 159.23 77.71 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 124.633 1.173 . . . . 0.0 110.558 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.86 129.36 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.466 3.444 . . . . 0.0 110.89 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -101.51 -21.34 14.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.671 1.188 . . . . 0.0 109.887 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 20.6 t-20 -109.52 148.69 30.79 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -23.83 67.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.108 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.48 -44.38 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.277 1.853 . . . . 0.0 107.542 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 16.8 mt-10 -57.84 -40.89 81.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -58.07 -51.2 70.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.555 1.142 . . . . 0.0 109.724 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.28 -52.7 64.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.196 0.598 . . . . 0.0 111.558 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.79 -42.87 99.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.868 0.758 . . . . 0.0 111.352 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.04 -33.42 72.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.78 -47.39 78.29 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.67 -34.85 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.468 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -59.81 -40.91 90.01 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 119.7 1.137 . . . . 0.0 109.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.94 -39.77 94.0 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.04 -32.04 72.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.351 -0.843 . . . . 0.0 112.066 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.57 -53.41 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.695 0.68 . . . . 0.0 109.855 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.3 mt -75.62 -25.57 57.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.18 66.99 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.496 1.522 . . . . 0.0 112.229 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' CG2' HD11 ' A' ' 32' ' ' ILE . 21.3 m -94.91 175.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 111.8 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 t -144.83 119.35 9.7 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.889 0.876 . . . . 0.0 109.329 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.5 0.84 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 124.668 1.128 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 29' ' ' VAL . 27.1 mm -90.72 125.06 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 126.347 1.859 . . . . 0.0 107.874 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.03 164.98 25.15 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.6 pt -67.94 -28.09 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.771 -0.841 . . . . 0.0 111.49 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.603 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.68 -3.48 32.94 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.218 2.207 . . . . 0.0 116.147 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -82.46 121.56 26.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.207 1.367 . . . . 0.0 108.823 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.33 127.64 33.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.576 0.35 . . . . 0.0 110.713 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 89.3 t80 -48.21 -44.22 32.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.479 1.912 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -69.36 -38.11 77.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.69 -28.16 65.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.028 -0.51 . . . . 0.0 110.781 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 38' ' ' PHE . 27.8 mt -71.03 -17.76 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.661 0.784 . . . . 0.0 109.206 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.46 2.69 8.15 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.935 1.255 . . . . 0.0 112.79 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 164.62 53.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -146.77 174.92 11.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.6 6.34 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.214 1.405 . . . . 0.0 112.779 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -43.76 94.84 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -66.17 -38.89 89.17 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.715 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.64 74.68 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.5 0.72 . . . . 0.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -64.03 -40.49 96.44 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 122.86 0.464 . . . . 0.0 110.276 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.61 92.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.182 0.446 . . . . 0.0 110.234 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.42 -52.96 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.56 -31.13 63.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.6 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.1 69.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.912 0.778 . . . . 0.0 111.374 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.66 -42.7 61.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.264 0.625 . . . . 0.0 109.343 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.85 -33.91 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 120.672 -1.268 . . . . 0.0 108.195 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.65 -42.42 91.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.392 0.996 . . . . 0.0 109.18 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -75.27 -31.75 60.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -74.48 -48.92 24.44 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 61' ' ' VAL . 68.5 m-85 -94.13 0.14 55.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.15 37.85 27.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.46 1.504 . . . . 0.0 109.851 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 59' ' ' TYR . 12.7 p -141.41 124.9 15.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -67.37 130.74 44.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.565 -0.71 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 tt -118.03 87.99 30.22 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 159.2 54.15 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.475 2.116 . . . . 0.0 112.168 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -40.93 51.07 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.724 2.01 . . . . 0.0 109.785 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -53.46 -32.18 48.9 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.393 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -87.28 -47.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 119.982 1.264 . . . . 0.0 109.328 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -47.31 76.5 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.554 0.742 . . . . 0.0 111.749 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -31.74 43.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.974 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -39.38 71.1 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.67 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -137.47 78.31 38.48 Favored Pre-proline 0 N--CA 1.453 -0.312 0 O-C-N 124.271 0.982 . . . . 0.0 109.39 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 52.69 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.707 2.938 . . . . 0.0 111.756 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.85 147.78 48.39 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 120.224 1.375 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 74' ' ' ILE . 8.4 mm -58.12 -40.68 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -53.8 -46.21 71.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.229 0.468 . . . . 0.0 110.682 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.42 -51.42 44.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.09 -38.12 89.92 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 125.005 1.322 . . . . 0.0 109.86 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.49 94.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.978 0.808 . . . . 0.0 109.385 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -74.54 -44.87 49.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 111.395 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HG21 ' A' ' 67' ' ' VAL . 27.7 t80 -62.22 -44.07 97.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.25 -43.2 50.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.508 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.05 98.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 t -67.73 -29.9 69.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.777 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 . . . . . 0 CA--C 1.515 -0.369 0 CA-C-N 119.074 0.852 . . . . 0.0 109.407 -179.734 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.86 0.362 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -46.08 132.61 9.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.396 2.678 . . . . 0.0 113.174 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.5 t -140.05 117.62 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.25 158.23 38.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.116 0.885 . . . . 0.0 110.02 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.51 149.74 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.49 2.793 . . . . 0.0 112.023 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -123.61 -21.58 5.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.589 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -102.87 141.11 36.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.96 -18.66 0.82 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.713 1.205 . . . . 0.0 113.881 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.78 -54.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.636 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.77 -42.77 58.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.893 2.077 . . . . 0.0 110.103 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 t -60.86 -44.88 96.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.837 0.711 . . . . 0.0 110.78 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -61.25 -45.37 94.8 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.636 -1.29 . . . . 0.0 110.756 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.89 -38.45 88.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.121 0.873 . . . . 0.0 111.452 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.48 75.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.1 -37.53 75.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.4 -40.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -60.45 -41.11 93.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.72 -38.88 72.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.547 0.612 . . . . 0.0 109.858 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -68.45 -32.85 73.17 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -86.31 -46.25 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 123.022 1.391 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.14 -33.2 71.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.357 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.13 38.82 54.44 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.64 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.015 1.726 . . . . 0.0 107.108 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 p -136.72 138.85 41.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 110.71 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.15 66.64 1.51 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.21 1.386 . . . . 0.0 112.186 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.7 mm -83.89 129.5 37.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.52 167.58 28.75 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.029 0.831 . . . . 0.0 111.326 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.62 -24.55 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.987 0.915 . . . . 0.0 112.553 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -0.26 21.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.454 1.501 . . . . 0.0 114.911 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.03 122.8 26.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 118.868 0.758 . . . . 0.0 109.557 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -67.23 123.73 21.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.331 1.052 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -46.36 -45.95 18.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.429 1.892 . . . . 0.0 112.876 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -70.72 -24.07 62.57 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.752 -1.218 . . . . 0.0 112.224 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -74.28 -37.14 63.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.46 29.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 125.965 1.706 . . . . 0.0 109.981 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.32 5.37 34.94 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.159 -2.213 . . . . 0.0 113.936 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.64 142.19 43.47 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 108.135 -1.986 . . . . 0.0 108.135 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -132.81 173.18 11.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.847 0.823 . . . . 0.0 108.886 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.62 -47.48 28.94 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.347 0.659 . . . . 0.0 111.628 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -48.26 73.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.91 0.323 . . . . 0.0 110.587 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.97 -39.59 90.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.86 80.53 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.163 0.985 . . . . 0.0 110.427 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.78 -37.9 87.57 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.56 75.23 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.222 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 26' ' ' VAL . 70.9 t -63.08 -53.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.65 69.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.064 0.946 . . . . 0.0 112.231 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.19 -47.48 67.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.651 0.739 . . . . 0.0 109.904 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 7.6 mm100 -67.16 -39.98 86.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 109.987 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 t -64.59 -47.46 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 121.35 -0.844 . . . . 0.0 108.775 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.22 -37.65 86.16 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.529 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 10.6 ptm180 -75.85 -32.26 59.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.48 -48.14 8.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . 80.1 m-85 -92.36 0.33 57.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.352 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 49.93 43.09 25.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.596 1.089 . . . . 0.0 109.199 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 81' ' ' VAL . 8.2 p -136.1 128.43 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 123.365 0.666 . . . . 0.0 110.657 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -69.45 120.72 15.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -114.76 78.71 5.33 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.42 158.15 42.26 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.23 1.287 . . . . 0.0 111.503 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.72 -26.86 67.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.344 1.058 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -52.97 -41.59 64.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.262 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.29 -37.23 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-N 119.719 1.145 . . . . 0.0 109.021 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.3 -50.08 60.05 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.445 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -30.7 56.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.16 -31.43 49.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.119 0.872 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -134.68 72.76 68.75 Favored Pre-proline 0 N--CA 1.449 -0.52 0 C-N-CA 125.468 1.507 . . . . 0.0 107.898 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.18 53.28 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 113.093 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.62 147.38 46.88 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 120.311 1.414 . . . . 0.0 110.455 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.12 -44.08 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.86 -46.68 74.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.576 0.35 . . . . 0.0 111.404 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.17 85.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.301 1.04 . . . . 0.0 113.233 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -42.97 84.91 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 125.345 1.458 . . . . 0.0 107.246 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.46 97.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.749 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -76.24 -36.72 58.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.201 1.364 . . . . 0.0 111.159 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -60.99 -51.46 69.17 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 61' ' ' VAL . 77.4 t -68.63 -47.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.692 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.13 -51.79 60.79 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.801 1.182 . . . . 0.0 113.304 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -64.41 -22.41 66.95 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 119.125 0.875 . . . . 0.0 112.98 -179.619 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -47.33 131.03 13.48 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.105 0.962 . . . . 0.0 113.274 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.62 116.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 102.468 -3.16 . . . . 0.0 102.468 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.01 161.19 65.08 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.615 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.58 72.96 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.682 1.588 . . . . 0.0 110.056 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 p -132.24 -13.95 3.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.477 0.311 . . . . 0.0 111.283 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 141.95 28.53 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -28.14 8.04 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -44.78 19.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 119.086 0.857 . . . . 0.0 109.154 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -51.94 -42.51 62.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.269 1.027 . . . . 0.0 109.983 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -54.26 -50.54 66.98 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.331 1.019 . . . . 0.0 110.431 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.29 -50.12 75.22 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 111.7 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.25 -41.66 85.26 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 119.99 -1.694 . . . . 0.0 112.724 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.61 71.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 124.531 1.144 . . . . 0.0 111.024 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.7 -47.87 43.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.108 0.867 . . . . 0.0 111.23 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.01 -37.89 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.055 0.542 . . . . 0.0 109.743 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.68 -39.69 85.36 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.212 -0.93 . . . . 0.0 111.012 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -57.27 -43.18 82.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.276 0.63 . . . . 0.0 110.646 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -64.11 -31.73 73.04 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.726 0.81 . . . . 0.0 112.591 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.66 -44.44 15.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.899 0.772 . . . . 0.0 111.715 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.27 -24.09 40.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.114 0.966 . . . . 0.0 112.728 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.79 23.93 68.42 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.901 1.239 . . . . 0.0 111.936 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.0 175.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.467 1.633 . . . . 0.0 106.599 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 t -141.76 143.48 33.51 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.001 1.273 . . . . 0.0 107.859 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 69.15 1.41 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 41' ' ' ILE . 49.7 mm -91.27 121.79 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.3 169.13 45.29 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 118.45 0.568 . . . . 0.0 112.67 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 pt -68.54 -24.08 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 120.948 -1.325 . . . . 0.0 111.466 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.512 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.89 -3.37 24.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.12 2.568 . . . . 0.0 113.117 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.71 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -69.44 124.23 23.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -77.32 117.33 18.72 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.963 1.305 . . . . 0.0 108.777 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.09 -48.05 11.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.893 1.677 . . . . 0.0 113.223 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -71.08 -33.64 70.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.876 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -67.95 -29.54 68.62 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 36' ' ' ASP . 30.9 mt -72.01 -3.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.985 0.914 . . . . 0.0 109.389 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.84 -0.56 33.96 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.033 1.778 . . . . 0.0 111.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.57 160.81 46.71 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 118.618 1.209 . . . . 0.0 110.64 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -151.18 179.2 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.184 1.394 . . . . 0.0 108.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.26 -50.71 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.133 1.373 . . . . 0.0 113.251 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -46.51 86.93 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.449 0.568 . . . . 0.0 110.324 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.7 mmtp -63.48 -39.2 93.83 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 121.205 -0.934 . . . . 0.0 110.798 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -42.39 69.61 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.662 0.665 . . . . 0.0 109.268 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 mmt -65.98 -41.52 91.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.164 0.586 . . . . 0.0 109.768 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.28 83.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 118.377 -0.82 . . . . 0.0 112.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.4 t -72.2 -52.3 25.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.83 -31.59 39.84 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.59 72.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.593 0.633 . . . . 0.0 111.447 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.09 -37.35 61.58 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.574 0.702 . . . . 0.0 110.921 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -64.63 -47.37 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 121.082 -1.011 . . . . 0.0 108.961 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -40.7 90.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.344 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -75.27 -29.1 60.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.65 -48.09 8.16 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.607 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.29 -3.7 58.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 51.49 39.17 24.01 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.268 1.827 . . . . 0.0 110.886 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.596 HG11 HG13 ' A' ' 81' ' ' VAL . 11.7 p -141.25 132.31 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.748 0.785 . . . . 0.0 112.085 -177.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -71.53 115.66 10.96 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.15 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -110.19 83.72 3.26 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.3 157.79 58.29 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.669 2.246 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -33.49 54.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.436 1.494 . . . . 0.0 110.522 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -30.85 47.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.146 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.92 -46.85 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -49.72 60.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.277 1.431 . . . . 0.0 110.926 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -31.01 38.75 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.641 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.94 -37.11 83.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.076 0.853 . . . . 0.0 110.502 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -141.76 79.31 16.91 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.263 1.025 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 52.56 3.58 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.951 3.101 . . . . 0.0 113.189 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 147.21 49.21 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.887 -1.133 . . . . 0.0 109.535 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.47 -48.21 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -52.32 -47.82 65.79 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.623 0.577 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.47 98.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.27 -41.48 63.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.62 73.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.255 1.022 . . . . 0.0 109.315 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.42 -38.63 77.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.787 1.176 . . . . 0.0 111.552 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -67.16 -46.13 74.95 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.094 0.558 . . . . 0.0 110.627 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 HG11 ' A' ' 61' ' ' VAL . 78.0 t -73.78 -42.79 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.155 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.99 84.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.86 0.754 . . . . 0.0 112.804 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -61.98 -32.71 73.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.349 0.522 . . . . 0.0 109.64 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 . . . . . 0 C--N 1.343 0.293 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.699 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.87 123.91 4.86 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.131 1.372 . . . . 0.0 114.138 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -146.33 117.6 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -68.81 172.41 4.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.329 1.051 . . . . 0.0 112.008 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.762 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 52.9 Cg_endo -68.14 146.46 70.35 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.02 2.48 . . . . 0.0 111.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -118.82 -13.51 9.53 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.607 0.763 . . . . 0.0 111.733 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -120.31 147.11 45.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.29 -26.14 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.663 -1.636 . . . . 0.0 113.502 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.73 -55.1 17.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 120.496 1.498 . . . . 0.0 107.792 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.54 -44.08 65.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.618 1.967 . . . . 0.0 109.728 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -40.32 85.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.305 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.37 -50.74 71.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 119.325 0.966 . . . . 0.0 110.237 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 19' ' ' LEU . 5.6 mp -63.45 -41.94 98.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.413 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.21 -36.16 68.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.977 0.911 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.29 -49.94 15.67 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 118.973 0.806 . . . . 0.0 110.409 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.0 mt -51.39 -40.94 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 38' ' ' PHE . 8.2 m0 -64.95 -45.83 84.11 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.319 1.448 . . . . 0.0 110.223 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -59.33 -37.12 77.0 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.369 0.668 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -70.57 -29.08 65.42 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.49 -55.73 7.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.764 0.826 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.9 mt -74.51 -20.51 59.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.631 1.172 . . . . 0.0 113.523 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 32.93 68.49 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.034 0.834 . . . . 0.0 111.847 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.14 175.21 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.4 1.88 . . . . 0.0 109.634 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -139.25 127.77 23.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.028 0.931 . . . . 0.0 112.945 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 69.27 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mm -87.02 123.39 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 107.383 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.5 174.32 44.82 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 pt -80.76 -26.83 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 118.725 1.263 . . . . 0.0 110.628 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.776 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -96.71 4.84 51.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.013 2.525 . . . . 0.0 113.877 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -62.99 123.35 18.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.651 1.581 . . . . 0.0 113.107 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.73 105.3 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.226 -1.546 . . . . 0.0 107.09 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' A' ' 41' ' ' ILE . 92.5 t80 -41.74 -47.55 4.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 113.237 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -69.62 -33.19 72.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.277 0.944 . . . . 0.0 108.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 38' ' ' PHE . 31.2 mt -71.29 -15.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.016 0.926 . . . . 0.0 109.587 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.16 -6.86 23.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.078 1.799 . . . . 0.0 112.541 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.76 157.77 33.91 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.675 1.237 . . . . 0.0 110.276 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -143.33 171.45 14.1 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.04 -48.68 11.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.321 1.048 . . . . 0.0 112.475 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -46.04 82.91 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.762 -0.586 . . . . 0.0 110.657 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -66.05 -42.17 89.85 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 121.444 -0.785 . . . . 0.0 110.036 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.35 -43.71 67.94 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.303 1.041 . . . . 0.0 110.187 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.5 mtm -63.72 -30.41 71.51 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.657 0.383 . . . . 0.0 111.811 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.52 -35.39 68.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.62 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.29 -48.28 86.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.82 64.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.139 0.976 . . . . 0.0 111.337 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.84 87.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.144 0.884 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -73.25 -36.15 66.36 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.63 0.729 . . . . 0.0 110.385 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.04 -45.18 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 1.2 t-80 -61.02 -36.73 80.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.477 -0.765 . . . . 0.0 111.489 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -76.79 -32.07 57.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -89.63 -44.86 9.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.04 0.924 . . . . 0.0 112.17 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -90.25 -0.62 57.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.883 1.273 . . . . 0.0 109.897 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 49.2 42.04 20.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.206 1.402 . . . . 0.0 111.002 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 81' ' ' VAL . 14.5 p -152.39 139.86 13.51 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 O-C-N 120.847 -1.158 . . . . 0.0 111.883 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 30.6 tt0 -66.8 143.77 56.7 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.193 -0.317 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.33 82.42 57.91 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.79 149.24 72.71 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.819 1.68 . . . . 0.0 111.147 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.8 -27.43 41.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 125.088 1.355 . . . . 0.0 111.294 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -53.19 -36.49 61.01 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.682 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.57 -47.27 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -48.9 47.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.007 1.723 . . . . 0.0 111.531 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -29.72 37.99 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.082 0.953 . . . . 0.0 112.848 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.69 -31.89 59.9 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.256 0.347 . . . . 0.0 111.336 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -134.58 74.52 65.37 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.88 56.32 3.55 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.346 3.364 . . . . 0.0 112.687 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.98 147.43 36.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.846 1.203 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -54.81 -49.26 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 108.876 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -52.38 -50.51 62.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.21 96.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.59 -44.58 56.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.048 1.339 . . . . 0.0 107.559 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.42 66.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.258 1.023 . . . . 0.0 109.678 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.33 -40.25 74.27 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.322 0.389 . . . . 0.0 111.099 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.55 -48.13 82.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.636 0.774 . . . . 0.0 110.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.428 HG13 HG11 ' A' ' 61' ' ' VAL . 71.3 t -72.24 -38.46 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.733 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.71 74.04 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.258 0.935 . . . . 0.0 111.426 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -63.51 -32.35 73.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.626 0.194 . . . . 0.0 111.379 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.3 p -158.29 -11.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -90.71 73.61 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.57 1.85 11.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.02 156.51 30.07 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.277 0.49 . . . . 0.0 111.252 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -74.06 172.18 12.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.157 0.983 . . . . 0.0 108.424 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.02 133.66 56.3 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.556 0.617 . . . . 0.0 109.819 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -139.54 117.25 11.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.48 87.92 Favored Pre-proline 0 C--O 1.24 0.593 0 O-C-N 124.048 0.843 . . . . 0.0 109.106 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.94 144.37 87.84 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.205 2.603 . . . . 0.0 110.042 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 p -124.69 -11.57 7.23 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -108.89 133.36 53.02 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.33 -39.11 2.96 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.56 -50.45 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.356 0.98 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -58.41 -41.28 84.61 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.824 2.049 . . . . 0.0 108.633 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -64.28 -35.13 79.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.37 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -77.05 -35.43 56.79 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.949 -1.095 . . . . 0.0 111.688 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.22 -37.68 72.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.602 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.54 80.63 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.67 -47.21 73.17 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.6 mt -57.27 -38.45 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.569 0.747 . . . . 0.0 109.955 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -64.75 -42.8 94.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -57.73 -41.95 82.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -69.38 -22.04 63.75 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.02 -1.05 . . . . 0.0 113.723 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.92 -41.88 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.864 0.756 . . . . 0.0 110.632 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -83.77 -22.84 31.74 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.736 1.214 . . . . 0.0 112.733 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.2 35.02 69.98 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.93 173.9 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -130.41 148.67 52.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.487 1.115 . . . . 0.0 108.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 53.16 1.41 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.082 0.849 . . . . 0.0 113.521 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.0 mm -91.12 121.4 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.96 26.74 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 122.623 1.124 . . . . 0.0 112.339 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.04 -24.16 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 O-C-N 121.687 -0.89 . . . . 0.0 111.93 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.6 -0.14 22.18 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.582 2.353 . . . . 0.0 113.371 -179.227 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.767 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -67.94 116.17 8.29 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.62 110.84 12.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.681 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.3 t80 -40.02 -46.26 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.95 2.1 . . . . 0.0 113.908 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -68.09 -32.94 73.62 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.716 -0.615 . . . . 0.0 112.152 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.48 -32.09 69.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.194 0.906 . . . . 0.0 109.394 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 36' ' ' ASP . 23.2 mt -70.43 -20.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.67 7.88 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.545 1.069 . . . . 0.0 112.212 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.56 160.77 40.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.44 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 20.5 p80 -148.2 177.74 9.15 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.6 1.16 . . . . 0.0 108.212 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.32 -52.38 12.85 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.126 0.97 . . . . 0.0 112.995 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -47.72 73.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.914 1.233 . . . . 0.0 110.504 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 63.3 mmtt -62.56 -43.15 99.52 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.196 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -57.16 -41.79 79.85 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.243 1.417 . . . . 0.0 110.996 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 74.7 mtm -68.81 -37.28 79.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.71 71.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.703 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.36 -52.69 52.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.06 69.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.518 1.054 . . . . 0.0 112.085 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -78.02 -32.8 51.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.183 0.992 . . . . 0.0 111.348 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 59' ' ' TYR . 59.3 t -71.89 -40.08 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.065 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -37.97 82.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.813 1.188 . . . . 0.0 109.219 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -76.0 -31.77 59.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.26 -47.96 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.572 0.749 . . . . 0.0 111.869 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HG11 ' A' ' 81' ' ' VAL . 16.8 m-85 -94.48 0.49 55.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.741 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 55.66 37.44 28.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.737 1.215 . . . . 0.0 109.56 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 81' ' ' VAL . 9.4 p -140.56 136.72 36.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.38 132.92 44.59 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.839 1.255 . . . . 0.0 110.029 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.2 tp -130.07 86.11 55.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 123.97 0.908 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.76 153.68 77.12 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.673 1.582 . . . . 0.0 110.453 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.5 -30.12 62.62 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.543 0.737 . . . . 0.0 110.463 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -53.03 -30.69 37.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.117 0.967 . . . . 0.0 111.94 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.08 -46.3 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.431 1.092 . . . . 0.0 108.842 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -57.24 -46.55 82.89 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.598 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -36.57 58.51 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.289 -0.882 . . . . 0.0 111.42 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.53 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.596 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.55 73.1 62.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 124.361 1.064 . . . . 0.0 109.151 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.16 54.25 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.378 3.385 . . . . 0.0 110.804 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 147.62 41.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.178 0.899 . . . . 0.0 110.572 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 mm -57.77 -44.46 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 124.98 1.312 . . . . 0.0 108.617 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -55.83 -47.75 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.854 0.297 . . . . 0.0 110.986 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.85 -52.57 64.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.05 -41.28 97.97 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 108.235 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.7 92.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.027 0.83 . . . . 0.0 110.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -74.61 -40.88 61.29 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.958 0.503 . . . . 0.0 111.182 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -63.23 -42.72 99.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 61' ' ' VAL . 55.8 t -71.43 -46.34 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.55 -49.7 67.11 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 t -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.278 0.361 . . . . 0.0 111.376 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mtt85 -87.66 -35.96 17.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.228 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 p -69.12 -19.6 64.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -60.08 162.1 6.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.265 1.031 . . . . 0.0 111.068 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -73.55 95.01 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.057 1.343 . . . . 0.0 112.558 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.91 171.52 14.64 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -137.92 67.58 1.42 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -57.18 -34.3 68.33 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.51 1.124 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t60 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 127.576 2.35 . . . . 0.0 110.203 178.568 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 N--CA 1.472 0.212 0 N-CA-C 109.815 -0.879 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.63 150.65 23.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -81.5 176.31 9.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.422 1.889 . . . . 0.0 109.007 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 62.84 14.64 7.56 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.536 1.135 . . . . 0.0 110.774 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 153.69 36.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.143 1.377 . . . . 0.0 110.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.25 174.52 5.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -47.35 129.88 13.12 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.326 1.051 . . . . 0.0 113.107 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.43 117.46 3.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 156.89 73.91 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 124.039 0.837 . . . . 0.0 109.484 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.99 164.49 24.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.336 2.024 . . . . 0.0 112.766 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -134.18 -12.13 2.49 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.929 1.292 . . . . 0.0 112.259 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.34 144.68 35.55 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.02 -38.51 37.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.319 1.048 . . . . 0.0 112.179 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.29 -55.41 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.514 1.126 . . . . 0.0 110.457 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.69 -36.79 57.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 109.601 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -61.06 -46.97 88.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.743 0.817 . . . . 0.0 111.163 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -60.08 -49.44 77.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.536 0.607 . . . . 0.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.73 -42.1 97.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.915 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.01 69.99 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.527 0.603 . . . . 0.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -71.27 -46.78 60.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.3 mt -59.32 -35.09 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 121.525 -0.735 . . . . 0.0 109.701 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -62.28 -42.27 99.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.273 -0.892 . . . . 0.0 109.25 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.78 -33.82 76.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 109.191 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.34 -26.38 63.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.088 -1.008 . . . . 0.0 112.271 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.03 -55.41 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 118.276 0.489 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.82 -17.22 60.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.034 0.934 . . . . 0.0 113.24 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.57 21.66 72.83 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.244 0.926 . . . . 0.0 111.651 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 32' ' ' ILE . 32.3 m -94.87 174.31 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -143.85 109.09 5.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.85 39.98 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.744 1.164 . . . . 0.0 113.052 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 29' ' ' VAL . 36.6 mm -77.78 124.84 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.099 1.449 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.39 169.93 16.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.442 1.496 . . . . 0.0 110.788 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.81 -26.57 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.109 -1.23 . . . . 0.0 112.971 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.464 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.93 1.75 43.01 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.771 1.628 . . . . 0.0 112.97 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -69.49 127.29 32.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.285 0.564 . . . . 0.0 109.872 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -78.95 114.46 17.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.942 1.297 . . . . 0.0 110.871 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -44.01 -49.65 8.6 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.641 1.176 . . . . 0.0 113.627 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -76.44 -27.69 56.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.06 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.23 -30.17 67.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.092 1.315 . . . . 0.0 109.784 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.93 -13.68 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.61 -0.94 30.64 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.729 1.157 . . . . 0.0 112.627 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 133.36 33.93 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.71 175.11 5.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.94 -49.5 15.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.288 1.035 . . . . 0.0 112.019 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.31 -47.23 82.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.46 0.304 . . . . 0.0 110.575 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -64.75 -35.26 80.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.675 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.9 84.77 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.278 0.945 . . . . 0.0 109.261 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.3 mtm -69.57 -37.22 76.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.74 81.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.685 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.07 -49.73 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.993 1.27 . . . . 0.0 107.69 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.07 64.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.98 0.912 . . . . 0.0 111.15 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.63 85.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.682 0.793 . . . . 0.0 110.537 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.48 -38.98 48.04 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.461 0.573 . . . . 0.0 110.458 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 t -62.31 -47.32 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.438 1.095 . . . . 0.0 109.274 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.56 89.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.507 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.92 -31.79 59.3 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.93 -48.42 12.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.772 0.829 . . . . 0.0 110.751 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -91.12 -3.09 57.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.936 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 52.41 43.74 30.61 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.306 1.442 . . . . 0.0 110.316 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.33 129.61 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.1 134.45 51.86 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.204 1.186 . . . . 0.0 114.204 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.74 84.25 61.0 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.56 153.33 76.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.693 1.595 . . . . 0.0 109.729 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -27.74 63.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.652 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -59.62 -26.87 65.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.917 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.34 -48.2 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -50.09 61.79 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.444 1.497 . . . . 0.0 111.25 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -30.24 39.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.967 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.16 -27.13 59.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.586 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -141.42 68.5 26.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.334 1.454 . . . . 0.0 110.626 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.36 57.36 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.38 3.387 . . . . 0.0 114.012 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.64 147.25 37.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -54.65 -47.99 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 124.73 1.212 . . . . 0.0 107.879 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -52.24 -42.76 63.89 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.82 72.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.33 -40.17 64.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.69 68.54 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.094 -0.955 . . . . 0.0 108.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.21 -38.34 78.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.19 -51.9 61.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.823 0.849 . . . . 0.0 109.009 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.7 -39.67 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.24 77.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.364 1.066 . . . . 0.0 113.353 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 t -64.82 -28.93 69.9 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.831 0.707 . . . . 0.0 110.281 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -80.46 -31.74 37.31 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 118.583 0.629 . . . . 0.0 109.861 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -72.8 14.44 0.27 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 0.0 111.067 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -118.09 82.92 1.92 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.75 92.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 0.0 112.633 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -112.53 143.24 44.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.654 1.582 . . . . 0.0 109.168 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -90.35 -7.63 52.77 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.204 1.002 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -71.77 89.44 1.04 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.716 1.207 . . . . 0.0 109.839 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m80 . . . . . 0 C--O 1.247 0.972 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.347 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.476 0.465 0 N-CA-C 110.887 -0.467 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.18 -169.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.493 1.917 . . . . 0.0 110.518 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.43 69.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.238 1.015 . . . . 0.0 110.588 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.42 -21.11 30.87 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.932 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.03 158.89 30.28 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.018 1.327 . . . . 0.0 110.199 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -92.4 178.81 5.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.446 1.499 . . . . 0.0 109.415 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -55.34 133.44 49.62 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.81 1.244 . . . . 0.0 112.118 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.18 117.03 9.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.82 158.46 69.4 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 124.079 0.862 . . . . 0.0 109.425 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.91 139.66 75.25 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.611 1.541 . . . . 0.0 110.471 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -111.13 -10.45 14.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.654 1.182 . . . . 0.0 111.319 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -121.59 152.87 38.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.48 1.036 . . . . 0.0 109.238 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.7 -36.41 67.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.239 0.616 . . . . 0.0 111.496 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.95 -49.79 70.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.81 -35.87 77.6 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.473 0.709 . . . . 0.0 110.041 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 t -65.59 -49.07 70.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -54.41 -56.52 17.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.773 0.829 . . . . 0.0 110.208 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.12 -42.36 90.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.991 -1.004 . . . . 0.0 113.274 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.48 66.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 123.87 0.731 . . . . 0.0 109.981 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -72.46 -37.73 68.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.7 mm -59.14 -38.73 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -67.46 -41.1 85.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.737 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.06 -35.1 77.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.018 0.826 . . . . 0.0 109.165 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -71.0 -43.19 68.5 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.064 -1.023 . . . . 0.0 111.269 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.56 -54.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.63 0.772 . . . . 0.0 111.371 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.7 -26.73 66.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 111.731 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.3 59.8 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.938 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.36 174.22 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.945 1.298 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t -132.32 135.11 45.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.73 60.79 0.84 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.22 0.914 . . . . 0.0 112.973 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.44 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -90.84 121.75 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.25 163.46 31.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 118.831 0.741 . . . . 0.0 111.5 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.2 pt -65.12 -22.18 30.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.309 1.044 . . . . 0.0 110.937 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.95 21.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.62 1.968 . . . . 0.0 113.834 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.63 128.48 35.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.319 0.963 . . . . 0.0 110.433 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -75.83 118.31 18.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.148 0.979 . . . . 0.0 109.423 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' ILE . 87.5 t80 -48.92 -40.47 30.16 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.689 1.195 . . . . 0.0 111.792 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -72.34 -28.99 63.39 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 112.608 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -69.47 -33.0 72.26 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 32' ' ' ILE . 12.2 mt -75.86 29.64 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 126.199 1.8 . . . . 0.0 109.301 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 10.04 64.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 119.223 -2.173 . . . . 0.0 112.563 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.51 151.93 47.19 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.504 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.0 p80 -143.42 172.58 12.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.36 -53.96 6.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.99 1.316 . . . . 0.0 112.823 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tp -55.52 -47.32 76.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.694 0.679 . . . . 0.0 111.827 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 72.6 mmtt -59.94 -42.69 94.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.138 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.56 90.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.136 0.974 . . . . 0.0 109.257 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.45 ' HG2' HD23 ' A' ' 65' ' ' LEU . 63.4 mtm -61.44 -37.99 85.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.513 0.725 . . . . 0.0 109.772 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -28.9 68.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.171 0.588 . . . . 0.0 110.769 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.8 t -72.54 -48.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -29.99 59.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.14 -53.54 36.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 122.106 0.955 . . . . 0.0 108.815 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -65.27 -38.42 90.23 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.812 1.645 . . . . 0.0 109.824 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.09 -46.1 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 -38.92 87.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 118.693 0.678 . . . . 0.0 110.72 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -76.53 -31.9 57.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.28 -44.7 11.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.384 0.538 . . . . 0.0 112.13 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -93.14 -0.78 56.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.816 0.446 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 52.93 37.94 25.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.222 1.409 . . . . 0.0 110.984 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.1 129.7 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.413 0.625 . . . . 0.0 112.396 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.69 117.81 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.5 tp -111.4 88.77 9.43 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.57 157.13 63.2 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.974 1.782 . . . . 0.0 110.786 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.2 OUTLIER -61.14 -27.37 68.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.578 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -54.77 -28.83 51.69 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 110.89 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.87 -43.38 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.909 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -47.91 83.72 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.126 0.571 . . . . 0.0 111.054 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -33.16 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.2 -31.9 58.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.813 0.278 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -140.49 74.12 28.95 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.891 0.876 . . . . 0.0 109.153 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.87 53.28 3.23 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.373 3.382 . . . . 0.0 113.306 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.65 147.8 48.72 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.808 1.185 . . . . 0.0 110.612 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.31 -43.4 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -57.77 -47.33 82.84 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.51 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.03 97.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.0 -42.83 62.85 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.59 91.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 109.933 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.92 -44.96 72.05 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.477 0.58 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.34 -42.38 98.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.37 -37.65 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.9 -46.09 89.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.683 0.674 . . . . 0.0 110.213 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -29.54 70.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.464 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -85.98 -28.57 24.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.096 0.862 . . . . 0.0 112.821 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -32.98 71.58 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.036 1.335 . . . . 0.0 108.106 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -85.86 141.38 29.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.14 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -124.5 177.29 5.99 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.878 1.271 . . . . 0.0 107.959 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -129.02 3.56 5.29 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.477 -0.764 . . . . 0.0 110.706 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -103.17 149.35 24.73 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -100.67 67.63 1.28 Allowed 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 . . . . . 0 C--O 1.255 1.343 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.525 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.528 0.2 0 N-CA-C 114.242 0.824 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.77 159.39 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.6 0.76 . . . . 0.0 110.128 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 t -163.44 176.31 9.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.471 2.308 . . . . 0.0 106.065 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -124.97 7.96 8.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.883 1.673 . . . . 0.0 109.943 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.2 8.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.687 1.595 . . . . 0.0 113.927 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -77.12 166.67 22.96 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.776 1.23 . . . . 0.0 110.705 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.491 ' HA ' HD21 ' A' ' 35' ' ' LEU . 2.5 t80 -58.82 138.23 57.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.494 1.517 . . . . 0.0 109.438 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.9 t -147.55 119.24 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.61 160.39 44.21 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.277 1.031 . . . . 0.0 109.535 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.62 152.08 58.31 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.103 2.535 . . . . 0.0 114.223 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -123.01 -18.49 6.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.282 2.233 . . . . 0.0 112.595 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.46 148.72 40.47 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.19 62.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.727 1.211 . . . . 0.0 110.547 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.45 -47.51 83.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.39 -31.28 71.92 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.598 0.759 . . . . 0.0 110.004 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -52.21 53.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.757 0.823 . . . . 0.0 110.231 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -57.54 -52.75 64.12 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.7 -42.09 83.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.653 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -33.4 65.42 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.79 0.436 . . . . 0.0 111.687 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.61 -48.69 66.08 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.068 0.461 . . . . 0.0 109.896 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.75 -34.82 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.089 0.956 . . . . 0.0 110.123 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -67.25 -43.71 81.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 119.033 0.833 . . . . 0.0 110.691 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.43 -44.78 76.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.783 0.833 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -60.06 -30.46 69.22 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.701 1.2 . . . . 0.0 113.084 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.35 -49.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.708 0.685 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -69.16 -23.04 63.9 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.51 1.124 . . . . 0.0 112.102 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 34.6 66.99 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.733 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.08 173.92 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -138.34 127.17 23.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.78 32.9 0.97 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 124.235 0.922 . . . . 0.0 111.006 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.25 127.76 31.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 -169.32 24.24 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.47 1.509 . . . . 0.0 110.64 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.236 1.815 . . . . 0.0 113.378 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.596 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.69 0.78 22.63 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -176.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' HD11 ' A' ' 41' ' ' ILE . 7.7 p-10 -60.04 122.31 14.04 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.986 1.714 . . . . 0.0 110.843 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -75.66 103.07 5.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -39.89 -48.56 2.33 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 113.766 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.63 -30.69 63.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.24 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.34 -32.17 72.09 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.406 1.003 . . . . 0.0 109.659 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' A' ' 36' ' ' ASP . 23.4 mt -71.37 -7.58 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 125.338 1.455 . . . . 0.0 110.493 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.16 3.0 41.84 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.552 1.073 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 151.5 52.28 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -142.34 176.93 8.62 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.269 -1.136 . . . . 0.0 108.21 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.44 -53.05 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.211 1.404 . . . . 0.0 112.33 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.21 -46.23 86.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.904 0.32 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.1 mmtp -61.56 -42.49 98.92 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.786 -0.571 . . . . 0.0 110.042 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.42 67.66 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.058 0.943 . . . . 0.0 109.94 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mmt -67.85 -38.77 83.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 109.484 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.74 70.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.025 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.5 t -76.26 -50.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.67 -36.14 34.35 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 112.756 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.55 63.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.816 0.817 . . . . 0.0 111.517 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -72.51 -33.63 67.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 122.193 0.997 . . . . 0.0 110.741 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.33 -46.27 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 C-N-CA 124.682 1.193 . . . . 0.0 108.892 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -61.67 -41.56 97.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -75.15 -29.19 60.41 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.428 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -87.08 -49.09 7.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.818 0.735 . . . . 0.0 112.615 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 61' ' ' VAL . 17.4 m-85 -90.89 -2.36 57.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.514 0.726 . . . . 0.0 110.74 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 53.69 38.7 28.99 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.855 0.752 . . . . 0.0 110.176 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.6 p -124.01 120.54 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.183 0.993 . . . . 0.0 111.695 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.42 111.07 7.29 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.73 85.35 3.86 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 122.962 0.505 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 154.67 69.88 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.488 2.792 . . . . 0.0 111.878 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -27.31 64.12 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.582 1.553 . . . . 0.0 110.016 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -53.18 -32.93 50.41 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.305 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.31 -46.49 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -43.59 72.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.908 0.483 . . . . 0.0 111.924 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -30.54 40.31 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 119.068 -0.492 . . . . 0.0 111.34 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.99 73.83 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.97 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -140.78 76.87 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 110.472 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.02 59.37 5.19 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.621 2.881 . . . . 0.0 114.057 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 148.52 38.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.347 0.976 . . . . 0.0 110.442 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 mm -60.48 -40.95 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -56.03 -45.32 79.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.202 0.456 . . . . 0.0 110.926 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.9 95.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.15 0.98 . . . . 0.0 113.465 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.18 -38.91 68.99 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.77 -51.39 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.652 0.66 . . . . 0.0 109.598 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -69.26 -33.09 72.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.962 0.801 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 83' ' ' THR . 84.8 t80 -67.05 -51.63 52.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.661 0.743 . . . . 0.0 109.071 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.7 -35.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -37.4 87.12 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.202 0.91 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 80' ' ' TYR . 1.2 t -71.05 -15.86 62.57 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.517 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -102.65 -32.7 9.75 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.307 1.043 . . . . 0.0 113.059 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 t -87.52 19.56 3.29 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.743 2.417 . . . . 0.0 112.612 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -55.03 136.99 47.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.279 1.399 . . . . 0.0 110.803 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -68.4 148.65 50.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -59.83 118.33 6.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -133.11 50.64 2.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 108.607 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -133.8 168.55 18.52 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 109.742 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 179.444 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 CA-C-O 118.649 -0.646 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.83 163.45 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.531 1.06 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.1 p -121.94 58.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.267 1.027 . . . . 0.0 109.912 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 7.75 0.36 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.554 2.342 . . . . 0.0 115.048 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.92 129.1 14.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.193 2.197 . . . . 0.0 114.328 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.65 159.35 33.17 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HA ' HD21 ' A' ' 35' ' ' LEU . 80.2 t80 -38.77 131.66 1.3 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.119 2.168 . . . . 0.0 114.54 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.5 t -144.44 116.95 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.17 162.19 56.92 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.77 147.4 41.0 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.57 2.18 . . . . 0.0 112.029 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -121.89 -1.58 9.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.016 1.326 . . . . 0.0 112.042 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.32 150.51 52.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.77 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.529 0.732 . . . . 0.0 111.243 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.52 -49.61 81.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.78 -35.72 69.02 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -49.46 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 110.609 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -55.31 -50.08 70.51 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.871 0.468 . . . . 0.0 110.452 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.89 -42.08 98.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.889 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.05 67.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 123.694 0.621 . . . . 0.0 110.561 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.72 -40.04 76.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.466 0.576 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.75 -38.19 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -62.32 -38.86 91.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.75 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -59.82 -39.15 84.09 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 118.611 0.641 . . . . 0.0 110.119 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 67.3 mtm-85 -68.74 -44.33 74.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.789 1.177 . . . . 0.0 113.93 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.05 -43.28 58.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 122.231 0.213 . . . . 0.0 111.132 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.49 -21.83 38.43 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 122.574 0.35 . . . . 0.0 111.316 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.81 35.71 90.06 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.454 -1.192 . . . . 0.0 111.56 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.47 175.13 10.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 t -132.11 150.06 52.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.39 52.06 1.26 Allowed Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.735 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.63 130.18 41.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.67 19.87 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 126.711 2.101 . . . . 0.0 109.773 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.6 pt -83.03 -22.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.97 -1.13 19.22 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.3 119.08 26.19 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 122.834 1.302 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.41 124.02 20.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.095 1.758 . . . . 0.0 111.19 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -48.04 -46.41 33.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.998 1.719 . . . . 0.0 110.633 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.52 -31.38 69.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.541 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -71.41 -34.52 70.43 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -70.86 -31.13 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.37 -11.67 4.08 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.008 0.822 . . . . 0.0 113.825 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.89 159.74 27.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.353 1.076 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -147.56 178.86 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.445 1.498 . . . . 0.0 108.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.51 -53.33 7.12 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.076 1.351 . . . . 0.0 113.304 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tp -56.03 -49.0 74.91 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.276 0.944 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.55 -44.44 96.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.349 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -53.12 -39.42 63.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.634 0.774 . . . . 0.0 110.46 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.5 mtm -66.05 -37.47 85.92 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -40.44 88.18 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.9 -52.73 57.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -28.62 63.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.448 1.099 . . . . 0.0 112.845 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.38 -49.83 31.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.843 0.747 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -65.57 -36.38 83.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.706 0.402 . . . . 0.0 110.04 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.51 -40.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -59.57 -40.32 86.96 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 119.218 0.917 . . . . 0.0 109.799 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.25 7.4 ptm180 -77.09 -33.42 56.99 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -80.68 -39.76 26.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -101.54 -1.36 33.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.791 0.436 . . . . 0.0 110.66 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 56.02 38.85 30.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.735 1.214 . . . . 0.0 110.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' HIS . 11.8 p -148.85 133.13 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 O-C-N 121.654 -0.653 . . . . 0.0 112.629 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.14 141.67 58.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.339 1.855 . . . . 0.0 112.817 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.7 tp -128.75 96.61 29.27 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 109.912 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.95 153.49 68.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.621 2.214 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.86 68.11 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.49 1.516 . . . . 0.0 110.13 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -52.92 -27.56 19.33 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.023 0.929 . . . . 0.0 110.082 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 46.2 t -88.02 -49.11 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.69 1.196 . . . . 0.0 109.534 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -57.46 -45.18 85.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -24.17 45.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.986 0.914 . . . . 0.0 112.518 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.49 -39.31 22.64 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.488 0.586 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.24 77.21 30.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 O-C-N 124.168 0.918 . . . . 0.0 110.893 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.04 57.75 2.71 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.894 3.729 . . . . 0.0 113.228 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -141.73 149.77 40.92 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 121.245 1.839 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.1 -40.24 76.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -57.05 -46.66 82.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.909 0.777 . . . . 0.0 111.192 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.45 86.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.72 -42.65 63.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.3 70.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.96 0.904 . . . . 0.0 109.802 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.83 -39.0 76.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.367 0.53 . . . . 0.0 111.639 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 34.3 t80 -64.2 -46.93 81.72 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.85 -41.53 77.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.23 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.01 90.41 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.643 1.11 . . . . 0.0 112.268 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -63.93 -20.89 66.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.713 0.688 . . . . 0.0 110.873 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -92.29 -38.18 12.22 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.034 0.933 . . . . 0.0 110.164 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.5 m -74.26 -20.64 60.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.508 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -93.97 108.29 20.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -128.55 -160.13 1.0 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.915 2.086 . . . . 0.0 106.394 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.36 -74.96 0.59 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -147.98 133.76 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -80.05 99.44 7.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 . . . . . 0 C--O 1.247 0.969 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.655 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.48 0.702 0 CA-C-O 119.256 -0.393 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.3 158.68 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.202 1.401 . . . . 0.0 111.716 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 97.28 3.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -80.42 -21.86 41.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.178 0.991 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.31 120.08 11.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.789 1.236 . . . . 0.0 110.609 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -62.08 151.02 36.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.679 1.592 . . . . 0.0 108.87 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HA ' HD21 ' A' ' 35' ' ' LEU . 12.3 t80 -50.38 137.25 19.01 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.592 1.557 . . . . 0.0 110.997 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.1 t -142.03 118.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.91 162.18 31.94 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.458 0.703 . . . . 0.0 110.567 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.13 154.64 69.5 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.015 1.81 . . . . 0.0 109.231 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -129.73 -12.9 4.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -121.09 153.18 37.79 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -23.47 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.94 -49.84 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.552 1.523 . . . . 0.0 108.64 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -55.14 -45.3 75.63 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.406 1.882 . . . . 0.0 108.689 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.2 t -56.6 -37.92 71.31 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.031 2.132 . . . . 0.0 110.71 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.2 mmpt? -78.02 -45.44 23.67 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.67 -41.18 94.54 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.77 72.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.493 1.121 . . . . 0.0 109.858 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.21 -43.02 74.95 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.23 0.468 . . . . 0.0 110.501 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.86 -37.45 80.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.453 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -61.88 -44.57 96.54 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.902 0.774 . . . . 0.0 110.759 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -52.15 -47.13 65.59 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.536 1.134 . . . . 0.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -59.91 -16.15 27.3 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 51' ' ' VAL . 4.7 t -111.85 -43.02 4.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.057 0.943 . . . . 0.0 111.821 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.02 -26.25 60.33 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 121.76 -0.587 . . . . 0.0 110.672 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.18 50.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 118.379 0.536 . . . . 0.0 111.809 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.48 169.62 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -138.03 111.4 8.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 108.063 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.91 69.58 0.44 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.021 1.296 . . . . 0.0 110.677 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.45 122.04 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.364 1.466 . . . . 0.0 109.544 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.54 161.05 44.24 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.19 0.905 . . . . 0.0 110.849 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 5.9 pt -69.5 -21.29 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 121.469 -1.018 . . . . 0.0 112.581 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.6 -4.77 17.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.87 2.068 . . . . 0.0 112.836 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -71.91 122.56 21.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.675 0.67 . . . . 0.0 109.627 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -70.62 114.32 8.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.286 1.435 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -42.86 -42.07 3.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.863 1.665 . . . . 0.0 114.341 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -75.43 -27.41 58.96 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.431 -0.793 . . . . 0.0 111.965 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.0 -28.41 64.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.097 0.862 . . . . 0.0 109.325 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.77 29.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.836 2.054 . . . . 0.0 109.118 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.88 -0.87 49.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 119.786 -1.821 . . . . 0.0 113.834 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.29 157.0 49.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 119.032 1.416 . . . . 0.0 110.811 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -143.49 173.95 11.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.09 -30.07 24.37 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.71 -52.23 22.29 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.4 mmtp -55.44 -41.38 72.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 109.832 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.99 64.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.561 0.745 . . . . 0.0 111.74 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.91 -38.33 61.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.305 1.042 . . . . 0.0 110.004 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.3 75.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.41 0.284 . . . . 0.0 110.252 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 HG21 ' A' ' 26' ' ' VAL . 11.6 t -76.62 -45.83 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.84 -34.08 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.35 1.06 . . . . 0.0 112.35 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.14 82.56 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.558 0.694 . . . . 0.0 109.854 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -67.97 -42.74 80.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.294 1.037 . . . . 0.0 110.164 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -62.46 -47.83 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 123.731 0.813 . . . . 0.0 109.502 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.24 90.4 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.024 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -75.74 -33.04 60.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.6 -49.28 8.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.543 0.611 . . . . 0.0 111.041 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -88.2 1.92 53.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.393 0.677 . . . . 0.0 111.502 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 51.73 38.9 24.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.984 1.314 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.55 128.4 7.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 O-C-N 121.233 -0.917 . . . . 0.0 112.408 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.34 122.07 15.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.64 88.65 14.0 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.86 160.31 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.268 1.312 . . . . 0.0 110.99 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.91 -26.0 58.37 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.307 1.443 . . . . 0.0 108.559 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -51.88 -44.47 63.73 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.22 1.008 . . . . 0.0 111.718 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 t -77.69 -40.88 28.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.45 0.7 . . . . 0.0 109.633 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -42.14 98.62 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.603 0.761 . . . . 0.0 110.718 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -41.54 23.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.47 78.92 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.496 -0.882 . . . . 0.0 112.54 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -143.08 74.95 17.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.156 0.982 . . . . 0.0 111.319 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 59.85 2.46 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.879 3.719 . . . . 0.0 113.302 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.01 147.59 37.14 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.285 -1.509 . . . . 0.0 109.829 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 34' ' ' ILE . 21.6 mm -60.03 -44.38 94.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -57.11 -44.89 83.69 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.029 0.831 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.79 93.49 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.005 0.522 . . . . 0.0 111.895 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.4 -44.43 71.43 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.35 65.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.719 0.808 . . . . 0.0 110.923 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -72.34 -34.53 68.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.978 0.808 . . . . 0.0 112.457 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -68.38 -52.51 32.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.257 0.623 . . . . 0.0 110.357 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.79 -44.54 85.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.172 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.97 77.21 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -75.81 -26.17 57.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.357 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -74.98 -51.11 14.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 p -83.06 29.46 0.47 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.351 1.46 . . . . 0.0 109.835 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -63.91 159.37 19.92 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.129 0.877 . . . . 0.0 109.037 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -139.46 121.26 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 41.37 72.01 0.18 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.118 1.767 . . . . 0.0 112.902 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -150.8 93.39 1.94 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -121.48 27.81 8.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.003 1.721 . . . . 0.0 111.52 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.6 m170 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 117.123 -1.418 . . . . 0.0 110.155 179.858 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.476 0.458 0 N-CA-C 111.384 -0.275 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.58 161.49 21.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.129 0.971 . . . . 0.0 108.953 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 m -67.57 149.85 49.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 59.26 13.9 3.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 113.032 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.19 129.29 20.96 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.4 156.9 36.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.355 1.462 . . . . 0.0 109.348 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' HA ' HD21 ' A' ' 35' ' ' LEU . 9.6 t80 -52.8 137.6 31.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.049 2.14 . . . . 0.0 111.205 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -144.85 117.52 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.01 152.86 82.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.49 150.46 75.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.85 2.367 . . . . 0.0 110.475 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 p -127.1 -17.78 4.74 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -102.4 142.28 33.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -22.42 0.91 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.598 1.559 . . . . 0.0 115.089 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.43 -48.81 19.51 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.021 0 CA-C-N 119.25 0.932 . . . . 0.0 109.376 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.23 -45.82 72.41 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.875 2.07 . . . . 0.0 110.14 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 t -59.19 -38.76 80.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.526 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -70.66 -38.85 73.85 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.128 0.422 . . . . 0.0 111.829 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.09 -40.06 86.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 -34.51 73.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 123.843 0.714 . . . . 0.0 109.482 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -63.86 -49.39 72.95 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 118.397 0.544 . . . . 0.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.1 -37.87 80.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.923 0.489 . . . . 0.0 110.053 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -64.03 -42.34 97.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.229 -0.92 . . . . 0.0 109.974 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -62.39 -32.36 73.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.047 0.939 . . . . 0.0 109.808 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.73 -43.03 26.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.172 -0.955 . . . . 0.0 111.37 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.65 -55.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.3 mt -68.47 -30.22 69.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.236 0.614 . . . . 0.0 112.082 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.85 43.34 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 123.664 0.649 . . . . 0.0 111.81 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.21 175.58 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.989 1.715 . . . . 0.0 108.144 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -138.57 139.72 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 107.758 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.74 38.76 2.31 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.38 0.514 . . . . 0.0 112.925 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.528 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -81.69 122.28 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.81 -178.39 30.76 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.578 1.561 . . . . 0.0 110.831 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 pt -74.09 -26.72 21.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 O-C-N 121.403 -1.057 . . . . 0.0 113.179 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.03 -3.5 23.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.711 2.004 . . . . 0.0 113.95 -178.344 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.0 m-20 -68.04 116.58 8.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.5 m-20 -73.61 127.69 33.45 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.6 t80 -48.97 -45.64 42.38 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.499 1.12 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.98 -38.66 91.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.467 0.707 . . . . 0.0 110.879 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -66.81 -20.74 66.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.772 1.229 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 32' ' ' ILE . 11.3 mt -89.39 7.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 120.98 -1.075 . . . . 0.0 108.118 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.94 0.64 87.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 119.631 -1.918 . . . . 0.0 113.676 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.45 139.51 30.61 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.425 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 24.5 p80 -121.99 175.19 6.45 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.161 -1.199 . . . . 0.0 108.434 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.053 0.941 . . . . 0.0 112.94 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.172 0.442 . . . . 0.0 111.907 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 16.6 mmtp -64.64 -42.38 95.51 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.0 79.02 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.832 1.253 . . . . 0.0 111.265 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.4 mmt -55.65 -42.83 75.61 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.819 0.848 . . . . 0.0 110.193 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.59 -38.6 91.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.838 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.25 -48.49 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.54 -28.25 59.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.514 0.726 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -50.56 47.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.927 0.785 . . . . 0.0 110.081 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -68.27 -36.53 79.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.05 0.929 . . . . 0.0 110.328 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -67.3 -45.67 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -40.16 86.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.021 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -75.87 -31.22 59.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -84.97 -48.24 9.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.551 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -87.07 -1.63 58.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 52.33 39.01 26.47 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 111.089 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.9 138.26 14.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.55 125.08 28.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.975 0.893 . . . . 0.0 110.172 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tt -113.82 91.87 23.19 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.42 155.32 70.66 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.424 1.416 . . . . 0.0 110.935 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.15 -28.83 19.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.126 1.37 . . . . 0.0 111.686 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.68 -44.35 66.17 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.554 0.742 . . . . 0.0 112.236 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 80' ' ' TYR . 48.4 t -80.84 -37.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -44.56 95.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.208 0.603 . . . . 0.0 110.491 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -40.8 26.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.561 1.545 . . . . 0.0 110.934 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.01 71.75 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.992 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -134.25 70.65 73.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.66 0.784 . . . . 0.0 110.161 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.12 59.35 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.562 3.508 . . . . 0.0 111.908 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.96 147.9 37.73 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.878 1.672 . . . . 0.0 109.396 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.45 -42.79 85.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.78 -49.07 66.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.869 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.27 -40.4 90.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.05 -38.5 66.48 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.28 69.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.385 0.538 . . . . 0.0 110.208 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.13 -39.38 72.03 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.239 0.337 . . . . 0.0 111.795 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 67' ' ' VAL . 48.6 t80 -63.75 -47.37 81.29 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 110.018 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.21 -37.38 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.95 -46.74 88.44 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.632 1.105 . . . . 0.0 112.082 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -63.41 -17.38 62.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.28 0.491 . . . . 0.0 110.467 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -98.58 -29.23 13.18 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.953 -1.092 . . . . 0.0 112.05 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.9 p -77.2 -4.68 45.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.988 0.813 . . . . 0.0 110.868 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -114.32 173.54 6.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.195 2.598 . . . . 0.0 108.735 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -107.65 172.52 6.79 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.192 0.997 . . . . 0.0 108.731 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -147.35 5.72 0.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.383 0.673 . . . . 0.0 112.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -149.2 102.85 3.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -153.18 116.26 4.58 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 . . . . . 0 C--O 1.252 1.186 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.162 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 CA--C 1.532 0.403 0 N-CA-C 112.664 0.217 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.76 161.89 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 129.27 3.028 . . . . 0.0 115.666 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 m -91.85 89.18 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.7 5.77 2.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 0.0 112.552 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 155.84 37.21 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 120.77 -1.206 . . . . 0.0 112.112 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -82.5 171.23 14.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.489 ' HA ' HD21 ' A' ' 35' ' ' LEU . 38.6 t80 -51.36 135.42 27.01 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -147.92 117.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 162.18 14.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.378 1.071 . . . . 0.0 110.228 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.15 151.02 84.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.382 2.054 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 -6.02 3.62 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.965 0.906 . . . . 0.0 111.995 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -117.38 140.09 50.02 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.15 -33.81 41.98 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.82 -38.12 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.847 0.749 . . . . 0.0 109.667 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.9 -38.76 92.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -61.93 -46.65 88.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.598 1.159 . . . . 0.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -56.56 -58.13 9.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.893 0.877 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.76 -36.35 83.59 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.017 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.17 63.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.424 0.689 . . . . 0.0 110.764 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.15 -48.39 23.86 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -54.39 -41.42 53.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.126 1.371 . . . . 0.0 111.151 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -61.97 -42.22 98.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.729 0.812 . . . . 0.0 111.558 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.64 -46.05 87.95 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.5 mmm-85 -62.27 -23.92 66.97 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.929 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -92.4 -55.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 119.929 1.241 . . . . 0.0 109.445 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.36 -23.87 66.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.82 33.75 57.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.99 174.11 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.8 p -134.7 132.08 38.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.307 1.443 . . . . 0.0 107.698 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.71 45.74 0.95 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 123.966 0.793 . . . . 0.0 113.21 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.2 121.89 27.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.86 35.68 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.3 0.952 . . . . 0.0 111.029 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.5 pt -81.69 -21.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 120.45 -1.618 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.82 1.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.137 1.775 . . . . 0.0 113.418 -178.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.66 122.44 15.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.931 1.348 . . . . 0.0 111.828 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -81.02 108.34 14.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.1 t80 -44.88 -45.15 10.14 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.974 1.709 . . . . 0.0 113.718 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -73.73 -27.83 61.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.537 -0.727 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.37 -30.25 69.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 38' ' ' PHE . 16.2 mt -77.37 6.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 126.484 1.914 . . . . 0.0 109.984 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 3.35 79.84 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 119.659 -1.901 . . . . 0.0 112.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.58 157.98 47.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 107.817 -2.113 . . . . 0.0 107.817 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 18.6 p80 -147.06 178.59 8.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.61 -54.63 5.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.913 1.285 . . . . 0.0 112.247 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.04 -45.8 75.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 64.8 mmtt -64.41 -44.07 92.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -40.09 68.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.309 1.044 . . . . 0.0 111.459 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 mtm -65.68 -35.47 80.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.524 0.33 . . . . 0.0 111.168 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.95 78.49 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.949 0.9 . . . . 0.0 111.612 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.01 -41.68 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.74 70.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.484 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.76 48.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.59 -38.59 85.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.93 -46.36 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -40.93 90.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.52 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -29.37 58.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.83 -48.44 8.76 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 61' ' ' VAL . 53.1 m-85 -96.23 2.16 52.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 111.505 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 55.85 31.83 18.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.264 0.626 . . . . 0.0 111.877 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.8 p -133.87 128.99 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 123.317 0.647 . . . . 0.0 112.601 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.54 124.98 25.54 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.6 tp -112.22 87.63 9.39 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.05 156.81 64.42 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.753 0.969 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -27.54 65.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.261 1.024 . . . . 0.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.77 -29.08 62.28 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.961 0.8 . . . . 0.0 111.079 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 80' ' ' TYR . 49.4 t -86.64 -43.5 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -49.06 79.24 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 123.055 0.542 . . . . 0.0 111.159 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -29.12 61.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.62 -29.91 27.33 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.635 0.652 . . . . 0.0 112.085 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -138.58 68.02 44.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 109.213 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.78 57.95 4.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.56 2.84 . . . . 0.0 114.88 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.16 148.21 37.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.383 0.992 . . . . 0.0 110.558 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -56.28 -44.08 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -52.31 -49.66 63.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.894 0.77 . . . . 0.0 111.42 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.18 99.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.05 -43.09 62.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.262 1.425 . . . . 0.0 108.516 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.82 88.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -73.31 -37.12 66.3 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.253 0.621 . . . . 0.0 111.493 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 67' ' ' VAL . 17.3 t80 -65.51 -41.11 93.52 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.16 -43.6 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.69 90.64 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -15.86 63.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.328 0.651 . . . . 0.0 112.23 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -101.07 -31.92 10.84 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.9 t -67.61 4.3 1.12 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.85 2.46 . . . . 0.0 111.51 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -137.1 82.26 1.92 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -75.76 -47.76 24.6 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -77.33 -172.59 2.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.214 1.006 . . . . 0.0 109.315 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -112.97 -6.69 13.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.975 0.91 . . . . 0.0 112.487 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -124.25 156.16 37.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.192 1.397 . . . . 0.0 108.569 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 117.347 -1.311 . . . . 0.0 107.773 179.459 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 N--CA 1.479 0.619 0 CA-C-O 119.73 -0.196 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.35 174.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.847 1.259 . . . . 0.0 110.498 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 m -114.09 143.28 45.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.528 1.531 . . . . 0.0 107.151 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -123.88 8.54 8.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.438 0.695 . . . . 0.0 111.568 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.13 165.85 15.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.564 1.146 . . . . 0.0 111.141 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -76.27 170.66 15.91 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -42.95 124.5 3.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.4 1.88 . . . . 0.0 114.967 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.0 t -146.86 116.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.04 161.62 15.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.109 1.763 . . . . 0.0 112.672 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.06 148.47 93.1 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.625 2.883 . . . . 0.0 112.65 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 p -114.66 -21.14 10.38 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.255 1.422 . . . . 0.0 113.656 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -109.97 162.86 14.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.377 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -34.28 77.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.837 1.655 . . . . 0.0 110.612 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.1 -50.99 28.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.75 -43.4 76.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 126.342 1.857 . . . . 0.0 109.427 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -65.52 -32.96 74.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.328 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -68.45 -48.7 63.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.786 1.176 . . . . 0.0 108.896 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.65 -41.86 82.31 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.086 0.955 . . . . 0.0 110.918 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.02 67.84 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.207 1.003 . . . . 0.0 111.95 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -77.42 -37.35 51.96 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 118.937 0.79 . . . . 0.0 110.127 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.89 -40.17 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.518 -0.739 . . . . 0.0 109.76 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -59.41 -39.21 82.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.302 0.641 . . . . 0.0 111.874 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -63.69 -32.84 74.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.495 0.718 . . . . 0.0 110.902 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -68.01 -35.7 78.73 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.817 -1.177 . . . . 0.0 111.484 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.22 -54.83 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.27 0.628 . . . . 0.0 110.838 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.18 -24.83 57.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.4 21.67 69.3 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.426 1.012 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 m -105.15 175.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.505 1.122 . . . . 0.0 110.458 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 t -139.32 112.75 8.28 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.35 62.8 0.34 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 123.202 0.429 . . . . 0.0 112.435 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.7 mm -86.63 137.83 20.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.83 177.19 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 124.89 1.233 . . . . 0.0 111.741 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 pt -78.87 -22.42 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 121.082 -1.246 . . . . 0.0 113.41 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.72 0.78 22.58 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.251 34.9 p30 -76.11 129.56 36.98 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 123.192 1.472 . . . . 0.0 112.706 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -74.1 111.59 9.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.849 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' HD12 ' A' ' 41' ' ' ILE . 85.4 t80 -43.46 -45.94 6.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.737 1.615 . . . . 0.0 112.604 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -66.99 -37.02 83.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -67.62 -31.45 71.48 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.652 0.781 . . . . 0.0 109.98 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 38' ' ' PHE . 24.2 mt -71.98 -6.26 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.286 1.034 . . . . 0.0 109.27 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.39 10.24 27.78 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 126.024 1.774 . . . . 0.0 112.908 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.9 159.31 47.46 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.878 1.339 . . . . 0.0 110.111 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' HIS . . . . . 0.436 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 20.1 p80 -146.86 178.07 8.62 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.344 1.458 . . . . 0.0 107.906 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.57 -54.75 5.77 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.633 1.173 . . . . 0.0 112.739 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -54.95 -50.54 68.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.857 0.863 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.2 mmtp -61.86 -39.31 91.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.893 -1.051 . . . . 0.0 111.149 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.96 96.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.497 1.044 . . . . 0.0 108.847 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.4 mtm -66.69 -37.45 84.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.942 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.31 92.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.221 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.9 t -72.65 -45.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.691 1.132 . . . . 0.0 108.057 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.32 -32.74 57.35 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.938 0.895 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.03 83.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.213 0.461 . . . . 0.0 111.064 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -77.74 -43.33 31.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 122.002 0.906 . . . . 0.0 108.885 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.78 -46.46 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 124.049 0.94 . . . . 0.0 109.605 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -60.61 -41.08 94.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.778 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -75.53 -32.39 60.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -82.51 -45.99 13.99 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 123.219 0.607 . . . . 0.0 111.873 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB2' HG12 ' A' ' 61' ' ' VAL . 71.9 m-85 -93.96 -3.01 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.899 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 53.82 46.97 24.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.754 1.221 . . . . 0.0 108.761 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 59' ' ' TYR . 8.6 p -140.08 126.97 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 48.0 tt0 -73.04 115.0 11.84 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.66 88.54 16.47 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.81 153.85 63.9 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.05 1.167 . . . . 0.0 109.725 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.84 -26.36 9.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.855 2.062 . . . . 0.0 110.35 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.29 -44.35 64.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.616 1.166 . . . . 0.0 110.641 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 56.5 t -77.66 -45.72 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.566 0.747 . . . . 0.0 109.085 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -42.62 74.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.453 0.701 . . . . 0.0 110.716 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -37.45 28.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.281 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.44 98.81 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.336 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -137.64 83.38 25.05 Favored Pre-proline 0 N--CA 1.448 -0.56 0 O-C-N 124.396 1.06 . . . . 0.0 109.222 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 60.77 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.164 2.576 . . . . 0.0 110.95 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.18 148.66 38.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.972 1.715 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mm -57.17 -43.01 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.83 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.55 -48.99 76.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.864 0.756 . . . . 0.0 111.587 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.69 -41.45 86.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.148 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.4 -42.25 62.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.26 76.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.703 1.201 . . . . 0.0 110.849 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -37.88 64.94 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.894 0.77 . . . . 0.0 110.311 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 43.8 t80 -63.31 -48.08 79.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.535 0.607 . . . . 0.0 110.929 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.432 HG13 HG11 ' A' ' 61' ' ' VAL . 28.8 t -69.7 -40.82 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.11 86.57 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 118.998 0.817 . . . . 0.0 112.528 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 t -73.16 -13.93 61.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.231 0.469 . . . . 0.0 110.118 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -97.75 -39.74 8.9 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 119.542 1.064 . . . . 0.0 109.684 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.2 t -68.29 -39.95 81.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.793 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -97.8 108.47 21.19 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.613 0.765 . . . . 0.0 109.874 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -80.58 104.22 10.96 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -94.91 107.11 19.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.674 0.789 . . . . 0.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.94 170.96 15.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.419 1.088 . . . . 0.0 108.271 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -131.05 62.49 1.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.15 1.38 . . . . 0.0 108.452 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 C--O 1.251 1.161 0 N-CA-C 103.226 -2.879 . . . . 0.0 103.226 178.845 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 N--CA 1.48 0.715 0 CA-C-O 120.927 0.303 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.17 -33.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 122.539 1.162 . . . . 0.0 109.795 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 141.82 57.09 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 131.226 3.811 . . . . 0.0 107.097 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 66.62 3.0 2.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.166 1.386 . . . . 0.0 113.57 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.75 126.29 13.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -58.48 146.14 36.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.357 2.263 . . . . 0.0 110.784 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -48.11 125.47 9.24 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.806 2.442 . . . . 0.0 110.48 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.2 t -135.22 117.39 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 152.89 72.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.056 0.942 . . . . 0.0 111.458 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.49 151.57 84.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.951 2.434 . . . . 0.0 111.081 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -129.2 -13.87 4.4 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.719 1.208 . . . . 0.0 111.229 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 25.0 t-20 -90.08 152.09 21.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.28 70.78 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.899 0.48 . . . . 0.0 110.162 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -78.28 -51.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.734 1.614 . . . . 0.0 110.833 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 2.1 mt-10 -55.37 -37.96 68.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.132 0.573 . . . . 0.0 110.089 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 t -59.97 -52.29 66.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 123.843 0.714 . . . . 0.0 109.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.4 mmpt? -56.5 -49.2 75.4 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.75 -38.8 92.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 117.486 -1.245 . . . . 0.0 111.075 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.15 -30.09 70.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.76 0.709 . . . . 0.0 110.174 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.98 -44.08 97.01 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -63.52 -39.23 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.689 1.196 . . . . 0.0 109.586 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -55.46 -43.85 75.86 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.868 0.758 . . . . 0.0 109.967 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.4 -32.28 72.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.745 0.702 . . . . 0.0 110.643 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -76.22 -16.36 59.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.486 -1.384 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.04 -36.23 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.641 0.776 . . . . 0.0 110.078 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.19 -42.13 12.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.971 1.308 . . . . 0.0 111.537 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.75 40.32 7.24 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.394 -1.226 . . . . 0.0 110.948 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.253 3.4 m -128.24 177.22 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.664 1.232 . . . . 0.0 108.686 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.3 t -143.59 108.26 4.88 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 119.981 -1.7 . . . . 0.0 108.233 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.97 41.93 0.15 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.453 1.501 . . . . 0.0 114.167 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 41' ' ' ILE . 39.5 mm -76.42 145.38 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 120.193 1.997 . . . . 0.0 108.507 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.03 175.5 15.88 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.389 1.947 . . . . 0.0 110.079 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 pt -75.63 -30.83 22.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.433 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -101.13 -0.52 36.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.523 1.129 . . . . 0.0 113.382 -178.368 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.2 m-20 -69.53 116.59 10.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -67.45 117.57 9.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 84.3 t80 -45.94 -45.58 15.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.542 1.537 . . . . 0.0 111.893 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -70.67 -29.77 66.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.45 0.7 . . . . 0.0 112.53 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -76.91 -30.29 56.08 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.51 -0.744 . . . . 0.0 110.39 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 32' ' ' ILE . 32.3 mt -70.72 -31.05 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.264 0.484 . . . . 0.0 110.389 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.58 -2.45 2.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.907 1.242 . . . . 0.0 111.651 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.7 157.83 53.59 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -136.66 172.96 12.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.83 -45.92 20.5 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.336 0.654 . . . . 0.0 112.47 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.03 -49.29 78.46 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.517 0.598 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -60.64 -38.83 86.1 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.395 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -35.23 62.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.844 1.202 . . . . 0.0 111.006 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.6 mtm -73.85 -42.06 61.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.55 74.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.082 1.353 . . . . 0.0 111.327 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.9 -53.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.98 -36.28 65.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.081 0.952 . . . . 0.0 112.316 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.21 -52.49 65.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.692 0.797 . . . . 0.0 111.565 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -75.72 -33.27 60.3 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.635 -0.666 . . . . 0.0 111.799 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.99 -44.09 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.658 1.183 . . . . 0.0 108.909 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -41.08 88.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.611 0.641 . . . . 0.0 110.261 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.69 -34.44 60.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.89 -48.16 13.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.802 0.689 . . . . 0.0 111.585 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CB ' HG12 ' A' ' 61' ' ' VAL . 23.7 m-85 -91.34 3.18 55.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.165 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 48.8 38.81 12.67 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.269 1.428 . . . . 0.0 110.445 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 81' ' ' VAL . 7.3 p -143.46 117.65 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 123.678 0.791 . . . . 0.0 110.14 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -64.12 140.01 58.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 tt -120.38 84.54 35.44 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.85 144.81 94.16 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.3 14.81 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.885 1.274 . . . . 0.0 110.462 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -53.28 -35.11 59.73 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 t -87.97 -44.24 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 119.121 0.873 . . . . 0.0 109.135 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -51.63 63.29 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 123.536 0.734 . . . . 0.0 110.796 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -71.57 -37.91 70.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.295 0.638 . . . . 0.0 111.573 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.6 84.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.75 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.86 78.6 29.82 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.861 1.264 . . . . 0.0 108.653 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 55.39 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.846 3.031 . . . . 0.0 111.043 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.25 147.16 47.41 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.194 0.906 . . . . 0.0 110.098 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 74' ' ' ILE . 4.5 mm -61.17 -39.3 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.31 -51.2 60.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 111.867 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.31 97.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.695 1.598 . . . . 0.0 114.212 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.1 -40.4 65.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.847 1.259 . . . . 0.0 108.417 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -51.75 68.22 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 119.028 0.831 . . . . 0.0 109.385 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.77 -38.5 89.23 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.497 0.319 . . . . 0.0 111.622 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.93 -51.97 48.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.246 1.018 . . . . 0.0 110.377 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.633 HG13 HG11 ' A' ' 61' ' ' VAL . 70.9 t -66.42 -41.84 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 123.346 0.404 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.18 78.67 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -70.9 -24.91 62.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.68 0.218 . . . . 0.0 110.568 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -77.09 -40.73 44.96 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.687 -1.258 . . . . 0.0 108.694 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -78.41 3.43 15.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.285 1.034 . . . . 0.0 112.308 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -49.17 116.31 1.64 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.981 2.113 . . . . 0.0 111.942 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.29 65.1 1.16 Allowed 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -78.65 76.15 5.15 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.239 1.415 . . . . 0.0 107.737 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -154.16 -69.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -78.17 -5.39 51.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.26 1.824 . . . . 0.0 112.229 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.113 0 C-N-CA 127.322 2.249 . . . . 0.0 107.263 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 110.325 -0.683 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.07 162.01 34.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 123.319 0.648 . . . . 0.0 109.264 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -85.66 62.22 7.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 55.26 10.6 0.46 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.91 2.484 . . . . 0.0 113.998 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.46 -10.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 129.032 2.933 . . . . 0.0 118.182 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.33 144.36 54.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -52.01 123.33 10.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 0.0 111.638 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -138.37 117.26 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 160.07 44.08 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.356 1.462 . . . . 0.0 110.101 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.33 145.16 99.18 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.887 3.058 . . . . 0.0 113.353 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -116.65 -11.67 10.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 0.0 112.391 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -125.3 145.4 50.03 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.33 -29.31 9.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.372 1.069 . . . . 0.0 112.863 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.47 -53.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.673 0.749 . . . . 0.0 109.58 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -55.85 -42.96 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.605 1.962 . . . . 0.0 109.272 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -66.08 -31.82 72.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.424 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -72.31 -40.37 67.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.038 1.29 . . . . 0.0 109.761 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -69.07 -39.07 79.3 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.079 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 -33.83 70.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.487 1.117 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -69.55 -40.79 76.62 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 117.999 0.363 . . . . 0.0 111.171 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.18 -36.39 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -62.49 -35.64 80.0 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.652 -0.655 . . . . 0.0 109.659 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.54 -39.9 88.82 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.59 -0.694 . . . . 0.0 109.624 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -65.84 -38.81 89.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 51' ' ' VAL . 48.8 t -81.37 -44.57 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.0 mt -85.91 -24.03 26.77 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.055 0.542 . . . . 0.0 112.128 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.29 31.15 59.61 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.268 -0.74 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.27 171.33 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.7 p -143.04 138.22 29.8 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.954 1.252 . . . . 0.0 111.521 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.34 42.6 1.05 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.978 1.275 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.49 121.55 28.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.786 0.834 . . . . 0.0 109.68 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -90.97 169.31 33.48 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.67 1.129 . . . . 0.0 110.67 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.3 pt -71.28 -25.94 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.099 -1.236 . . . . 0.0 111.973 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.28 1.03 32.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.069 2.147 . . . . 0.0 112.724 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.676 ' HB3' HD11 ' A' ' 41' ' ' ILE . 10.8 m-20 -65.68 116.73 7.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.15 0.98 . . . . 0.0 108.559 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -74.78 112.83 11.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.0 t80 -43.08 -52.46 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.503 1.521 . . . . 0.0 112.471 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.74 -33.02 72.28 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.319 -0.863 . . . . 0.0 111.666 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -68.65 -23.09 64.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.117 0.967 . . . . 0.0 110.461 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 36' ' ' ASP . 15.2 mt -84.25 14.01 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 125.339 1.456 . . . . 0.0 109.157 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 9.6 70.21 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 119.368 -2.083 . . . . 0.0 113.721 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 170.51 54.31 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 118.306 1.053 . . . . 0.0 112.047 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -155.08 176.7 12.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 108.03 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.92 -46.09 60.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.558 0.743 . . . . 0.0 112.563 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.26 -49.1 72.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.122 0.874 . . . . 0.0 109.401 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -59.38 -46.58 88.28 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.38 62.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.052 0.842 . . . . 0.0 113.048 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.1 mtm -75.63 -39.79 57.28 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 109.776 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.086 1.354 . . . . 0.0 111.574 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 26' ' ' VAL . 97.8 t -68.71 -53.56 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.89 61.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.356 1.463 . . . . 0.0 113.779 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.32 -50.63 59.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.493 1.042 . . . . 0.0 108.646 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.05 -31.96 56.58 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 121.984 0.897 . . . . 0.0 110.992 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.63 -42.58 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -42.1 98.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.311 0.96 . . . . 0.0 109.573 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -74.18 -30.02 62.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.188 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.89 -49.55 10.88 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.822 0.737 . . . . 0.0 110.379 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.84 -1.56 57.89 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 55.68 40.89 30.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.991 1.317 . . . . 0.0 109.804 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.585 HG11 HG13 ' A' ' 81' ' ' VAL . 2.5 p -150.38 130.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.76 128.25 34.96 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.132 0.573 . . . . 0.0 109.548 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.75 86.7 13.39 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.41 141.75 52.22 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.713 1.608 . . . . 0.0 109.735 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -27.33 16.84 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.742 1.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -53.9 -32.25 52.75 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.057 0.844 . . . . 0.0 111.577 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 80' ' ' TYR . 59.4 t -86.81 -46.54 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -54.58 -47.73 72.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.509 1.124 . . . . 0.0 111.488 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.94 -36.46 62.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.149 0.58 . . . . 0.0 111.003 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -33.11 67.58 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.224 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -141.36 74.43 24.17 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.385 1.474 . . . . 0.0 109.366 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.98 56.49 3.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 125.062 3.841 . . . . 0.0 113.894 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.45 148.35 42.62 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.883 -1.136 . . . . 0.0 111.773 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -56.7 -42.96 78.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -54.99 -49.89 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.163 0.438 . . . . 0.0 110.892 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.48 97.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.24 -40.86 70.79 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.41 79.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.441 0.564 . . . . 0.0 110.206 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.25 -40.48 67.65 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.923 0.489 . . . . 0.0 111.728 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' CE1' HG21 ' A' ' 67' ' ' VAL . 61.2 t80 -63.27 -43.82 96.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.585 HG13 HG11 ' A' ' 61' ' ' VAL . 74.2 t -74.03 -35.89 42.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.866 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -35.59 71.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.248 0.931 . . . . 0.0 112.73 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 t -82.31 -18.64 41.56 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.216 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -93.23 -47.83 6.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.742 1.155 . . . . 0.0 109.506 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -83.81 34.93 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.989 2.116 . . . . 0.0 107.357 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -64.39 172.54 2.5 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.876 1.67 . . . . 0.0 110.673 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.21 -34.26 0.17 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -74.09 69.32 1.48 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.881 1.272 . . . . 0.0 111.993 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -70.09 110.76 5.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -129.78 90.23 2.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.663 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 N--CA 1.476 0.492 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.36 152.32 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.685 1.194 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -105.53 38.97 1.85 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.7 1.2 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.5 1.48 1.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.224 1.41 . . . . 0.0 114.451 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.68 123.29 48.92 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.332 1.453 . . . . 0.0 109.998 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -68.63 165.27 19.65 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.801 0.688 . . . . 0.0 109.679 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . 0.433 ' HA ' HD21 ' A' ' 35' ' ' LEU . 5.9 t80 -50.48 133.88 24.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.957 2.103 . . . . 0.0 112.791 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.55 118.98 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.46 157.59 77.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.251 1.02 . . . . 0.0 111.614 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 155.3 71.38 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.484 2.789 . . . . 0.0 112.926 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.3 t -130.78 -20.22 2.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.466 1.107 . . . . 0.0 112.419 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 7.4 t-20 -98.72 143.72 28.77 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.99 -27.1 12.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.02 0.928 . . . . 0.0 113.49 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.95 -46.64 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 120.388 1.449 . . . . 0.0 109.186 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 3.9 mt-10 -56.82 -35.27 68.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.21 1.404 . . . . 0.0 110.471 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -63.2 -49.09 75.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -57.42 -48.64 78.59 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.36 -41.68 94.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.664 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.67 -34.6 73.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.725 0.641 . . . . 0.0 109.93 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -66.41 -50.59 62.93 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.55 -37.38 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.286 1.034 . . . . 0.0 110.339 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -62.43 -44.8 95.54 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.718 0.69 . . . . 0.0 111.204 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.35 -32.86 70.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.227 0.611 . . . . 0.0 111.538 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -67.69 -43.02 81.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.523 0.601 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.7 -52.05 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 123.646 0.778 . . . . 0.0 111.864 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.88 -25.63 62.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.636 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.53 57.94 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.12 174.64 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.648 1.179 . . . . 0.0 110.023 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -144.07 114.45 7.52 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.36 27.17 0.52 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.727 1.156 . . . . 0.0 112.36 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.13 125.48 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.687 1.243 . . . . 0.0 110.819 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 175.76 22.42 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.367 1.461 . . . . 0.0 112.051 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.28 -28.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 121.098 -1.237 . . . . 0.0 112.193 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.61 2.28 28.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.465 1.906 . . . . 0.0 112.53 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.19 122.84 17.59 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.21 119.43 25.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.513 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -46.79 -46.44 20.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.236 1.814 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -74.75 -31.36 61.78 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.647 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -63.62 -36.97 85.57 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.8 mt -72.13 6.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 125.455 1.502 . . . . 0.0 109.809 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.61 3.72 80.61 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 119.543 -1.973 . . . . 0.0 111.309 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.87 145.8 49.03 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 120.081 1.941 . . . . 0.0 108.933 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -139.49 -179.39 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.297 1.039 . . . . 0.0 109.127 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.61 -53.04 12.31 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.918 1.287 . . . . 0.0 112.224 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -49.17 72.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.142 0.577 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 54.8 mmtt -61.93 -44.75 96.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.842 -0.537 . . . . 0.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.4 83.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.486 1.114 . . . . 0.0 110.217 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.85 -41.29 91.1 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.592 0.757 . . . . 0.0 109.5 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.5 75.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.179 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 4.5 t -69.9 -51.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 120.56 1.527 . . . . 0.0 107.33 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.88 -33.01 61.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.132 0.973 . . . . 0.0 113.027 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.95 75.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.265 0.626 . . . . 0.0 110.695 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -76.49 -34.18 58.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.705 0.765 . . . . 0.0 111.495 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.54 -44.98 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -39.03 84.41 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.535 0.607 . . . . 0.0 110.122 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -76.15 -31.79 58.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.12 -47.42 8.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.86 0.464 . . . . 0.0 111.783 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -90.09 0.71 57.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.749 0.419 . . . . 0.0 110.571 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 52.74 36.51 21.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.477 1.111 . . . . 0.0 111.441 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.75 123.0 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.235 0.54 . . . . 0.0 112.13 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.91 110.34 2.85 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.905 -1.122 . . . . 0.0 108.452 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 tp -100.34 93.14 2.5 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.049 1.34 . . . . 0.0 110.941 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.0 145.18 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.707 3.605 . . . . 0.0 111.096 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -29.37 9.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.709 2.404 . . . . 0.0 111.428 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -52.97 -26.66 15.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 48.4 t -87.5 -50.05 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.799 1.64 . . . . 0.0 109.212 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -46.57 63.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.005 0.922 . . . . 0.0 110.718 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -30.7 38.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.368 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.0 -30.95 58.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.948 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.38 69.25 13.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 111.394 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.37 60.43 3.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.787 3.658 . . . . 0.0 112.998 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.2 147.12 36.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.901 -1.125 . . . . 0.0 109.045 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 mm -56.9 -47.51 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 C-N-CA 124.11 0.964 . . . . 0.0 108.662 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.87 -47.37 80.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.635 0.584 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.43 81.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.2 -41.47 85.75 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.718 1.607 . . . . 0.0 108.716 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.82 99.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.512 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.6 -46.59 58.79 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 118.571 0.623 . . . . 0.0 110.403 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.578 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 22.1 t80 -58.9 -42.35 89.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.3 t -73.49 -41.33 56.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.122 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.04 82.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.677 1.126 . . . . 0.0 112.334 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -70.74 -29.35 65.58 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.546 0.612 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -86.32 -36.8 19.07 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.94 -1.1 . . . . 0.0 111.792 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.2 m -76.47 -4.13 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 111.631 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.55 153.22 44.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 121.169 -0.957 . . . . 0.0 111.762 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 53.76 67.44 1.0 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.753 2.421 . . . . 0.0 115.826 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -134.51 162.15 33.06 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.703 1.601 . . . . 0.0 107.244 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.8 t60 -136.8 84.88 2.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.561 0.696 . . . . 0.0 109.277 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -76.2 32.43 0.12 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.608 0.763 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.245 0.821 0 C-N-CA 125.598 1.559 . . . . 0.0 107.166 179.66 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 N--CA 1.48 0.699 0 CA-C-O 119.378 -0.342 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 168.71 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 111.351 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.01 114.43 2.11 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.141 1.777 . . . . 0.0 106.503 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -149.09 64.03 1.04 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.411 0.624 . . . . 0.0 110.582 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.38 156.4 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -70.78 159.2 34.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.17 1.388 . . . . 0.0 111.628 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -56.34 128.72 37.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.268 1.827 . . . . 0.0 114.07 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.96 117.61 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.11 163.41 17.44 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.297 1.439 . . . . 0.0 110.786 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.9 148.89 82.96 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.236 1.957 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 p -130.43 -12.15 3.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -110.2 143.66 40.0 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -28.38 6.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.873 1.269 . . . . 0.0 114.229 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.49 -40.76 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 119.525 1.057 . . . . 0.0 109.442 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -56.36 -39.02 72.2 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.089 0.556 . . . . 0.0 110.305 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.5 t -63.1 -49.11 75.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.852 0.72 . . . . 0.0 109.587 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -54.89 -52.29 63.34 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.678 0.672 . . . . 0.0 110.369 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -64.51 -41.63 96.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.253 -0.88 . . . . 0.0 112.716 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.78 74.55 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.5 -45.75 71.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.5 -41.85 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -61.14 -41.97 97.7 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 121.11 -0.994 . . . . 0.0 109.905 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.7 -45.13 95.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.476 0.58 . . . . 0.0 111.403 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -70.75 -39.85 73.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.577 1.081 . . . . 0.0 112.902 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.01 -55.88 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -74.96 -28.32 60.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.06 19.6 60.74 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.124 1.821 . . . . 0.0 113.093 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.07 174.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.15 1.38 . . . . 0.0 108.462 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 t -145.36 132.04 19.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.661 0.664 . . . . 0.0 112.409 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.21 0.88 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.0 mm -78.25 128.47 38.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.22 161.08 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.118 0.843 . . . . 0.0 112.66 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.55 -21.35 26.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.934 1.294 . . . . 0.0 111.193 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.9 -3.89 18.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.175 2.19 . . . . 0.0 114.301 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -75.8 131.09 39.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.556 1.071 . . . . 0.0 111.003 -177.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 5.3 m120 -80.28 119.95 23.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 41' ' ' ILE . 82.7 t80 -40.97 -46.26 2.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.879 2.071 . . . . 0.0 114.403 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -67.84 -32.3 72.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 112.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.14 -32.04 68.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.635 0.652 . . . . 0.0 109.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 38' ' ' PHE . 28.4 mt -71.23 -9.93 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.445 1.098 . . . . 0.0 110.397 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.26 1.91 23.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 124.367 0.984 . . . . 0.0 111.864 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 152.51 52.1 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -143.43 179.86 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.51 -49.27 36.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.222 0.919 . . . . 0.0 111.974 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.68 -48.32 81.47 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -59.85 -43.43 94.64 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.057 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.58 77.71 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.68 0.792 . . . . 0.0 110.009 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.74 -39.56 94.6 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.26 77.88 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.059 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.2 -50.73 55.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.47 -32.65 65.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.098 0.959 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.87 99.46 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.042 0.537 . . . . 0.0 110.485 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -78.4 -40.95 34.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 121.473 0.654 . . . . 0.0 111.252 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -64.28 -46.13 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 O-C-N 121.621 -0.674 . . . . 0.0 110.727 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -37.16 85.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.849 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -76.04 -30.22 58.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -89.71 -48.69 7.11 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.95 -3.8 59.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 109.783 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 50.98 45.17 28.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.766 2.026 . . . . 0.0 110.342 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.487 HG11 HG13 ' A' ' 81' ' ' VAL . 12.6 p -144.38 128.7 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.472 0.709 . . . . 0.0 110.286 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.86 125.63 25.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -116.19 79.67 8.86 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -66.6 150.35 83.89 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.423 2.082 . . . . 0.0 112.951 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -26.59 64.67 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.592 1.557 . . . . 0.0 109.933 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -53.32 -41.97 66.23 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.327 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -37.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -49.67 -51.1 40.57 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.505 1.122 . . . . 0.0 109.545 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -36.53 69.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.944 0.898 . . . . 0.0 111.484 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -37.17 85.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.508 0.505 . . . . 0.0 111.476 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -138.56 75.34 38.22 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 107.962 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 74.3 Cg_endo -76.66 64.26 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.37 2.714 . . . . 0.0 112.147 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.09 147.09 36.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.673 1.124 . . . . 0.0 110.226 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -55.82 -49.8 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 108.735 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -52.82 -48.12 67.19 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.091 0.556 . . . . 0.0 111.142 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.65 73.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.185 0.994 . . . . 0.0 113.281 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.1 -43.43 78.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.938 1.695 . . . . 0.0 108.864 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.24 74.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -68.8 -42.64 77.03 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.422 1.089 . . . . 0.0 111.769 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -63.96 -43.24 96.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.685 0.794 . . . . 0.0 109.737 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 61' ' ' VAL . 94.9 t -74.06 -36.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.546 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -49.0 72.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.881 0.473 . . . . 0.0 110.486 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -65.22 -28.11 69.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.44 -7.58 31.32 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.7 t -126.16 38.49 4.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.263 1.825 . . . . 0.0 108.227 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -53.0 116.87 2.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.631 1.172 . . . . 0.0 110.081 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -85.08 -5.95 59.33 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.611 1.165 . . . . 0.0 110.988 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -85.59 152.36 23.2 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -66.09 119.86 12.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -130.31 145.41 51.77 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 116.812 -1.566 . . . . 0.0 112.032 -179.842 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 CA-C-O 119.003 -0.499 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.6 171.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.854 1.262 . . . . 0.0 109.76 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.7 m -79.65 75.1 6.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.05 1.34 . . . . 0.0 107.989 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.19 -7.19 45.05 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.659 -0.651 . . . . 0.0 111.115 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 178.45 6.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.396 1.878 . . . . 0.0 109.367 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -121.62 155.28 35.42 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -45.29 120.5 2.5 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.75 1.62 . . . . 0.0 110.943 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.42 119.73 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 159.94 5.52 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.52 1.528 . . . . 0.0 111.513 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.82 152.74 77.03 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.646 2.231 . . . . 0.0 111.034 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -127.01 -14.08 5.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 23.2 t30 -118.6 145.08 45.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.52 54.32 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 122.84 0.456 . . . . 0.0 111.763 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.9 -45.0 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 7.2 mt-10 -60.73 -42.13 96.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -49.34 76.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.206 0.941 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -56.99 -54.48 46.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.876 0.87 . . . . 0.0 110.907 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.93 -37.58 87.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.21 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.46 72.37 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.069 0.849 . . . . 0.0 109.755 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.86 -48.16 80.23 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.27 -38.83 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -67.37 -44.98 77.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.062 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -55.38 -42.1 73.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.821 0.848 . . . . 0.0 110.295 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -71.62 -41.88 68.33 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.298 -0.876 . . . . 0.0 112.839 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -71.51 -45.16 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.601 0.76 . . . . 0.0 110.997 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.43 -32.15 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.92 0.888 . . . . 0.0 110.707 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.32 26.07 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.04 171.91 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.566 1.546 . . . . 0.0 108.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -143.92 127.94 17.5 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.39 40.1 0.6 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.396 1.95 . . . . 0.0 110.961 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.2 mm -77.64 126.24 37.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.842 0.857 . . . . 0.0 109.219 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.09 -179.07 38.72 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 121.807 0.671 . . . . 0.0 111.71 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 -28.27 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.245 0.618 . . . . 0.0 111.687 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.54 -4.1 20.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.421 1.489 . . . . 0.0 113.921 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.655 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -61.62 123.19 17.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.21 115.33 17.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.221 0.608 . . . . 0.0 110.833 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' HA ' HD12 ' A' ' 41' ' ' ILE . 73.0 t80 -44.75 -46.5 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.502 1.121 . . . . 0.0 113.256 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -67.46 -29.78 69.32 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.19 -31.19 34.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 36' ' ' ASP . 24.2 mt -71.08 -21.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.172 0.442 . . . . 0.0 110.051 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.69 -5.21 5.48 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.74 1.162 . . . . 0.0 113.479 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.98 157.98 53.22 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -146.18 176.93 9.37 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.31 6.6 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.157 1.783 . . . . 0.0 112.39 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -37.2 76.98 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -76.1 -37.93 57.53 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 120.215 -1.553 . . . . 0.0 110.984 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.46 72.87 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.415 1.486 . . . . 0.0 112.71 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -44.23 96.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.75 72.17 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.722 1.209 . . . . 0.0 110.741 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.45 -53.15 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.09 71.31 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.914 0.486 . . . . 0.0 110.952 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.93 72.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.061 0.846 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -72.38 -31.45 65.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.017 0.913 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.37 -42.78 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -40.61 87.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 121.758 -0.589 . . . . 0.0 110.086 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -33.73 59.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.12 -39.61 14.43 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' HG12 ' A' ' 61' ' ' VAL . 14.1 m-85 -97.8 0.93 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 50.97 37.78 18.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.305 1.042 . . . . 0.0 110.437 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG11 HG13 ' A' ' 81' ' ' VAL . 14.1 p -138.48 129.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.403 0.681 . . . . 0.0 112.785 -178.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -80.82 116.61 20.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.65 92.76 6.41 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 127.197 2.199 . . . . 0.0 105.345 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.3 152.25 82.67 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.988 1.792 . . . . 0.0 110.524 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -28.84 22.23 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.701 1.6 . . . . 0.0 110.276 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -52.28 -39.58 60.64 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.505 1.122 . . . . 0.0 112.133 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.64 -38.92 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -50.68 72.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.972 0.909 . . . . 0.0 110.808 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.35 56.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.628 1.571 . . . . 0.0 109.882 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.53 70.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.572 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.36 73.99 35.76 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.185 1.394 . . . . 0.0 108.596 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.96 62.0 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.423 3.415 . . . . 0.0 109.869 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.61 146.95 36.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.19 -42.35 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -54.75 -42.89 72.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.061 0.846 . . . . 0.0 111.318 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.12 -44.47 88.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.16 -38.76 66.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.367 1.467 . . . . 0.0 108.077 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.32 69.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.562 0.745 . . . . 0.0 109.348 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.02 -38.93 79.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.241 0.473 . . . . 0.0 111.243 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 -48.27 81.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.449 HG13 HG11 ' A' ' 61' ' ' VAL . 54.3 t -72.21 -40.24 65.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 O-C-N 123.825 0.703 . . . . 0.0 110.033 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.26 76.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.753 1.161 . . . . 0.0 114.034 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -73.36 -24.41 60.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.322 0.249 . . . . 0.0 111.323 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -87.95 -44.94 10.65 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.094 0.557 . . . . 0.0 109.732 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -83.1 38.73 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -60.88 146.67 45.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.937 -1.102 . . . . 0.0 112.635 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -75.6 9.45 2.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.673 2.389 . . . . 0.0 111.033 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -54.59 110.07 0.59 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.932 2.493 . . . . 0.0 109.145 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.9 m80 43.23 65.03 1.04 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.944 1.698 . . . . 0.0 111.247 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -148.08 165.9 29.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.752 1.221 . . . . 0.0 108.58 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 C--O 1.242 0.675 0 C-N-CA 125.42 1.488 . . . . 0.0 108.352 -179.82 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.479 0.626 0 CA-C-O 118.61 -0.662 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.31 166.04 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.58 1.082 . . . . 0.0 110.421 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -159.32 166.48 31.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.22 31.21 5.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 127.664 2.386 . . . . 0.0 106.752 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.18 159.92 30.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.84 1.656 . . . . 0.0 110.722 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.91 154.24 19.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.499 1.919 . . . . 0.0 111.658 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.41 130.69 47.42 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.202 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.3 t -145.22 117.52 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.91 160.67 19.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.869 1.268 . . . . 0.0 111.236 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.73 160.81 11.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.654 2.903 . . . . 0.0 114.222 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -127.96 -38.16 1.86 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.04 -1.891 . . . . 0.0 112.294 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 1.4 t-20 -89.48 163.7 15.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.18 71.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.773 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.32 -49.96 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.235 0.614 . . . . 0.0 109.558 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 12.0 mt-10 -54.33 -41.58 69.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.863 0.865 . . . . 0.0 109.139 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -54.5 -37.7 65.6 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.607 1.563 . . . . 0.0 110.758 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -76.93 -57.29 3.93 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 120.17 1.35 . . . . 0.0 111.302 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -53.31 -41.96 66.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.518 1.127 . . . . 0.0 113.101 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.42 69.19 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 123.57 0.544 . . . . 0.0 110.378 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -77.74 -34.93 52.36 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.215 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.36 -36.04 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -62.91 -33.98 76.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.956 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -63.59 -37.84 88.85 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -68.88 -15.97 63.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.563 HG21 HG22 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -104.11 -54.45 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 119.201 0.909 . . . . 0.0 110.355 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.55 -27.43 64.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.822 0.849 . . . . 0.0 111.983 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.49 39.02 51.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.48 174.56 12.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.918 1.287 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -134.89 138.24 43.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.0 1.32 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.03 64.04 0.95 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.587 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.18 141.37 14.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.3 -173.14 18.57 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 125.393 1.473 . . . . 0.0 111.025 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 pt -84.92 -28.85 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.24 1.96 24.31 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -81.49 123.51 28.68 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.403 1.097 . . . . 0.0 110.8 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -69.93 122.52 19.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.585 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.58 -46.82 39.72 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.314 1.846 . . . . 0.0 111.98 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.36 -31.65 69.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.181 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -67.96 -33.06 73.94 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.14 0.882 . . . . 0.0 109.046 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.03 -11.64 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.834 0.854 . . . . 0.0 108.812 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.85 3.64 26.55 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.209 1.862 . . . . 0.0 114.206 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.98 152.91 48.32 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.297 1.549 . . . . 0.0 111.827 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -138.31 175.56 9.46 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.464 1.506 . . . . 0.0 108.144 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.26 -49.23 34.31 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.931 0.892 . . . . 0.0 112.92 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.17 -51.11 67.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.568 1.077 . . . . 0.0 109.411 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mmtt -59.41 -48.09 82.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.01 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.17 68.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.687 1.595 . . . . 0.0 110.542 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmt -66.09 -39.36 89.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.859 0.864 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.201 -0.905 . . . . 0.0 110.802 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 26' ' ' VAL . 1.7 t -67.71 -50.78 57.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.01 -32.05 63.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.85 63.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.554 0.615 . . . . 0.0 109.366 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.44 -40.04 77.46 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.883 0.473 . . . . 0.0 111.184 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -63.64 -49.23 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -39.98 91.74 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.306 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -30.95 59.73 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -83.88 -48.22 10.25 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.029 0.831 . . . . 0.0 110.449 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -87.42 -3.58 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.592 0.557 . . . . 0.0 110.742 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 59.02 38.02 24.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.52 1.055 . . . . 0.0 111.515 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.68 126.92 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.101 -0.999 . . . . 0.0 112.681 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.87 142.0 58.58 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.97 78.61 74.61 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.74 152.99 79.48 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.734 1.623 . . . . 0.0 111.173 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -28.43 47.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.905 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -54.27 -33.53 58.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.488 1.115 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -88.17 -51.78 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 107.902 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -48.9 35.62 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.454 1.902 . . . . 0.0 111.41 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.85 40.63 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.643 -0.66 . . . . 0.0 112.296 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.85 79.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.223 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -138.33 79.63 30.19 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.519 1.128 . . . . 0.0 108.528 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.74 55.26 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 124.635 3.556 . . . . 0.0 112.651 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 147.8 38.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.549 1.068 . . . . 0.0 110.906 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 mm -54.94 -44.97 75.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.527 1.131 . . . . 0.0 108.749 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -54.19 -39.3 66.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.638 0.654 . . . . 0.0 111.913 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.32 27.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.675 -0.641 . . . . 0.0 112.204 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.4 -40.58 93.6 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 126.51 1.924 . . . . 0.0 109.726 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.37 -51.29 68.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.913 0.778 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.0 -35.7 64.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.081 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 67' ' ' VAL . 13.9 t80 -66.07 -41.11 91.2 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.4 -43.12 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -47.11 85.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.717 0.807 . . . . 0.0 112.539 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -63.49 -19.31 64.64 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.348 -0.845 . . . . 0.0 111.386 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.3 mtt-85 -100.74 -25.51 14.11 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.5 p -60.8 -35.6 76.9 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.514 0.597 . . . . 0.0 110.479 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -63.36 121.35 13.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.175 1.39 . . . . 0.0 108.578 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -68.68 139.54 55.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -142.73 127.51 18.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.722 0.809 . . . . 0.0 109.475 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -74.0 99.84 3.4 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.575 1.179 . . . . 0.0 108.898 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -139.0 97.21 3.26 Favored 'General case' 0 C--N 1.321 -0.643 1 N-CA-C 100.036 -4.061 . . . . 0.0 100.036 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.367 -1.302 . . . . 0.0 108.244 -179.338 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.476 0.485 0 CA-C-O 118.619 -0.659 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 t -57.97 153.96 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -138.63 157.69 45.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -138.31 43.95 2.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.953 0.882 . . . . 0.0 110.089 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.33 164.24 12.49 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.461 1.504 . . . . 0.0 111.284 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -86.6 179.54 6.79 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.31 123.12 11.92 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.463 0.705 . . . . 0.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.08 117.05 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 162.36 25.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.471 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.25 137.32 78.12 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.528 2.152 . . . . 0.0 110.755 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 p -106.05 -23.53 12.61 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.258 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -107.32 146.72 31.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.9 57.99 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -69.4 -44.66 79.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.36 -36.39 80.07 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.504 0.721 . . . . 0.0 109.422 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -56.99 -52.43 65.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 109.512 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -56.53 -54.75 42.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.723 0.409 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.95 -47.85 81.7 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.769 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.99 -32.92 62.09 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.54 -38.91 67.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.3 -34.98 66.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 119.257 0.935 . . . . 0.0 109.98 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -62.62 -42.97 99.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 122.026 -0.421 . . . . 0.0 109.919 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -32.06 70.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.135 0.974 . . . . 0.0 111.559 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.39 -40.42 57.99 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.882 0.873 . . . . 0.0 109.982 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.34 -55.71 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 119.109 0.868 . . . . 0.0 109.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.72 -35.94 82.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.018 0.927 . . . . 0.0 111.095 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.1 15.24 70.09 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.216 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 169.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.4 t -136.05 146.33 46.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.24 0.927 . . . . 0.0 108.876 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.79 38.0 3.77 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.906 1.717 . . . . 0.0 111.324 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 41' ' ' ILE . 20.1 mm -72.22 128.16 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.345 1.073 . . . . 0.0 109.493 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.45 175.96 23.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.965 1.269 . . . . 0.0 111.005 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.411 HG13 HD13 ' A' ' 35' ' ' LEU . 18.2 pt -70.8 -23.8 24.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.921 1.689 . . . . 0.0 112.73 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -108.35 0.2 21.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.872 1.669 . . . . 0.0 113.792 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.77 115.62 14.56 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.4 122.97 22.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 122.829 0.452 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -45.98 -45.08 15.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.939 1.296 . . . . 0.0 113.352 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.43 -32.63 62.71 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -72.26 -31.09 65.47 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.004 0.922 . . . . 0.0 111.59 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 HD12 ' A' ' 32' ' ' ILE . 23.4 mt -70.65 -21.23 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.14 -4.55 6.37 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 118.664 -1.076 . . . . 0.0 111.548 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.18 162.91 48.85 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.017 1.408 . . . . 0.0 109.821 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -152.32 174.55 13.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.52 -50.91 12.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.242 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.04 -46.06 79.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.702 0.228 . . . . 0.0 110.941 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -67.82 -37.89 82.53 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.02 72.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.014 0.926 . . . . 0.0 110.167 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -58.66 -42.93 89.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.024 0.53 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.34 69.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.648 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -72.02 -51.55 30.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.56 -34.33 64.66 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.231 0.612 . . . . 0.0 111.66 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.22 86.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.775 0.83 . . . . 0.0 110.713 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -77.77 -39.82 42.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.855 0.862 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.0 -47.21 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -35.39 80.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.535 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -76.68 -33.44 58.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -89.18 -48.77 7.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.375 0.534 . . . . 0.0 111.768 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' HB2' HG12 ' A' ' 61' ' ' VAL . 39.8 m-85 -85.13 -3.0 58.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.981 0.512 . . . . 0.0 109.994 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 54.38 35.2 22.49 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.246 1.019 . . . . 0.0 110.395 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.3 p -141.75 131.61 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.3 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -70.46 140.93 52.06 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.723 0.773 . . . . 0.0 111.64 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 tp -127.15 93.09 42.38 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 127.507 2.323 . . . . 0.0 105.683 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -73.19 152.75 50.88 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.072 1.848 . . . . 0.0 109.094 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.1 -26.85 51.38 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.755 0.822 . . . . 0.0 110.95 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -54.26 -36.55 63.71 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.956 0.903 . . . . 0.0 112.908 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -85.87 -40.19 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -49.96 75.04 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.963 1.305 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -39.06 64.7 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.663 0.785 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.13 71.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 119.034 -1.066 . . . . 0.0 112.655 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -137.08 67.79 55.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.533 0.733 . . . . 0.0 111.628 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.18 50.37 1.52 Allowed 'Trans proline' 0 CA--C 1.54 0.821 1 C-N-CA 126.394 4.73 . . . . 0.0 114.92 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.91 147.05 44.02 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.6 mm -56.82 -46.23 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 126.984 2.113 . . . . 0.0 108.099 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -54.11 -41.63 68.54 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.898 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.35 -46.12 67.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.07 -36.84 75.23 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.449 1.1 . . . . 0.0 108.758 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.83 -51.54 61.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.43 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -66.32 -37.76 86.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.552 1.069 . . . . 0.0 110.496 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -63.97 -53.84 43.81 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.66 0.784 . . . . 0.0 109.324 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.96 -40.83 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.9 79.88 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.536 1.134 . . . . 0.0 113.296 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 t -73.49 -25.0 60.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.258 0.481 . . . . 0.0 110.093 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -15.89 29.89 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.96 -1.019 . . . . 0.0 113.031 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 p -75.75 -4.81 42.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 110.02 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.77 141.52 32.36 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.161 1.384 . . . . 0.0 109.404 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -165.76 140.5 4.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -88.06 93.67 9.56 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.76 160.08 20.92 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -161.24 168.21 24.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.159 0.984 . . . . 0.0 109.689 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.243 0 C-N-CA 127.514 2.326 . . . . 0.0 105.65 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.541 0.868 0 N-CA-C 113.747 0.634 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.16 168.99 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.762 2.425 . . . . 0.0 111.456 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -128.14 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -64.88 4.39 0.44 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.82 -5.88 40.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.704 2.002 . . . . 0.0 112.836 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -60.92 145.99 48.33 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.57 122.44 14.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.78 0.718 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.61 115.99 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.02 159.23 77.71 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 124.633 1.173 . . . . 0.0 110.558 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.86 129.36 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.466 3.444 . . . . 0.0 110.89 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -101.51 -21.34 14.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.671 1.188 . . . . 0.0 109.887 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 20.6 t-20 -109.52 148.69 30.79 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -23.83 67.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.108 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.48 -44.38 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.277 1.853 . . . . 0.0 107.542 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 16.8 mt-10 -57.84 -40.89 81.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -58.07 -51.2 70.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.555 1.142 . . . . 0.0 109.724 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.28 -52.7 64.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.196 0.598 . . . . 0.0 111.558 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.79 -42.87 99.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.868 0.758 . . . . 0.0 111.352 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.04 -33.42 72.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.78 -47.39 78.29 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.67 -34.85 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.468 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -59.81 -40.91 90.01 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 119.7 1.137 . . . . 0.0 109.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.94 -39.77 94.0 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.04 -32.04 72.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.351 -0.843 . . . . 0.0 112.066 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.57 -53.41 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.695 0.68 . . . . 0.0 109.855 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.3 mt -75.62 -25.57 57.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.18 66.99 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.496 1.522 . . . . 0.0 112.229 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' CG2' HD11 ' A' ' 32' ' ' ILE . 21.3 m -94.91 175.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 111.8 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 t -144.83 119.35 9.7 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.889 0.876 . . . . 0.0 109.329 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.5 0.84 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 124.668 1.128 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 29' ' ' VAL . 27.1 mm -90.72 125.06 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 126.347 1.859 . . . . 0.0 107.874 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.03 164.98 25.15 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.6 pt -67.94 -28.09 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.771 -0.841 . . . . 0.0 111.49 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.603 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.68 -3.48 32.94 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.218 2.207 . . . . 0.0 116.147 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -82.46 121.56 26.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.207 1.367 . . . . 0.0 108.823 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.33 127.64 33.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.576 0.35 . . . . 0.0 110.713 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 89.3 t80 -48.21 -44.22 32.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.479 1.912 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -69.36 -38.11 77.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.69 -28.16 65.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.028 -0.51 . . . . 0.0 110.781 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 38' ' ' PHE . 27.8 mt -71.03 -17.76 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.661 0.784 . . . . 0.0 109.206 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.46 2.69 8.15 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.935 1.255 . . . . 0.0 112.79 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 164.62 53.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -146.77 174.92 11.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.6 6.34 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.214 1.405 . . . . 0.0 112.779 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -43.76 94.84 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -66.17 -38.89 89.17 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.715 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.64 74.68 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.5 0.72 . . . . 0.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -64.03 -40.49 96.44 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 122.86 0.464 . . . . 0.0 110.276 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.61 92.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.182 0.446 . . . . 0.0 110.234 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.42 -52.96 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.56 -31.13 63.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.6 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.1 69.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.912 0.778 . . . . 0.0 111.374 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.66 -42.7 61.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.264 0.625 . . . . 0.0 109.343 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.85 -33.91 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 120.672 -1.268 . . . . 0.0 108.195 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.65 -42.42 91.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.392 0.996 . . . . 0.0 109.18 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -75.27 -31.75 60.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -74.48 -48.92 24.44 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 61' ' ' VAL . 68.5 m-85 -94.13 0.14 55.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.15 37.85 27.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.46 1.504 . . . . 0.0 109.851 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 59' ' ' TYR . 12.7 p -141.41 124.9 15.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -67.37 130.74 44.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.565 -0.71 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 tt -118.03 87.99 30.22 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 159.2 54.15 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.475 2.116 . . . . 0.0 112.168 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -40.93 51.07 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.724 2.01 . . . . 0.0 109.785 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -53.46 -32.18 48.9 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.393 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -87.28 -47.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 119.982 1.264 . . . . 0.0 109.328 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -47.31 76.5 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.554 0.742 . . . . 0.0 111.749 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -31.74 43.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.974 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -39.38 71.1 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.67 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -137.47 78.31 38.48 Favored Pre-proline 0 N--CA 1.453 -0.312 0 O-C-N 124.271 0.982 . . . . 0.0 109.39 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 52.69 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.707 2.938 . . . . 0.0 111.756 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.85 147.78 48.39 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 120.224 1.375 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 74' ' ' ILE . 8.4 mm -58.12 -40.68 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -53.8 -46.21 71.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.229 0.468 . . . . 0.0 110.682 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.42 -51.42 44.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.09 -38.12 89.92 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 125.005 1.322 . . . . 0.0 109.86 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.49 94.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.978 0.808 . . . . 0.0 109.385 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -74.54 -44.87 49.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 111.395 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HG21 ' A' ' 67' ' ' VAL . 27.7 t80 -62.22 -44.07 97.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.25 -43.2 50.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.508 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.05 98.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 t -67.73 -29.9 69.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.777 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -83.21 -43.99 15.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.074 0.852 . . . . 0.0 109.407 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 t -77.94 36.49 0.22 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.873 1.669 . . . . 0.0 109.395 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -69.11 133.21 47.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.129 -0.982 . . . . 0.0 109.649 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -67.69 121.57 16.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.26 150.73 13.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.643 0.735 . . . . 0.0 110.953 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -74.03 153.61 39.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -136.59 144.32 44.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.851 2.46 . . . . 0.0 105.414 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.644 2.378 . . . . 0.0 106.028 -178.669 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.477 0.535 0 N-CA-C 110.518 -0.608 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t 58.05 75.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 123.974 1.845 . . . . 0.0 108.719 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -130.96 36.9 3.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.517 -2.129 . . . . 0.0 110.164 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.25 -22.51 60.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.79 -0.569 . . . . 0.0 112.346 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 148.49 50.94 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -75.51 161.72 28.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.838 1.255 . . . . 0.0 110.709 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -46.08 132.61 9.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.396 2.678 . . . . 0.0 113.174 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.5 t -140.05 117.62 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.25 158.23 38.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.116 0.885 . . . . 0.0 110.02 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.51 149.74 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.49 2.793 . . . . 0.0 112.023 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -123.61 -21.58 5.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.589 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -102.87 141.11 36.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.96 -18.66 0.82 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.713 1.205 . . . . 0.0 113.881 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.78 -54.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.636 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.77 -42.77 58.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.893 2.077 . . . . 0.0 110.103 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 t -60.86 -44.88 96.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.837 0.711 . . . . 0.0 110.78 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -61.25 -45.37 94.8 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.636 -1.29 . . . . 0.0 110.756 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.89 -38.45 88.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.121 0.873 . . . . 0.0 111.452 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.48 75.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.1 -37.53 75.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.4 -40.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -60.45 -41.11 93.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.72 -38.88 72.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.547 0.612 . . . . 0.0 109.858 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -68.45 -32.85 73.17 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -86.31 -46.25 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 123.022 1.391 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.14 -33.2 71.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.357 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.13 38.82 54.44 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.64 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.015 1.726 . . . . 0.0 107.108 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 p -136.72 138.85 41.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 110.71 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.15 66.64 1.51 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.21 1.386 . . . . 0.0 112.186 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.7 mm -83.89 129.5 37.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.52 167.58 28.75 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.029 0.831 . . . . 0.0 111.326 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.62 -24.55 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.987 0.915 . . . . 0.0 112.553 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -0.26 21.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.454 1.501 . . . . 0.0 114.911 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.03 122.8 26.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 118.868 0.758 . . . . 0.0 109.557 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -67.23 123.73 21.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.331 1.052 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -46.36 -45.95 18.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.429 1.892 . . . . 0.0 112.876 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -70.72 -24.07 62.57 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.752 -1.218 . . . . 0.0 112.224 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -74.28 -37.14 63.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.46 29.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 125.965 1.706 . . . . 0.0 109.981 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.32 5.37 34.94 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.159 -2.213 . . . . 0.0 113.936 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.64 142.19 43.47 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 108.135 -1.986 . . . . 0.0 108.135 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -132.81 173.18 11.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.847 0.823 . . . . 0.0 108.886 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.62 -47.48 28.94 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.347 0.659 . . . . 0.0 111.628 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -48.26 73.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.91 0.323 . . . . 0.0 110.587 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.97 -39.59 90.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.86 80.53 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.163 0.985 . . . . 0.0 110.427 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.78 -37.9 87.57 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.56 75.23 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.222 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 26' ' ' VAL . 70.9 t -63.08 -53.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.65 69.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.064 0.946 . . . . 0.0 112.231 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.19 -47.48 67.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.651 0.739 . . . . 0.0 109.904 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 7.6 mm100 -67.16 -39.98 86.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 109.987 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 t -64.59 -47.46 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 121.35 -0.844 . . . . 0.0 108.775 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.22 -37.65 86.16 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.529 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 10.6 ptm180 -75.85 -32.26 59.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.48 -48.14 8.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . 80.1 m-85 -92.36 0.33 57.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.352 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 49.93 43.09 25.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.596 1.089 . . . . 0.0 109.199 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 81' ' ' VAL . 8.2 p -136.1 128.43 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 123.365 0.666 . . . . 0.0 110.657 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -69.45 120.72 15.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -114.76 78.71 5.33 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.42 158.15 42.26 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.23 1.287 . . . . 0.0 111.503 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.72 -26.86 67.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.344 1.058 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -52.97 -41.59 64.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.262 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.29 -37.23 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-N 119.719 1.145 . . . . 0.0 109.021 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.3 -50.08 60.05 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.445 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -30.7 56.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.16 -31.43 49.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.119 0.872 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -134.68 72.76 68.75 Favored Pre-proline 0 N--CA 1.449 -0.52 0 C-N-CA 125.468 1.507 . . . . 0.0 107.898 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.18 53.28 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 113.093 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.62 147.38 46.88 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 120.311 1.414 . . . . 0.0 110.455 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.12 -44.08 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.86 -46.68 74.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.576 0.35 . . . . 0.0 111.404 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.17 85.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.301 1.04 . . . . 0.0 113.233 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -42.97 84.91 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 125.345 1.458 . . . . 0.0 107.246 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.46 97.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.749 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -76.24 -36.72 58.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.201 1.364 . . . . 0.0 111.159 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -60.99 -51.46 69.17 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 61' ' ' VAL . 77.4 t -68.63 -47.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.692 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.13 -51.79 60.79 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.801 1.182 . . . . 0.0 113.304 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -64.41 -22.41 66.95 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -100.58 -24.07 14.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.125 0.875 . . . . 0.0 112.98 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.8 t -73.15 -23.6 60.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.38 116.34 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -56.42 149.84 16.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.778 0.831 . . . . 0.0 108.94 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 56.9 p-80 -140.26 30.41 1.97 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.598 0.759 . . . . 0.0 111.757 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 p80 46.06 33.97 1.88 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.674 2.79 . . . . 0.0 115.748 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -51.99 113.72 1.09 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.253 1.24 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.412 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 CA-C-O 118.247 -0.814 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -60.3 140.97 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 119.622 1.101 . . . . 0.0 109.813 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.9 p -84.12 149.79 25.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -130.83 17.48 5.18 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.242 1.017 . . . . 0.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 -10.49 22.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.596 1.558 . . . . 0.0 113.505 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -67.6 142.07 56.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -47.33 131.03 13.48 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.105 0.962 . . . . 0.0 113.274 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.62 116.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 102.468 -3.16 . . . . 0.0 102.468 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.01 161.19 65.08 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.615 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.58 72.96 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.682 1.588 . . . . 0.0 110.056 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 p -132.24 -13.95 3.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.477 0.311 . . . . 0.0 111.283 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 141.95 28.53 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -28.14 8.04 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -44.78 19.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 119.086 0.857 . . . . 0.0 109.154 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -51.94 -42.51 62.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.269 1.027 . . . . 0.0 109.983 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -54.26 -50.54 66.98 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.331 1.019 . . . . 0.0 110.431 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.29 -50.12 75.22 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 111.7 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.25 -41.66 85.26 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 119.99 -1.694 . . . . 0.0 112.724 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.61 71.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 124.531 1.144 . . . . 0.0 111.024 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.7 -47.87 43.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.108 0.867 . . . . 0.0 111.23 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.01 -37.89 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.055 0.542 . . . . 0.0 109.743 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.68 -39.69 85.36 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.212 -0.93 . . . . 0.0 111.012 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -57.27 -43.18 82.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.276 0.63 . . . . 0.0 110.646 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -64.11 -31.73 73.04 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.726 0.81 . . . . 0.0 112.591 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.66 -44.44 15.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.899 0.772 . . . . 0.0 111.715 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.27 -24.09 40.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.114 0.966 . . . . 0.0 112.728 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.79 23.93 68.42 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.901 1.239 . . . . 0.0 111.936 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.0 175.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.467 1.633 . . . . 0.0 106.599 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 t -141.76 143.48 33.51 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.001 1.273 . . . . 0.0 107.859 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 69.15 1.41 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 41' ' ' ILE . 49.7 mm -91.27 121.79 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.3 169.13 45.29 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 118.45 0.568 . . . . 0.0 112.67 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 pt -68.54 -24.08 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 120.948 -1.325 . . . . 0.0 111.466 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.512 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.89 -3.37 24.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.12 2.568 . . . . 0.0 113.117 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.71 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -69.44 124.23 23.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -77.32 117.33 18.72 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.963 1.305 . . . . 0.0 108.777 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.09 -48.05 11.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.893 1.677 . . . . 0.0 113.223 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -71.08 -33.64 70.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.876 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -67.95 -29.54 68.62 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 36' ' ' ASP . 30.9 mt -72.01 -3.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.985 0.914 . . . . 0.0 109.389 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.84 -0.56 33.96 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.033 1.778 . . . . 0.0 111.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.57 160.81 46.71 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 118.618 1.209 . . . . 0.0 110.64 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -151.18 179.2 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.184 1.394 . . . . 0.0 108.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.26 -50.71 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.133 1.373 . . . . 0.0 113.251 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -46.51 86.93 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.449 0.568 . . . . 0.0 110.324 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.7 mmtp -63.48 -39.2 93.83 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 121.205 -0.934 . . . . 0.0 110.798 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -42.39 69.61 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.662 0.665 . . . . 0.0 109.268 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 mmt -65.98 -41.52 91.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.164 0.586 . . . . 0.0 109.768 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.28 83.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 118.377 -0.82 . . . . 0.0 112.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.4 t -72.2 -52.3 25.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.83 -31.59 39.84 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.59 72.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.593 0.633 . . . . 0.0 111.447 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.09 -37.35 61.58 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.574 0.702 . . . . 0.0 110.921 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -64.63 -47.37 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 121.082 -1.011 . . . . 0.0 108.961 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -40.7 90.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.344 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -75.27 -29.1 60.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.65 -48.09 8.16 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.607 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.29 -3.7 58.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 51.49 39.17 24.01 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.268 1.827 . . . . 0.0 110.886 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.596 HG11 HG13 ' A' ' 81' ' ' VAL . 11.7 p -141.25 132.31 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.748 0.785 . . . . 0.0 112.085 -177.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -71.53 115.66 10.96 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.15 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -110.19 83.72 3.26 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.3 157.79 58.29 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.669 2.246 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -33.49 54.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.436 1.494 . . . . 0.0 110.522 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -30.85 47.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.146 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.92 -46.85 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -49.72 60.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.277 1.431 . . . . 0.0 110.926 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -31.01 38.75 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.641 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.94 -37.11 83.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.076 0.853 . . . . 0.0 110.502 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -141.76 79.31 16.91 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.263 1.025 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 52.56 3.58 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.951 3.101 . . . . 0.0 113.189 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 147.21 49.21 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.887 -1.133 . . . . 0.0 109.535 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.47 -48.21 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -52.32 -47.82 65.79 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.623 0.577 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.47 98.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.27 -41.48 63.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.62 73.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.255 1.022 . . . . 0.0 109.315 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.42 -38.63 77.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.787 1.176 . . . . 0.0 111.552 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -67.16 -46.13 74.95 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.094 0.558 . . . . 0.0 110.627 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 HG11 ' A' ' 61' ' ' VAL . 78.0 t -73.78 -42.79 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.155 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.99 84.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.86 0.754 . . . . 0.0 112.804 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -61.98 -32.71 73.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.349 0.522 . . . . 0.0 109.64 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -75.25 -37.93 60.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -33.5 64.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.299 1.04 . . . . 0.0 109.69 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -60.22 107.69 0.68 Allowed 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -117.95 32.84 5.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.865 2.066 . . . . 0.0 110.591 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -59.42 105.3 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.018 0.927 . . . . 0.0 110.555 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -139.02 41.62 2.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.34 1.856 . . . . 0.0 107.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -140.18 -15.44 0.99 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.055 0.942 . . . . 0.0 113.346 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.6 m80 . . . . . 0 C--O 1.246 0.886 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 179.1 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 113.798 0.653 . . . . 0.0 113.798 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.91 161.44 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.25 1.024 . . . . 0.0 112.07 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -146.81 119.0 8.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.928 1.691 . . . . 0.0 107.445 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.18 19.18 20.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.21 2.604 . . . . 0.0 109.006 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.16 164.31 25.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.884 1.273 . . . . 0.0 109.785 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -120.59 160.26 23.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 108.469 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.87 123.91 4.86 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.131 1.372 . . . . 0.0 114.138 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -146.33 117.6 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -68.81 172.41 4.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.329 1.051 . . . . 0.0 112.008 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.762 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 52.9 Cg_endo -68.14 146.46 70.35 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.02 2.48 . . . . 0.0 111.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -118.82 -13.51 9.53 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.607 0.763 . . . . 0.0 111.733 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -120.31 147.11 45.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.29 -26.14 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.663 -1.636 . . . . 0.0 113.502 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.73 -55.1 17.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 120.496 1.498 . . . . 0.0 107.792 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.54 -44.08 65.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.618 1.967 . . . . 0.0 109.728 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -40.32 85.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.305 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.37 -50.74 71.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 119.325 0.966 . . . . 0.0 110.237 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 19' ' ' LEU . 5.6 mp -63.45 -41.94 98.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.413 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.21 -36.16 68.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.977 0.911 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.29 -49.94 15.67 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 118.973 0.806 . . . . 0.0 110.409 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.0 mt -51.39 -40.94 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 38' ' ' PHE . 8.2 m0 -64.95 -45.83 84.11 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.319 1.448 . . . . 0.0 110.223 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -59.33 -37.12 77.0 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.369 0.668 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -70.57 -29.08 65.42 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.49 -55.73 7.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.764 0.826 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.9 mt -74.51 -20.51 59.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.631 1.172 . . . . 0.0 113.523 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 32.93 68.49 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.034 0.834 . . . . 0.0 111.847 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.14 175.21 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.4 1.88 . . . . 0.0 109.634 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -139.25 127.77 23.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.028 0.931 . . . . 0.0 112.945 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 69.27 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mm -87.02 123.39 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 107.383 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.5 174.32 44.82 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 pt -80.76 -26.83 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 118.725 1.263 . . . . 0.0 110.628 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.776 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -96.71 4.84 51.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.013 2.525 . . . . 0.0 113.877 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -62.99 123.35 18.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.651 1.581 . . . . 0.0 113.107 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.73 105.3 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.226 -1.546 . . . . 0.0 107.09 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' A' ' 41' ' ' ILE . 92.5 t80 -41.74 -47.55 4.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 113.237 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -69.62 -33.19 72.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.277 0.944 . . . . 0.0 108.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 38' ' ' PHE . 31.2 mt -71.29 -15.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.016 0.926 . . . . 0.0 109.587 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.16 -6.86 23.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.078 1.799 . . . . 0.0 112.541 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.76 157.77 33.91 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.675 1.237 . . . . 0.0 110.276 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -143.33 171.45 14.1 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.04 -48.68 11.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.321 1.048 . . . . 0.0 112.475 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -46.04 82.91 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.762 -0.586 . . . . 0.0 110.657 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -66.05 -42.17 89.85 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 121.444 -0.785 . . . . 0.0 110.036 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.35 -43.71 67.94 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.303 1.041 . . . . 0.0 110.187 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.5 mtm -63.72 -30.41 71.51 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.657 0.383 . . . . 0.0 111.811 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.52 -35.39 68.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.62 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.29 -48.28 86.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.82 64.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.139 0.976 . . . . 0.0 111.337 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.84 87.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.144 0.884 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -73.25 -36.15 66.36 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.63 0.729 . . . . 0.0 110.385 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.04 -45.18 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 1.2 t-80 -61.02 -36.73 80.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.477 -0.765 . . . . 0.0 111.489 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -76.79 -32.07 57.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -89.63 -44.86 9.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.04 0.924 . . . . 0.0 112.17 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -90.25 -0.62 57.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.883 1.273 . . . . 0.0 109.897 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 49.2 42.04 20.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.206 1.402 . . . . 0.0 111.002 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 81' ' ' VAL . 14.5 p -152.39 139.86 13.51 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 O-C-N 120.847 -1.158 . . . . 0.0 111.883 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 30.6 tt0 -66.8 143.77 56.7 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.193 -0.317 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.33 82.42 57.91 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.79 149.24 72.71 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.819 1.68 . . . . 0.0 111.147 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.8 -27.43 41.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 125.088 1.355 . . . . 0.0 111.294 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -53.19 -36.49 61.01 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.682 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.57 -47.27 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -48.9 47.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.007 1.723 . . . . 0.0 111.531 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -29.72 37.99 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.082 0.953 . . . . 0.0 112.848 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.69 -31.89 59.9 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.256 0.347 . . . . 0.0 111.336 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -134.58 74.52 65.37 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.88 56.32 3.55 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.346 3.364 . . . . 0.0 112.687 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.98 147.43 36.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.846 1.203 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -54.81 -49.26 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 108.876 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -52.38 -50.51 62.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.21 96.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.59 -44.58 56.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.048 1.339 . . . . 0.0 107.559 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.42 66.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.258 1.023 . . . . 0.0 109.678 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.33 -40.25 74.27 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.322 0.389 . . . . 0.0 111.099 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.55 -48.13 82.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.636 0.774 . . . . 0.0 110.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.428 HG13 HG11 ' A' ' 61' ' ' VAL . 71.3 t -72.24 -38.46 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.733 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.71 74.04 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.258 0.935 . . . . 0.0 111.426 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -63.51 -32.35 73.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.626 0.194 . . . . 0.0 111.379 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -75.8 -29.62 58.76 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.3 p -82.4 -10.75 58.93 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.88 86.25 2.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.027 0.931 . . . . 0.0 110.377 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -73.02 164.28 26.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.98 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -147.62 158.1 43.85 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.309 1.044 . . . . 0.0 109.841 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -74.79 46.01 0.27 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.507 2.323 . . . . 0.0 110.696 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -73.14 -11.05 60.39 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 120.278 -1.514 . . . . 0.0 112.796 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -179.65 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.02 133.66 56.3 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.556 0.617 . . . . 0.0 109.819 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -139.54 117.25 11.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.48 87.92 Favored Pre-proline 0 C--O 1.24 0.593 0 O-C-N 124.048 0.843 . . . . 0.0 109.106 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.94 144.37 87.84 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.205 2.603 . . . . 0.0 110.042 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 p -124.69 -11.57 7.23 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -108.89 133.36 53.02 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.33 -39.11 2.96 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.56 -50.45 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.356 0.98 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -58.41 -41.28 84.61 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.824 2.049 . . . . 0.0 108.633 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -64.28 -35.13 79.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.37 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -77.05 -35.43 56.79 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.949 -1.095 . . . . 0.0 111.688 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.22 -37.68 72.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.602 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.54 80.63 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.67 -47.21 73.17 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.6 mt -57.27 -38.45 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.569 0.747 . . . . 0.0 109.955 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -64.75 -42.8 94.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -57.73 -41.95 82.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -69.38 -22.04 63.75 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.02 -1.05 . . . . 0.0 113.723 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.92 -41.88 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.864 0.756 . . . . 0.0 110.632 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -83.77 -22.84 31.74 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.736 1.214 . . . . 0.0 112.733 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.2 35.02 69.98 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.93 173.9 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -130.41 148.67 52.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.487 1.115 . . . . 0.0 108.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 53.16 1.41 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.082 0.849 . . . . 0.0 113.521 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.0 mm -91.12 121.4 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.96 26.74 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 122.623 1.124 . . . . 0.0 112.339 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.04 -24.16 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 O-C-N 121.687 -0.89 . . . . 0.0 111.93 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.6 -0.14 22.18 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.582 2.353 . . . . 0.0 113.371 -179.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.767 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -67.94 116.17 8.29 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.62 110.84 12.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.681 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.3 t80 -40.02 -46.26 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.95 2.1 . . . . 0.0 113.908 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -68.09 -32.94 73.62 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.716 -0.615 . . . . 0.0 112.152 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.48 -32.09 69.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.194 0.906 . . . . 0.0 109.394 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 36' ' ' ASP . 23.2 mt -70.43 -20.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.67 7.88 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.545 1.069 . . . . 0.0 112.212 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.56 160.77 40.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.44 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 20.5 p80 -148.2 177.74 9.15 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.6 1.16 . . . . 0.0 108.212 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.32 -52.38 12.85 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.126 0.97 . . . . 0.0 112.995 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -47.72 73.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.914 1.233 . . . . 0.0 110.504 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 63.3 mmtt -62.56 -43.15 99.52 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.196 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -57.16 -41.79 79.85 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.243 1.417 . . . . 0.0 110.996 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 74.7 mtm -68.81 -37.28 79.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.71 71.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.703 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.36 -52.69 52.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.06 69.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.518 1.054 . . . . 0.0 112.085 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -78.02 -32.8 51.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.183 0.992 . . . . 0.0 111.348 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 59' ' ' TYR . 59.3 t -71.89 -40.08 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.065 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -37.97 82.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.813 1.188 . . . . 0.0 109.219 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -76.0 -31.77 59.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.26 -47.96 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.572 0.749 . . . . 0.0 111.869 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HG11 ' A' ' 81' ' ' VAL . 16.8 m-85 -94.48 0.49 55.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.741 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 55.66 37.44 28.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.737 1.215 . . . . 0.0 109.56 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 81' ' ' VAL . 9.4 p -140.56 136.72 36.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.38 132.92 44.59 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.839 1.255 . . . . 0.0 110.029 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.2 tp -130.07 86.11 55.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 123.97 0.908 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.76 153.68 77.12 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.673 1.582 . . . . 0.0 110.453 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.5 -30.12 62.62 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.543 0.737 . . . . 0.0 110.463 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -53.03 -30.69 37.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.117 0.967 . . . . 0.0 111.94 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.08 -46.3 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.431 1.092 . . . . 0.0 108.842 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -57.24 -46.55 82.89 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.598 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -36.57 58.51 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.289 -0.882 . . . . 0.0 111.42 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.53 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.596 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.55 73.1 62.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 124.361 1.064 . . . . 0.0 109.151 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.16 54.25 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.378 3.385 . . . . 0.0 110.804 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 147.62 41.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.178 0.899 . . . . 0.0 110.572 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 mm -57.77 -44.46 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 124.98 1.312 . . . . 0.0 108.617 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -55.83 -47.75 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.854 0.297 . . . . 0.0 110.986 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.85 -52.57 64.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.05 -41.28 97.97 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 108.235 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.7 92.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.027 0.83 . . . . 0.0 110.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -74.61 -40.88 61.29 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.958 0.503 . . . . 0.0 111.182 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -63.23 -42.72 99.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 61' ' ' VAL . 55.8 t -71.43 -46.34 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.55 -49.7 67.11 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 t -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.278 0.361 . . . . 0.0 111.376 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mtt85 . . . . . 0 N--CA 1.45 -0.444 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.228 179.292 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 . . . . . 0 N--CA 1.455 -0.218 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -47.35 129.88 13.12 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.326 1.051 . . . . 0.0 113.107 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.43 117.46 3.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 156.89 73.91 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 124.039 0.837 . . . . 0.0 109.484 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.99 164.49 24.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.336 2.024 . . . . 0.0 112.766 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -134.18 -12.13 2.49 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.929 1.292 . . . . 0.0 112.259 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.34 144.68 35.55 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.02 -38.51 37.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.319 1.048 . . . . 0.0 112.179 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.29 -55.41 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.514 1.126 . . . . 0.0 110.457 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.69 -36.79 57.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 109.601 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -61.06 -46.97 88.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.743 0.817 . . . . 0.0 111.163 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -60.08 -49.44 77.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.536 0.607 . . . . 0.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.73 -42.1 97.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.915 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.01 69.99 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.527 0.603 . . . . 0.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -71.27 -46.78 60.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.3 mt -59.32 -35.09 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 121.525 -0.735 . . . . 0.0 109.701 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -62.28 -42.27 99.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.273 -0.892 . . . . 0.0 109.25 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.78 -33.82 76.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 109.191 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.34 -26.38 63.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.088 -1.008 . . . . 0.0 112.271 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.03 -55.41 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 118.276 0.489 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.82 -17.22 60.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.034 0.934 . . . . 0.0 113.24 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.57 21.66 72.83 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.244 0.926 . . . . 0.0 111.651 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 32' ' ' ILE . 32.3 m -94.87 174.31 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -143.85 109.09 5.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.85 39.98 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.744 1.164 . . . . 0.0 113.052 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 29' ' ' VAL . 36.6 mm -77.78 124.84 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.099 1.449 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.39 169.93 16.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.442 1.496 . . . . 0.0 110.788 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.81 -26.57 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.109 -1.23 . . . . 0.0 112.971 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.464 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.93 1.75 43.01 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.771 1.628 . . . . 0.0 112.97 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -69.49 127.29 32.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.285 0.564 . . . . 0.0 109.872 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -78.95 114.46 17.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.942 1.297 . . . . 0.0 110.871 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -44.01 -49.65 8.6 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.641 1.176 . . . . 0.0 113.627 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -76.44 -27.69 56.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.06 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.23 -30.17 67.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.092 1.315 . . . . 0.0 109.784 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.93 -13.68 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.61 -0.94 30.64 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.729 1.157 . . . . 0.0 112.627 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 133.36 33.93 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.71 175.11 5.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.94 -49.5 15.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.288 1.035 . . . . 0.0 112.019 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.31 -47.23 82.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.46 0.304 . . . . 0.0 110.575 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -64.75 -35.26 80.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.675 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.9 84.77 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.278 0.945 . . . . 0.0 109.261 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.3 mtm -69.57 -37.22 76.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.74 81.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.685 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.07 -49.73 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.993 1.27 . . . . 0.0 107.69 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.07 64.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.98 0.912 . . . . 0.0 111.15 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.63 85.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.682 0.793 . . . . 0.0 110.537 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.48 -38.98 48.04 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.461 0.573 . . . . 0.0 110.458 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 t -62.31 -47.32 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.438 1.095 . . . . 0.0 109.274 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.56 89.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.507 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.92 -31.79 59.3 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.93 -48.42 12.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.772 0.829 . . . . 0.0 110.751 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -91.12 -3.09 57.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.936 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 52.41 43.74 30.61 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.306 1.442 . . . . 0.0 110.316 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.33 129.61 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.1 134.45 51.86 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.204 1.186 . . . . 0.0 114.204 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.74 84.25 61.0 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.56 153.33 76.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.693 1.595 . . . . 0.0 109.729 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -27.74 63.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.652 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -59.62 -26.87 65.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.917 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.34 -48.2 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -50.09 61.79 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.444 1.497 . . . . 0.0 111.25 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -30.24 39.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.967 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.16 -27.13 59.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.586 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -141.42 68.5 26.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.334 1.454 . . . . 0.0 110.626 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.36 57.36 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.38 3.387 . . . . 0.0 114.012 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.64 147.25 37.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -54.65 -47.99 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 124.73 1.212 . . . . 0.0 107.879 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -52.24 -42.76 63.89 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.82 72.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.33 -40.17 64.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.69 68.54 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.094 -0.955 . . . . 0.0 108.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.21 -38.34 78.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.19 -51.9 61.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.823 0.849 . . . . 0.0 109.009 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.7 -39.67 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.24 77.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.364 1.066 . . . . 0.0 113.353 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 t -64.82 -28.93 69.9 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.831 0.707 . . . . 0.0 110.281 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 . . . . . 0 C--O 1.218 -0.555 0 CA-C-N 118.583 0.629 . . . . 0.0 109.861 178.852 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -55.34 133.44 49.62 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.81 1.244 . . . . 0.0 112.118 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.18 117.03 9.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.82 158.46 69.4 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 124.079 0.862 . . . . 0.0 109.425 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.91 139.66 75.25 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.611 1.541 . . . . 0.0 110.471 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -111.13 -10.45 14.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.654 1.182 . . . . 0.0 111.319 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -121.59 152.87 38.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.48 1.036 . . . . 0.0 109.238 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.7 -36.41 67.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.239 0.616 . . . . 0.0 111.496 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.95 -49.79 70.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.81 -35.87 77.6 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.473 0.709 . . . . 0.0 110.041 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 t -65.59 -49.07 70.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -54.41 -56.52 17.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.773 0.829 . . . . 0.0 110.208 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.12 -42.36 90.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.991 -1.004 . . . . 0.0 113.274 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.48 66.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 123.87 0.731 . . . . 0.0 109.981 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -72.46 -37.73 68.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.7 mm -59.14 -38.73 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -67.46 -41.1 85.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.737 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.06 -35.1 77.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.018 0.826 . . . . 0.0 109.165 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -71.0 -43.19 68.5 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.064 -1.023 . . . . 0.0 111.269 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.56 -54.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.63 0.772 . . . . 0.0 111.371 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.7 -26.73 66.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 111.731 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.3 59.8 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.938 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.36 174.22 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.945 1.298 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t -132.32 135.11 45.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.73 60.79 0.84 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.22 0.914 . . . . 0.0 112.973 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.44 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -90.84 121.75 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.25 163.46 31.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 118.831 0.741 . . . . 0.0 111.5 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.2 pt -65.12 -22.18 30.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.309 1.044 . . . . 0.0 110.937 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.95 21.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.62 1.968 . . . . 0.0 113.834 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.63 128.48 35.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.319 0.963 . . . . 0.0 110.433 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -75.83 118.31 18.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.148 0.979 . . . . 0.0 109.423 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' ILE . 87.5 t80 -48.92 -40.47 30.16 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.689 1.195 . . . . 0.0 111.792 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -72.34 -28.99 63.39 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 112.608 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -69.47 -33.0 72.26 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 32' ' ' ILE . 12.2 mt -75.86 29.64 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 126.199 1.8 . . . . 0.0 109.301 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 10.04 64.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 119.223 -2.173 . . . . 0.0 112.563 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.51 151.93 47.19 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.504 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.0 p80 -143.42 172.58 12.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.36 -53.96 6.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.99 1.316 . . . . 0.0 112.823 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tp -55.52 -47.32 76.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.694 0.679 . . . . 0.0 111.827 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 72.6 mmtt -59.94 -42.69 94.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.138 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.56 90.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.136 0.974 . . . . 0.0 109.257 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.45 ' HG2' HD23 ' A' ' 65' ' ' LEU . 63.4 mtm -61.44 -37.99 85.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.513 0.725 . . . . 0.0 109.772 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -28.9 68.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.171 0.588 . . . . 0.0 110.769 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.8 t -72.54 -48.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -29.99 59.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.14 -53.54 36.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 122.106 0.955 . . . . 0.0 108.815 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -65.27 -38.42 90.23 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.812 1.645 . . . . 0.0 109.824 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.09 -46.1 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 -38.92 87.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 118.693 0.678 . . . . 0.0 110.72 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -76.53 -31.9 57.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.28 -44.7 11.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.384 0.538 . . . . 0.0 112.13 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -93.14 -0.78 56.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.816 0.446 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 52.93 37.94 25.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.222 1.409 . . . . 0.0 110.984 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.1 129.7 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.413 0.625 . . . . 0.0 112.396 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.69 117.81 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.5 tp -111.4 88.77 9.43 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.57 157.13 63.2 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.974 1.782 . . . . 0.0 110.786 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.2 OUTLIER -61.14 -27.37 68.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.578 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -54.77 -28.83 51.69 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 110.89 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.87 -43.38 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.909 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -47.91 83.72 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.126 0.571 . . . . 0.0 111.054 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -33.16 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.2 -31.9 58.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.813 0.278 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -140.49 74.12 28.95 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.891 0.876 . . . . 0.0 109.153 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.87 53.28 3.23 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.373 3.382 . . . . 0.0 113.306 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.65 147.8 48.72 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.808 1.185 . . . . 0.0 110.612 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.31 -43.4 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -57.77 -47.33 82.84 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.51 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.03 97.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.0 -42.83 62.85 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.59 91.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 109.933 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.92 -44.96 72.05 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.477 0.58 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.34 -42.38 98.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.37 -37.65 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.9 -46.09 89.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.683 0.674 . . . . 0.0 110.213 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -29.54 70.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.464 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 . . . . . 0 N--CA 1.469 0.505 0 CA-C-N 119.096 0.862 . . . . 0.0 112.821 -179.693 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 119.194 -0.431 . . . . 0.0 110.705 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.491 ' HA ' HD21 ' A' ' 35' ' ' LEU . 2.5 t80 -58.82 138.23 57.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.494 1.517 . . . . 0.0 109.438 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.9 t -147.55 119.24 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.61 160.39 44.21 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.277 1.031 . . . . 0.0 109.535 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.62 152.08 58.31 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.103 2.535 . . . . 0.0 114.223 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -123.01 -18.49 6.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.282 2.233 . . . . 0.0 112.595 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.46 148.72 40.47 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.19 62.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.727 1.211 . . . . 0.0 110.547 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.45 -47.51 83.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.39 -31.28 71.92 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.598 0.759 . . . . 0.0 110.004 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -52.21 53.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.757 0.823 . . . . 0.0 110.231 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -57.54 -52.75 64.12 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.7 -42.09 83.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.653 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -33.4 65.42 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.79 0.436 . . . . 0.0 111.687 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.61 -48.69 66.08 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.068 0.461 . . . . 0.0 109.896 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.75 -34.82 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.089 0.956 . . . . 0.0 110.123 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -67.25 -43.71 81.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 119.033 0.833 . . . . 0.0 110.691 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.43 -44.78 76.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.783 0.833 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -60.06 -30.46 69.22 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.701 1.2 . . . . 0.0 113.084 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.35 -49.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.708 0.685 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -69.16 -23.04 63.9 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.51 1.124 . . . . 0.0 112.102 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 34.6 66.99 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.733 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.08 173.92 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -138.34 127.17 23.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.78 32.9 0.97 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 124.235 0.922 . . . . 0.0 111.006 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.25 127.76 31.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 -169.32 24.24 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.47 1.509 . . . . 0.0 110.64 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.236 1.815 . . . . 0.0 113.378 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.596 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.69 0.78 22.63 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -176.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' HD11 ' A' ' 41' ' ' ILE . 7.7 p-10 -60.04 122.31 14.04 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.986 1.714 . . . . 0.0 110.843 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -75.66 103.07 5.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -39.89 -48.56 2.33 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 113.766 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.63 -30.69 63.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.24 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.34 -32.17 72.09 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.406 1.003 . . . . 0.0 109.659 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' A' ' 36' ' ' ASP . 23.4 mt -71.37 -7.58 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 125.338 1.455 . . . . 0.0 110.493 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.16 3.0 41.84 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.552 1.073 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 151.5 52.28 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -142.34 176.93 8.62 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.269 -1.136 . . . . 0.0 108.21 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.44 -53.05 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.211 1.404 . . . . 0.0 112.33 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.21 -46.23 86.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.904 0.32 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.1 mmtp -61.56 -42.49 98.92 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.786 -0.571 . . . . 0.0 110.042 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.42 67.66 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.058 0.943 . . . . 0.0 109.94 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mmt -67.85 -38.77 83.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 109.484 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.74 70.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.025 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.5 t -76.26 -50.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.67 -36.14 34.35 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 112.756 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.55 63.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.816 0.817 . . . . 0.0 111.517 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -72.51 -33.63 67.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 122.193 0.997 . . . . 0.0 110.741 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.33 -46.27 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 C-N-CA 124.682 1.193 . . . . 0.0 108.892 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -61.67 -41.56 97.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -75.15 -29.19 60.41 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.428 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -87.08 -49.09 7.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.818 0.735 . . . . 0.0 112.615 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 61' ' ' VAL . 17.4 m-85 -90.89 -2.36 57.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.514 0.726 . . . . 0.0 110.74 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 53.69 38.7 28.99 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.855 0.752 . . . . 0.0 110.176 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.6 p -124.01 120.54 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.183 0.993 . . . . 0.0 111.695 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.42 111.07 7.29 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.73 85.35 3.86 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 122.962 0.505 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 154.67 69.88 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.488 2.792 . . . . 0.0 111.878 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -27.31 64.12 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.582 1.553 . . . . 0.0 110.016 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -53.18 -32.93 50.41 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.305 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.31 -46.49 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -43.59 72.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.908 0.483 . . . . 0.0 111.924 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -30.54 40.31 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 119.068 -0.492 . . . . 0.0 111.34 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.99 73.83 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.97 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -140.78 76.87 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 110.472 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.02 59.37 5.19 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.621 2.881 . . . . 0.0 114.057 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 148.52 38.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.347 0.976 . . . . 0.0 110.442 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 mm -60.48 -40.95 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -56.03 -45.32 79.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.202 0.456 . . . . 0.0 110.926 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.9 95.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.15 0.98 . . . . 0.0 113.465 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.18 -38.91 68.99 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.77 -51.39 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.652 0.66 . . . . 0.0 109.598 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -69.26 -33.09 72.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.962 0.801 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 83' ' ' THR . 84.8 t80 -67.05 -51.63 52.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.661 0.743 . . . . 0.0 109.071 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.7 -35.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -37.4 87.12 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.202 0.91 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 80' ' ' TYR . 1.2 t -71.05 -15.86 62.57 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.517 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.307 1.043 . . . . 0.0 113.059 178.054 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 . . . . . 0 CA--C 1.533 0.315 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HA ' HD21 ' A' ' 35' ' ' LEU . 80.2 t80 -38.77 131.66 1.3 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.119 2.168 . . . . 0.0 114.54 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.5 t -144.44 116.95 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.17 162.19 56.92 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.77 147.4 41.0 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.57 2.18 . . . . 0.0 112.029 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -121.89 -1.58 9.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.016 1.326 . . . . 0.0 112.042 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.32 150.51 52.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.77 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.529 0.732 . . . . 0.0 111.243 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.52 -49.61 81.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.78 -35.72 69.02 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -49.46 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 110.609 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -55.31 -50.08 70.51 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.871 0.468 . . . . 0.0 110.452 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.89 -42.08 98.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.889 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.05 67.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 123.694 0.621 . . . . 0.0 110.561 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.72 -40.04 76.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.466 0.576 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.75 -38.19 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -62.32 -38.86 91.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.75 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -59.82 -39.15 84.09 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 118.611 0.641 . . . . 0.0 110.119 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.594 HH21 ' NE2' ' A' ' 54' ' ' GLN . 67.3 mtm-85 -68.74 -44.33 74.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.789 1.177 . . . . 0.0 113.93 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.05 -43.28 58.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 122.231 0.213 . . . . 0.0 111.132 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.49 -21.83 38.43 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 122.574 0.35 . . . . 0.0 111.316 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.81 35.71 90.06 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.454 -1.192 . . . . 0.0 111.56 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.47 175.13 10.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 t -132.11 150.06 52.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.39 52.06 1.26 Allowed Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.735 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.63 130.18 41.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.67 19.87 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 126.711 2.101 . . . . 0.0 109.773 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.6 pt -83.03 -22.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.97 -1.13 19.22 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.3 119.08 26.19 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 122.834 1.302 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.41 124.02 20.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.095 1.758 . . . . 0.0 111.19 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -48.04 -46.41 33.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.998 1.719 . . . . 0.0 110.633 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.52 -31.38 69.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.541 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -71.41 -34.52 70.43 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -70.86 -31.13 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.37 -11.67 4.08 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.008 0.822 . . . . 0.0 113.825 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.89 159.74 27.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.353 1.076 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -147.56 178.86 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.445 1.498 . . . . 0.0 108.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.51 -53.33 7.12 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.076 1.351 . . . . 0.0 113.304 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tp -56.03 -49.0 74.91 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.276 0.944 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.55 -44.44 96.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.349 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -53.12 -39.42 63.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.634 0.774 . . . . 0.0 110.46 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.5 mtm -66.05 -37.47 85.92 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -40.44 88.18 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.9 -52.73 57.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -28.62 63.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.448 1.099 . . . . 0.0 112.845 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.38 -49.83 31.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.843 0.747 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.594 ' NE2' HH21 ' A' ' 25' ' ' ARG . 0.7 OUTLIER -65.57 -36.38 83.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.706 0.402 . . . . 0.0 110.04 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.51 -40.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -59.57 -40.32 86.96 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 119.218 0.917 . . . . 0.0 109.799 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.25 7.4 ptm180 -77.09 -33.42 56.99 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -80.68 -39.76 26.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -101.54 -1.36 33.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.791 0.436 . . . . 0.0 110.66 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 56.02 38.85 30.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.735 1.214 . . . . 0.0 110.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' HIS . 11.8 p -148.85 133.13 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 O-C-N 121.654 -0.653 . . . . 0.0 112.629 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.14 141.67 58.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.339 1.855 . . . . 0.0 112.817 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.7 tp -128.75 96.61 29.27 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 109.912 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.95 153.49 68.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.621 2.214 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.86 68.11 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.49 1.516 . . . . 0.0 110.13 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -52.92 -27.56 19.33 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.023 0.929 . . . . 0.0 110.082 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.57 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 46.2 t -88.02 -49.11 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.69 1.196 . . . . 0.0 109.534 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -57.46 -45.18 85.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -24.17 45.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.986 0.914 . . . . 0.0 112.518 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.49 -39.31 22.64 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.488 0.586 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.24 77.21 30.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 O-C-N 124.168 0.918 . . . . 0.0 110.893 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.04 57.75 2.71 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.894 3.729 . . . . 0.0 113.228 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -141.73 149.77 40.92 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 121.245 1.839 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.1 -40.24 76.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -57.05 -46.66 82.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.909 0.777 . . . . 0.0 111.192 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.45 86.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.72 -42.65 63.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.3 70.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.96 0.904 . . . . 0.0 109.802 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.83 -39.0 76.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.367 0.53 . . . . 0.0 111.639 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 34.3 t80 -64.2 -46.93 81.72 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.85 -41.53 77.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.23 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.01 90.41 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.643 1.11 . . . . 0.0 112.268 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -63.93 -20.89 66.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.713 0.688 . . . . 0.0 110.873 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 . . . . . 0 C--O 1.235 0.335 0 C-N-CA 124.034 0.933 . . . . 0.0 110.164 178.563 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HA ' HD21 ' A' ' 35' ' ' LEU . 12.3 t80 -50.38 137.25 19.01 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.592 1.557 . . . . 0.0 110.997 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.1 t -142.03 118.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.91 162.18 31.94 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.458 0.703 . . . . 0.0 110.567 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.13 154.64 69.5 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.015 1.81 . . . . 0.0 109.231 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -129.73 -12.9 4.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -121.09 153.18 37.79 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -23.47 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.94 -49.84 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.552 1.523 . . . . 0.0 108.64 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -55.14 -45.3 75.63 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.406 1.882 . . . . 0.0 108.689 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.2 t -56.6 -37.92 71.31 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.031 2.132 . . . . 0.0 110.71 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.2 mmpt? -78.02 -45.44 23.67 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.67 -41.18 94.54 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.77 72.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.493 1.121 . . . . 0.0 109.858 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.21 -43.02 74.95 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.23 0.468 . . . . 0.0 110.501 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.86 -37.45 80.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.453 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -61.88 -44.57 96.54 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.902 0.774 . . . . 0.0 110.759 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -52.15 -47.13 65.59 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.536 1.134 . . . . 0.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -59.91 -16.15 27.3 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 51' ' ' VAL . 4.7 t -111.85 -43.02 4.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.057 0.943 . . . . 0.0 111.821 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.02 -26.25 60.33 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 121.76 -0.587 . . . . 0.0 110.672 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.18 50.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 118.379 0.536 . . . . 0.0 111.809 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.48 169.62 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -138.03 111.4 8.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 108.063 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.91 69.58 0.44 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.021 1.296 . . . . 0.0 110.677 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.45 122.04 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.364 1.466 . . . . 0.0 109.544 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.54 161.05 44.24 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.19 0.905 . . . . 0.0 110.849 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 5.9 pt -69.5 -21.29 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 121.469 -1.018 . . . . 0.0 112.581 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.6 -4.77 17.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.87 2.068 . . . . 0.0 112.836 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -71.91 122.56 21.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.675 0.67 . . . . 0.0 109.627 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -70.62 114.32 8.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.286 1.435 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -42.86 -42.07 3.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.863 1.665 . . . . 0.0 114.341 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -75.43 -27.41 58.96 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.431 -0.793 . . . . 0.0 111.965 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.0 -28.41 64.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.097 0.862 . . . . 0.0 109.325 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.77 29.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.836 2.054 . . . . 0.0 109.118 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.88 -0.87 49.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 119.786 -1.821 . . . . 0.0 113.834 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.29 157.0 49.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 119.032 1.416 . . . . 0.0 110.811 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -143.49 173.95 11.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.09 -30.07 24.37 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.71 -52.23 22.29 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.4 mmtp -55.44 -41.38 72.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 109.832 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.99 64.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.561 0.745 . . . . 0.0 111.74 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.91 -38.33 61.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.305 1.042 . . . . 0.0 110.004 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.3 75.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.41 0.284 . . . . 0.0 110.252 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 HG21 ' A' ' 26' ' ' VAL . 11.6 t -76.62 -45.83 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.84 -34.08 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.35 1.06 . . . . 0.0 112.35 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.14 82.56 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.558 0.694 . . . . 0.0 109.854 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -67.97 -42.74 80.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.294 1.037 . . . . 0.0 110.164 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -62.46 -47.83 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 123.731 0.813 . . . . 0.0 109.502 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.24 90.4 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.024 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -75.74 -33.04 60.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.6 -49.28 8.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.543 0.611 . . . . 0.0 111.041 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -88.2 1.92 53.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.393 0.677 . . . . 0.0 111.502 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 51.73 38.9 24.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.984 1.314 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.55 128.4 7.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 O-C-N 121.233 -0.917 . . . . 0.0 112.408 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.34 122.07 15.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.64 88.65 14.0 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.86 160.31 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.268 1.312 . . . . 0.0 110.99 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.91 -26.0 58.37 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.307 1.443 . . . . 0.0 108.559 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -51.88 -44.47 63.73 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.22 1.008 . . . . 0.0 111.718 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 t -77.69 -40.88 28.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.45 0.7 . . . . 0.0 109.633 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -42.14 98.62 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.603 0.761 . . . . 0.0 110.718 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -41.54 23.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.47 78.92 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.496 -0.882 . . . . 0.0 112.54 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -143.08 74.95 17.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.156 0.982 . . . . 0.0 111.319 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 59.85 2.46 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.879 3.719 . . . . 0.0 113.302 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.01 147.59 37.14 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.285 -1.509 . . . . 0.0 109.829 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 34' ' ' ILE . 21.6 mm -60.03 -44.38 94.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -57.11 -44.89 83.69 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.029 0.831 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.79 93.49 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.005 0.522 . . . . 0.0 111.895 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.4 -44.43 71.43 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.35 65.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.719 0.808 . . . . 0.0 110.923 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -72.34 -34.53 68.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.978 0.808 . . . . 0.0 112.457 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -68.38 -52.51 32.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.257 0.623 . . . . 0.0 110.357 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.79 -44.54 85.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.172 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.97 77.21 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -75.81 -26.17 57.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.357 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.453 -0.321 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.594 ' HA ' HD21 ' A' ' 35' ' ' LEU . 9.6 t80 -52.8 137.6 31.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.049 2.14 . . . . 0.0 111.205 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -144.85 117.52 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.01 152.86 82.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.49 150.46 75.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.85 2.367 . . . . 0.0 110.475 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 p -127.1 -17.78 4.74 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -102.4 142.28 33.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -22.42 0.91 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.598 1.559 . . . . 0.0 115.089 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.43 -48.81 19.51 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.021 0 CA-C-N 119.25 0.932 . . . . 0.0 109.376 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.23 -45.82 72.41 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.875 2.07 . . . . 0.0 110.14 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 t -59.19 -38.76 80.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.526 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -70.66 -38.85 73.85 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.128 0.422 . . . . 0.0 111.829 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.09 -40.06 86.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 -34.51 73.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 123.843 0.714 . . . . 0.0 109.482 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -63.86 -49.39 72.95 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 118.397 0.544 . . . . 0.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.1 -37.87 80.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.923 0.489 . . . . 0.0 110.053 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -64.03 -42.34 97.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.229 -0.92 . . . . 0.0 109.974 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -62.39 -32.36 73.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.047 0.939 . . . . 0.0 109.808 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.73 -43.03 26.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.172 -0.955 . . . . 0.0 111.37 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.65 -55.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.3 mt -68.47 -30.22 69.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.236 0.614 . . . . 0.0 112.082 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.85 43.34 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 123.664 0.649 . . . . 0.0 111.81 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.21 175.58 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.989 1.715 . . . . 0.0 108.144 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -138.57 139.72 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 107.758 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.74 38.76 2.31 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.38 0.514 . . . . 0.0 112.925 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.528 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -81.69 122.28 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.81 -178.39 30.76 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.578 1.561 . . . . 0.0 110.831 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 pt -74.09 -26.72 21.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 O-C-N 121.403 -1.057 . . . . 0.0 113.179 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.03 -3.5 23.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.711 2.004 . . . . 0.0 113.95 -178.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.0 m-20 -68.04 116.58 8.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.61 127.69 33.45 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.6 t80 -48.97 -45.64 42.38 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.499 1.12 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.98 -38.66 91.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.467 0.707 . . . . 0.0 110.879 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -66.81 -20.74 66.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.772 1.229 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 32' ' ' ILE . 11.3 mt -89.39 7.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 120.98 -1.075 . . . . 0.0 108.118 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.94 0.64 87.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 119.631 -1.918 . . . . 0.0 113.676 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.45 139.51 30.61 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.425 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 24.5 p80 -121.99 175.19 6.45 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.161 -1.199 . . . . 0.0 108.434 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.053 0.941 . . . . 0.0 112.94 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.172 0.442 . . . . 0.0 111.907 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.425 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 16.6 mmtp -64.64 -42.38 95.51 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.0 79.02 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.832 1.253 . . . . 0.0 111.265 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.4 mmt -55.65 -42.83 75.61 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.819 0.848 . . . . 0.0 110.193 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.59 -38.6 91.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.838 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.25 -48.49 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.54 -28.25 59.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.514 0.726 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -50.56 47.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.927 0.785 . . . . 0.0 110.081 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -68.27 -36.53 79.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.05 0.929 . . . . 0.0 110.328 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -67.3 -45.67 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -40.16 86.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.021 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -75.87 -31.22 59.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -84.97 -48.24 9.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.551 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -87.07 -1.63 58.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 52.33 39.01 26.47 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 111.089 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.9 138.26 14.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.55 125.08 28.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.975 0.893 . . . . 0.0 110.172 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tt -113.82 91.87 23.19 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.42 155.32 70.66 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.424 1.416 . . . . 0.0 110.935 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.15 -28.83 19.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.126 1.37 . . . . 0.0 111.686 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.68 -44.35 66.17 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.554 0.742 . . . . 0.0 112.236 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 80' ' ' TYR . 48.4 t -80.84 -37.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -44.56 95.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.208 0.603 . . . . 0.0 110.491 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -40.8 26.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.561 1.545 . . . . 0.0 110.934 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.01 71.75 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.992 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -134.25 70.65 73.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.66 0.784 . . . . 0.0 110.161 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.12 59.35 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.562 3.508 . . . . 0.0 111.908 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.96 147.9 37.73 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.878 1.672 . . . . 0.0 109.396 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.45 -42.79 85.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.78 -49.07 66.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.869 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.27 -40.4 90.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.05 -38.5 66.48 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.28 69.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.385 0.538 . . . . 0.0 110.208 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.13 -39.38 72.03 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.239 0.337 . . . . 0.0 111.795 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 67' ' ' VAL . 48.6 t80 -63.75 -47.37 81.29 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 110.018 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.21 -37.38 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.95 -46.74 88.44 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.632 1.105 . . . . 0.0 112.082 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -63.41 -17.38 62.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.28 0.491 . . . . 0.0 110.467 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 . . . . . 0 C--N 1.342 0.277 0 O-C-N 120.953 -1.092 . . . . 0.0 112.05 178.882 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 . . . . . 0 CA--C 1.542 0.641 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.489 ' HA ' HD21 ' A' ' 35' ' ' LEU . 38.6 t80 -51.36 135.42 27.01 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -147.92 117.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 162.18 14.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.378 1.071 . . . . 0.0 110.228 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.15 151.02 84.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.382 2.054 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 -6.02 3.62 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.965 0.906 . . . . 0.0 111.995 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -117.38 140.09 50.02 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.15 -33.81 41.98 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.82 -38.12 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.847 0.749 . . . . 0.0 109.667 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.9 -38.76 92.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -61.93 -46.65 88.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.598 1.159 . . . . 0.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -56.56 -58.13 9.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.893 0.877 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.76 -36.35 83.59 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.017 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.17 63.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.424 0.689 . . . . 0.0 110.764 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.15 -48.39 23.86 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -54.39 -41.42 53.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.126 1.371 . . . . 0.0 111.151 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -61.97 -42.22 98.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.729 0.812 . . . . 0.0 111.558 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.64 -46.05 87.95 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.5 mmm-85 -62.27 -23.92 66.97 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.929 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -92.4 -55.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 119.929 1.241 . . . . 0.0 109.445 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.36 -23.87 66.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.82 33.75 57.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.99 174.11 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.8 p -134.7 132.08 38.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.307 1.443 . . . . 0.0 107.698 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.71 45.74 0.95 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 123.966 0.793 . . . . 0.0 113.21 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.2 121.89 27.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.86 35.68 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.3 0.952 . . . . 0.0 111.029 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.5 pt -81.69 -21.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 120.45 -1.618 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.82 1.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.137 1.775 . . . . 0.0 113.418 -178.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.66 122.44 15.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.931 1.348 . . . . 0.0 111.828 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -81.02 108.34 14.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.1 t80 -44.88 -45.15 10.14 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.974 1.709 . . . . 0.0 113.718 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -73.73 -27.83 61.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.537 -0.727 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.37 -30.25 69.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 38' ' ' PHE . 16.2 mt -77.37 6.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 126.484 1.914 . . . . 0.0 109.984 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 3.35 79.84 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 119.659 -1.901 . . . . 0.0 112.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.58 157.98 47.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 107.817 -2.113 . . . . 0.0 107.817 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.451 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 18.6 p80 -147.06 178.59 8.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.61 -54.63 5.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.913 1.285 . . . . 0.0 112.247 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.04 -45.8 75.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 64.8 mmtt -64.41 -44.07 92.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -40.09 68.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.309 1.044 . . . . 0.0 111.459 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 mtm -65.68 -35.47 80.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.524 0.33 . . . . 0.0 111.168 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.95 78.49 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.949 0.9 . . . . 0.0 111.612 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.01 -41.68 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.74 70.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.484 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.76 48.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.59 -38.59 85.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.93 -46.36 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -40.93 90.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.52 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -29.37 58.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.83 -48.44 8.76 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 61' ' ' VAL . 53.1 m-85 -96.23 2.16 52.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 111.505 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 55.85 31.83 18.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.264 0.626 . . . . 0.0 111.877 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.8 p -133.87 128.99 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 123.317 0.647 . . . . 0.0 112.601 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.54 124.98 25.54 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.6 tp -112.22 87.63 9.39 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.05 156.81 64.42 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.753 0.969 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -27.54 65.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.261 1.024 . . . . 0.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.77 -29.08 62.28 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.961 0.8 . . . . 0.0 111.079 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 80' ' ' TYR . 49.4 t -86.64 -43.5 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -49.06 79.24 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 123.055 0.542 . . . . 0.0 111.159 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -29.12 61.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.62 -29.91 27.33 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.635 0.652 . . . . 0.0 112.085 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -138.58 68.02 44.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 109.213 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.78 57.95 4.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.56 2.84 . . . . 0.0 114.88 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.16 148.21 37.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.383 0.992 . . . . 0.0 110.558 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -56.28 -44.08 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -52.31 -49.66 63.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.894 0.77 . . . . 0.0 111.42 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.18 99.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.05 -43.09 62.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.262 1.425 . . . . 0.0 108.516 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.82 88.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -73.31 -37.12 66.3 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.253 0.621 . . . . 0.0 111.493 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 67' ' ' VAL . 17.3 t80 -65.51 -41.11 93.52 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.16 -43.6 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.69 90.64 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -15.86 63.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.328 0.651 . . . . 0.0 112.23 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 . . . . . 0 N--CA 1.462 0.151 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 178.224 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 . . . . . 0 C--O 1.224 -0.248 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -42.95 124.5 3.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.4 1.88 . . . . 0.0 114.967 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.0 t -146.86 116.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.04 161.62 15.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.109 1.763 . . . . 0.0 112.672 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.06 148.47 93.1 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.625 2.883 . . . . 0.0 112.65 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 p -114.66 -21.14 10.38 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.255 1.422 . . . . 0.0 113.656 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -109.97 162.86 14.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.377 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -34.28 77.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.837 1.655 . . . . 0.0 110.612 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.1 -50.99 28.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.75 -43.4 76.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 126.342 1.857 . . . . 0.0 109.427 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -65.52 -32.96 74.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.328 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -68.45 -48.7 63.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.786 1.176 . . . . 0.0 108.896 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.65 -41.86 82.31 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.086 0.955 . . . . 0.0 110.918 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.02 67.84 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.207 1.003 . . . . 0.0 111.95 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -77.42 -37.35 51.96 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 118.937 0.79 . . . . 0.0 110.127 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.89 -40.17 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.518 -0.739 . . . . 0.0 109.76 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -59.41 -39.21 82.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.302 0.641 . . . . 0.0 111.874 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -63.69 -32.84 74.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.495 0.718 . . . . 0.0 110.902 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -68.01 -35.7 78.73 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.817 -1.177 . . . . 0.0 111.484 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.22 -54.83 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.27 0.628 . . . . 0.0 110.838 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.18 -24.83 57.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.4 21.67 69.3 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.426 1.012 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 m -105.15 175.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.505 1.122 . . . . 0.0 110.458 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 t -139.32 112.75 8.28 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.35 62.8 0.34 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 123.202 0.429 . . . . 0.0 112.435 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.7 mm -86.63 137.83 20.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.83 177.19 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 124.89 1.233 . . . . 0.0 111.741 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 pt -78.87 -22.42 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 121.082 -1.246 . . . . 0.0 113.41 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.416 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.72 0.78 22.58 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.251 34.9 p30 -76.11 129.56 36.98 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 123.192 1.472 . . . . 0.0 112.706 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -74.1 111.59 9.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.849 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' HD12 ' A' ' 41' ' ' ILE . 85.4 t80 -43.46 -45.94 6.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.737 1.615 . . . . 0.0 112.604 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -66.99 -37.02 83.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -67.62 -31.45 71.48 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.652 0.781 . . . . 0.0 109.98 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 38' ' ' PHE . 24.2 mt -71.98 -6.26 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.286 1.034 . . . . 0.0 109.27 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.39 10.24 27.78 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 126.024 1.774 . . . . 0.0 112.908 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.9 159.31 47.46 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.878 1.339 . . . . 0.0 110.111 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . 0.436 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 20.1 p80 -146.86 178.07 8.62 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.344 1.458 . . . . 0.0 107.906 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.57 -54.75 5.77 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.633 1.173 . . . . 0.0 112.739 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -54.95 -50.54 68.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.857 0.863 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.2 mmtp -61.86 -39.31 91.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.893 -1.051 . . . . 0.0 111.149 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.96 96.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.497 1.044 . . . . 0.0 108.847 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.4 mtm -66.69 -37.45 84.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.942 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.31 92.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.221 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.9 t -72.65 -45.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.691 1.132 . . . . 0.0 108.057 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.32 -32.74 57.35 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.938 0.895 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.03 83.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.213 0.461 . . . . 0.0 111.064 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -77.74 -43.33 31.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 122.002 0.906 . . . . 0.0 108.885 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.78 -46.46 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 124.049 0.94 . . . . 0.0 109.605 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -60.61 -41.08 94.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.778 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -75.53 -32.39 60.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -82.51 -45.99 13.99 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 123.219 0.607 . . . . 0.0 111.873 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB2' HG12 ' A' ' 61' ' ' VAL . 71.9 m-85 -93.96 -3.01 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.899 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 53.82 46.97 24.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.754 1.221 . . . . 0.0 108.761 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 59' ' ' TYR . 8.6 p -140.08 126.97 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 48.0 tt0 -73.04 115.0 11.84 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.66 88.54 16.47 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.81 153.85 63.9 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.05 1.167 . . . . 0.0 109.725 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.84 -26.36 9.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.855 2.062 . . . . 0.0 110.35 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.29 -44.35 64.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.616 1.166 . . . . 0.0 110.641 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 56.5 t -77.66 -45.72 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.566 0.747 . . . . 0.0 109.085 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -42.62 74.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.453 0.701 . . . . 0.0 110.716 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -37.45 28.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.281 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.44 98.81 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.336 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -137.64 83.38 25.05 Favored Pre-proline 0 N--CA 1.448 -0.56 0 O-C-N 124.396 1.06 . . . . 0.0 109.222 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 60.77 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.164 2.576 . . . . 0.0 110.95 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.18 148.66 38.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.972 1.715 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mm -57.17 -43.01 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.83 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.55 -48.99 76.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.864 0.756 . . . . 0.0 111.587 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.69 -41.45 86.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.148 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.4 -42.25 62.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.26 76.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.703 1.201 . . . . 0.0 110.849 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -37.88 64.94 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.894 0.77 . . . . 0.0 110.311 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 43.8 t80 -63.31 -48.08 79.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.535 0.607 . . . . 0.0 110.929 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.432 HG13 HG11 ' A' ' 61' ' ' VAL . 28.8 t -69.7 -40.82 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.11 86.57 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 118.998 0.817 . . . . 0.0 112.528 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 t -73.16 -13.93 61.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.231 0.469 . . . . 0.0 110.118 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 . . . . . 0 C--O 1.225 -0.201 0 CA-C-N 119.542 1.064 . . . . 0.0 109.684 177.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 . . . . . 0 N--CA 1.455 -0.224 0 CA-C-O 118.811 -0.614 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -48.11 125.47 9.24 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.806 2.442 . . . . 0.0 110.48 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.2 t -135.22 117.39 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 152.89 72.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.056 0.942 . . . . 0.0 111.458 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.49 151.57 84.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.951 2.434 . . . . 0.0 111.081 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -129.2 -13.87 4.4 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.719 1.208 . . . . 0.0 111.229 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 25.0 t-20 -90.08 152.09 21.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.28 70.78 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.899 0.48 . . . . 0.0 110.162 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -78.28 -51.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.734 1.614 . . . . 0.0 110.833 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 2.1 mt-10 -55.37 -37.96 68.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.132 0.573 . . . . 0.0 110.089 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 t -59.97 -52.29 66.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 123.843 0.714 . . . . 0.0 109.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.4 mmpt? -56.5 -49.2 75.4 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.75 -38.8 92.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 117.486 -1.245 . . . . 0.0 111.075 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.15 -30.09 70.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.76 0.709 . . . . 0.0 110.174 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.98 -44.08 97.01 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -63.52 -39.23 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.689 1.196 . . . . 0.0 109.586 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -55.46 -43.85 75.86 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.868 0.758 . . . . 0.0 109.967 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.4 -32.28 72.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.745 0.702 . . . . 0.0 110.643 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -76.22 -16.36 59.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.486 -1.384 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.04 -36.23 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.641 0.776 . . . . 0.0 110.078 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.19 -42.13 12.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.971 1.308 . . . . 0.0 111.537 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.75 40.32 7.24 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.394 -1.226 . . . . 0.0 110.948 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.253 3.4 m -128.24 177.22 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.664 1.232 . . . . 0.0 108.686 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.3 t -143.59 108.26 4.88 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 119.981 -1.7 . . . . 0.0 108.233 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.97 41.93 0.15 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.453 1.501 . . . . 0.0 114.167 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 41' ' ' ILE . 39.5 mm -76.42 145.38 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 120.193 1.997 . . . . 0.0 108.507 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.03 175.5 15.88 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.389 1.947 . . . . 0.0 110.079 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 pt -75.63 -30.83 22.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.433 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -101.13 -0.52 36.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.523 1.129 . . . . 0.0 113.382 -178.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.585 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.2 m-20 -69.53 116.59 10.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -67.45 117.57 9.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 84.3 t80 -45.94 -45.58 15.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.542 1.537 . . . . 0.0 111.893 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -70.67 -29.77 66.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.45 0.7 . . . . 0.0 112.53 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -76.91 -30.29 56.08 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.51 -0.744 . . . . 0.0 110.39 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 32' ' ' ILE . 32.3 mt -70.72 -31.05 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.264 0.484 . . . . 0.0 110.389 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.58 -2.45 2.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.907 1.242 . . . . 0.0 111.651 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.7 157.83 53.59 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -136.66 172.96 12.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.83 -45.92 20.5 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.336 0.654 . . . . 0.0 112.47 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.03 -49.29 78.46 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.517 0.598 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -60.64 -38.83 86.1 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.395 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -35.23 62.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.844 1.202 . . . . 0.0 111.006 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.6 mtm -73.85 -42.06 61.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.55 74.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.082 1.353 . . . . 0.0 111.327 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.9 -53.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.98 -36.28 65.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.081 0.952 . . . . 0.0 112.316 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.21 -52.49 65.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.692 0.797 . . . . 0.0 111.565 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -75.72 -33.27 60.3 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.635 -0.666 . . . . 0.0 111.799 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.99 -44.09 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.658 1.183 . . . . 0.0 108.909 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -41.08 88.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.611 0.641 . . . . 0.0 110.261 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.69 -34.44 60.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.89 -48.16 13.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.802 0.689 . . . . 0.0 111.585 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CB ' HG12 ' A' ' 61' ' ' VAL . 23.7 m-85 -91.34 3.18 55.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.165 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 48.8 38.81 12.67 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.269 1.428 . . . . 0.0 110.445 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 81' ' ' VAL . 7.3 p -143.46 117.65 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 123.678 0.791 . . . . 0.0 110.14 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -64.12 140.01 58.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 tt -120.38 84.54 35.44 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.85 144.81 94.16 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.3 14.81 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.885 1.274 . . . . 0.0 110.462 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -53.28 -35.11 59.73 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 t -87.97 -44.24 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 119.121 0.873 . . . . 0.0 109.135 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -51.63 63.29 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 123.536 0.734 . . . . 0.0 110.796 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -71.57 -37.91 70.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.295 0.638 . . . . 0.0 111.573 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.6 84.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.75 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.86 78.6 29.82 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.861 1.264 . . . . 0.0 108.653 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 55.39 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.846 3.031 . . . . 0.0 111.043 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.25 147.16 47.41 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.194 0.906 . . . . 0.0 110.098 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 74' ' ' ILE . 4.5 mm -61.17 -39.3 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.31 -51.2 60.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 111.867 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.31 97.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.695 1.598 . . . . 0.0 114.212 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.1 -40.4 65.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.847 1.259 . . . . 0.0 108.417 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -51.75 68.22 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 119.028 0.831 . . . . 0.0 109.385 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.77 -38.5 89.23 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.497 0.319 . . . . 0.0 111.622 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.93 -51.97 48.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.246 1.018 . . . . 0.0 110.377 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.633 HG13 HG11 ' A' ' 61' ' ' VAL . 70.9 t -66.42 -41.84 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 123.346 0.404 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.18 78.67 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -70.9 -24.91 62.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.68 0.218 . . . . 0.0 110.568 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 . . . . . 0 N--CA 1.461 0.12 0 O-C-N 120.687 -1.258 . . . . 0.0 108.694 178.59 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.225 -0.231 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -52.01 123.33 10.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 0.0 111.638 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -138.37 117.26 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 160.07 44.08 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.356 1.462 . . . . 0.0 110.101 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.33 145.16 99.18 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.887 3.058 . . . . 0.0 113.353 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -116.65 -11.67 10.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 0.0 112.391 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -125.3 145.4 50.03 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.33 -29.31 9.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.372 1.069 . . . . 0.0 112.863 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.47 -53.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.673 0.749 . . . . 0.0 109.58 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -55.85 -42.96 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.605 1.962 . . . . 0.0 109.272 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -66.08 -31.82 72.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.424 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -72.31 -40.37 67.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.038 1.29 . . . . 0.0 109.761 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -69.07 -39.07 79.3 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.079 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 -33.83 70.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.487 1.117 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -69.55 -40.79 76.62 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 117.999 0.363 . . . . 0.0 111.171 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.18 -36.39 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -62.49 -35.64 80.0 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.652 -0.655 . . . . 0.0 109.659 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.54 -39.9 88.82 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.59 -0.694 . . . . 0.0 109.624 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -65.84 -38.81 89.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 51' ' ' VAL . 48.8 t -81.37 -44.57 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.0 mt -85.91 -24.03 26.77 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.055 0.542 . . . . 0.0 112.128 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.29 31.15 59.61 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.268 -0.74 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.27 171.33 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.7 p -143.04 138.22 29.8 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.954 1.252 . . . . 0.0 111.521 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.34 42.6 1.05 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.978 1.275 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.49 121.55 28.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.786 0.834 . . . . 0.0 109.68 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -90.97 169.31 33.48 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.67 1.129 . . . . 0.0 110.67 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.3 pt -71.28 -25.94 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.099 -1.236 . . . . 0.0 111.973 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.28 1.03 32.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.069 2.147 . . . . 0.0 112.724 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.676 ' HB3' HD11 ' A' ' 41' ' ' ILE . 10.8 m-20 -65.68 116.73 7.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.15 0.98 . . . . 0.0 108.559 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -74.78 112.83 11.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.0 t80 -43.08 -52.46 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.503 1.521 . . . . 0.0 112.471 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.74 -33.02 72.28 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.319 -0.863 . . . . 0.0 111.666 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -68.65 -23.09 64.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.117 0.967 . . . . 0.0 110.461 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 36' ' ' ASP . 15.2 mt -84.25 14.01 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 125.339 1.456 . . . . 0.0 109.157 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 9.6 70.21 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 119.368 -2.083 . . . . 0.0 113.721 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 170.51 54.31 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 118.306 1.053 . . . . 0.0 112.047 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -155.08 176.7 12.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 108.03 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.92 -46.09 60.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.558 0.743 . . . . 0.0 112.563 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.26 -49.1 72.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.122 0.874 . . . . 0.0 109.401 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -59.38 -46.58 88.28 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.38 62.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.052 0.842 . . . . 0.0 113.048 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.1 mtm -75.63 -39.79 57.28 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 109.776 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.086 1.354 . . . . 0.0 111.574 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 26' ' ' VAL . 97.8 t -68.71 -53.56 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.89 61.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.356 1.463 . . . . 0.0 113.779 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.32 -50.63 59.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.493 1.042 . . . . 0.0 108.646 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.05 -31.96 56.58 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 121.984 0.897 . . . . 0.0 110.992 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.63 -42.58 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -42.1 98.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.311 0.96 . . . . 0.0 109.573 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -74.18 -30.02 62.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.188 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.89 -49.55 10.88 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.822 0.737 . . . . 0.0 110.379 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.84 -1.56 57.89 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 55.68 40.89 30.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.991 1.317 . . . . 0.0 109.804 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.585 HG11 HG13 ' A' ' 81' ' ' VAL . 2.5 p -150.38 130.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.76 128.25 34.96 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.132 0.573 . . . . 0.0 109.548 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.75 86.7 13.39 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.41 141.75 52.22 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.713 1.608 . . . . 0.0 109.735 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -27.33 16.84 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.742 1.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -53.9 -32.25 52.75 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.057 0.844 . . . . 0.0 111.577 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 80' ' ' TYR . 59.4 t -86.81 -46.54 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -54.58 -47.73 72.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.509 1.124 . . . . 0.0 111.488 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.94 -36.46 62.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.149 0.58 . . . . 0.0 111.003 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -33.11 67.58 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.224 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -141.36 74.43 24.17 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.385 1.474 . . . . 0.0 109.366 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.98 56.49 3.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 125.062 3.841 . . . . 0.0 113.894 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.45 148.35 42.62 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.883 -1.136 . . . . 0.0 111.773 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -56.7 -42.96 78.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -54.99 -49.89 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.163 0.438 . . . . 0.0 110.892 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.48 97.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.24 -40.86 70.79 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.41 79.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.441 0.564 . . . . 0.0 110.206 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.25 -40.48 67.65 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.923 0.489 . . . . 0.0 111.728 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.412 ' CE1' HG21 ' A' ' 67' ' ' VAL . 61.2 t80 -63.27 -43.82 96.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.585 HG13 HG11 ' A' ' 61' ' ' VAL . 74.2 t -74.03 -35.89 42.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.866 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -35.59 71.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.248 0.931 . . . . 0.0 112.73 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 t -82.31 -18.64 41.56 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.216 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 . . . . . 0 N--CA 1.468 0.46 0 CA-C-N 119.742 1.155 . . . . 0.0 109.506 179.227 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 . . . . . 0 CA--C 1.536 0.43 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . 0.433 ' HA ' HD21 ' A' ' 35' ' ' LEU . 5.9 t80 -50.48 133.88 24.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.957 2.103 . . . . 0.0 112.791 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.55 118.98 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.46 157.59 77.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.251 1.02 . . . . 0.0 111.614 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 155.3 71.38 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.484 2.789 . . . . 0.0 112.926 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.3 t -130.78 -20.22 2.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.466 1.107 . . . . 0.0 112.419 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 7.4 t-20 -98.72 143.72 28.77 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.99 -27.1 12.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.02 0.928 . . . . 0.0 113.49 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.95 -46.64 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 120.388 1.449 . . . . 0.0 109.186 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 3.9 mt-10 -56.82 -35.27 68.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.21 1.404 . . . . 0.0 110.471 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -63.2 -49.09 75.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -57.42 -48.64 78.59 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.36 -41.68 94.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.664 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.67 -34.6 73.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.725 0.641 . . . . 0.0 109.93 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -66.41 -50.59 62.93 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.55 -37.38 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.286 1.034 . . . . 0.0 110.339 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -62.43 -44.8 95.54 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.718 0.69 . . . . 0.0 111.204 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.35 -32.86 70.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.227 0.611 . . . . 0.0 111.538 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -67.69 -43.02 81.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.523 0.601 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.7 -52.05 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 123.646 0.778 . . . . 0.0 111.864 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.88 -25.63 62.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.636 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.53 57.94 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.12 174.64 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.648 1.179 . . . . 0.0 110.023 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -144.07 114.45 7.52 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.36 27.17 0.52 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.727 1.156 . . . . 0.0 112.36 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.13 125.48 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.687 1.243 . . . . 0.0 110.819 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 175.76 22.42 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.367 1.461 . . . . 0.0 112.051 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.28 -28.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 121.098 -1.237 . . . . 0.0 112.193 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.61 2.28 28.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.465 1.906 . . . . 0.0 112.53 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.19 122.84 17.59 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.21 119.43 25.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.513 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -46.79 -46.44 20.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.236 1.814 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -74.75 -31.36 61.78 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.647 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -63.62 -36.97 85.57 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.8 mt -72.13 6.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 125.455 1.502 . . . . 0.0 109.809 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.61 3.72 80.61 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 119.543 -1.973 . . . . 0.0 111.309 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.87 145.8 49.03 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 120.081 1.941 . . . . 0.0 108.933 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -139.49 -179.39 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.297 1.039 . . . . 0.0 109.127 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.61 -53.04 12.31 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.918 1.287 . . . . 0.0 112.224 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -49.17 72.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.142 0.577 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 54.8 mmtt -61.93 -44.75 96.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.842 -0.537 . . . . 0.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.4 83.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.486 1.114 . . . . 0.0 110.217 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.85 -41.29 91.1 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.592 0.757 . . . . 0.0 109.5 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.5 75.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.179 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 4.5 t -69.9 -51.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 120.56 1.527 . . . . 0.0 107.33 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.88 -33.01 61.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.132 0.973 . . . . 0.0 113.027 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.95 75.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.265 0.626 . . . . 0.0 110.695 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -76.49 -34.18 58.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.705 0.765 . . . . 0.0 111.495 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.54 -44.98 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -39.03 84.41 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.535 0.607 . . . . 0.0 110.122 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -76.15 -31.79 58.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.12 -47.42 8.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.86 0.464 . . . . 0.0 111.783 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -90.09 0.71 57.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.749 0.419 . . . . 0.0 110.571 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 52.74 36.51 21.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.477 1.111 . . . . 0.0 111.441 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.75 123.0 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.235 0.54 . . . . 0.0 112.13 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.91 110.34 2.85 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.905 -1.122 . . . . 0.0 108.452 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 tp -100.34 93.14 2.5 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.049 1.34 . . . . 0.0 110.941 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.0 145.18 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.707 3.605 . . . . 0.0 111.096 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -29.37 9.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.709 2.404 . . . . 0.0 111.428 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -52.97 -26.66 15.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.578 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 48.4 t -87.5 -50.05 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.799 1.64 . . . . 0.0 109.212 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -46.57 63.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.005 0.922 . . . . 0.0 110.718 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -30.7 38.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.368 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.0 -30.95 58.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.948 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.38 69.25 13.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 111.394 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.37 60.43 3.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.787 3.658 . . . . 0.0 112.998 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.2 147.12 36.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.901 -1.125 . . . . 0.0 109.045 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 mm -56.9 -47.51 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 C-N-CA 124.11 0.964 . . . . 0.0 108.662 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.87 -47.37 80.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.635 0.584 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.43 81.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.2 -41.47 85.75 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.718 1.607 . . . . 0.0 108.716 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.82 99.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.512 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.6 -46.59 58.79 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 118.571 0.623 . . . . 0.0 110.403 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.578 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 22.1 t80 -58.9 -42.35 89.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.3 t -73.49 -41.33 56.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.122 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.04 82.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.677 1.126 . . . . 0.0 112.334 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -70.74 -29.35 65.58 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.546 0.612 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 . . . . . 0 CA--C 1.517 -0.3 0 O-C-N 120.94 -1.1 . . . . 0.0 111.792 -178.993 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -56.34 128.72 37.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.268 1.827 . . . . 0.0 114.07 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.96 117.61 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.11 163.41 17.44 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.297 1.439 . . . . 0.0 110.786 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.9 148.89 82.96 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.236 1.957 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 p -130.43 -12.15 3.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.2 143.66 40.0 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -28.38 6.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.873 1.269 . . . . 0.0 114.229 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.49 -40.76 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 119.525 1.057 . . . . 0.0 109.442 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -56.36 -39.02 72.2 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.089 0.556 . . . . 0.0 110.305 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.5 t -63.1 -49.11 75.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.852 0.72 . . . . 0.0 109.587 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -54.89 -52.29 63.34 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.678 0.672 . . . . 0.0 110.369 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -64.51 -41.63 96.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.253 -0.88 . . . . 0.0 112.716 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.78 74.55 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.5 -45.75 71.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.5 -41.85 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -61.14 -41.97 97.7 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 121.11 -0.994 . . . . 0.0 109.905 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.7 -45.13 95.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.476 0.58 . . . . 0.0 111.403 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -70.75 -39.85 73.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.577 1.081 . . . . 0.0 112.902 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.01 -55.88 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -74.96 -28.32 60.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.06 19.6 60.74 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.124 1.821 . . . . 0.0 113.093 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.07 174.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.15 1.38 . . . . 0.0 108.462 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 t -145.36 132.04 19.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.661 0.664 . . . . 0.0 112.409 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.21 0.88 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.0 mm -78.25 128.47 38.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.22 161.08 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.118 0.843 . . . . 0.0 112.66 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.55 -21.35 26.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.934 1.294 . . . . 0.0 111.193 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.9 -3.89 18.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.175 2.19 . . . . 0.0 114.301 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -75.8 131.09 39.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.556 1.071 . . . . 0.0 111.003 -177.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 5.3 m120 -80.28 119.95 23.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 41' ' ' ILE . 82.7 t80 -40.97 -46.26 2.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.879 2.071 . . . . 0.0 114.403 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -67.84 -32.3 72.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 112.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.14 -32.04 68.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.635 0.652 . . . . 0.0 109.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 38' ' ' PHE . 28.4 mt -71.23 -9.93 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.445 1.098 . . . . 0.0 110.397 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.26 1.91 23.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 124.367 0.984 . . . . 0.0 111.864 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 152.51 52.1 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -143.43 179.86 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.51 -49.27 36.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.222 0.919 . . . . 0.0 111.974 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.68 -48.32 81.47 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -59.85 -43.43 94.64 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.057 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.58 77.71 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.68 0.792 . . . . 0.0 110.009 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.74 -39.56 94.6 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.26 77.88 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.059 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.2 -50.73 55.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.47 -32.65 65.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.098 0.959 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.87 99.46 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.042 0.537 . . . . 0.0 110.485 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -78.4 -40.95 34.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 121.473 0.654 . . . . 0.0 111.252 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -64.28 -46.13 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 O-C-N 121.621 -0.674 . . . . 0.0 110.727 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -37.16 85.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.849 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -76.04 -30.22 58.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -89.71 -48.69 7.11 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.95 -3.8 59.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 109.783 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 50.98 45.17 28.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.766 2.026 . . . . 0.0 110.342 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.487 HG11 HG13 ' A' ' 81' ' ' VAL . 12.6 p -144.38 128.7 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.472 0.709 . . . . 0.0 110.286 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.86 125.63 25.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -116.19 79.67 8.86 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -66.6 150.35 83.89 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.423 2.082 . . . . 0.0 112.951 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -26.59 64.67 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.592 1.557 . . . . 0.0 109.933 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -53.32 -41.97 66.23 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.327 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -37.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -49.67 -51.1 40.57 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.505 1.122 . . . . 0.0 109.545 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -36.53 69.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.944 0.898 . . . . 0.0 111.484 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -37.17 85.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.508 0.505 . . . . 0.0 111.476 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -138.56 75.34 38.22 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 107.962 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 74.3 Cg_endo -76.66 64.26 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.37 2.714 . . . . 0.0 112.147 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.09 147.09 36.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.673 1.124 . . . . 0.0 110.226 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -55.82 -49.8 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 108.735 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -52.82 -48.12 67.19 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.091 0.556 . . . . 0.0 111.142 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.65 73.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.185 0.994 . . . . 0.0 113.281 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.1 -43.43 78.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.938 1.695 . . . . 0.0 108.864 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.24 74.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -68.8 -42.64 77.03 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.422 1.089 . . . . 0.0 111.769 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -63.96 -43.24 96.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.685 0.794 . . . . 0.0 109.737 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 61' ' ' VAL . 94.9 t -74.06 -36.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.546 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -49.0 72.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.881 0.473 . . . . 0.0 110.486 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -65.22 -28.11 69.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.223 -0.305 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 . . . . . 0 N--CA 1.463 0.184 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -45.29 120.5 2.5 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.75 1.62 . . . . 0.0 110.943 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.42 119.73 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 159.94 5.52 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.52 1.528 . . . . 0.0 111.513 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.82 152.74 77.03 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.646 2.231 . . . . 0.0 111.034 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -127.01 -14.08 5.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 23.2 t30 -118.6 145.08 45.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.52 54.32 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 122.84 0.456 . . . . 0.0 111.763 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.9 -45.0 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 7.2 mt-10 -60.73 -42.13 96.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -49.34 76.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.206 0.941 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -56.99 -54.48 46.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.876 0.87 . . . . 0.0 110.907 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.93 -37.58 87.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.21 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.46 72.37 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.069 0.849 . . . . 0.0 109.755 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.86 -48.16 80.23 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.27 -38.83 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -67.37 -44.98 77.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.062 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -55.38 -42.1 73.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.821 0.848 . . . . 0.0 110.295 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -71.62 -41.88 68.33 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.298 -0.876 . . . . 0.0 112.839 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -71.51 -45.16 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.601 0.76 . . . . 0.0 110.997 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.43 -32.15 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.92 0.888 . . . . 0.0 110.707 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.32 26.07 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.04 171.91 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.566 1.546 . . . . 0.0 108.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -143.92 127.94 17.5 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.39 40.1 0.6 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.396 1.95 . . . . 0.0 110.961 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.2 mm -77.64 126.24 37.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.842 0.857 . . . . 0.0 109.219 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.09 -179.07 38.72 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 121.807 0.671 . . . . 0.0 111.71 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 -28.27 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.245 0.618 . . . . 0.0 111.687 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.54 -4.1 20.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.421 1.489 . . . . 0.0 113.921 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.655 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -61.62 123.19 17.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.21 115.33 17.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.221 0.608 . . . . 0.0 110.833 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.458 ' HA ' HD12 ' A' ' 41' ' ' ILE . 73.0 t80 -44.75 -46.5 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.502 1.121 . . . . 0.0 113.256 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -67.46 -29.78 69.32 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.19 -31.19 34.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 36' ' ' ASP . 24.2 mt -71.08 -21.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.172 0.442 . . . . 0.0 110.051 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.69 -5.21 5.48 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.74 1.162 . . . . 0.0 113.479 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.98 157.98 53.22 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -146.18 176.93 9.37 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.31 6.6 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.157 1.783 . . . . 0.0 112.39 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -37.2 76.98 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -76.1 -37.93 57.53 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 120.215 -1.553 . . . . 0.0 110.984 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.46 72.87 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.415 1.486 . . . . 0.0 112.71 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -44.23 96.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.75 72.17 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.722 1.209 . . . . 0.0 110.741 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.45 -53.15 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.09 71.31 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.914 0.486 . . . . 0.0 110.952 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.93 72.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.061 0.846 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -72.38 -31.45 65.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.017 0.913 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.37 -42.78 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -40.61 87.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 121.758 -0.589 . . . . 0.0 110.086 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -33.73 59.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.12 -39.61 14.43 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' HG12 ' A' ' 61' ' ' VAL . 14.1 m-85 -97.8 0.93 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 50.97 37.78 18.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.305 1.042 . . . . 0.0 110.437 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG11 HG13 ' A' ' 81' ' ' VAL . 14.1 p -138.48 129.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.403 0.681 . . . . 0.0 112.785 -178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -80.82 116.61 20.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.65 92.76 6.41 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 127.197 2.199 . . . . 0.0 105.345 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.3 152.25 82.67 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.988 1.792 . . . . 0.0 110.524 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -28.84 22.23 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.701 1.6 . . . . 0.0 110.276 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -52.28 -39.58 60.64 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.505 1.122 . . . . 0.0 112.133 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.64 -38.92 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -50.68 72.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.972 0.909 . . . . 0.0 110.808 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.35 56.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.628 1.571 . . . . 0.0 109.882 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.53 70.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.572 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.36 73.99 35.76 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.185 1.394 . . . . 0.0 108.596 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.96 62.0 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.423 3.415 . . . . 0.0 109.869 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.61 146.95 36.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.19 -42.35 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -54.75 -42.89 72.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.061 0.846 . . . . 0.0 111.318 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.12 -44.47 88.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.16 -38.76 66.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.367 1.467 . . . . 0.0 108.077 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.32 69.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.562 0.745 . . . . 0.0 109.348 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.02 -38.93 79.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.241 0.473 . . . . 0.0 111.243 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 -48.27 81.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.449 HG13 HG11 ' A' ' 61' ' ' VAL . 54.3 t -72.21 -40.24 65.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 O-C-N 123.825 0.703 . . . . 0.0 110.033 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.26 76.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.753 1.161 . . . . 0.0 114.034 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -73.36 -24.41 60.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.322 0.249 . . . . 0.0 111.323 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 . . . . . 0 N--CA 1.464 0.252 0 C-N-CA 123.094 0.557 . . . . 0.0 109.732 179.839 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 119.182 -0.437 . . . . 0.0 111.658 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.41 130.69 47.42 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.202 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.3 t -145.22 117.52 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.91 160.67 19.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.869 1.268 . . . . 0.0 111.236 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.73 160.81 11.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.654 2.903 . . . . 0.0 114.222 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -127.96 -38.16 1.86 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.04 -1.891 . . . . 0.0 112.294 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 1.4 t-20 -89.48 163.7 15.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.18 71.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.773 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.32 -49.96 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.235 0.614 . . . . 0.0 109.558 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 12.0 mt-10 -54.33 -41.58 69.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.863 0.865 . . . . 0.0 109.139 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -54.5 -37.7 65.6 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.607 1.563 . . . . 0.0 110.758 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -76.93 -57.29 3.93 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 120.17 1.35 . . . . 0.0 111.302 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -53.31 -41.96 66.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.518 1.127 . . . . 0.0 113.101 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.42 69.19 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 123.57 0.544 . . . . 0.0 110.378 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -77.74 -34.93 52.36 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.215 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.36 -36.04 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -62.91 -33.98 76.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.956 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -63.59 -37.84 88.85 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -68.88 -15.97 63.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.563 HG21 HG22 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -104.11 -54.45 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 119.201 0.909 . . . . 0.0 110.355 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.55 -27.43 64.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.822 0.849 . . . . 0.0 111.983 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.49 39.02 51.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.48 174.56 12.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.918 1.287 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -134.89 138.24 43.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.0 1.32 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.03 64.04 0.95 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.587 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.18 141.37 14.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.3 -173.14 18.57 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 125.393 1.473 . . . . 0.0 111.025 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 pt -84.92 -28.85 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.24 1.96 24.31 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -81.49 123.51 28.68 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.403 1.097 . . . . 0.0 110.8 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -69.93 122.52 19.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.585 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.58 -46.82 39.72 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.314 1.846 . . . . 0.0 111.98 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.36 -31.65 69.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.181 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -67.96 -33.06 73.94 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.14 0.882 . . . . 0.0 109.046 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.03 -11.64 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.834 0.854 . . . . 0.0 108.812 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.85 3.64 26.55 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.209 1.862 . . . . 0.0 114.206 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.98 152.91 48.32 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.297 1.549 . . . . 0.0 111.827 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -138.31 175.56 9.46 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.464 1.506 . . . . 0.0 108.144 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.26 -49.23 34.31 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.931 0.892 . . . . 0.0 112.92 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.17 -51.11 67.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.568 1.077 . . . . 0.0 109.411 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mmtt -59.41 -48.09 82.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.01 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.17 68.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.687 1.595 . . . . 0.0 110.542 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmt -66.09 -39.36 89.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.859 0.864 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.201 -0.905 . . . . 0.0 110.802 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 26' ' ' VAL . 1.7 t -67.71 -50.78 57.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.01 -32.05 63.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.85 63.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.554 0.615 . . . . 0.0 109.366 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.44 -40.04 77.46 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.883 0.473 . . . . 0.0 111.184 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -63.64 -49.23 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -39.98 91.74 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.306 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -30.95 59.73 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -83.88 -48.22 10.25 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.029 0.831 . . . . 0.0 110.449 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -87.42 -3.58 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.592 0.557 . . . . 0.0 110.742 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 59.02 38.02 24.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.52 1.055 . . . . 0.0 111.515 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.68 126.92 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.101 -0.999 . . . . 0.0 112.681 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.87 142.0 58.58 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.97 78.61 74.61 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.74 152.99 79.48 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.734 1.623 . . . . 0.0 111.173 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -28.43 47.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.905 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -54.27 -33.53 58.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.488 1.115 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -88.17 -51.78 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 107.902 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -48.9 35.62 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.454 1.902 . . . . 0.0 111.41 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.85 40.63 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.643 -0.66 . . . . 0.0 112.296 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.85 79.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.223 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -138.33 79.63 30.19 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.519 1.128 . . . . 0.0 108.528 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.74 55.26 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 124.635 3.556 . . . . 0.0 112.651 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 147.8 38.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.549 1.068 . . . . 0.0 110.906 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 mm -54.94 -44.97 75.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.527 1.131 . . . . 0.0 108.749 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -54.19 -39.3 66.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.638 0.654 . . . . 0.0 111.913 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.32 27.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.675 -0.641 . . . . 0.0 112.204 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.4 -40.58 93.6 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 126.51 1.924 . . . . 0.0 109.726 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.37 -51.29 68.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.913 0.778 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.0 -35.7 64.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.081 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 67' ' ' VAL . 13.9 t80 -66.07 -41.11 91.2 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.4 -43.12 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -47.11 85.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.717 0.807 . . . . 0.0 112.539 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -63.49 -19.31 64.64 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.348 -0.845 . . . . 0.0 111.386 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.3 mtt-85 . . . . . 0 CA--C 1.521 -0.149 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.536 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 . . . . . 0 C--O 1.225 -0.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.31 123.12 11.92 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.463 0.705 . . . . 0.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.08 117.05 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 162.36 25.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.471 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.25 137.32 78.12 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.528 2.152 . . . . 0.0 110.755 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 p -106.05 -23.53 12.61 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.258 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -107.32 146.72 31.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.9 57.99 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -69.4 -44.66 79.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.36 -36.39 80.07 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.504 0.721 . . . . 0.0 109.422 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -56.99 -52.43 65.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 109.512 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -56.53 -54.75 42.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.723 0.409 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.95 -47.85 81.7 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.769 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.99 -32.92 62.09 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.54 -38.91 67.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.3 -34.98 66.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 119.257 0.935 . . . . 0.0 109.98 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -62.62 -42.97 99.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 122.026 -0.421 . . . . 0.0 109.919 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -32.06 70.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.135 0.974 . . . . 0.0 111.559 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.39 -40.42 57.99 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.882 0.873 . . . . 0.0 109.982 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.34 -55.71 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 119.109 0.868 . . . . 0.0 109.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.72 -35.94 82.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.018 0.927 . . . . 0.0 111.095 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.1 15.24 70.09 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.216 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 169.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.4 t -136.05 146.33 46.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.24 0.927 . . . . 0.0 108.876 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.79 38.0 3.77 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.906 1.717 . . . . 0.0 111.324 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 41' ' ' ILE . 20.1 mm -72.22 128.16 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.345 1.073 . . . . 0.0 109.493 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.45 175.96 23.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.965 1.269 . . . . 0.0 111.005 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.411 HG13 HD13 ' A' ' 35' ' ' LEU . 18.2 pt -70.8 -23.8 24.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.921 1.689 . . . . 0.0 112.73 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -108.35 0.2 21.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.872 1.669 . . . . 0.0 113.792 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.77 115.62 14.56 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.4 122.97 22.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 122.829 0.452 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -45.98 -45.08 15.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.939 1.296 . . . . 0.0 113.352 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.43 -32.63 62.71 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -72.26 -31.09 65.47 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.004 0.922 . . . . 0.0 111.59 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 HD12 ' A' ' 32' ' ' ILE . 23.4 mt -70.65 -21.23 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.14 -4.55 6.37 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 118.664 -1.076 . . . . 0.0 111.548 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.18 162.91 48.85 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.017 1.408 . . . . 0.0 109.821 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -152.32 174.55 13.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.52 -50.91 12.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.242 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.04 -46.06 79.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.702 0.228 . . . . 0.0 110.941 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -67.82 -37.89 82.53 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.02 72.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.014 0.926 . . . . 0.0 110.167 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -58.66 -42.93 89.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.024 0.53 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.34 69.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.648 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -72.02 -51.55 30.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.56 -34.33 64.66 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.231 0.612 . . . . 0.0 111.66 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.22 86.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.775 0.83 . . . . 0.0 110.713 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -77.77 -39.82 42.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.855 0.862 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.0 -47.21 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -35.39 80.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.535 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -76.68 -33.44 58.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -89.18 -48.77 7.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.375 0.534 . . . . 0.0 111.768 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' HB2' HG12 ' A' ' 61' ' ' VAL . 39.8 m-85 -85.13 -3.0 58.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.981 0.512 . . . . 0.0 109.994 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 54.38 35.2 22.49 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.246 1.019 . . . . 0.0 110.395 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.3 p -141.75 131.61 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.3 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -70.46 140.93 52.06 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.723 0.773 . . . . 0.0 111.64 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 tp -127.15 93.09 42.38 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 127.507 2.323 . . . . 0.0 105.683 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -73.19 152.75 50.88 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.072 1.848 . . . . 0.0 109.094 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.1 -26.85 51.38 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.755 0.822 . . . . 0.0 110.95 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -54.26 -36.55 63.71 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.956 0.903 . . . . 0.0 112.908 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -85.87 -40.19 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -49.96 75.04 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.963 1.305 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -39.06 64.7 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.663 0.785 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.13 71.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 119.034 -1.066 . . . . 0.0 112.655 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -137.08 67.79 55.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.533 0.733 . . . . 0.0 111.628 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.18 50.37 1.52 Allowed 'Trans proline' 0 CA--C 1.54 0.821 1 C-N-CA 126.394 4.73 . . . . 0.0 114.92 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.91 147.05 44.02 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.6 mm -56.82 -46.23 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 126.984 2.113 . . . . 0.0 108.099 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -54.11 -41.63 68.54 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.898 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.35 -46.12 67.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.07 -36.84 75.23 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.449 1.1 . . . . 0.0 108.758 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.83 -51.54 61.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.43 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -66.32 -37.76 86.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.552 1.069 . . . . 0.0 110.496 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -63.97 -53.84 43.81 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.66 0.784 . . . . 0.0 109.324 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.96 -40.83 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.9 79.88 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.536 1.134 . . . . 0.0 113.296 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 t -73.49 -25.0 60.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.258 0.481 . . . . 0.0 110.093 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.343 0.286 0 CA-C-O 117.96 -1.019 . . . . 0.0 113.031 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 . . . . . 0 C--O 1.224 -0.27 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.57 122.44 14.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.78 0.718 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.61 115.99 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.02 159.23 77.71 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 124.633 1.173 . . . . 0.0 110.558 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.86 129.36 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.466 3.444 . . . . 0.0 110.89 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -101.51 -21.34 14.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.671 1.188 . . . . 0.0 109.887 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 20.6 t-20 -109.52 148.69 30.79 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -23.83 67.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.108 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.48 -44.38 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.277 1.853 . . . . 0.0 107.542 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 16.8 mt-10 -57.84 -40.89 81.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -58.07 -51.2 70.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.555 1.142 . . . . 0.0 109.724 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.28 -52.7 64.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.196 0.598 . . . . 0.0 111.558 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.79 -42.87 99.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.868 0.758 . . . . 0.0 111.352 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.04 -33.42 72.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.78 -47.39 78.29 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.67 -34.85 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.468 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -59.81 -40.91 90.01 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 119.7 1.137 . . . . 0.0 109.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.94 -39.77 94.0 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.04 -32.04 72.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.351 -0.843 . . . . 0.0 112.066 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.57 -53.41 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.695 0.68 . . . . 0.0 109.855 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.3 mt -75.62 -25.57 57.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.18 66.99 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.496 1.522 . . . . 0.0 112.229 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.439 ' CG2' HD11 ' A' ' 32' ' ' ILE . 21.3 m -94.91 175.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 111.8 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 t -144.83 119.35 9.7 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.889 0.876 . . . . 0.0 109.329 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.5 0.84 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 124.668 1.128 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 29' ' ' VAL . 27.1 mm -90.72 125.06 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 126.347 1.859 . . . . 0.0 107.874 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.03 164.98 25.15 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.6 pt -67.94 -28.09 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.771 -0.841 . . . . 0.0 111.49 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.603 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.68 -3.48 32.94 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.218 2.207 . . . . 0.0 116.147 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -82.46 121.56 26.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.207 1.367 . . . . 0.0 108.823 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.33 127.64 33.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.576 0.35 . . . . 0.0 110.713 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 89.3 t80 -48.21 -44.22 32.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.479 1.912 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -69.36 -38.11 77.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.69 -28.16 65.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.028 -0.51 . . . . 0.0 110.781 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 38' ' ' PHE . 27.8 mt -71.03 -17.76 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.661 0.784 . . . . 0.0 109.206 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.46 2.69 8.15 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.935 1.255 . . . . 0.0 112.79 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 164.62 53.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -146.77 174.92 11.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.6 6.34 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.214 1.405 . . . . 0.0 112.779 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -43.76 94.84 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -66.17 -38.89 89.17 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.715 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.64 74.68 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.5 0.72 . . . . 0.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -64.03 -40.49 96.44 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 122.86 0.464 . . . . 0.0 110.276 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.61 92.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.182 0.446 . . . . 0.0 110.234 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.42 -52.96 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.56 -31.13 63.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.6 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.1 69.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.912 0.778 . . . . 0.0 111.374 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.66 -42.7 61.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.264 0.625 . . . . 0.0 109.343 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.85 -33.91 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 120.672 -1.268 . . . . 0.0 108.195 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.65 -42.42 91.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.392 0.996 . . . . 0.0 109.18 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -75.27 -31.75 60.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -74.48 -48.92 24.44 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 61' ' ' VAL . 68.5 m-85 -94.13 0.14 55.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.15 37.85 27.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.46 1.504 . . . . 0.0 109.851 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 59' ' ' TYR . 12.7 p -141.41 124.9 15.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -67.37 130.74 44.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.565 -0.71 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 tt -118.03 87.99 30.22 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 159.2 54.15 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.475 2.116 . . . . 0.0 112.168 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -40.93 51.07 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.724 2.01 . . . . 0.0 109.785 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -53.46 -32.18 48.9 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.393 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -87.28 -47.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 119.982 1.264 . . . . 0.0 109.328 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -47.31 76.5 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.554 0.742 . . . . 0.0 111.749 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -31.74 43.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.974 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -39.38 71.1 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.67 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -137.47 78.31 38.48 Favored Pre-proline 0 N--CA 1.453 -0.312 0 O-C-N 124.271 0.982 . . . . 0.0 109.39 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 52.69 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.707 2.938 . . . . 0.0 111.756 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.85 147.78 48.39 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 120.224 1.375 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 74' ' ' ILE . 8.4 mm -58.12 -40.68 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -53.8 -46.21 71.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.229 0.468 . . . . 0.0 110.682 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.42 -51.42 44.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.09 -38.12 89.92 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 125.005 1.322 . . . . 0.0 109.86 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.49 94.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.978 0.808 . . . . 0.0 109.385 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -74.54 -44.87 49.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 111.395 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HG21 ' A' ' 67' ' ' VAL . 27.7 t80 -62.22 -44.07 97.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.25 -43.2 50.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.508 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.05 98.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 t -67.73 -29.9 69.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.777 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 . . . . . 0 CA--C 1.515 -0.369 0 CA-C-N 119.074 0.852 . . . . 0.0 109.407 -179.734 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 . . . . . 0 N--CA 1.449 -0.524 0 CA-C-O 120.86 0.362 . . . . 0.0 110.709 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -46.08 132.61 9.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.396 2.678 . . . . 0.0 113.174 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.5 t -140.05 117.62 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.25 158.23 38.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.116 0.885 . . . . 0.0 110.02 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.51 149.74 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.49 2.793 . . . . 0.0 112.023 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -123.61 -21.58 5.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.589 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -102.87 141.11 36.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.96 -18.66 0.82 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.713 1.205 . . . . 0.0 113.881 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.78 -54.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.636 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.77 -42.77 58.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.893 2.077 . . . . 0.0 110.103 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 t -60.86 -44.88 96.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.837 0.711 . . . . 0.0 110.78 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -61.25 -45.37 94.8 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.636 -1.29 . . . . 0.0 110.756 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.89 -38.45 88.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.121 0.873 . . . . 0.0 111.452 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.48 75.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.1 -37.53 75.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.4 -40.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -60.45 -41.11 93.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.72 -38.88 72.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.547 0.612 . . . . 0.0 109.858 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -68.45 -32.85 73.17 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -86.31 -46.25 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 123.022 1.391 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.14 -33.2 71.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.357 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.13 38.82 54.44 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.64 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.015 1.726 . . . . 0.0 107.108 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 p -136.72 138.85 41.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 110.71 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.15 66.64 1.51 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.21 1.386 . . . . 0.0 112.186 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.7 mm -83.89 129.5 37.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.52 167.58 28.75 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.029 0.831 . . . . 0.0 111.326 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.62 -24.55 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.987 0.915 . . . . 0.0 112.553 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -0.26 21.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.454 1.501 . . . . 0.0 114.911 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.03 122.8 26.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 118.868 0.758 . . . . 0.0 109.557 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -67.23 123.73 21.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.331 1.052 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -46.36 -45.95 18.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.429 1.892 . . . . 0.0 112.876 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -70.72 -24.07 62.57 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.752 -1.218 . . . . 0.0 112.224 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -74.28 -37.14 63.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.46 29.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 125.965 1.706 . . . . 0.0 109.981 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.32 5.37 34.94 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.159 -2.213 . . . . 0.0 113.936 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.64 142.19 43.47 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 108.135 -1.986 . . . . 0.0 108.135 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -132.81 173.18 11.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.847 0.823 . . . . 0.0 108.886 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.62 -47.48 28.94 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.347 0.659 . . . . 0.0 111.628 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -48.26 73.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.91 0.323 . . . . 0.0 110.587 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.97 -39.59 90.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.86 80.53 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.163 0.985 . . . . 0.0 110.427 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.78 -37.9 87.57 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.56 75.23 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.222 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 26' ' ' VAL . 70.9 t -63.08 -53.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.65 69.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.064 0.946 . . . . 0.0 112.231 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.19 -47.48 67.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.651 0.739 . . . . 0.0 109.904 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 7.6 mm100 -67.16 -39.98 86.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 109.987 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 t -64.59 -47.46 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 121.35 -0.844 . . . . 0.0 108.775 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.22 -37.65 86.16 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.529 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 10.6 ptm180 -75.85 -32.26 59.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.48 -48.14 8.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . 80.1 m-85 -92.36 0.33 57.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.352 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 49.93 43.09 25.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.596 1.089 . . . . 0.0 109.199 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 81' ' ' VAL . 8.2 p -136.1 128.43 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 123.365 0.666 . . . . 0.0 110.657 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -69.45 120.72 15.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -114.76 78.71 5.33 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.42 158.15 42.26 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.23 1.287 . . . . 0.0 111.503 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.72 -26.86 67.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.344 1.058 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -52.97 -41.59 64.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.262 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.29 -37.23 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-N 119.719 1.145 . . . . 0.0 109.021 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.3 -50.08 60.05 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.445 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -30.7 56.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.16 -31.43 49.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.119 0.872 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -134.68 72.76 68.75 Favored Pre-proline 0 N--CA 1.449 -0.52 0 C-N-CA 125.468 1.507 . . . . 0.0 107.898 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.18 53.28 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 113.093 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.62 147.38 46.88 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 120.311 1.414 . . . . 0.0 110.455 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.12 -44.08 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.86 -46.68 74.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.576 0.35 . . . . 0.0 111.404 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.17 85.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.301 1.04 . . . . 0.0 113.233 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -42.97 84.91 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 125.345 1.458 . . . . 0.0 107.246 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.46 97.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.749 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -76.24 -36.72 58.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.201 1.364 . . . . 0.0 111.159 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -60.99 -51.46 69.17 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 61' ' ' VAL . 77.4 t -68.63 -47.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.692 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.13 -51.79 60.79 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.801 1.182 . . . . 0.0 113.304 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -64.41 -22.41 66.95 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 . . . . . 0 N--CA 1.466 0.33 0 CA-C-N 119.125 0.875 . . . . 0.0 112.98 -179.619 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -47.33 131.03 13.48 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.105 0.962 . . . . 0.0 113.274 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.62 116.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 102.468 -3.16 . . . . 0.0 102.468 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.01 161.19 65.08 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.615 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.58 72.96 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.682 1.588 . . . . 0.0 110.056 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 p -132.24 -13.95 3.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.477 0.311 . . . . 0.0 111.283 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 141.95 28.53 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -28.14 8.04 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -44.78 19.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 119.086 0.857 . . . . 0.0 109.154 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -51.94 -42.51 62.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.269 1.027 . . . . 0.0 109.983 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -54.26 -50.54 66.98 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.331 1.019 . . . . 0.0 110.431 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.29 -50.12 75.22 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 111.7 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.25 -41.66 85.26 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 119.99 -1.694 . . . . 0.0 112.724 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.61 71.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 124.531 1.144 . . . . 0.0 111.024 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.7 -47.87 43.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.108 0.867 . . . . 0.0 111.23 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.01 -37.89 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.055 0.542 . . . . 0.0 109.743 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.68 -39.69 85.36 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.212 -0.93 . . . . 0.0 111.012 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -57.27 -43.18 82.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.276 0.63 . . . . 0.0 110.646 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -64.11 -31.73 73.04 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.726 0.81 . . . . 0.0 112.591 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.66 -44.44 15.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.899 0.772 . . . . 0.0 111.715 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.27 -24.09 40.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.114 0.966 . . . . 0.0 112.728 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.79 23.93 68.42 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.901 1.239 . . . . 0.0 111.936 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.0 175.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.467 1.633 . . . . 0.0 106.599 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 t -141.76 143.48 33.51 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.001 1.273 . . . . 0.0 107.859 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 69.15 1.41 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 41' ' ' ILE . 49.7 mm -91.27 121.79 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.3 169.13 45.29 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 118.45 0.568 . . . . 0.0 112.67 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 pt -68.54 -24.08 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 120.948 -1.325 . . . . 0.0 111.466 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.512 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.89 -3.37 24.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.12 2.568 . . . . 0.0 113.117 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.71 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -69.44 124.23 23.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -77.32 117.33 18.72 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.963 1.305 . . . . 0.0 108.777 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.09 -48.05 11.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.893 1.677 . . . . 0.0 113.223 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -71.08 -33.64 70.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.876 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -67.95 -29.54 68.62 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 36' ' ' ASP . 30.9 mt -72.01 -3.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.985 0.914 . . . . 0.0 109.389 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.84 -0.56 33.96 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.033 1.778 . . . . 0.0 111.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.57 160.81 46.71 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 118.618 1.209 . . . . 0.0 110.64 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -151.18 179.2 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.184 1.394 . . . . 0.0 108.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.26 -50.71 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.133 1.373 . . . . 0.0 113.251 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -46.51 86.93 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.449 0.568 . . . . 0.0 110.324 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.7 mmtp -63.48 -39.2 93.83 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 121.205 -0.934 . . . . 0.0 110.798 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -42.39 69.61 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.662 0.665 . . . . 0.0 109.268 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 mmt -65.98 -41.52 91.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.164 0.586 . . . . 0.0 109.768 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.28 83.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 118.377 -0.82 . . . . 0.0 112.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.4 t -72.2 -52.3 25.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.83 -31.59 39.84 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.59 72.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.593 0.633 . . . . 0.0 111.447 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.09 -37.35 61.58 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.574 0.702 . . . . 0.0 110.921 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -64.63 -47.37 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 121.082 -1.011 . . . . 0.0 108.961 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -40.7 90.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.344 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -75.27 -29.1 60.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.65 -48.09 8.16 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.607 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.29 -3.7 58.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 51.49 39.17 24.01 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.268 1.827 . . . . 0.0 110.886 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.596 HG11 HG13 ' A' ' 81' ' ' VAL . 11.7 p -141.25 132.31 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.748 0.785 . . . . 0.0 112.085 -177.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -71.53 115.66 10.96 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.15 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -110.19 83.72 3.26 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.3 157.79 58.29 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.669 2.246 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -33.49 54.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.436 1.494 . . . . 0.0 110.522 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -30.85 47.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.146 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.92 -46.85 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -49.72 60.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.277 1.431 . . . . 0.0 110.926 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -31.01 38.75 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.641 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.94 -37.11 83.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.076 0.853 . . . . 0.0 110.502 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -141.76 79.31 16.91 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.263 1.025 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 52.56 3.58 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.951 3.101 . . . . 0.0 113.189 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 147.21 49.21 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.887 -1.133 . . . . 0.0 109.535 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.47 -48.21 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -52.32 -47.82 65.79 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.623 0.577 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.47 98.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.27 -41.48 63.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.62 73.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.255 1.022 . . . . 0.0 109.315 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.42 -38.63 77.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.787 1.176 . . . . 0.0 111.552 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -67.16 -46.13 74.95 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.094 0.558 . . . . 0.0 110.627 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 HG11 ' A' ' 61' ' ' VAL . 78.0 t -73.78 -42.79 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.155 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.99 84.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.86 0.754 . . . . 0.0 112.804 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -61.98 -32.71 73.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.349 0.522 . . . . 0.0 109.64 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 . . . . . 0 C--N 1.343 0.293 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.699 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.87 123.91 4.86 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.131 1.372 . . . . 0.0 114.138 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -146.33 117.6 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -68.81 172.41 4.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.329 1.051 . . . . 0.0 112.008 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.762 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 52.9 Cg_endo -68.14 146.46 70.35 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.02 2.48 . . . . 0.0 111.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -118.82 -13.51 9.53 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.607 0.763 . . . . 0.0 111.733 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -120.31 147.11 45.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.29 -26.14 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.663 -1.636 . . . . 0.0 113.502 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.73 -55.1 17.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 120.496 1.498 . . . . 0.0 107.792 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.54 -44.08 65.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.618 1.967 . . . . 0.0 109.728 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -40.32 85.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.305 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.37 -50.74 71.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 119.325 0.966 . . . . 0.0 110.237 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 19' ' ' LEU . 5.6 mp -63.45 -41.94 98.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.413 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.21 -36.16 68.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.977 0.911 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.29 -49.94 15.67 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 118.973 0.806 . . . . 0.0 110.409 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.0 mt -51.39 -40.94 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 38' ' ' PHE . 8.2 m0 -64.95 -45.83 84.11 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.319 1.448 . . . . 0.0 110.223 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -59.33 -37.12 77.0 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.369 0.668 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -70.57 -29.08 65.42 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.49 -55.73 7.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.764 0.826 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.9 mt -74.51 -20.51 59.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.631 1.172 . . . . 0.0 113.523 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 32.93 68.49 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.034 0.834 . . . . 0.0 111.847 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.14 175.21 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.4 1.88 . . . . 0.0 109.634 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -139.25 127.77 23.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.028 0.931 . . . . 0.0 112.945 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 69.27 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mm -87.02 123.39 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 107.383 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.5 174.32 44.82 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 pt -80.76 -26.83 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 118.725 1.263 . . . . 0.0 110.628 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.776 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -96.71 4.84 51.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.013 2.525 . . . . 0.0 113.877 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -62.99 123.35 18.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.651 1.581 . . . . 0.0 113.107 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.73 105.3 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.226 -1.546 . . . . 0.0 107.09 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' A' ' 41' ' ' ILE . 92.5 t80 -41.74 -47.55 4.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 113.237 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -69.62 -33.19 72.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.277 0.944 . . . . 0.0 108.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 38' ' ' PHE . 31.2 mt -71.29 -15.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.016 0.926 . . . . 0.0 109.587 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.16 -6.86 23.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.078 1.799 . . . . 0.0 112.541 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.76 157.77 33.91 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.675 1.237 . . . . 0.0 110.276 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -143.33 171.45 14.1 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.04 -48.68 11.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.321 1.048 . . . . 0.0 112.475 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -46.04 82.91 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.762 -0.586 . . . . 0.0 110.657 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -66.05 -42.17 89.85 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 121.444 -0.785 . . . . 0.0 110.036 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.35 -43.71 67.94 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.303 1.041 . . . . 0.0 110.187 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.5 mtm -63.72 -30.41 71.51 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.657 0.383 . . . . 0.0 111.811 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.52 -35.39 68.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.62 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.29 -48.28 86.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.82 64.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.139 0.976 . . . . 0.0 111.337 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.84 87.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.144 0.884 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -73.25 -36.15 66.36 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.63 0.729 . . . . 0.0 110.385 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.04 -45.18 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 1.2 t-80 -61.02 -36.73 80.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.477 -0.765 . . . . 0.0 111.489 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -76.79 -32.07 57.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -89.63 -44.86 9.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.04 0.924 . . . . 0.0 112.17 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -90.25 -0.62 57.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.883 1.273 . . . . 0.0 109.897 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 49.2 42.04 20.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.206 1.402 . . . . 0.0 111.002 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 81' ' ' VAL . 14.5 p -152.39 139.86 13.51 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 O-C-N 120.847 -1.158 . . . . 0.0 111.883 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 30.6 tt0 -66.8 143.77 56.7 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.193 -0.317 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.33 82.42 57.91 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.79 149.24 72.71 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.819 1.68 . . . . 0.0 111.147 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.8 -27.43 41.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 125.088 1.355 . . . . 0.0 111.294 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -53.19 -36.49 61.01 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.682 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.57 -47.27 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -48.9 47.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.007 1.723 . . . . 0.0 111.531 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -29.72 37.99 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.082 0.953 . . . . 0.0 112.848 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.69 -31.89 59.9 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.256 0.347 . . . . 0.0 111.336 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -134.58 74.52 65.37 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.88 56.32 3.55 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.346 3.364 . . . . 0.0 112.687 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.98 147.43 36.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.846 1.203 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -54.81 -49.26 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 108.876 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -52.38 -50.51 62.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.21 96.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.59 -44.58 56.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.048 1.339 . . . . 0.0 107.559 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.42 66.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.258 1.023 . . . . 0.0 109.678 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.33 -40.25 74.27 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.322 0.389 . . . . 0.0 111.099 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.55 -48.13 82.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.636 0.774 . . . . 0.0 110.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.428 HG13 HG11 ' A' ' 61' ' ' VAL . 71.3 t -72.24 -38.46 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.733 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.71 74.04 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.258 0.935 . . . . 0.0 111.426 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -63.51 -32.35 73.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.626 0.194 . . . . 0.0 111.379 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 . . . . . 0 N--CA 1.466 0.366 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 179.654 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo . . . . . 0 CA--C 1.531 0.371 0 N-CA-C 109.819 -0.877 . . . . 0.0 109.819 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 6.3 p -158.29 -11.78 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 113.259 0.836 . . . . 0.0 113.259 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.3 m -90.71 73.61 6.68 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 -179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -119.57 1.85 11.16 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -178.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.02 156.51 30.07 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 118.277 0.49 . . . . 0.0 111.252 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -74.06 172.18 12.16 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.157 0.983 . . . . 0.0 108.424 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.5 t80 -59.02 133.66 56.3 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 118.556 0.617 . . . . 0.0 109.819 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 76.0 t -139.54 117.25 11.12 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 104.551 -2.388 . . . . 0.0 104.551 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.15 152.48 87.92 Favored Pre-proline 0 C--O 1.24 0.593 0 O-C-N 124.048 0.843 . . . . 0.0 109.106 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -63.94 144.37 87.84 Favored 'Trans proline' 0 N--CA 1.458 -0.589 0 C-N-CA 123.205 2.603 . . . . 0.0 110.042 179.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 23.0 p -124.69 -11.57 7.23 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 20.2 m-80 -108.89 133.36 53.02 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 101.318 -3.586 . . . . 0.0 101.318 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -43.33 -39.11 2.96 Favored 'General case' 0 C--O 1.225 -0.214 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -177.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -60.56 -50.45 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 119.356 0.98 . . . . 0.0 109.223 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -58.41 -41.28 84.61 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 126.824 2.049 . . . . 0.0 108.633 -179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -64.28 -35.13 79.83 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.37 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -77.05 -35.43 56.79 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.949 -1.095 . . . . 0.0 111.688 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mt -71.22 -37.68 72.03 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 118.505 -0.759 . . . . 0.0 109.602 179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.43 -36.54 80.63 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -66.67 -47.21 73.17 Favored 'General case' 0 C--O 1.225 -0.202 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 79.6 mt -57.27 -38.45 61.94 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 123.569 0.747 . . . . 0.0 109.955 -179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 13.3 m0 -64.75 -42.8 94.87 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-O 118.591 -0.718 . . . . 0.0 109.794 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -57.73 -41.95 82.88 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 mtp180 -69.38 -22.04 63.75 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 121.02 -1.05 . . . . 0.0 113.723 -179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.7 t -94.92 -41.88 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 118.864 0.756 . . . . 0.0 110.632 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.2 mt -83.77 -22.84 31.74 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 124.736 1.214 . . . . 0.0 112.733 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.2 35.02 69.98 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-O 119.24 -0.755 . . . . 0.0 111.922 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.2 m -135.93 173.9 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.0 p -130.41 148.67 52.25 Favored 'General case' 0 N--CA 1.444 -0.74 0 C-N-CA 124.487 1.115 . . . . 0.0 108.995 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.02 53.16 1.41 Allowed Glycine 0 CA--C 1.521 0.443 0 C-N-CA 124.082 0.849 . . . . 0.0 113.521 178.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.0 mm -91.12 121.4 41.48 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.96 26.74 Favored Glycine 0 CA--C 1.521 0.428 0 CA-C-O 122.623 1.124 . . . . 0.0 112.339 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 27.7 pt -70.04 -24.16 26.05 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 O-C-N 121.687 -0.89 . . . . 0.0 111.93 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.6 -0.14 22.18 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 127.582 2.353 . . . . 0.0 113.371 -179.227 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.767 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -67.94 116.17 8.29 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.033 -1.469 . . . . 0.0 107.033 -179.389 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -77.62 110.84 12.78 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.681 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.3 t80 -40.02 -46.26 2.07 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.95 2.1 . . . . 0.0 113.908 -178.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -68.09 -32.94 73.62 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.716 -0.615 . . . . 0.0 112.152 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.2 tm0? -70.48 -32.09 69.48 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 119.194 0.906 . . . . 0.0 109.394 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.767 HD11 ' HB3' ' A' ' 36' ' ' ASP . 23.2 mt -70.43 -20.13 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 125.13 -9.67 7.88 Favored Glycine 0 CA--C 1.524 0.619 0 C-N-CA 124.545 1.069 . . . . 0.0 112.212 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -64.56 160.77 40.15 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.44 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 20.5 p80 -148.2 177.74 9.15 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.6 1.16 . . . . 0.0 108.212 -179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.32 -52.38 12.85 Favored 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 124.126 0.97 . . . . 0.0 112.995 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -54.82 -47.72 73.72 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 119.914 1.233 . . . . 0.0 110.504 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.44 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 63.3 mmtt -62.56 -43.15 99.52 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-O 118.665 -0.683 . . . . 0.0 110.196 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -57.16 -41.79 79.85 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.243 1.417 . . . . 0.0 110.996 -178.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 74.7 mtm -68.81 -37.28 79.11 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.28 -30.71 71.19 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 118.891 -0.576 . . . . 0.0 109.703 178.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 30.1 t -64.36 -52.69 52.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.02 -26.92 61.11 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.61 1.164 . . . . 0.0 112.128 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.94 -49.06 69.28 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.518 1.054 . . . . 0.0 112.085 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -78.02 -32.8 51.24 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-O 122.183 0.992 . . . . 0.0 111.348 -178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 59' ' ' TYR . 59.3 t -71.89 -40.08 68.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-O 118.416 -0.802 . . . . 0.0 109.065 179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.56 -37.97 82.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 119.813 1.188 . . . . 0.0 109.219 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -76.0 -31.77 59.11 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.844 -0.742 . . . . 0.0 112.792 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -80.26 -47.96 13.78 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.572 0.749 . . . . 0.0 111.869 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.458 ' CD2' HG11 ' A' ' 81' ' ' VAL . 16.8 m-85 -94.48 0.49 55.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 118.772 -0.632 . . . . 0.0 111.741 -178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 55.66 37.44 28.87 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.737 1.215 . . . . 0.0 109.56 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG11 HG13 ' A' ' 81' ' ' VAL . 9.4 p -140.56 136.72 36.0 Favored 'Isoleucine or valine' 0 C--N 1.347 0.489 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 -177.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -72.38 132.92 44.59 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 124.839 1.255 . . . . 0.0 110.029 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.2 tp -130.07 86.11 55.39 Favored Pre-proline 0 C--O 1.239 0.521 0 C-N-CA 123.97 0.908 . . . . 0.0 109.691 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -66.76 153.68 77.12 Favored 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 121.673 1.582 . . . . 0.0 110.453 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 21.3 tp -56.5 -30.12 62.62 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 123.543 0.737 . . . . 0.0 110.463 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -53.03 -30.69 37.08 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.117 0.967 . . . . 0.0 111.94 179.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.3 t -89.08 -46.3 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.535 0 C-N-CA 124.431 1.092 . . . . 0.0 108.842 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.444 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.1 OUTLIER -57.24 -46.55 82.89 Favored 'General case' 0 C--O 1.221 -0.44 0 C-N-CA 123.607 0.763 . . . . 0.0 111.598 -178.068 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -76.22 -36.57 58.51 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 121.289 -0.882 . . . . 0.0 111.42 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -34.34 68.53 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 119.424 -0.91 . . . . 0.0 111.596 -178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -135.55 73.1 62.93 Favored Pre-proline 0 N--CA 1.449 -0.48 0 C-N-CA 124.361 1.064 . . . . 0.0 109.151 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -76.16 54.25 4.12 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 124.378 3.385 . . . . 0.0 110.804 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -139.72 147.62 41.16 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-N 119.178 0.899 . . . . 0.0 110.572 -178.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 11.8 mm -57.77 -44.46 86.04 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 C-N-CA 124.98 1.312 . . . . 0.0 108.617 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -55.83 -47.75 76.66 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 117.854 0.297 . . . . 0.0 110.986 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.85 -52.57 64.89 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 112.891 0.7 . . . . 0.0 112.891 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -62.05 -41.28 97.97 Favored 'General case' 0 C--O 1.215 -0.756 0 C-N-CA 124.688 1.195 . . . . 0.0 108.235 -179.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.19 -44.7 92.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 119.027 0.83 . . . . 0.0 110.992 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -74.61 -40.88 61.29 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 122.958 0.503 . . . . 0.0 111.182 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 18.5 t80 -63.23 -42.72 99.27 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.462 HG13 HG11 ' A' ' 61' ' ' VAL . 55.8 t -71.43 -46.34 64.55 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.193 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.745 -179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.55 -49.7 67.11 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.2 t -64.43 -24.79 67.75 Favored 'General case' 0 N--CA 1.451 -0.399 0 O-C-N 123.278 0.361 . . . . 0.0 111.376 -177.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 23.7 mtt85 -87.66 -35.96 17.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 118.986 -0.531 . . . . 0.0 110.228 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 13.7 p -69.12 -19.6 64.04 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 51.5 m170 -60.08 162.1 6.13 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.265 1.031 . . . . 0.0 111.068 179.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.0 t-160 -73.55 95.01 2.21 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.057 1.343 . . . . 0.0 112.558 -178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -76.91 171.52 14.64 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 177.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 17.3 t-160 -137.92 67.58 1.42 Allowed 'General case' 0 C--O 1.236 0.368 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 32.6 m-70 -57.18 -34.3 68.33 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 124.51 1.124 . . . . 0.0 110.416 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 10.1 t60 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 127.576 2.35 . . . . 0.0 110.203 178.568 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo . . . . . 0 N--CA 1.472 0.212 0 N-CA-C 109.815 -0.879 . . . . 0.0 109.815 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.4 t -138.63 150.65 23.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 p -81.5 176.31 9.79 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.422 1.889 . . . . 0.0 109.007 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 62.84 14.64 7.56 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.536 1.135 . . . . 0.0 110.774 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 153.69 36.61 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.143 1.377 . . . . 0.0 110.141 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -106.25 174.52 5.85 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 42.4 t80 -47.35 129.88 13.12 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 124.326 1.051 . . . . 0.0 113.107 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 96.9 t -143.43 117.46 3.73 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.27 156.89 73.91 Favored Pre-proline 0 CA--C 1.54 0.57 0 O-C-N 124.039 0.837 . . . . 0.0 109.484 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -64.99 164.49 24.68 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.336 2.024 . . . . 0.0 112.766 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.4 p -134.18 -12.13 2.49 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.929 1.292 . . . . 0.0 112.259 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -108.34 144.68 35.55 Favored 'General case' 0 CA--C 1.512 -0.519 0 N-CA-C 105.703 -1.962 . . . . 0.0 105.703 178.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.02 -38.51 37.83 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.319 1.048 . . . . 0.0 112.179 -179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.1 t -68.29 -55.41 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 C-N-CA 124.514 1.126 . . . . 0.0 110.457 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -52.69 -36.79 57.84 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.157 0.983 . . . . 0.0 109.601 -179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.4 t -61.06 -46.97 88.51 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.743 0.817 . . . . 0.0 111.163 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -60.08 -49.44 77.66 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 118.536 0.607 . . . . 0.0 111.176 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.73 -42.1 97.95 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 118.046 -0.978 . . . . 0.0 111.915 -179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.67 -35.01 69.99 Favored 'General case' 0 CA--C 1.527 0.087 0 CA-C-N 118.527 0.603 . . . . 0.0 110.08 179.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.1 mm-40 -71.27 -46.78 60.15 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.524 -0.546 . . . . 0.0 109.524 179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 77.3 mt -59.32 -35.09 56.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 O-C-N 121.525 -0.735 . . . . 0.0 109.701 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.7 m0 -62.28 -42.27 99.2 Favored 'General case' 0 N--CA 1.455 -0.224 0 O-C-N 121.273 -0.892 . . . . 0.0 109.25 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.78 -33.82 76.76 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.659 0.784 . . . . 0.0 109.191 178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -70.34 -26.38 63.72 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 121.088 -1.008 . . . . 0.0 112.271 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.5 t -92.03 -55.41 6.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 118.276 0.489 . . . . 0.0 109.974 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.0 mt -74.82 -17.22 60.65 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.034 0.934 . . . . 0.0 113.24 -177.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 67.57 21.66 72.83 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.244 0.926 . . . . 0.0 111.651 -179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.414 HG21 HD11 ' A' ' 32' ' ' ILE . 32.3 m -94.87 174.31 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 124.527 1.131 . . . . 0.0 109.998 -179.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 18.2 t -143.85 109.09 5.04 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 106.506 -1.664 . . . . 0.0 106.506 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 130.85 39.98 0.25 Allowed Glycine 0 CA--C 1.526 0.752 0 C-N-CA 124.744 1.164 . . . . 0.0 113.052 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.414 HD11 HG21 ' A' ' 29' ' ' VAL . 36.6 mm -77.78 124.84 36.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 CA-C-N 119.099 1.449 . . . . 0.0 110.396 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -105.39 169.93 16.89 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.442 1.496 . . . . 0.0 110.788 178.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.7 pt -69.81 -26.57 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.109 -1.23 . . . . 0.0 112.971 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.464 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.93 1.75 43.01 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 125.771 1.628 . . . . 0.0 112.97 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -69.49 127.29 32.48 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.285 0.564 . . . . 0.0 109.872 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -78.95 114.46 17.92 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.942 1.297 . . . . 0.0 110.871 -178.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -44.01 -49.65 8.6 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 124.641 1.176 . . . . 0.0 113.627 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -76.44 -27.69 56.32 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-O 118.725 -0.655 . . . . 0.0 112.06 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -70.23 -30.17 67.18 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 120.092 1.315 . . . . 0.0 109.784 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.6 mt -70.93 -13.68 17.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.686 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.61 -0.94 30.64 Favored Glycine 0 CA--C 1.525 0.685 0 C-N-CA 124.729 1.157 . . . . 0.0 112.627 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.09 133.36 33.93 Favored Glycine 0 C--N 1.338 0.639 0 N-CA-C 107.035 -2.426 . . . . 0.0 107.035 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -109.71 175.11 5.57 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 179.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.94 -49.5 15.73 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 124.288 1.035 . . . . 0.0 112.019 -179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.31 -47.23 82.05 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.46 0.304 . . . . 0.0 110.575 179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.7 mmtp -64.75 -35.26 80.5 Favored 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 118.112 -0.947 . . . . 0.0 110.675 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.15 -41.9 84.77 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.278 0.945 . . . . 0.0 109.261 -179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 57.3 mtm -69.57 -37.22 76.88 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.786 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.74 81.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 118.795 -0.621 . . . . 0.0 110.685 179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.3 t -68.07 -49.73 65.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 CA-C-N 119.993 1.27 . . . . 0.0 107.69 179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -30.07 64.26 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.98 0.912 . . . . 0.0 111.15 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -65.75 -44.63 85.34 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.682 0.793 . . . . 0.0 110.537 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -77.48 -38.98 48.04 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 118.461 0.573 . . . . 0.0 110.458 -179.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.6 t -62.31 -47.32 93.61 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.82 0 C-N-CA 124.438 1.095 . . . . 0.0 109.274 -179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.88 -40.56 89.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 C-N-CA 119.781 -0.767 . . . . 0.0 110.507 -178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -75.92 -31.79 59.3 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 114.955 1.465 . . . . 0.0 114.955 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -80.93 -48.42 12.34 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 123.772 0.829 . . . . 0.0 110.751 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -91.12 -3.09 57.39 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.936 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 73.6 mt-30 52.41 43.74 30.61 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 125.306 1.442 . . . . 0.0 110.316 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.33 129.61 5.59 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -67.1 134.45 51.86 Favored 'General case' 0 C--O 1.24 0.6 0 N-CA-C 114.204 1.186 . . . . 0.0 114.204 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tt -125.74 84.25 61.0 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 178.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -67.56 153.33 76.68 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 121.693 1.595 . . . . 0.0 109.729 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.66 -27.74 63.13 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 118.411 -0.804 . . . . 0.0 110.652 -179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 8.8 ptpt -59.62 -26.87 65.83 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.917 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 93.3 t -88.34 -48.2 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.018 -1.475 . . . . 0.0 107.018 178.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.92 -50.09 61.79 Favored 'General case' 0 C--O 1.225 -0.198 0 C-N-CA 125.444 1.497 . . . . 0.0 111.25 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.99 -30.24 39.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 118.988 -0.529 . . . . 0.0 111.967 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.16 -27.13 59.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 120.049 -0.661 . . . . 0.0 110.586 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -141.42 68.5 26.13 Favored Pre-proline 0 CA--C 1.544 0.741 0 C-N-CA 125.334 1.454 . . . . 0.0 110.626 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.36 57.36 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 124.38 3.387 . . . . 0.0 114.012 -178.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.64 147.25 37.26 Favored 'General case' 0 CA--C 1.515 -0.386 0 O-C-N 121.057 -1.027 . . . . 0.0 108.943 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.0 mm -54.65 -47.99 72.2 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 124.73 1.212 . . . . 0.0 107.879 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 65.9 tttt -52.24 -42.76 63.89 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.276 0.472 . . . . 0.0 112.276 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.54 -41.82 72.01 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.4 mt -73.33 -40.17 64.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.78 -51.69 68.54 Favored 'General case' 0 N--CA 1.445 -0.725 0 CA-C-O 118.094 -0.955 . . . . 0.0 108.562 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 -69.21 -38.34 78.53 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.0 t80 -64.19 -51.9 61.49 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.823 0.849 . . . . 0.0 109.009 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 88.1 t -65.7 -39.67 85.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.23 -49.24 77.79 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 124.364 1.066 . . . . 0.0 113.353 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.1 t -64.82 -28.93 69.9 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 123.831 0.707 . . . . 0.0 110.281 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 12.5 mtt-85 -80.46 -31.74 37.31 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-N 118.583 0.629 . . . . 0.0 109.861 178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 29.3 t -72.8 14.44 0.27 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.452 2.701 . . . . 0.0 111.067 178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -118.09 82.92 1.92 Allowed 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 104.22 -2.511 . . . . 0.0 104.22 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.6 t60 -57.75 92.79 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.583 1.153 . . . . 0.0 112.633 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -112.53 143.24 44.02 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 125.654 1.582 . . . . 0.0 109.168 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 13.1 t-80 -90.35 -7.63 52.77 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.204 1.002 . . . . 0.0 112.456 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -71.77 89.44 1.04 Allowed 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.716 1.207 . . . . 0.0 109.839 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 24.5 m80 . . . . . 0 C--O 1.247 0.972 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.347 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo . . . . . 0 N--CA 1.476 0.465 0 N-CA-C 110.887 -0.467 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.8 m -76.18 -169.04 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 126.493 1.917 . . . . 0.0 110.518 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.43 69.53 1.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.238 1.015 . . . . 0.0 110.588 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -84.42 -21.11 30.87 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.932 179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.03 158.89 30.28 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 125.018 1.327 . . . . 0.0 110.199 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 11.8 mp0 -92.4 178.81 5.72 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 125.446 1.499 . . . . 0.0 109.415 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -55.34 133.44 49.62 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.81 1.244 . . . . 0.0 112.118 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.2 t -140.18 117.03 9.14 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 102.768 -3.049 . . . . 0.0 102.768 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.82 158.46 69.4 Favored Pre-proline 0 CA--C 1.539 0.551 0 O-C-N 124.079 0.862 . . . . 0.0 109.425 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.91 139.66 75.25 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 121.611 1.541 . . . . 0.0 110.471 -179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.1 t -111.13 -10.45 14.32 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.654 1.182 . . . . 0.0 111.319 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 60.5 t30 -121.59 152.87 38.78 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-N 119.48 1.036 . . . . 0.0 109.238 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -55.7 -36.41 67.14 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.239 0.616 . . . . 0.0 111.496 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -66.95 -49.79 70.6 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.306 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -178.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -60.81 -35.87 77.6 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.473 0.709 . . . . 0.0 110.041 -178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.6 t -65.59 -49.07 70.15 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.9 mmtt -54.41 -56.52 17.85 Favored 'General case' 0 CA--C 1.521 -0.152 0 C-N-CA 123.773 0.829 . . . . 0.0 110.208 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.0 mp -59.12 -42.36 90.38 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-O 117.991 -1.004 . . . . 0.0 113.274 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.81 -35.48 66.39 Favored 'General case' 0 N--CA 1.454 -0.234 0 O-C-N 123.87 0.731 . . . . 0.0 109.981 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -72.46 -37.73 68.45 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 119.632 -0.827 . . . . 0.0 110.563 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.7 mm -59.14 -38.73 75.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -67.46 -41.1 85.21 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 118.399 -0.81 . . . . 0.0 109.737 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -62.06 -35.1 77.62 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 119.018 0.826 . . . . 0.0 109.165 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -71.0 -43.19 68.5 Favored 'General case' 0 N--CA 1.456 -0.152 0 O-C-N 121.064 -1.023 . . . . 0.0 111.269 -179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 57.8 t -77.56 -54.7 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 C-N-CA 123.63 0.772 . . . . 0.0 111.371 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.0 mt -67.7 -26.73 66.32 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 123.945 0.898 . . . . 0.0 111.731 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 75.63 29.3 59.8 Favored Glycine 0 CA--C 1.526 0.77 0 CA-C-O 119.175 -0.792 . . . . 0.0 112.938 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 28.3 m -124.36 174.22 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 C-N-CA 124.945 1.298 . . . . 0.0 107.618 178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 42.4 t -132.32 135.11 45.97 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.73 60.79 0.84 Allowed Glycine 0 CA--C 1.524 0.64 0 C-N-CA 124.22 0.914 . . . . 0.0 112.973 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.44 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -90.84 121.75 41.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.25 163.46 31.53 Favored Glycine 0 CA--C 1.527 0.835 0 CA-C-N 118.831 0.741 . . . . 0.0 111.5 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 39.2 pt -65.12 -22.18 30.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 124.309 1.044 . . . . 0.0 110.937 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.6 -0.95 21.66 Favored 'General case' 0 N--CA 1.445 -0.708 0 C-N-CA 126.62 1.968 . . . . 0.0 113.834 179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 27.5 t0 -72.63 128.48 35.68 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 119.319 0.963 . . . . 0.0 110.433 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -75.83 118.31 18.5 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.148 0.979 . . . . 0.0 109.423 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' HA ' HD12 ' A' ' 41' ' ' ILE . 87.5 t80 -48.92 -40.47 30.16 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.689 1.195 . . . . 0.0 111.792 178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -72.34 -28.99 63.39 Favored 'General case' 0 CA--C 1.532 0.255 0 O-C-N 121.583 -0.698 . . . . 0.0 112.608 -179.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -69.47 -33.0 72.26 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.44 HD13 HD12 ' A' ' 32' ' ' ILE . 12.2 mt -75.86 29.64 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.098 0 C-N-CA 126.199 1.8 . . . . 0.0 109.301 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.08 10.04 64.55 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 119.223 -2.173 . . . . 0.0 112.563 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -72.51 151.93 47.19 Favored Glycine 0 N--CA 1.446 -0.641 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.504 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 29.0 p80 -143.42 172.58 12.58 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.36 -53.96 6.3 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 124.99 1.316 . . . . 0.0 112.823 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.8 tp -55.52 -47.32 76.45 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 118.694 0.679 . . . . 0.0 111.827 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.504 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 72.6 mmtt -59.94 -42.69 94.55 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 118.229 -0.891 . . . . 0.0 109.138 -179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.02 -45.56 90.39 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.136 0.974 . . . . 0.0 109.257 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.45 ' HG2' HD23 ' A' ' 65' ' ' LEU . 63.4 mtm -61.44 -37.99 85.55 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.513 0.725 . . . . 0.0 109.772 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.2 -28.9 68.47 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.171 0.588 . . . . 0.0 110.769 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 47' ' ' LYS . 7.8 t -72.54 -48.87 45.03 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 178.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -29.99 59.1 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.14 -53.54 36.47 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-O 122.106 0.955 . . . . 0.0 108.815 -179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.2 mm100 -65.27 -38.42 90.23 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.812 1.645 . . . . 0.0 109.824 -178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.09 -46.1 88.75 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.204 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.86 -38.92 87.24 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 118.693 0.678 . . . . 0.0 110.72 -178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 -76.53 -31.9 57.92 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -86.28 -44.7 11.91 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.384 0.538 . . . . 0.0 112.13 -177.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -93.14 -0.78 56.87 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 122.816 0.446 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 52.93 37.94 25.71 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.222 1.409 . . . . 0.0 110.984 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.2 p -140.1 129.7 28.3 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.251 0 CA-C-O 121.413 0.625 . . . . 0.0 112.396 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -68.69 117.81 10.88 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 67.5 tp -111.4 88.77 9.43 Favored Pre-proline 0 N--CA 1.451 -0.414 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -67.57 157.13 63.2 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 121.974 1.782 . . . . 0.0 110.786 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.45 HD23 ' HG2' ' A' ' 49' ' ' MET . 0.2 OUTLIER -61.14 -27.37 68.34 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 117.971 -1.014 . . . . 0.0 110.578 -179.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -54.77 -28.83 51.69 Favored 'General case' 0 C--N 1.343 0.295 0 CA-C-N 119.275 0.943 . . . . 0.0 110.89 179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 58.2 t -87.87 -43.38 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 C-N-CA 123.565 0.746 . . . . 0.0 109.909 179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.58 -47.91 83.72 Favored 'General case' 0 C--O 1.225 -0.231 0 C-N-CA 123.126 0.571 . . . . 0.0 111.054 -178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.72 -33.16 64.23 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.2 -31.9 58.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 117.813 0.278 . . . . 0.0 111.563 -178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -140.49 74.12 28.95 Favored Pre-proline 0 CA--C 1.538 0.505 0 C-N-CA 123.891 0.876 . . . . 0.0 109.153 -178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.87 53.28 3.23 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 124.373 3.382 . . . . 0.0 113.306 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.65 147.8 48.72 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-N 119.808 1.185 . . . . 0.0 110.612 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -57.31 -43.4 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 30.6 ttpt -57.77 -47.33 82.84 Favored 'General case' 0 C--N 1.339 0.128 0 C-N-CA 120.261 -0.576 . . . . 0.0 111.51 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -62.13 -41.03 97.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 113.716 1.006 . . . . 0.0 113.716 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.0 mt -73.0 -42.83 62.85 Favored 'General case' 0 C--O 1.213 -0.841 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.77 -45.59 91.81 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.348 1.059 . . . . 0.0 109.933 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -68.92 -44.96 72.05 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 118.477 0.58 . . . . 0.0 110.557 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -61.34 -42.38 98.59 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 55.8 t -74.37 -37.65 45.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.278 -179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.9 -46.09 89.44 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 118.683 0.674 . . . . 0.0 110.213 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.04 -29.54 70.67 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 118.887 -0.578 . . . . 0.0 110.464 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 62.5 mtt85 -85.98 -28.57 24.15 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.096 0.862 . . . . 0.0 112.821 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.18 -32.98 71.58 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 125.036 1.335 . . . . 0.0 108.106 178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -85.86 141.38 29.65 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -124.5 177.29 5.99 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.878 1.271 . . . . 0.0 107.959 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -129.02 3.56 5.29 Favored 'General case' 0 N--CA 1.466 0.353 0 O-C-N 121.477 -0.764 . . . . 0.0 110.706 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 67.2 m-70 -103.17 149.35 24.73 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -100.67 67.63 1.28 Allowed 'General case' 0 C--O 1.237 0.395 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 . . . . . 0 C--O 1.255 1.343 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 178.525 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 CA--C 1.528 0.2 0 N-CA-C 114.242 0.824 . . . . 0.0 114.242 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 97.6 t -119.77 159.39 20.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 123.6 0.76 . . . . 0.0 110.128 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 t -163.44 176.31 9.91 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.471 2.308 . . . . 0.0 106.065 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -124.97 7.96 8.03 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.883 1.673 . . . . 0.0 109.943 179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -54.24 150.2 8.82 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.687 1.595 . . . . 0.0 113.927 -179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -77.12 166.67 22.96 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.776 1.23 . . . . 0.0 110.705 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.491 ' HA ' HD21 ' A' ' 35' ' ' LEU . 2.5 t80 -58.82 138.23 57.33 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.494 1.517 . . . . 0.0 109.438 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.9 t -147.55 119.24 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.183 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.61 160.39 44.21 Favored Pre-proline 0 CA--C 1.543 0.677 0 C-N-CA 124.277 1.031 . . . . 0.0 109.535 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -58.62 152.08 58.31 Favored 'Trans proline' 0 N--CA 1.46 -0.478 0 C-N-CA 123.103 2.535 . . . . 0.0 114.223 -179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.3 p -123.01 -18.49 6.38 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 127.282 2.233 . . . . 0.0 112.595 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -116.46 148.72 40.47 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 176.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.23 -35.19 62.18 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.727 1.211 . . . . 0.0 110.547 179.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -66.45 -47.51 83.61 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.191 0 O-C-N 121.457 -0.777 . . . . 0.0 109.412 -179.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -62.39 -31.28 71.92 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.598 0.759 . . . . 0.0 110.004 -178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.3 t -65.72 -52.21 53.12 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.757 0.823 . . . . 0.0 110.231 178.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mmtm -57.54 -52.75 64.12 Favored 'General case' 0 CA--C 1.52 -0.175 0 C-N-CA 122.941 0.496 . . . . 0.0 111.996 -177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.1 mp -57.7 -42.09 83.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.653 179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -33.4 65.42 Favored 'General case' 0 N--CA 1.457 -0.122 0 C-N-CA 122.79 0.436 . . . . 0.0 111.687 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -67.61 -48.69 66.08 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-O 121.068 0.461 . . . . 0.0 109.896 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 mm -57.75 -34.82 48.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 124.089 0.956 . . . . 0.0 110.123 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.7 m0 -67.25 -43.71 81.21 Favored 'General case' 0 N--CA 1.456 -0.148 0 CA-C-N 119.033 0.833 . . . . 0.0 110.691 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -55.43 -44.78 76.61 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 123.783 0.833 . . . . 0.0 109.786 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -60.06 -30.46 69.22 Favored 'General case' 0 N--CA 1.461 0.116 0 C-N-CA 124.701 1.2 . . . . 0.0 113.084 -178.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.35 -49.19 12.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.708 0.685 . . . . 0.0 111.733 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 93.1 mt -69.16 -23.04 63.9 Favored 'General case' 0 N--CA 1.461 0.119 0 C-N-CA 124.51 1.124 . . . . 0.0 112.102 -178.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.66 34.6 66.99 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-O 119.486 -0.619 . . . . 0.0 112.733 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 35.1 m -129.08 173.92 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 107.537 -1.283 . . . . 0.0 107.537 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.7 t -138.34 127.17 23.78 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 121.78 32.9 0.97 Allowed Glycine 0 CA--C 1.52 0.365 0 C-N-CA 124.235 0.922 . . . . 0.0 111.006 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.7 mm -69.25 127.76 31.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 -169.32 24.24 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.47 1.509 . . . . 0.0 110.64 178.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.0 pt -84.69 -27.27 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 C-N-CA 126.236 1.815 . . . . 0.0 113.378 178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.596 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.69 0.78 22.63 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 116.734 2.124 . . . . 0.0 116.734 -176.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.408 ' HB2' HD11 ' A' ' 41' ' ' ILE . 7.7 p-10 -60.04 122.31 14.04 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.986 1.714 . . . . 0.0 110.843 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 30.2 m-20 -75.66 103.07 5.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -39.89 -48.56 2.33 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.804 1.642 . . . . 0.0 113.766 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -73.63 -30.69 63.11 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 118.629 -0.7 . . . . 0.0 112.24 -179.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 56.3 tp60 -68.34 -32.17 72.09 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 119.406 1.003 . . . . 0.0 109.659 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.408 HD11 ' HB2' ' A' ' 36' ' ' ASP . 23.4 mt -71.37 -7.58 9.47 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.938 0 C-N-CA 125.338 1.455 . . . . 0.0 110.493 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.16 3.0 41.84 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.552 1.073 . . . . 0.0 111.48 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.58 151.5 52.28 Favored Glycine 0 C--N 1.339 0.722 0 N-CA-C 108.23 -1.948 . . . . 0.0 108.23 178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 19.1 p80 -142.34 176.93 8.62 Favored 'General case' 0 C--N 1.328 -0.366 0 O-C-N 121.269 -1.136 . . . . 0.0 108.21 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.44 -53.05 7.29 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.211 1.404 . . . . 0.0 112.33 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.4 tp -58.21 -46.23 86.24 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.904 0.32 . . . . 0.0 111.534 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 28.1 mmtp -61.56 -42.49 98.92 Favored 'General case' 0 C--O 1.223 -0.33 0 O-C-N 121.786 -0.571 . . . . 0.0 110.042 179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.94 -45.42 67.66 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.058 0.943 . . . . 0.0 109.94 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.1 mmt -67.85 -38.77 83.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.94 0.896 . . . . 0.0 109.484 179.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.97 -28.74 70.02 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 118.136 -0.935 . . . . 0.0 111.025 179.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.5 t -76.26 -50.27 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 106.241 -1.763 . . . . 0.0 106.241 178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -50.67 -36.14 34.35 Favored 'General case' 0 C--O 1.22 -0.486 0 C-N-CA 126.268 1.827 . . . . 0.0 112.756 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.64 -52.55 63.9 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.816 0.817 . . . . 0.0 111.517 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 16.0 mt-30 -72.51 -33.63 67.04 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 122.193 0.997 . . . . 0.0 110.741 -178.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -66.33 -46.27 87.45 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.991 0 C-N-CA 124.682 1.193 . . . . 0.0 108.892 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -61.67 -41.56 97.72 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -75.15 -29.19 60.41 Favored 'General case' 0 C--N 1.322 -0.596 0 C-N-CA 118.869 -1.132 . . . . 0.0 113.428 -179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -87.08 -49.09 7.55 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 118.818 0.735 . . . . 0.0 112.615 -178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.423 ' HB2' HG12 ' A' ' 61' ' ' VAL . 17.4 m-85 -90.89 -2.36 57.75 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.514 0.726 . . . . 0.0 110.74 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 53.69 38.7 28.99 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 118.855 0.752 . . . . 0.0 110.176 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 59' ' ' TYR . 6.6 p -124.01 120.54 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 124.183 0.993 . . . . 0.0 111.695 -177.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -72.42 111.07 7.29 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 104.403 -2.443 . . . . 0.0 104.403 177.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -109.73 85.35 3.86 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 122.962 0.505 . . . . 0.0 111.183 -178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.12 154.67 69.88 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.488 2.792 . . . . 0.0 111.878 179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.38 -27.31 64.12 Favored 'General case' 0 N--CA 1.46 0.073 0 C-N-CA 125.582 1.553 . . . . 0.0 110.016 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -53.18 -32.93 50.41 Favored 'General case' 0 C--N 1.342 0.243 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.305 179.035 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.1 t -87.31 -46.49 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 119.405 1.002 . . . . 0.0 108.894 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.55 -43.59 72.13 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 122.908 0.483 . . . . 0.0 111.924 -178.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -79.86 -30.54 40.31 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 119.068 -0.492 . . . . 0.0 111.34 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.99 73.83 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 119.221 -0.419 . . . . 0.0 109.97 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -140.78 76.87 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 124.495 1.118 . . . . 0.0 110.472 -179.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 80.3 Cg_endo -75.02 59.37 5.19 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.621 2.881 . . . . 0.0 114.057 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -142.23 148.52 38.27 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.347 0.976 . . . . 0.0 110.442 178.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.8 mm -60.48 -40.95 85.87 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt -56.03 -45.32 79.19 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 118.202 0.456 . . . . 0.0 110.926 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.37 -42.9 95.94 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.15 0.98 . . . . 0.0 113.465 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.18 -38.91 68.99 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 124.818 1.247 . . . . 0.0 108.192 -179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.77 -51.39 69.55 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 118.652 0.66 . . . . 0.0 109.598 179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -69.26 -33.09 72.7 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.962 0.801 . . . . 0.0 111.559 -179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 83' ' ' THR . 84.8 t80 -67.05 -51.63 52.18 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-O 121.661 0.743 . . . . 0.0 109.071 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 54.5 t -66.7 -35.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -37.4 87.12 Favored 'General case' 0 CA--C 1.528 0.121 0 CA-C-N 119.202 0.91 . . . . 0.0 110.872 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.48 HG22 ' O ' ' A' ' 80' ' ' TYR . 1.2 t -71.05 -15.86 62.57 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 119.335 -0.364 . . . . 0.0 111.517 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 10.8 mtt-85 -102.65 -32.7 9.75 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.307 1.043 . . . . 0.0 113.059 178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 12.6 t -87.52 19.56 3.29 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 127.743 2.417 . . . . 0.0 112.612 -178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 83' ' ' THR . 33.8 m80 -55.03 136.99 47.34 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.279 1.399 . . . . 0.0 110.803 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -68.4 148.65 50.37 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 106.631 -1.618 . . . . 0.0 106.631 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.6 m80 -59.83 118.33 6.07 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -133.11 50.64 2.21 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 126.025 1.73 . . . . 0.0 108.607 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.8 p-80 -133.8 168.55 18.52 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.098 0.959 . . . . 0.0 109.742 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 9.5 t-80 . . . . . 0 C--O 1.251 1.184 0 N-CA-C 103.783 -2.673 . . . . 0.0 103.783 179.444 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 N--CA 1.479 0.669 0 CA-C-O 118.649 -0.646 . . . . 0.0 113.531 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.83 163.45 1.77 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-N 119.531 1.06 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.1 p -121.94 58.8 1.01 Allowed 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 124.267 1.027 . . . . 0.0 109.912 -178.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 56.29 7.75 0.36 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.554 2.342 . . . . 0.0 115.048 -179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -47.92 129.1 14.29 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 127.193 2.197 . . . . 0.0 114.328 -178.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -73.65 159.35 33.17 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 107.069 -1.456 . . . . 0.0 107.069 178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.432 ' HA ' HD21 ' A' ' 35' ' ' LEU . 80.2 t80 -38.77 131.66 1.3 Allowed 'General case' 0 C--O 1.235 0.301 0 C-N-CA 127.119 2.168 . . . . 0.0 114.54 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 79.5 t -144.44 116.95 2.64 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.544 0 N-CA-C 101.902 -3.37 . . . . 0.0 101.902 177.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.17 162.19 56.92 Favored Pre-proline 0 CA--C 1.542 0.65 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -53.77 147.4 41.0 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.57 2.18 . . . . 0.0 112.029 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.8 t -121.89 -1.58 9.37 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.016 1.326 . . . . 0.0 112.042 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -131.32 150.51 52.12 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 104.376 -2.453 . . . . 0.0 104.376 178.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -56.62 -37.77 71.17 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 123.529 0.732 . . . . 0.0 111.243 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 76.8 t -63.52 -49.61 81.81 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.186 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -56.78 -35.72 69.02 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 -179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.12 -49.46 64.8 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 122.972 0.509 . . . . 0.0 110.609 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 40.3 mmtt -55.31 -50.08 70.51 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 122.871 0.468 . . . . 0.0 110.452 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.89 -42.08 98.65 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.889 178.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.34 -33.05 67.35 Favored 'General case' 0 N--CA 1.455 -0.177 0 O-C-N 123.694 0.621 . . . . 0.0 110.561 179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -69.72 -40.04 76.48 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 118.466 0.576 . . . . 0.0 111.086 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 65.5 mt -62.75 -38.19 81.05 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -62.32 -38.86 91.08 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 118.29 -0.862 . . . . 0.0 110.75 179.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 69.7 mt-10 -59.82 -39.15 84.09 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 118.611 0.641 . . . . 0.0 110.119 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.594 HH21 ' NE2' ' A' ' 54' ' ' GLN . 67.3 mtm-85 -68.74 -44.33 74.02 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-N 119.789 1.177 . . . . 0.0 113.93 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 45.1 t -73.05 -43.28 58.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 C-N-CA 122.231 0.213 . . . . 0.0 111.132 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 89.5 mt -81.49 -21.83 38.43 Favored 'General case' 0 CA--C 1.519 -0.236 0 C-N-CA 122.574 0.35 . . . . 0.0 111.316 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.81 35.71 90.06 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.454 -1.192 . . . . 0.0 111.56 178.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 31.8 m -136.47 175.13 10.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.188 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.4 t -132.11 150.06 52.25 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 106.194 -1.78 . . . . 0.0 106.194 177.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.39 52.06 1.26 Allowed Glycine 0 N--CA 1.453 -0.174 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.735 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 41.0 mm -91.63 130.18 41.17 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.344 -1.724 . . . . 0.0 106.344 178.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.67 19.87 Favored Glycine 0 N--CA 1.438 -1.19 0 C-N-CA 126.711 2.101 . . . . 0.0 109.773 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.6 pt -83.03 -22.98 8.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 116.015 1.857 . . . . 0.0 116.015 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.432 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -108.97 -1.13 19.22 Favored 'General case' 0 CA--C 1.515 -0.402 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 -177.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.3 119.08 26.19 Favored 'General case' 0 N--CA 1.437 -1.116 0 CA-C-O 122.834 1.302 . . . . 0.0 110.975 -177.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -63.41 124.02 20.24 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 126.095 1.758 . . . . 0.0 111.19 -178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.7 t80 -48.04 -46.41 33.24 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.998 1.719 . . . . 0.0 110.633 178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -69.52 -31.38 69.58 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 118.307 -0.854 . . . . 0.0 112.541 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -71.41 -34.52 70.43 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.6 mt -70.86 -31.13 44.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 136.37 -11.67 4.08 Favored Glycine 0 C--N 1.339 0.737 0 CA-C-N 119.008 0.822 . . . . 0.0 113.825 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -60.89 159.74 27.05 Favored Glycine 0 CA--C 1.527 0.787 0 CA-C-N 118.353 1.076 . . . . 0.0 110.614 179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.1 p80 -147.56 178.86 8.11 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 125.445 1.498 . . . . 0.0 108.527 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.51 -53.33 7.12 Favored 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.076 1.351 . . . . 0.0 113.304 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.0 tp -56.03 -49.0 74.91 Favored 'General case' 0 C--N 1.346 0.421 0 CA-C-N 119.276 0.944 . . . . 0.0 110.637 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp -60.55 -44.44 96.12 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 119.141 -0.457 . . . . 0.0 110.349 -179.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.405 ' HB1' ' HG ' ' A' ' 68' ' ' LEU . . . -53.12 -39.42 63.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.634 0.774 . . . . 0.0 110.46 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 61.5 mtm -66.05 -37.47 85.92 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.78 -40.44 88.18 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 44.6 t -59.9 -52.73 57.7 Favored 'Isoleucine or valine' 0 C--N 1.344 0.337 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.21 -28.62 63.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.448 1.099 . . . . 0.0 112.845 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.38 -49.83 31.04 Favored 'General case' 0 N--CA 1.453 -0.281 0 CA-C-N 118.843 0.747 . . . . 0.0 110.61 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.594 ' NE2' HH21 ' A' ' 25' ' ' ARG . 0.7 OUTLIER -65.57 -36.38 83.59 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 122.706 0.402 . . . . 0.0 110.04 -179.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 44.0 t -70.51 -40.93 77.96 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.396 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.43 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 0.8 OUTLIER -59.57 -40.32 86.96 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 119.218 0.917 . . . . 0.0 109.799 -179.089 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . 0.25 7.4 ptm180 -77.09 -33.42 56.99 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 114.427 1.269 . . . . 0.0 114.427 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.9 mm-40 -80.68 -39.76 26.65 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -101.54 -1.36 33.16 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 122.791 0.436 . . . . 0.0 110.66 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 56.02 38.85 30.38 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 124.735 1.214 . . . . 0.0 110.512 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 56' ' ' HIS . 11.8 p -148.85 133.13 8.97 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 O-C-N 121.654 -0.653 . . . . 0.0 112.629 -177.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -65.14 141.67 58.61 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.339 1.855 . . . . 0.0 112.817 -178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.7 tp -128.75 96.61 29.27 Favored Pre-proline 0 C--N 1.343 0.311 0 C-N-CA 124.397 1.079 . . . . 0.0 109.912 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.95 153.49 68.01 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.621 2.214 . . . . 0.0 110.101 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.37 -26.86 68.11 Favored 'General case' 0 CA--C 1.517 -0.306 0 C-N-CA 125.49 1.516 . . . . 0.0 110.13 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 12.7 ptmm? -52.92 -27.56 19.33 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 124.023 0.929 . . . . 0.0 110.082 179.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.57 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 46.2 t -88.02 -49.11 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 C-N-CA 124.69 1.196 . . . . 0.0 109.534 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' HG ' ' HB1' ' A' ' 48' ' ' ALA . 0.3 OUTLIER -57.46 -45.18 85.06 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -177.749 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -24.17 45.65 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.986 0.914 . . . . 0.0 112.518 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.49 -39.31 22.64 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 118.488 0.586 . . . . 0.0 110.729 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -139.24 77.21 30.68 Favored Pre-proline 0 CA--C 1.536 0.442 0 O-C-N 124.168 0.918 . . . . 0.0 110.893 -178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -72.04 57.75 2.71 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 124.894 3.729 . . . . 0.0 113.228 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.1 p -141.73 149.77 40.92 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 121.245 1.839 . . . . 0.0 111.657 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 16.3 mm -58.1 -40.24 76.23 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.342 0 N-CA-C 107.181 -1.414 . . . . 0.0 107.181 177.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.8 ttpt -57.05 -46.66 82.28 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 118.909 0.777 . . . . 0.0 111.192 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.15 -40.45 86.7 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mt -72.72 -42.65 63.91 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.74 -51.3 70.12 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.96 0.904 . . . . 0.0 109.802 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -69.83 -39.0 76.73 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.367 0.53 . . . . 0.0 111.639 -179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.57 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 34.3 t80 -64.2 -46.93 81.72 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 84.2 t -70.85 -41.53 77.29 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.301 0 C-N-CA 119.421 -0.912 . . . . 0.0 109.23 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.71 -46.01 90.41 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 119.643 1.11 . . . . 0.0 112.268 -179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 t -63.93 -20.89 66.2 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.713 0.688 . . . . 0.0 110.873 -179.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -92.29 -38.18 12.22 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.034 0.933 . . . . 0.0 110.164 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 64.5 m -74.26 -20.64 60.08 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 118.453 -0.784 . . . . 0.0 111.508 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -93.97 108.29 20.11 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -128.55 -160.13 1.0 Allowed 'General case' 0 C--O 1.236 0.345 0 C-N-CA 126.915 2.086 . . . . 0.0 106.394 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 52.7 m-70 -119.36 -74.96 0.59 Allowed 'General case' 0 CA--C 1.52 -0.202 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 12.7 t60 -147.98 133.76 18.98 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.1 t60 -80.05 99.44 7.69 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.098 -1.815 . . . . 0.0 106.098 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 . . . . . 0 C--O 1.247 0.969 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.655 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo . . . . . 0 N--CA 1.48 0.702 0 CA-C-O 119.256 -0.393 . . . . 0.0 112.928 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -58.3 158.68 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.202 1.401 . . . . 0.0 111.716 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.92 97.28 3.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.118 -2.549 . . . . 0.0 104.118 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.1 tp10 -80.42 -21.86 41.77 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.178 0.991 . . . . 0.0 111.246 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.31 120.08 11.52 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.789 1.236 . . . . 0.0 110.609 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -62.08 151.02 36.69 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.679 1.592 . . . . 0.0 108.87 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.445 ' HA ' HD21 ' A' ' 35' ' ' LEU . 12.3 t80 -50.38 137.25 19.01 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.592 1.557 . . . . 0.0 110.997 179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.1 t -142.03 118.44 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 N-CA-C 102.94 -2.985 . . . . 0.0 102.94 178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.91 162.18 31.94 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 123.458 0.703 . . . . 0.0 110.567 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_endo -64.13 154.64 69.5 Favored 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.015 1.81 . . . . 0.0 109.231 178.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 39.9 p -129.73 -12.9 4.27 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 114.152 1.167 . . . . 0.0 114.152 -178.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -121.09 153.18 37.79 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.38 -23.47 6.02 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.94 -49.84 16.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 120.552 1.523 . . . . 0.0 108.64 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -55.14 -45.3 75.63 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 126.406 1.882 . . . . 0.0 108.689 -178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.2 t -56.6 -37.92 71.31 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 127.031 2.132 . . . . 0.0 110.71 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.651 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.2 mmpt? -78.02 -45.44 23.67 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 113.221 0.823 . . . . 0.0 113.221 -179.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.8 mt -60.67 -41.18 94.54 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.995 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.7 -36.77 72.43 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.493 1.121 . . . . 0.0 109.858 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -69.21 -43.02 74.95 Favored 'General case' 0 C--O 1.227 -0.118 0 CA-C-N 118.23 0.468 . . . . 0.0 110.501 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.0 mm -64.86 -37.45 80.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 118.699 -0.667 . . . . 0.0 110.453 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.2 m0 -61.88 -44.57 96.54 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 118.902 0.774 . . . . 0.0 110.759 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -52.15 -47.13 65.59 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.536 1.134 . . . . 0.0 110.624 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.9 mtp85 -59.91 -16.15 27.3 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.209 1.404 . . . . 0.0 113.84 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 51' ' ' VAL . 4.7 t -111.85 -43.02 4.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.057 0.943 . . . . 0.0 111.821 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 85.6 mt -74.02 -26.25 60.33 Favored 'General case' 0 C--O 1.227 -0.098 0 O-C-N 121.76 -0.587 . . . . 0.0 110.672 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 77.66 31.18 50.86 Favored Glycine 0 CA--C 1.524 0.624 0 CA-C-N 118.379 0.536 . . . . 0.0 111.809 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.48 169.62 18.61 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 15.8 p -138.03 111.4 8.02 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.578 1.151 . . . . 0.0 108.063 179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 115.91 69.58 0.44 Allowed Glycine 0 CA--C 1.528 0.865 0 C-N-CA 125.021 1.296 . . . . 0.0 110.677 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.45 122.04 39.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 125.364 1.466 . . . . 0.0 109.544 179.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -80.54 161.05 44.24 Favored Glycine 0 CA--C 1.528 0.887 0 CA-C-N 119.19 0.905 . . . . 0.0 110.849 179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.408 ' HA ' ' HB ' ' A' ' 74' ' ' ILE . 5.9 pt -69.5 -21.29 24.59 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 121.469 -1.018 . . . . 0.0 112.581 -178.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.6 -4.77 17.99 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 126.87 2.068 . . . . 0.0 112.836 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -71.91 122.56 21.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.675 0.67 . . . . 0.0 109.627 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 29.6 t-20 -70.62 114.32 8.61 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 125.286 1.435 . . . . 0.0 110.319 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.4 t80 -42.86 -42.07 3.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.863 1.665 . . . . 0.0 114.341 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -75.43 -27.41 58.96 Favored 'General case' 0 CA--C 1.53 0.206 0 O-C-N 121.431 -0.793 . . . . 0.0 111.965 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -71.0 -28.41 64.4 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 119.097 0.862 . . . . 0.0 109.325 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 12.1 mt -80.77 29.65 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.836 2.054 . . . . 0.0 109.118 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.88 -0.87 49.67 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 119.786 -1.821 . . . . 0.0 113.834 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.29 157.0 49.98 Favored Glycine 0 CA--C 1.526 0.737 0 CA-C-N 119.032 1.416 . . . . 0.0 110.811 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -143.49 173.95 11.18 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -52.09 -30.07 24.37 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.9 tt -70.71 -52.23 22.29 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.527 ' O ' HG23 ' A' ' 51' ' ' VAL . 24.4 mmtp -55.44 -41.38 72.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 123.152 0.581 . . . . 0.0 109.832 -179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.56 -38.99 64.41 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 123.561 0.745 . . . . 0.0 111.74 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 1.6 mmt -74.91 -38.33 61.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 124.305 1.042 . . . . 0.0 110.004 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.3 75.97 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.41 0.284 . . . . 0.0 110.252 179.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.529 HG22 HG21 ' A' ' 26' ' ' VAL . 11.6 t -76.62 -45.83 32.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.84 -34.08 58.2 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 124.35 1.06 . . . . 0.0 112.35 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -66.02 -45.14 82.56 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.558 0.694 . . . . 0.0 109.854 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -67.97 -42.74 80.41 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.294 1.037 . . . . 0.0 110.164 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -62.46 -47.83 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.075 0 C-N-CA 123.731 0.813 . . . . 0.0 109.502 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.21 -38.24 90.4 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.024 -178.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -75.74 -33.04 60.23 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -84.6 -49.28 8.7 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 118.543 0.611 . . . . 0.0 111.041 -177.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -88.2 1.92 53.36 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.393 0.677 . . . . 0.0 111.502 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 51.73 38.9 24.15 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.984 1.314 . . . . 0.0 110.508 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 p -146.55 128.4 7.43 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 O-C-N 121.233 -0.917 . . . . 0.0 112.408 -177.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 50.9 tt0 -64.34 122.07 15.81 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 57.9 tp -113.64 88.65 14.0 Favored Pre-proline 0 C--O 1.234 0.286 0 N-CA-C 104.86 -2.274 . . . . 0.0 104.86 178.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -69.86 160.31 50.16 Favored 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 121.268 1.312 . . . . 0.0 110.99 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.91 -26.0 58.37 Favored 'General case' 0 C--O 1.218 -0.576 0 C-N-CA 125.307 1.443 . . . . 0.0 108.559 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.1 mtpt -51.88 -44.47 63.73 Favored 'General case' 0 CA--C 1.515 -0.389 0 C-N-CA 124.22 1.008 . . . . 0.0 111.718 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 t -77.69 -40.88 28.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 C-N-CA 123.45 0.7 . . . . 0.0 109.633 -178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.79 -42.14 98.62 Favored 'General case' 0 C--O 1.223 -0.301 0 C-N-CA 123.603 0.761 . . . . 0.0 110.718 -178.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.71 -41.54 23.44 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 125.013 1.325 . . . . 0.0 110.749 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -35.47 78.92 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.496 -0.882 . . . . 0.0 112.54 -178.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.5 mt-30 -143.08 74.95 17.57 Favored Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 124.156 0.982 . . . . 0.0 111.319 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.26 59.85 2.46 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 124.879 3.719 . . . . 0.0 113.302 -179.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.01 147.59 37.14 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 120.285 -1.509 . . . . 0.0 109.829 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 34' ' ' ILE . 21.6 mm -60.03 -44.38 94.68 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.5 ttpt -57.11 -44.89 83.69 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 119.029 0.831 . . . . 0.0 111.179 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.68 -44.79 93.49 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.005 0.522 . . . . 0.0 111.895 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.4 mt -69.4 -44.43 71.43 Favored 'General case' 0 C--O 1.214 -0.798 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.35 65.72 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.719 0.808 . . . . 0.0 110.923 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -72.34 -34.53 68.12 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.978 0.808 . . . . 0.0 112.457 -179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.7 t80 -68.38 -52.51 32.27 Favored 'General case' 0 C--O 1.233 0.227 0 C-N-CA 123.257 0.623 . . . . 0.0 110.357 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 94.9 t -67.79 -44.54 85.54 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-O 118.173 -0.918 . . . . 0.0 109.172 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.39 -39.97 77.21 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 114.289 1.218 . . . . 0.0 114.289 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.9 t -75.81 -26.17 57.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 119.036 -1.066 . . . . 0.0 110.357 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -74.98 -51.11 14.46 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 54.2 p -83.06 29.46 0.47 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 125.351 1.46 . . . . 0.0 109.835 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 40.2 p-80 -63.91 159.37 19.92 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.129 0.877 . . . . 0.0 109.037 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 69.4 m80 -139.46 121.26 15.44 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 59.7 m-70 41.37 72.01 0.18 Allowed 'General case' 0 C--O 1.237 0.44 0 C-N-CA 126.118 1.767 . . . . 0.0 112.902 178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 22.5 t-160 -150.8 93.39 1.94 Allowed 'General case' 0 N--CA 1.455 -0.203 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -121.48 27.81 8.07 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.003 1.721 . . . . 0.0 111.52 -179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 34.6 m170 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 117.123 -1.418 . . . . 0.0 110.155 179.858 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo . . . . . 0 N--CA 1.476 0.458 0 N-CA-C 111.384 -0.275 . . . . 0.0 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.7 p -121.58 161.49 21.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 124.129 0.971 . . . . 0.0 108.953 178.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.5 m -67.57 149.85 49.58 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 59.26 13.9 3.33 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 113.032 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -50.19 129.29 20.96 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -178.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -68.4 156.9 36.92 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 125.355 1.462 . . . . 0.0 109.348 179.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.594 ' HA ' HD21 ' A' ' 35' ' ' LEU . 9.6 t80 -52.8 137.6 31.38 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 127.049 2.14 . . . . 0.0 111.205 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 82.1 t -144.85 117.52 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.01 152.86 82.8 Favored Pre-proline 0 CA--C 1.541 0.601 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 178.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.49 150.46 75.49 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.85 2.367 . . . . 0.0 110.475 179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 12.9 p -127.1 -17.78 4.74 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -102.4 142.28 33.87 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 105.384 -2.08 . . . . 0.0 105.384 177.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.07 -22.42 0.91 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.598 1.559 . . . . 0.0 115.089 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 55.5 t -80.43 -48.81 19.51 Favored 'Isoleucine or valine' 0 C--O 1.229 -0.021 0 CA-C-N 119.25 0.932 . . . . 0.0 109.376 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -54.23 -45.82 72.41 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 126.875 2.07 . . . . 0.0 110.14 -178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 35.5 t -59.19 -38.76 80.64 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.526 -179.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -70.66 -38.85 73.85 Favored 'General case' 0 CA--C 1.508 -0.663 0 CA-C-N 118.128 0.422 . . . . 0.0 111.829 -177.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mt -67.09 -40.06 86.88 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.29 -34.51 73.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 123.843 0.714 . . . . 0.0 109.482 179.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -63.86 -49.39 72.95 Favored 'General case' 0 N--CA 1.457 -0.101 0 CA-C-N 118.397 0.544 . . . . 0.0 110.064 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.5 mm -63.1 -37.87 80.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 122.923 0.489 . . . . 0.0 110.053 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.6 m0 -64.03 -42.34 97.11 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 121.229 -0.92 . . . . 0.0 109.974 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -62.39 -32.36 73.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.047 0.939 . . . . 0.0 109.808 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -78.73 -43.03 26.66 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 121.172 -0.955 . . . . 0.0 111.37 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 97.0 t -68.65 -55.43 15.95 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.3 mt -68.47 -30.22 69.02 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.236 0.614 . . . . 0.0 112.082 -178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.86 37.85 43.34 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 123.664 0.649 . . . . 0.0 111.81 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 25.7 m -129.21 175.58 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 125.989 1.715 . . . . 0.0 108.144 179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.8 t -138.57 139.72 38.75 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 125.353 1.461 . . . . 0.0 107.758 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.74 38.76 2.31 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.38 0.514 . . . . 0.0 112.925 179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.528 HD12 HD13 ' A' ' 41' ' ' ILE . 49.4 mm -81.69 122.28 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -99.81 -178.39 30.76 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.578 1.561 . . . . 0.0 110.831 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 46.0 pt -74.09 -26.72 21.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 O-C-N 121.403 -1.057 . . . . 0.0 113.179 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.03 -3.5 23.12 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.711 2.004 . . . . 0.0 113.95 -178.344 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.419 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.0 m-20 -68.04 116.58 8.83 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 106.322 -1.733 . . . . 0.0 106.322 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -73.61 127.69 33.45 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.495 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.6 t80 -48.97 -45.64 42.38 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 124.499 1.12 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -63.98 -38.66 91.89 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.467 0.707 . . . . 0.0 110.879 178.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.9 tp60 -66.81 -20.74 66.0 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.772 1.229 . . . . 0.0 110.448 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.528 HD13 HD12 ' A' ' 32' ' ' ILE . 11.3 mt -89.39 7.13 3.81 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.023 0 O-C-N 120.98 -1.075 . . . . 0.0 108.118 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.94 0.64 87.31 Favored Glycine 0 CA--C 1.529 0.928 0 O-C-N 119.631 -1.918 . . . . 0.0 113.676 179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.45 139.51 30.61 Favored Glycine 0 C--N 1.337 0.586 0 N-CA-C 108.148 -1.981 . . . . 0.0 108.148 179.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.425 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 24.5 p80 -121.99 175.19 6.45 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 121.161 -1.199 . . . . 0.0 108.434 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.89 -49.87 10.72 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.053 0.941 . . . . 0.0 112.94 -178.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.8 tp -57.32 -45.04 84.64 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 118.172 0.442 . . . . 0.0 111.907 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.425 ' HE3' ' NE2' ' A' ' 44' ' ' HIS . 16.6 mmtp -64.64 -42.38 95.51 Favored 'General case' 0 C--O 1.223 -0.297 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.96 -45.0 79.02 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 124.832 1.253 . . . . 0.0 111.265 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 17.4 mmt -55.65 -42.83 75.61 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 123.819 0.848 . . . . 0.0 110.193 179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.59 -38.6 91.56 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.838 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.9 t -64.25 -48.49 85.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.54 -28.25 59.62 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.514 0.726 . . . . 0.0 111.169 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.08 -50.56 47.15 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.927 0.785 . . . . 0.0 110.081 179.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.9 mt-30 -68.27 -36.53 79.55 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.05 0.929 . . . . 0.0 110.328 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.8 t -67.3 -45.67 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.96 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.63 -40.16 86.71 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.701 -0.8 . . . . 0.0 111.021 -178.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.4 ptp180 -75.87 -31.22 59.16 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 89.4 mt-10 -84.97 -48.24 9.46 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.324 0.583 . . . . 0.0 110.551 -178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -87.07 -1.63 58.03 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.005 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 43.5 mt-30 52.33 39.01 26.47 Favored 'General case' 0 C--N 1.345 0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 111.089 179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -149.9 138.26 14.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 -177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 58.5 tt0 -77.55 125.08 28.77 Favored 'General case' 0 N--CA 1.445 -0.675 0 CA-C-O 121.975 0.893 . . . . 0.0 110.172 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.8 tt -113.82 91.87 23.19 Favored Pre-proline 0 N--CA 1.446 -0.626 0 N-CA-C 102.212 -3.255 . . . . 0.0 102.212 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.42 155.32 70.66 Favored 'Trans proline' 0 N--CA 1.45 -1.059 0 C-N-CA 121.424 1.416 . . . . 0.0 110.935 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 23.6 tp -52.15 -28.83 19.45 Favored 'General case' 0 CA--C 1.515 -0.38 0 C-N-CA 125.126 1.37 . . . . 0.0 111.686 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 58.5 mtpt -52.68 -44.35 66.17 Favored 'General case' 0 CA--C 1.51 -0.582 0 C-N-CA 123.554 0.742 . . . . 0.0 112.236 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 80' ' ' TYR . 48.4 t -80.84 -37.91 16.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.49 -44.56 95.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.208 0.603 . . . . 0.0 110.491 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.21 -40.8 26.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.561 1.545 . . . . 0.0 110.934 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.2 -36.01 71.75 Favored 'General case' 0 C--O 1.234 0.249 0 C-N-CA 120.027 -0.669 . . . . 0.0 111.992 -178.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -134.25 70.65 73.23 Favored Pre-proline 0 CA--C 1.536 0.415 0 C-N-CA 123.66 0.784 . . . . 0.0 110.161 -179.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -74.12 59.35 4.47 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 124.562 3.508 . . . . 0.0 111.908 -179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -141.96 147.9 37.73 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.878 1.672 . . . . 0.0 109.396 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 24.6 mm -58.45 -42.79 85.21 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.09 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 177.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -52.78 -49.07 66.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.9 0.381 . . . . 0.0 110.869 179.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.27 -40.4 90.07 Favored 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.3 mt -73.05 -38.5 66.48 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.47 -51.28 69.07 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-N 118.385 0.538 . . . . 0.0 110.208 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -71.13 -39.38 72.03 Favored 'General case' 0 CA--C 1.531 0.218 0 O-C-N 123.239 0.337 . . . . 0.0 111.795 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.419 ' CE2' HG21 ' A' ' 67' ' ' VAL . 48.6 t80 -63.75 -47.37 81.29 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-O 121.195 0.522 . . . . 0.0 110.018 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 86.2 t -68.21 -37.38 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.95 -46.74 88.44 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.632 1.105 . . . . 0.0 112.082 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 13.8 t -63.41 -17.38 62.59 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 118.28 0.491 . . . . 0.0 110.467 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 32.7 mtt-85 -98.58 -29.23 13.18 Favored 'General case' 0 C--N 1.342 0.277 0 O-C-N 120.953 -1.092 . . . . 0.0 112.05 178.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 50.9 p -77.2 -4.68 45.93 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 118.988 0.813 . . . . 0.0 110.868 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 66.4 m-70 -114.32 173.54 6.4 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 128.195 2.598 . . . . 0.0 108.735 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 24.9 m-70 -107.65 172.52 6.79 Favored 'General case' 0 C--N 1.332 -0.188 0 C-N-CA 124.192 0.997 . . . . 0.0 108.731 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 31.1 p80 -147.35 5.72 0.83 Allowed 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.383 0.673 . . . . 0.0 112.809 179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -149.2 102.85 3.27 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 18.7 t-80 -153.18 116.26 4.58 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 . . . . . 0 C--O 1.252 1.186 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.162 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 CA--C 1.532 0.403 0 N-CA-C 112.664 0.217 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 26.8 m -49.76 161.89 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 129.27 3.028 . . . . 0.0 115.666 -178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 m -91.85 89.18 6.93 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 102.417 -3.179 . . . . 0.0 102.417 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -136.7 5.77 2.91 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.796 0.838 . . . . 0.0 112.552 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -74.76 155.84 37.21 Favored 'General case' 0 C--O 1.238 0.483 0 O-C-N 120.77 -1.206 . . . . 0.0 112.112 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 71.3 mt-30 -82.5 171.23 14.35 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.489 ' HA ' HD21 ' A' ' 35' ' ' LEU . 38.6 t80 -51.36 135.42 27.01 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 115.396 1.628 . . . . 0.0 115.396 -178.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.0 t -147.92 117.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.166 0 N-CA-C 106.506 -1.665 . . . . 0.0 106.506 178.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.22 162.18 14.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 124.378 1.071 . . . . 0.0 110.228 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.15 151.02 84.68 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.382 2.054 . . . . 0.0 112.001 -179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -131.75 -6.02 3.62 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 123.965 0.906 . . . . 0.0 111.995 -179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -117.38 140.09 50.02 Favored 'General case' 0 C--N 1.345 0.376 0 N-CA-C 102.938 -2.986 . . . . 0.0 102.938 177.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -52.15 -33.81 41.98 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.4 t -72.82 -38.12 56.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 118.847 0.749 . . . . 0.0 109.667 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -63.9 -38.76 92.29 Favored 'General case' 0 C--O 1.222 -0.385 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.4 t -61.93 -46.65 88.41 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.598 1.159 . . . . 0.0 109.593 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -56.56 -58.13 9.38 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.893 0.877 . . . . 0.0 111.122 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.4 mp -63.76 -36.35 83.59 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 118.502 -0.761 . . . . 0.0 112.017 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.17 -27.17 63.59 Favored 'General case' 0 N--CA 1.456 -0.146 0 C-N-CA 123.424 0.689 . . . . 0.0 110.764 178.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -75.15 -48.39 23.86 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.4 mm -54.39 -41.42 53.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.126 1.371 . . . . 0.0 111.151 -178.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.6 m0 -61.97 -42.22 98.88 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.729 0.812 . . . . 0.0 111.558 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.1 mt-10 -58.64 -46.05 87.95 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.5 mmm-85 -62.27 -23.92 66.97 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 118.054 -0.974 . . . . 0.0 112.929 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.2 t -92.4 -55.92 5.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 119.929 1.241 . . . . 0.0 109.445 179.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.2 mt -66.36 -23.87 66.41 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.82 33.75 57.26 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.259 -0.736 . . . . 0.0 111.259 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.99 174.11 9.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.8 p -134.7 132.08 38.43 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.307 1.443 . . . . 0.0 107.698 178.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 109.71 45.74 0.95 Allowed Glycine 0 N--CA 1.466 0.651 0 C-N-CA 123.966 0.793 . . . . 0.0 113.21 179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 45.2 mm -75.2 121.89 27.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.87 179.86 35.68 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.3 0.952 . . . . 0.0 111.029 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.5 pt -81.69 -21.01 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 O-C-N 120.45 -1.618 . . . . 0.0 112.24 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.489 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -107.82 1.95 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.137 1.775 . . . . 0.0 113.418 -178.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -61.66 122.44 15.31 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 122.931 1.348 . . . . 0.0 111.828 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -81.02 108.34 14.61 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.529 ' HA ' HD12 ' A' ' 41' ' ' ILE . 76.1 t80 -44.88 -45.15 10.14 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.974 1.709 . . . . 0.0 113.718 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -73.73 -27.83 61.39 Favored 'General case' 0 CA--C 1.536 0.427 0 O-C-N 121.537 -0.727 . . . . 0.0 111.193 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -67.37 -30.25 69.99 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.529 HD12 ' HA ' ' A' ' 38' ' ' PHE . 16.2 mt -77.37 6.91 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.986 0 C-N-CA 126.484 1.914 . . . . 0.0 109.984 179.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.98 3.35 79.84 Favored Glycine 0 C--N 1.336 0.571 0 O-C-N 119.659 -1.901 . . . . 0.0 112.123 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.58 157.98 47.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 107.817 -2.113 . . . . 0.0 107.817 178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.451 ' NE2' ' HE2' ' A' ' 47' ' ' LYS . 18.6 p80 -147.06 178.59 8.25 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.61 -54.63 5.93 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 124.913 1.285 . . . . 0.0 112.247 -179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.04 -45.8 75.26 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.451 ' HE2' ' NE2' ' A' ' 44' ' ' HIS . 64.8 mmtt -64.41 -44.07 92.41 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.67 -40.09 68.74 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.309 1.044 . . . . 0.0 111.459 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 59.7 mtm -65.68 -35.47 80.85 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 122.524 0.33 . . . . 0.0 111.168 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.68 -41.95 78.49 Favored 'General case' 0 CA--C 1.521 -0.149 0 C-N-CA 123.949 0.9 . . . . 0.0 111.612 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.0 t -65.01 -41.68 92.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.46 -30.74 70.79 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.463 0.705 . . . . 0.0 111.484 178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.95 -49.76 48.61 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.6 mm100 -60.59 -38.59 85.16 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.6 t -65.93 -46.36 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.305 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.85 -40.93 90.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 C-N-CA 120.215 -0.594 . . . . 0.0 110.52 -178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 11.1 ptm180 -75.69 -29.37 58.99 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -85.83 -48.44 8.76 Favored 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.443 ' HB2' HG12 ' A' ' 61' ' ' VAL . 53.1 m-85 -96.23 2.16 52.73 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.825 0.85 . . . . 0.0 111.505 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 55.85 31.83 18.46 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 123.264 0.626 . . . . 0.0 111.877 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.443 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.8 p -133.87 128.99 54.29 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 C-N-CA 123.317 0.647 . . . . 0.0 112.601 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.54 124.98 25.54 Favored 'General case' 0 N--CA 1.442 -0.845 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 177.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 63.6 tp -112.22 87.63 9.39 Favored Pre-proline 0 N--CA 1.452 -0.347 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 178.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.05 156.81 64.42 Favored 'Trans proline' 0 N--CA 1.448 -1.192 0 C-N-CA 120.753 0.969 . . . . 0.0 110.783 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.32 -27.54 65.98 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.261 1.024 . . . . 0.0 110.633 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -56.77 -29.08 62.28 Favored 'General case' 0 C--O 1.221 -0.413 0 CA-C-N 118.961 0.8 . . . . 0.0 111.079 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 80' ' ' TYR . 49.4 t -86.64 -43.5 16.11 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.29 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.47 -49.06 79.24 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 123.055 0.542 . . . . 0.0 111.159 -178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -74.22 -29.12 61.57 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 118.37 -0.824 . . . . 0.0 112.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.62 -29.91 27.33 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-N 118.635 0.652 . . . . 0.0 112.085 -179.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.7 mt-30 -138.58 68.02 44.73 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 124.418 1.087 . . . . 0.0 109.213 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -74.78 57.95 4.58 Favored 'Trans proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.56 2.84 . . . . 0.0 114.88 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.16 148.21 37.89 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 119.383 0.992 . . . . 0.0 110.558 178.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -56.28 -44.08 78.56 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.262 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -52.31 -49.66 63.76 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 118.894 0.77 . . . . 0.0 111.42 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.05 -43.18 99.27 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.2 mt -73.05 -43.09 62.4 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 125.262 1.425 . . . . 0.0 108.516 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.26 -44.82 88.55 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -73.31 -37.12 66.3 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 123.253 0.621 . . . . 0.0 111.493 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.411 ' CE2' HG21 ' A' ' 67' ' ' VAL . 17.3 t80 -65.51 -41.11 93.52 Favored 'General case' 0 CA--C 1.528 0.129 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -73.16 -43.6 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.116 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.69 90.64 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.188 -0.945 . . . . 0.0 111.577 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -68.57 -15.86 63.67 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.328 0.651 . . . . 0.0 112.23 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 53.6 mtt-85 -101.07 -31.92 10.84 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.105 -0.997 . . . . 0.0 110.129 178.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 37.9 t -67.61 4.3 1.12 Allowed 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.85 2.46 . . . . 0.0 111.51 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -137.1 82.26 1.92 Allowed 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 30.6 t60 -75.76 -47.76 24.6 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -77.33 -172.59 2.52 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.214 1.006 . . . . 0.0 109.315 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 52.1 m170 -112.97 -6.69 13.75 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 123.975 0.91 . . . . 0.0 112.487 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 17.3 t60 -124.25 156.16 37.35 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 125.192 1.397 . . . . 0.0 108.569 179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 33.6 m170 . . . . . 0 C--O 1.245 0.823 0 CA-C-O 117.347 -1.311 . . . . 0.0 107.773 179.459 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo . . . . . 0 N--CA 1.479 0.619 0 CA-C-O 119.73 -0.196 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.35 174.55 11.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 C-N-CA 124.847 1.259 . . . . 0.0 110.498 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.1 m -114.09 143.28 45.04 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 125.528 1.531 . . . . 0.0 107.151 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -123.88 8.54 8.74 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.438 0.695 . . . . 0.0 111.568 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -67.13 165.85 15.12 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.564 1.146 . . . . 0.0 111.141 178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.8 mm100 -76.27 170.66 15.91 Favored 'General case' 0 C--O 1.224 -0.248 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -42.95 124.5 3.17 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.4 1.88 . . . . 0.0 114.967 -179.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.0 t -146.86 116.94 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 177.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.04 161.62 15.57 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.109 1.763 . . . . 0.0 112.672 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.06 148.47 93.1 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.625 2.883 . . . . 0.0 112.65 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.9 p -114.66 -21.14 10.38 Favored 'General case' 0 C--O 1.233 0.236 0 C-N-CA 125.255 1.422 . . . . 0.0 113.656 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -109.97 162.86 14.11 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-O 121.042 0.449 . . . . 0.0 110.377 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.58 -34.28 77.89 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.837 1.655 . . . . 0.0 110.612 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 91.3 t -73.1 -50.99 28.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 -179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -55.75 -43.4 76.61 Favored 'General case' 0 C--N 1.333 -0.142 0 C-N-CA 126.342 1.857 . . . . 0.0 109.427 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 22.5 t -65.52 -32.96 74.84 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.248 -0.882 . . . . 0.0 112.328 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.7 mmtt -68.45 -48.7 63.85 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 119.786 1.176 . . . . 0.0 108.896 -179.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mt -57.65 -41.86 82.31 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 124.086 0.955 . . . . 0.0 110.918 -179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.14 -30.02 67.84 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.207 1.003 . . . . 0.0 111.95 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -77.42 -37.35 51.96 Favored 'General case' 0 CA--C 1.523 -0.096 0 CA-C-N 118.937 0.79 . . . . 0.0 110.127 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.3 mm -60.89 -40.17 84.39 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 O-C-N 121.518 -0.739 . . . . 0.0 109.76 -178.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.3 m0 -59.41 -39.21 82.69 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.302 0.641 . . . . 0.0 111.874 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 92.2 mt-10 -63.69 -32.84 74.45 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.495 0.718 . . . . 0.0 110.902 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -68.01 -35.7 78.73 Favored 'General case' 0 N--CA 1.472 0.647 0 O-C-N 120.817 -1.177 . . . . 0.0 111.484 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 39.7 t -88.22 -54.83 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 123.27 0.628 . . . . 0.0 110.838 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.5 mt -75.18 -24.83 57.91 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 -177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.4 21.67 69.3 Favored Glycine 0 CA--C 1.528 0.885 0 CA-C-N 119.426 1.012 . . . . 0.0 113.806 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 19.4 m -105.15 175.15 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.505 1.122 . . . . 0.0 110.458 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.2 t -139.32 112.75 8.28 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 179.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 116.35 62.8 0.34 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 123.202 0.429 . . . . 0.0 112.435 178.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 46.7 mm -86.63 137.83 20.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.83 177.19 18.67 Favored Glycine 0 N--CA 1.442 -0.944 0 C-N-CA 124.89 1.233 . . . . 0.0 111.741 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 38.1 pt -78.87 -22.42 12.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 O-C-N 121.082 -1.246 . . . . 0.0 113.41 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.416 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.72 0.78 22.58 Favored 'General case' 0 C--O 1.232 0.184 0 N-CA-C 115.811 1.782 . . . . 0.0 115.811 -178.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . 0.251 34.9 p30 -76.11 129.56 36.98 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 123.192 1.472 . . . . 0.0 112.706 -178.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -74.1 111.59 9.41 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 114.267 -1.333 . . . . 0.0 108.849 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.452 ' HA ' HD12 ' A' ' 41' ' ' ILE . 85.4 t80 -43.46 -45.94 6.59 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.737 1.615 . . . . 0.0 112.604 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 65.4 m-85 -66.99 -37.02 83.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 43.3 tt0 -67.62 -31.45 71.48 Favored 'General case' 0 N--CA 1.458 -0.057 0 C-N-CA 123.652 0.781 . . . . 0.0 109.98 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 38' ' ' PHE . 24.2 mt -71.98 -6.26 7.4 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.881 0 C-N-CA 124.286 1.034 . . . . 0.0 109.27 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.39 10.24 27.78 Favored Glycine 0 C--N 1.34 0.758 0 C-N-CA 126.024 1.774 . . . . 0.0 112.908 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -77.9 159.31 47.46 Favored Glycine 0 CA--C 1.529 0.92 0 CA-C-N 118.878 1.339 . . . . 0.0 110.111 179.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . 0.436 ' NE2' ' HE3' ' A' ' 47' ' ' LYS . 20.1 p80 -146.86 178.07 8.62 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.344 1.458 . . . . 0.0 107.906 179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.57 -54.75 5.77 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.633 1.173 . . . . 0.0 112.739 -178.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.2 tt -54.95 -50.54 68.62 Favored 'General case' 0 CA--C 1.516 -0.33 0 C-N-CA 123.857 0.863 . . . . 0.0 110.042 -179.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.621 ' O ' HG23 ' A' ' 51' ' ' VAL . 32.2 mmtp -61.86 -39.31 91.41 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 117.893 -1.051 . . . . 0.0 111.149 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.09 -44.96 96.57 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 119.497 1.044 . . . . 0.0 108.847 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 71.4 mtm -66.69 -37.45 84.75 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.942 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.26 -39.31 92.47 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.221 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 47' ' ' LYS . 1.9 t -72.65 -45.78 56.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.212 0 CA-C-N 119.691 1.132 . . . . 0.0 108.057 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.32 -32.74 57.35 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.938 0.895 . . . . 0.0 111.203 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.04 -37.03 83.37 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 118.213 0.461 . . . . 0.0 111.064 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -77.74 -43.33 31.22 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 122.002 0.906 . . . . 0.0 108.885 179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t -59.78 -46.46 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.989 0 C-N-CA 124.049 0.94 . . . . 0.0 109.605 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 0.8 OUTLIER -60.61 -41.08 94.09 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 119.911 -0.716 . . . . 0.0 110.778 -178.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -75.53 -32.39 60.45 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.298 1.222 . . . . 0.0 114.298 -178.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 59.2 mm-40 -82.51 -45.99 13.99 Favored 'General case' 0 C--N 1.328 -0.37 0 C-N-CA 123.219 0.607 . . . . 0.0 111.873 -177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.481 ' HB2' HG12 ' A' ' 61' ' ' VAL . 71.9 m-85 -93.96 -3.01 52.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 118.26 -0.876 . . . . 0.0 112.899 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 53.82 46.97 24.66 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.754 1.221 . . . . 0.0 108.761 -178.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.481 HG12 ' HB2' ' A' ' 59' ' ' TYR . 8.6 p -140.08 126.97 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.255 0 N-CA-C 113.665 0.987 . . . . 0.0 113.665 -178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.434 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 48.0 tt0 -73.04 115.0 11.84 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 178.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tt -114.66 88.54 16.47 Favored Pre-proline 0 N--CA 1.448 -0.527 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.81 153.85 63.9 Favored 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 121.05 1.167 . . . . 0.0 109.725 179.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -51.84 -26.36 9.78 Favored 'General case' 0 C--O 1.223 -0.306 0 C-N-CA 126.855 2.062 . . . . 0.0 110.35 179.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 35.9 mtpt -52.29 -44.35 64.97 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.616 1.166 . . . . 0.0 110.641 179.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.46 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 56.5 t -77.66 -45.72 28.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 123.566 0.747 . . . . 0.0 109.085 -178.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.43 -42.62 74.41 Favored 'General case' 0 N--CA 1.461 0.107 0 C-N-CA 123.453 0.701 . . . . 0.0 110.716 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -81.25 -37.45 28.52 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 118.154 -0.926 . . . . 0.0 111.281 178.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.44 98.81 Favored 'General case' 0 CA--C 1.516 -0.344 0 C-N-CA 119.663 -0.815 . . . . 0.0 110.336 -178.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -137.64 83.38 25.05 Favored Pre-proline 0 N--CA 1.448 -0.56 0 O-C-N 124.396 1.06 . . . . 0.0 109.222 -177.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -75.46 60.77 5.86 Favored 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.164 2.576 . . . . 0.0 110.95 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -142.18 148.66 38.59 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 120.972 1.715 . . . . 0.0 111.439 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 21.2 mm -57.17 -43.01 80.89 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.284 0 CA-C-O 118.126 -0.94 . . . . 0.0 108.83 178.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 26.0 ttpp -56.55 -48.99 76.11 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 118.864 0.756 . . . . 0.0 111.587 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.69 -41.45 86.24 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.148 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.1 mt -73.4 -42.25 62.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.04 -49.26 76.36 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.703 1.201 . . . . 0.0 110.849 179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.74 -37.88 64.94 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.894 0.77 . . . . 0.0 110.311 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.46 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 43.8 t80 -63.31 -48.08 79.56 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 118.535 0.607 . . . . 0.0 110.929 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.432 HG13 HG11 ' A' ' 61' ' ' VAL . 28.8 t -69.7 -40.82 79.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.96 -37.11 86.57 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 118.998 0.817 . . . . 0.0 112.528 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.2 t -73.16 -13.93 61.27 Favored 'General case' 0 CA--C 1.533 0.318 0 CA-C-N 118.231 0.469 . . . . 0.0 110.118 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 11.8 mtt180 -97.75 -39.74 8.9 Favored 'General case' 0 C--O 1.225 -0.201 0 CA-C-N 119.542 1.064 . . . . 0.0 109.684 177.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 10.2 t -68.29 -39.95 81.94 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.888 0.875 . . . . 0.0 111.793 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 14.6 m-70 -97.8 108.47 21.19 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.613 0.765 . . . . 0.0 109.874 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -80.58 104.22 10.96 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.0 t-80 -94.91 107.11 19.13 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 123.674 0.789 . . . . 0.0 109.333 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -76.94 170.96 15.55 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 124.419 1.088 . . . . 0.0 108.271 179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -131.05 62.49 1.62 Allowed 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.15 1.38 . . . . 0.0 108.452 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 . . . . . 0 C--O 1.251 1.161 0 N-CA-C 103.226 -2.879 . . . . 0.0 103.226 178.845 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo . . . . . 0 N--CA 1.48 0.715 0 CA-C-O 120.927 0.303 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.17 -33.46 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 CA-C-O 122.539 1.162 . . . . 0.0 109.795 178.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.27 141.82 57.09 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 131.226 3.811 . . . . 0.0 107.097 179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 66.62 3.0 2.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.166 1.386 . . . . 0.0 113.57 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -49.75 126.29 13.52 Favored 'General case' 0 C--O 1.238 0.469 0 CA-C-N 119.556 1.071 . . . . 0.0 111.505 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -58.48 146.14 36.38 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 127.357 2.263 . . . . 0.0 110.784 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -48.11 125.47 9.24 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 127.806 2.442 . . . . 0.0 110.48 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.2 t -135.22 117.39 21.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.345 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.47 152.89 72.18 Favored Pre-proline 0 C--O 1.239 0.542 0 C-N-CA 124.056 0.942 . . . . 0.0 111.458 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -65.49 151.57 84.52 Favored 'Trans proline' 0 N--CA 1.457 -0.618 0 C-N-CA 122.951 2.434 . . . . 0.0 111.081 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.1 p -129.2 -13.87 4.4 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 124.719 1.208 . . . . 0.0 111.229 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.484 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 25.0 t-20 -90.08 152.09 21.32 Favored 'General case' 0 C--O 1.238 0.465 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 178.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.91 -30.28 70.78 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 122.899 0.48 . . . . 0.0 110.162 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 90.2 t -78.28 -51.01 18.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 125.734 1.614 . . . . 0.0 110.833 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 2.1 mt-10 -55.37 -37.96 68.21 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.132 0.573 . . . . 0.0 110.089 -178.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 t -59.97 -52.29 66.05 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 123.843 0.714 . . . . 0.0 109.619 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.675 ' HA ' ' HE2' ' A' ' 18' ' ' LYS . 9.4 mmpt? -56.5 -49.2 75.4 Favored 'General case' 0 CA--C 1.512 -0.481 0 N-CA-C 113.302 0.853 . . . . 0.0 113.302 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.75 -38.8 92.21 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 117.486 -1.245 . . . . 0.0 111.075 178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.15 -30.09 70.99 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.76 0.709 . . . . 0.0 110.174 178.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -62.98 -44.08 97.01 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 78.2 mt -63.52 -39.23 84.57 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.138 0 C-N-CA 124.689 1.196 . . . . 0.0 109.586 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -55.46 -43.85 75.86 Favored 'General case' 0 CA--C 1.528 0.13 0 CA-C-N 118.868 0.758 . . . . 0.0 109.967 179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -61.4 -32.28 72.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 118.745 0.702 . . . . 0.0 110.643 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 52.2 mtp180 -76.22 -16.36 59.84 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 120.486 -1.384 . . . . 0.0 112.629 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.0 t -106.04 -36.23 3.5 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.641 0.776 . . . . 0.0 110.078 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 94.9 mt -88.19 -42.13 12.51 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.971 1.308 . . . . 0.0 111.537 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.75 40.32 7.24 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-O 118.394 -1.226 . . . . 0.0 110.948 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . 0.253 3.4 m -128.24 177.22 6.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 118.664 1.232 . . . . 0.0 108.686 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.3 t -143.59 108.26 4.88 Favored 'General case' 0 C--O 1.235 0.335 0 O-C-N 119.981 -1.7 . . . . 0.0 108.233 178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.97 41.93 0.15 Allowed Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.453 1.501 . . . . 0.0 114.167 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.592 HD12 HD13 ' A' ' 41' ' ' ILE . 39.5 mm -76.42 145.38 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 120.193 1.997 . . . . 0.0 108.507 178.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -116.03 175.5 15.88 Favored Glycine 0 C--N 1.336 0.565 0 C-N-CA 126.389 1.947 . . . . 0.0 110.079 178.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 23.9 pt -75.63 -30.83 22.19 Favored 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.433 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -101.13 -0.52 36.01 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.523 1.129 . . . . 0.0 113.382 -178.368 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.585 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.2 m-20 -69.53 116.59 10.12 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 -178.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -67.45 117.57 9.61 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.629 -1.249 . . . . 0.0 107.629 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 84.3 t80 -45.94 -45.58 15.62 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.542 1.537 . . . . 0.0 111.893 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -70.67 -29.77 66.19 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.45 0.7 . . . . 0.0 112.53 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -76.91 -30.29 56.08 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.51 -0.744 . . . . 0.0 110.39 178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.592 HD13 HD12 ' A' ' 32' ' ' ILE . 32.3 mt -70.72 -31.05 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-N 118.264 0.484 . . . . 0.0 110.389 -178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 140.58 -2.45 2.23 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.907 1.242 . . . . 0.0 111.651 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -70.7 157.83 53.59 Favored Glycine 0 C--N 1.338 0.665 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 12.5 p80 -136.66 172.96 12.24 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 179.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.83 -45.92 20.5 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 123.336 0.654 . . . . 0.0 112.47 -179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.2 tp -59.03 -49.29 78.46 Favored 'General case' 0 C--N 1.339 0.125 0 CA-C-N 118.517 0.598 . . . . 0.0 110.719 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.9 mmtp -60.64 -38.83 86.1 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-O 117.858 -1.067 . . . . 0.0 110.395 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -35.23 62.1 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 119.844 1.202 . . . . 0.0 111.006 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 14.6 mtm -73.85 -42.06 61.36 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.7 -34.55 74.53 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.082 1.353 . . . . 0.0 111.327 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 93.5 t -67.9 -53.57 29.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.98 -36.28 65.21 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.081 0.952 . . . . 0.0 112.316 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.21 -52.49 65.36 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.692 0.797 . . . . 0.0 111.565 -179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -75.72 -33.27 60.3 Favored 'General case' 0 C--N 1.331 -0.205 0 O-C-N 121.635 -0.666 . . . . 0.0 111.799 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t -65.99 -44.09 92.38 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 124.658 1.183 . . . . 0.0 108.909 179.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -59.35 -41.08 88.41 Favored 'General case' 0 CA--C 1.504 -0.791 0 CA-C-N 118.611 0.641 . . . . 0.0 110.261 -178.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.1 ptp180 -75.69 -34.44 60.41 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 114.491 1.293 . . . . 0.0 114.491 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -79.89 -48.16 13.91 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 123.802 0.689 . . . . 0.0 111.585 -178.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.417 ' CB ' HG12 ' A' ' 61' ' ' VAL . 23.7 m-85 -91.34 3.18 55.52 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 119.418 -0.325 . . . . 0.0 111.165 -179.495 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 48.8 38.81 12.67 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.269 1.428 . . . . 0.0 110.445 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.633 HG11 HG13 ' A' ' 81' ' ' VAL . 7.3 p -143.46 117.65 3.8 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.201 0 C-N-CA 123.678 0.791 . . . . 0.0 110.14 -177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -64.12 140.01 58.82 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 -179.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 tt -120.38 84.54 35.44 Favored Pre-proline 0 C--O 1.233 0.224 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 178.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -62.85 144.81 94.16 Favored 'Trans proline' 0 N--CA 1.445 -1.376 0 N-CA-C 109.198 -1.116 . . . . 0.0 109.198 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.33 -27.3 14.81 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.885 1.274 . . . . 0.0 110.462 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -53.28 -35.11 59.73 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 124.38 1.072 . . . . 0.0 111.262 179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 10.8 t -87.97 -44.24 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.337 0 CA-C-N 119.121 0.873 . . . . 0.0 109.135 179.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.98 -51.63 63.29 Favored 'General case' 0 C--O 1.223 -0.34 0 C-N-CA 123.536 0.734 . . . . 0.0 110.796 -178.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -71.57 -37.91 70.99 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 123.295 0.638 . . . . 0.0 111.573 179.922 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.08 -37.6 84.25 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.855 -0.338 . . . . 0.0 111.75 -177.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -138.86 78.6 29.82 Favored Pre-proline 0 N--CA 1.449 -0.485 0 C-N-CA 124.861 1.264 . . . . 0.0 108.653 -178.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -77.55 55.39 5.14 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.846 3.031 . . . . 0.0 111.043 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.25 147.16 47.41 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 119.194 0.906 . . . . 0.0 110.098 -179.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.414 HD13 ' HA ' ' A' ' 74' ' ' ILE . 4.5 mm -61.17 -39.3 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.31 -51.2 60.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.83 0.824 . . . . 0.0 111.867 179.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.05 -42.31 97.08 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 125.695 1.598 . . . . 0.0 114.212 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.1 -40.4 65.01 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.847 1.259 . . . . 0.0 108.417 -179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.28 -51.75 68.22 Favored 'General case' 0 C--O 1.222 -0.347 0 CA-C-N 119.028 0.831 . . . . 0.0 109.385 -179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -65.77 -38.5 89.23 Favored 'General case' 0 C--O 1.233 0.216 0 C-N-CA 122.497 0.319 . . . . 0.0 111.622 -179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -66.93 -51.97 48.75 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.246 1.018 . . . . 0.0 110.377 179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.633 HG13 HG11 ' A' ' 61' ' ' VAL . 70.9 t -66.42 -41.84 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 O-C-N 123.346 0.404 . . . . 0.0 110.165 -179.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.85 -48.18 78.67 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.699 1.0 . . . . 0.0 113.699 -178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.1 t -70.9 -24.91 62.57 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 117.68 0.218 . . . . 0.0 110.568 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 48.6 mtt-85 -77.09 -40.73 44.96 Favored 'General case' 0 N--CA 1.461 0.12 0 O-C-N 120.687 -1.258 . . . . 0.0 108.694 178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 1.6 t -78.41 3.43 15.81 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.285 1.034 . . . . 0.0 112.308 179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 20.8 t-80 -49.17 116.31 1.64 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.981 2.113 . . . . 0.0 111.942 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -74.29 65.1 1.16 Allowed 'General case' 0 C--O 1.239 0.543 0 C-N-CA 126.393 1.877 . . . . 0.0 111.447 179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -78.65 76.15 5.15 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 125.239 1.415 . . . . 0.0 107.737 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 -154.16 -69.12 0.14 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 10.8 t60 -78.17 -5.39 51.6 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.26 1.824 . . . . 0.0 112.229 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.25 1.113 0 C-N-CA 127.322 2.249 . . . . 0.0 107.263 -179.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo . . . . . 0 CA--C 1.532 0.422 0 N-CA-C 110.325 -0.683 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.0 m -137.07 162.01 34.66 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 C-N-CA 123.319 0.648 . . . . 0.0 109.264 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.7 p -85.66 62.22 7.33 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 178.107 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 55.26 10.6 0.46 Allowed 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.91 2.484 . . . . 0.0 113.998 -179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -53.46 -10.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 129.032 2.933 . . . . 0.0 118.182 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -68.33 144.36 54.83 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -52.01 123.33 10.19 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 123.551 0.741 . . . . 0.0 111.638 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -138.37 117.26 13.92 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 106.905 -1.516 . . . . 0.0 106.905 178.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.29 160.07 44.08 Favored Pre-proline 0 CA--C 1.544 0.726 0 C-N-CA 125.356 1.462 . . . . 0.0 110.101 178.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -60.33 145.16 99.18 Favored 'Trans proline' 0 CA--C 1.535 0.544 0 C-N-CA 123.887 3.058 . . . . 0.0 113.353 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.2 t -116.65 -11.67 10.99 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.841 1.256 . . . . 0.0 112.391 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 16.3 t30 -125.3 145.4 50.03 Favored 'General case' 0 CA--C 1.517 -0.327 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.33 -29.31 9.57 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.372 1.069 . . . . 0.0 112.863 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 46.9 t -67.47 -53.82 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 121.673 0.749 . . . . 0.0 109.58 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -55.85 -42.96 76.62 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.605 1.962 . . . . 0.0 109.272 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.7 t -66.08 -31.82 72.91 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-O 118.542 -0.742 . . . . 0.0 112.424 -179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -72.31 -40.37 67.56 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 120.038 1.29 . . . . 0.0 109.761 -179.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 6.5 mt -69.07 -39.07 79.3 Favored 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 118.145 -0.931 . . . . 0.0 112.079 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.83 -33.83 70.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 O-C-N 124.487 1.117 . . . . 0.0 111.063 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -69.55 -40.79 76.62 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-N 117.999 0.363 . . . . 0.0 111.171 -179.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 25.4 mm -62.18 -36.39 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -62.49 -35.64 80.0 Favored 'General case' 0 CA--C 1.534 0.337 0 O-C-N 121.652 -0.655 . . . . 0.0 109.659 178.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.7 mt-10 -66.54 -39.9 88.82 Favored 'General case' 0 C--O 1.226 -0.168 0 O-C-N 121.59 -0.694 . . . . 0.0 109.624 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -65.84 -38.81 89.87 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.965 0.728 . . . . 0.0 112.965 -179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.446 HG21 HG22 ' A' ' 51' ' ' VAL . 48.8 t -81.37 -44.57 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.0 mt -85.91 -24.03 26.77 Favored 'General case' 0 C--N 1.333 -0.141 0 C-N-CA 123.055 0.542 . . . . 0.0 112.128 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.29 31.15 59.61 Favored Glycine 0 CA--C 1.528 0.883 0 CA-C-O 119.268 -0.74 . . . . 0.0 111.906 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 t -125.27 171.33 14.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 179.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.7 p -143.04 138.22 29.8 Favored 'General case' 0 C--O 1.241 0.619 0 CA-C-N 119.954 1.252 . . . . 0.0 111.521 -179.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.34 42.6 1.05 Allowed Glycine 0 CA--C 1.522 0.526 0 C-N-CA 124.978 1.275 . . . . 0.0 110.154 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.2 mm -76.49 121.55 28.88 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 C-N-CA 123.786 0.834 . . . . 0.0 109.68 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 36' ' ' ASP . . . -90.97 169.31 33.48 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.67 1.129 . . . . 0.0 110.67 178.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.3 pt -71.28 -25.94 26.07 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 O-C-N 121.099 -1.236 . . . . 0.0 111.973 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.445 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.28 1.03 32.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 127.069 2.147 . . . . 0.0 112.724 -179.631 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.676 ' HB3' HD11 ' A' ' 41' ' ' ILE . 10.8 m-20 -65.68 116.73 7.21 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 124.15 0.98 . . . . 0.0 108.559 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -74.78 112.83 11.39 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.586 ' HA ' HD12 ' A' ' 41' ' ' ILE . 83.0 t80 -43.08 -52.46 5.38 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 125.503 1.521 . . . . 0.0 112.471 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -60.74 -33.02 72.28 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.319 -0.863 . . . . 0.0 111.666 -179.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 20.5 tt0 -68.65 -23.09 64.38 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.117 0.967 . . . . 0.0 110.461 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 36' ' ' ASP . 15.2 mt -84.25 14.01 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 125.339 1.456 . . . . 0.0 109.157 179.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.11 9.6 70.21 Favored Glycine 0 CA--C 1.526 0.778 0 O-C-N 119.368 -2.083 . . . . 0.0 113.721 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -75.07 170.51 54.31 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 118.306 1.053 . . . . 0.0 112.047 179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -155.08 176.7 12.2 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.957 1.303 . . . . 0.0 108.03 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -50.92 -46.09 60.66 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.558 0.743 . . . . 0.0 112.563 -178.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.26 -49.1 72.91 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 119.122 0.874 . . . . 0.0 109.401 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 mmtt -59.38 -46.58 88.28 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.72 -36.38 62.19 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 119.052 0.842 . . . . 0.0 113.048 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 62.1 mtm -75.63 -39.79 57.28 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 124.135 0.974 . . . . 0.0 109.776 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -63.49 -37.99 89.43 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.086 1.354 . . . . 0.0 111.574 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.446 HG22 HG21 ' A' ' 26' ' ' VAL . 97.8 t -68.71 -53.56 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.34 -26.89 61.67 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.356 1.463 . . . . 0.0 113.779 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -67.32 -50.63 59.32 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.493 1.042 . . . . 0.0 108.646 179.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -77.05 -31.96 56.58 Favored 'General case' 0 C--O 1.22 -0.493 0 CA-C-O 121.984 0.897 . . . . 0.0 110.992 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.63 -42.58 93.12 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 178.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -61.54 -42.1 98.32 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 119.311 0.96 . . . . 0.0 109.573 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -74.18 -30.02 62.04 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 118.839 -0.601 . . . . 0.0 112.188 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -80.89 -49.55 10.88 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-N 118.822 0.737 . . . . 0.0 110.379 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -86.84 -1.56 57.89 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 48.5 mt-30 55.68 40.89 30.92 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.991 1.317 . . . . 0.0 109.804 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.585 HG11 HG13 ' A' ' 81' ' ' VAL . 2.5 p -150.38 130.08 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -178.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -64.76 128.25 34.96 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.132 0.573 . . . . 0.0 109.548 179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -114.75 86.7 13.39 Favored Pre-proline 0 C--O 1.242 0.691 0 N-CA-C 105.693 -1.965 . . . . 0.0 105.693 178.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.41 141.75 52.22 Favored 'Trans proline' 0 N--CA 1.447 -1.257 0 C-N-CA 121.713 1.608 . . . . 0.0 109.735 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -27.33 16.84 Favored 'General case' 0 C--O 1.223 -0.311 0 C-N-CA 125.742 1.617 . . . . 0.0 110.567 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.0 ptmt -53.9 -32.25 52.75 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 119.057 0.844 . . . . 0.0 111.577 178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.412 HG21 ' CE1' ' A' ' 80' ' ' TYR . 59.4 t -86.81 -46.54 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.401 HD22 ' HA ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -54.58 -47.73 72.95 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.509 1.124 . . . . 0.0 111.488 -179.061 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CD1' ' C ' ' A' ' 69' ' ' PHE . 0.1 OUTLIER -74.94 -36.46 62.11 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.149 0.58 . . . . 0.0 111.003 179.846 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -72.11 -33.11 67.58 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 120.366 -0.534 . . . . 0.0 112.224 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 11.3 mt-30 -141.36 74.43 24.17 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.385 1.474 . . . . 0.0 109.366 -178.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.98 56.49 3.65 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 125.062 3.841 . . . . 0.0 113.894 -178.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.45 148.35 42.62 Favored 'General case' 0 CA--C 1.516 -0.352 0 O-C-N 120.883 -1.136 . . . . 0.0 111.773 179.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.3 mm -56.7 -42.96 78.17 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.208 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -54.99 -49.89 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.163 0.438 . . . . 0.0 110.892 179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.82 -41.48 97.83 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -178.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.6 mt -71.24 -40.86 70.79 Favored 'General case' 0 C--O 1.217 -0.63 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.48 -48.41 79.3 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.441 0.564 . . . . 0.0 110.206 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -72.25 -40.48 67.65 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 122.923 0.489 . . . . 0.0 111.728 -179.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.412 ' CE1' HG21 ' A' ' 67' ' ' VAL . 61.2 t80 -63.27 -43.82 96.89 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.585 HG13 HG11 ' A' ' 61' ' ' VAL . 74.2 t -74.03 -35.89 42.99 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-O 118.592 -0.718 . . . . 0.0 109.866 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.19 -35.59 71.83 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 119.248 0.931 . . . . 0.0 112.73 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 7.9 t -82.31 -18.64 41.56 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.553 -0.737 . . . . 0.0 112.216 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 20.5 mtt180 -93.23 -47.83 6.74 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 119.742 1.155 . . . . 0.0 109.506 179.227 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 26.8 t -83.81 34.93 0.5 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.989 2.116 . . . . 0.0 107.357 178.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -64.39 172.54 2.5 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.876 1.67 . . . . 0.0 110.673 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.21 -34.26 0.17 Allowed 'General case' 0 C--O 1.232 0.148 0 N-CA-C 113.38 0.881 . . . . 0.0 113.38 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 66.2 t-80 -74.09 69.32 1.48 Allowed 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.881 1.272 . . . . 0.0 111.993 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -70.09 110.76 5.31 Favored 'General case' 0 C--O 1.233 0.236 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -129.78 90.23 2.95 Favored 'General case' 0 C--O 1.24 0.575 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 . . . . . 0 C--O 1.253 1.254 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.663 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo . . . . . 0 N--CA 1.476 0.492 0 N-CA-C 110.87 -0.473 . . . . 0.0 110.87 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.36 152.32 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 124.685 1.194 . . . . 0.0 109.388 -179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.3 m -105.53 38.97 1.85 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.7 1.2 . . . . 0.0 110.784 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.5 1.48 1.18 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.224 1.41 . . . . 0.0 114.451 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -114.68 123.29 48.92 Favored 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.332 1.453 . . . . 0.0 109.998 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -68.63 165.27 19.65 Favored 'General case' 0 CA--C 1.536 0.43 0 O-C-N 123.801 0.688 . . . . 0.0 109.679 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . 0.433 ' HA ' HD21 ' A' ' 35' ' ' LEU . 5.9 t80 -50.48 133.88 24.36 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 126.957 2.103 . . . . 0.0 112.791 179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.9 t -145.55 118.98 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.46 157.59 77.47 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 124.251 1.02 . . . . 0.0 111.614 179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -66.92 155.3 71.38 Favored 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.484 2.789 . . . . 0.0 112.926 179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . 0.27 5.3 t -130.78 -20.22 2.87 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 124.466 1.107 . . . . 0.0 112.419 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.416 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 7.4 t-20 -98.72 143.72 28.77 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 177.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -51.99 -27.1 12.24 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.02 0.928 . . . . 0.0 113.49 -178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 47.6 t -76.95 -46.64 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 120.388 1.449 . . . . 0.0 109.186 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 3.9 mt-10 -56.82 -35.27 68.59 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 125.21 1.404 . . . . 0.0 110.471 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 t -63.2 -49.09 75.6 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.097 0.559 . . . . 0.0 110.583 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 59.8 mttt -57.42 -48.64 78.59 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -178.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.8 mp -60.36 -41.68 94.21 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 118.138 -0.934 . . . . 0.0 111.664 179.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.67 -34.6 73.06 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 123.725 0.641 . . . . 0.0 109.93 179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -66.41 -50.59 62.93 Favored 'General case' 0 C--O 1.23 0.067 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.1 mt -61.55 -37.38 77.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.286 1.034 . . . . 0.0 110.339 -179.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 7.1 m0 -62.43 -44.8 95.54 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 118.718 0.69 . . . . 0.0 111.204 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -59.35 -32.86 70.49 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.227 0.611 . . . . 0.0 111.538 -179.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 16.6 mmm180 -67.69 -43.02 81.1 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 118.523 0.601 . . . . 0.0 111.617 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.6 t -77.7 -52.05 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.218 0 C-N-CA 123.646 0.778 . . . . 0.0 111.864 -178.042 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 76.6 mt -70.88 -25.63 62.88 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-O 118.651 -0.69 . . . . 0.0 111.636 -178.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.67 33.53 57.94 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.206 -0.758 . . . . 0.0 111.206 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 8.4 m -120.12 174.64 4.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 124.648 1.179 . . . . 0.0 110.023 -179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.5 t -144.07 114.45 7.52 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 134.36 27.17 0.52 Allowed Glycine 0 CA--C 1.525 0.66 0 C-N-CA 124.727 1.156 . . . . 0.0 112.36 -179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 40.9 mm -66.13 125.48 23.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 CA-C-N 118.687 1.243 . . . . 0.0 110.819 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -104.93 175.76 22.42 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 125.367 1.461 . . . . 0.0 112.051 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.0 pt -70.28 -28.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.211 0 O-C-N 121.098 -1.237 . . . . 0.0 112.193 -179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 8' ' ' TYR . 0.0 OUTLIER -105.61 2.28 28.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 126.465 1.906 . . . . 0.0 112.53 -178.982 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -64.19 122.84 17.59 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 -179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -85.21 119.43 25.58 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.513 -179.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -46.79 -46.44 20.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 126.236 1.814 . . . . 0.0 112.59 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -74.75 -31.36 61.78 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-O 118.362 -0.828 . . . . 0.0 112.647 -179.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -63.62 -36.97 85.57 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.8 mt -72.13 6.25 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 C-N-CA 125.455 1.502 . . . . 0.0 109.809 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.61 3.72 80.61 Favored Glycine 0 CA--C 1.526 0.756 0 O-C-N 119.543 -1.973 . . . . 0.0 111.309 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.87 145.8 49.03 Favored Glycine 0 CA--C 1.529 0.949 0 CA-C-N 120.081 1.941 . . . . 0.0 108.933 178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -139.49 -179.39 5.87 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 124.297 1.039 . . . . 0.0 109.127 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -46.61 -53.04 12.31 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.918 1.287 . . . . 0.0 112.224 -179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -55.08 -49.17 72.34 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.142 0.577 . . . . 0.0 110.863 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.427 ' O ' HG23 ' A' ' 51' ' ' VAL . 54.8 mmtt -61.93 -44.75 96.12 Favored 'General case' 0 C--O 1.224 -0.274 0 O-C-N 121.842 -0.537 . . . . 0.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.19 -45.4 83.79 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 124.486 1.114 . . . . 0.0 110.217 -179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.8 mmt -59.85 -41.29 91.1 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 123.592 0.757 . . . . 0.0 109.5 179.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.05 -33.5 75.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 118.314 -0.851 . . . . 0.0 111.179 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 47' ' ' LYS . 4.5 t -69.9 -51.26 41.78 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 CA-C-N 120.56 1.527 . . . . 0.0 107.33 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -54.88 -33.01 61.44 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.132 0.973 . . . . 0.0 113.027 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.3 -48.95 75.93 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.265 0.626 . . . . 0.0 110.695 179.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -76.49 -34.18 58.64 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.705 0.765 . . . . 0.0 111.495 -179.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -65.54 -44.98 93.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.745 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -60.01 -39.03 84.41 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 118.535 0.607 . . . . 0.0 110.122 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -76.15 -31.79 58.76 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -87.12 -47.42 8.91 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 122.86 0.464 . . . . 0.0 111.783 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -90.09 0.71 57.0 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.749 0.419 . . . . 0.0 110.571 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 64.4 mt-30 52.74 36.51 21.34 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.477 1.111 . . . . 0.0 111.441 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.4 p -135.75 123.0 34.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 121.235 0.54 . . . . 0.0 112.13 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -65.91 110.34 2.85 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 120.905 -1.122 . . . . 0.0 108.452 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.3 tp -100.34 93.14 2.5 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 125.049 1.34 . . . . 0.0 110.941 -179.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.0 145.18 31.11 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 124.707 3.605 . . . . 0.0 111.096 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 -29.37 9.97 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 127.709 2.404 . . . . 0.0 111.428 179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 16.3 pttp -52.97 -26.66 15.9 Favored 'General case' 0 C--N 1.342 0.269 0 CA-C-O 118.422 -0.799 . . . . 0.0 111.0 -179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.578 HG21 ' CZ ' ' A' ' 80' ' ' TYR . 48.4 t -87.5 -50.05 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 125.799 1.64 . . . . 0.0 109.212 178.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.44 -46.57 63.04 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.005 0.922 . . . . 0.0 110.718 -178.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.16 -30.7 38.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-O 118.668 -0.682 . . . . 0.0 112.368 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -76.0 -30.95 58.71 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 119.374 -0.931 . . . . 0.0 111.948 -178.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -145.38 69.25 13.88 Favored Pre-proline 0 N--CA 1.444 -0.751 0 C-N-CA 124.085 0.954 . . . . 0.0 111.394 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -72.37 60.43 3.3 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 124.787 3.658 . . . . 0.0 112.998 -179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.2 147.12 36.03 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 120.901 -1.125 . . . . 0.0 109.045 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.7 mm -56.9 -47.51 82.98 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.623 0 C-N-CA 124.11 0.964 . . . . 0.0 108.662 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -56.87 -47.37 80.6 Favored 'General case' 0 N--CA 1.454 -0.25 0 O-C-N 123.635 0.584 . . . . 0.0 110.954 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.45 -48.43 81.77 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 113.121 0.785 . . . . 0.0 113.121 -178.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.3 mt -67.2 -41.47 85.75 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 125.718 1.607 . . . . 0.0 108.716 -178.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.47 -41.82 99.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 123.935 0.894 . . . . 0.0 109.512 179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -71.6 -46.59 58.79 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 118.571 0.623 . . . . 0.0 110.403 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.578 ' CZ ' HG21 ' A' ' 67' ' ' VAL . 22.1 t80 -58.9 -42.35 89.39 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 63.3 t -73.49 -41.33 56.29 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.51 0 C-N-CA 118.777 -1.169 . . . . 0.0 109.122 -179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.04 82.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 119.677 1.126 . . . . 0.0 112.334 -178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.8 t -70.74 -29.35 65.58 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.546 0.612 . . . . 0.0 110.616 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt-85 -86.32 -36.8 19.07 Favored 'General case' 0 CA--C 1.517 -0.3 0 O-C-N 120.94 -1.1 . . . . 0.0 111.792 -178.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 58.2 m -76.47 -4.13 40.93 Favored 'General case' 0 C--N 1.326 -0.452 0 C-N-CA 125.228 1.411 . . . . 0.0 111.631 179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -68.55 153.22 44.17 Favored 'General case' 0 N--CA 1.452 -0.375 0 O-C-N 121.169 -0.957 . . . . 0.0 111.762 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 34.2 m-70 53.76 67.44 1.0 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 127.753 2.421 . . . . 0.0 115.826 178.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -134.51 162.15 33.06 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 125.703 1.601 . . . . 0.0 107.244 177.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -136.8 84.88 2.1 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 121.561 0.696 . . . . 0.0 109.277 -179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.4 m-70 -76.2 32.43 0.12 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.608 0.763 . . . . 0.0 112.381 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 27.9 m-70 . . . . . 0 C--O 1.245 0.821 0 C-N-CA 125.598 1.559 . . . . 0.0 107.166 179.66 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo . . . . . 0 N--CA 1.48 0.699 0 CA-C-O 119.378 -0.342 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 14.6 p -72.89 168.71 1.82 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 125.775 1.63 . . . . 0.0 111.351 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.01 114.43 2.11 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.141 1.777 . . . . 0.0 106.503 178.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -149.09 64.03 1.04 Allowed 'General case' 0 N--CA 1.435 -1.203 0 CA-C-O 121.411 0.624 . . . . 0.0 110.582 -178.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.38 156.4 35.5 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.097 0.959 . . . . 0.0 111.715 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -70.78 159.2 34.98 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.17 1.388 . . . . 0.0 111.628 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -56.34 128.72 37.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 126.268 1.827 . . . . 0.0 114.07 -179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.2 t -138.96 117.61 13.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 105.158 -2.164 . . . . 0.0 105.158 177.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.11 163.41 17.44 Favored Pre-proline 0 CA--C 1.546 0.816 0 C-N-CA 125.297 1.439 . . . . 0.0 110.786 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -66.9 148.89 82.96 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.236 1.957 . . . . 0.0 111.103 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 81.4 p -130.43 -12.15 3.97 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -110.2 143.66 40.0 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 177.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -49.79 -28.38 6.2 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.873 1.269 . . . . 0.0 114.229 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.2 t -82.49 -40.76 17.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 CA-C-N 119.525 1.057 . . . . 0.0 109.442 -178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -56.36 -39.02 72.2 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 123.089 0.556 . . . . 0.0 110.305 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 44.5 t -63.1 -49.11 75.74 Favored 'General case' 0 N--CA 1.453 -0.287 0 O-C-N 123.852 0.72 . . . . 0.0 109.587 179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 27.4 mmtp -54.89 -52.29 63.34 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 118.678 0.672 . . . . 0.0 110.369 -179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.2 mp -64.51 -41.63 96.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 118.253 -0.88 . . . . 0.0 112.716 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.37 -35.78 74.55 Favored 'General case' 0 C--O 1.225 -0.217 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -68.5 -45.75 71.49 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 49.9 mm -60.5 -41.85 89.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 178.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 14.7 m0 -61.14 -41.97 97.7 Favored 'General case' 0 C--N 1.338 0.066 0 O-C-N 121.11 -0.994 . . . . 0.0 109.905 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -60.7 -45.13 95.38 Favored 'General case' 0 C--O 1.225 -0.212 0 CA-C-N 118.476 0.58 . . . . 0.0 111.403 179.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -70.75 -39.85 73.04 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 119.577 1.081 . . . . 0.0 112.902 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 69.7 t -65.01 -55.88 18.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 87.0 mt -74.96 -28.32 60.52 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 114.661 1.356 . . . . 0.0 114.661 -177.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.06 19.6 60.74 Favored Glycine 0 CA--C 1.535 1.328 0 C-N-CA 126.124 1.821 . . . . 0.0 113.093 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.07 174.85 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 C-N-CA 125.15 1.38 . . . . 0.0 108.462 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.7 t -145.36 132.04 19.95 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 118.661 0.664 . . . . 0.0 112.409 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 105.32 51.21 0.88 Allowed Glycine 0 CA--C 1.523 0.583 0 N-CA-C 109.172 -1.571 . . . . 0.0 109.172 -179.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 25.0 mm -78.25 128.47 38.27 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -91.22 161.08 27.5 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 122.118 0.843 . . . . 0.0 112.66 178.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 44.0 pt -68.55 -21.35 26.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.934 1.294 . . . . 0.0 111.193 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.48 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -107.9 -3.89 18.47 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 127.175 2.19 . . . . 0.0 114.301 -179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.552 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.7 OUTLIER -75.8 131.09 39.54 Favored 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 119.556 1.071 . . . . 0.0 111.003 -177.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 72' ' ' PRO . 5.3 m120 -80.28 119.95 23.7 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.07 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.601 ' HA ' HD12 ' A' ' 41' ' ' ILE . 82.7 t80 -40.97 -46.26 2.78 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 126.879 2.071 . . . . 0.0 114.403 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -67.84 -32.3 72.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.15 0.58 . . . . 0.0 112.291 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -71.14 -32.04 68.48 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 118.635 0.652 . . . . 0.0 109.983 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.601 HD12 ' HA ' ' A' ' 38' ' ' PHE . 28.4 mt -71.23 -9.93 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.445 1.098 . . . . 0.0 110.397 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.26 1.91 23.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 124.367 0.984 . . . . 0.0 111.864 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.22 152.51 52.1 Favored Glycine 0 N--CA 1.442 -0.904 0 N-CA-C 108.838 -1.705 . . . . 0.0 108.838 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -143.43 179.86 6.84 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.51 -49.27 36.67 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 119.222 0.919 . . . . 0.0 111.974 -178.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 8.2 tp -58.68 -48.32 81.47 Favored 'General case' 0 N--CA 1.46 0.068 0 N-CA-C 111.97 0.359 . . . . 0.0 111.97 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -59.85 -43.43 94.64 Favored 'General case' 0 C--O 1.222 -0.363 0 CA-C-O 118.331 -0.842 . . . . 0.0 109.057 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.67 -45.58 77.71 Favored 'General case' 0 C--N 1.341 0.226 0 C-N-CA 123.68 0.792 . . . . 0.0 110.009 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -63.74 -39.56 94.6 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.26 77.88 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 118.753 -0.641 . . . . 0.0 111.059 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.2 t -68.2 -50.73 55.33 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 N-CA-C 107.532 -1.285 . . . . 0.0 107.532 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.47 -32.65 65.16 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.098 0.959 . . . . 0.0 112.13 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.8 -41.87 99.46 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 123.042 0.537 . . . . 0.0 110.485 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -78.4 -40.95 34.54 Favored 'General case' 0 C--O 1.225 -0.217 0 CA-C-O 121.473 0.654 . . . . 0.0 111.252 179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.5 t -64.28 -46.13 94.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 O-C-N 121.621 -0.674 . . . . 0.0 110.727 -178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.68 -37.16 85.36 Favored 'General case' 0 N--CA 1.444 -0.747 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.849 -178.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 29.1 ptt85 -76.04 -30.22 58.33 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 71.6 mt-10 -89.71 -48.69 7.11 Favored 'General case' 0 CA--C 1.519 -0.223 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -85.95 -3.8 59.01 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.055 0.542 . . . . 0.0 109.783 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 50.98 45.17 28.08 Favored 'General case' 0 C--N 1.343 0.321 0 C-N-CA 126.766 2.026 . . . . 0.0 110.342 -179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.487 HG11 HG13 ' A' ' 81' ' ' VAL . 12.6 p -144.38 128.7 13.41 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 123.472 0.709 . . . . 0.0 110.286 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -64.86 125.63 25.44 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -116.19 79.67 8.86 Favored Pre-proline 0 CA--C 1.532 0.26 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -66.6 150.35 83.89 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 122.423 2.082 . . . . 0.0 112.951 -178.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.01 -26.59 64.67 Favored 'General case' 0 C--O 1.225 -0.197 0 C-N-CA 125.592 1.557 . . . . 0.0 109.933 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 13.7 ptmt -53.32 -41.97 66.23 Favored 'General case' 0 CA--C 1.518 -0.277 0 CA-C-O 118.206 -0.902 . . . . 0.0 112.327 -178.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 t -89.01 -37.9 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -49.67 -51.1 40.57 Favored 'General case' 0 C--O 1.221 -0.415 0 C-N-CA 124.505 1.122 . . . . 0.0 109.545 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.06 -36.53 69.59 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 123.944 0.898 . . . . 0.0 111.484 179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -65.78 -37.17 85.57 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 123.508 0.505 . . . . 0.0 111.476 -178.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -138.56 75.34 38.22 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.768 1.627 . . . . 0.0 107.962 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.403 ' O ' ' HA ' ' A' ' 37' ' ' ASN . 74.3 Cg_endo -76.66 64.26 7.44 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.37 2.714 . . . . 0.0 112.147 -178.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -142.09 147.09 36.18 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 119.673 1.124 . . . . 0.0 110.226 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 mm -55.82 -49.8 72.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 124.038 0.935 . . . . 0.0 108.735 179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -52.82 -48.12 67.19 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.091 0.556 . . . . 0.0 111.142 179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.64 -50.65 73.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.185 0.994 . . . . 0.0 113.281 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -68.1 -43.43 78.49 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.938 1.695 . . . . 0.0 108.864 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.28 -49.24 74.8 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 90.1 mt-30 -68.8 -42.64 77.03 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 124.422 1.089 . . . . 0.0 111.769 -179.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -63.96 -43.24 96.39 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 123.685 0.794 . . . . 0.0 109.737 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.487 HG13 HG11 ' A' ' 61' ' ' VAL . 94.9 t -74.06 -36.7 45.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.546 -179.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.79 -49.0 72.41 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 122.881 0.473 . . . . 0.0 110.486 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 t -65.22 -28.11 69.14 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-O 118.674 -0.679 . . . . 0.0 111.22 -179.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -97.44 -7.58 31.32 Favored 'General case' 0 C--O 1.223 -0.305 0 N-CA-C 114.246 1.202 . . . . 0.0 114.246 -177.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 11.7 t -126.16 38.49 4.13 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 126.263 1.825 . . . . 0.0 108.227 179.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -53.0 116.87 2.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.631 1.172 . . . . 0.0 110.081 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 25.6 p80 -85.08 -5.95 59.33 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.611 1.165 . . . . 0.0 110.988 179.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -85.59 152.36 23.2 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -66.09 119.86 12.16 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 48.7 t-80 -130.31 145.41 51.77 Favored 'General case' 0 C--O 1.239 0.547 0 N-CA-C 105.008 -2.219 . . . . 0.0 105.008 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 116.812 -1.566 . . . . 0.0 112.032 -179.842 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.534 0.506 0 CA-C-O 119.003 -0.499 . . . . 0.0 111.838 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -136.6 171.37 16.84 Favored 'Isoleucine or valine' 0 C--O 1.24 0.561 0 C-N-CA 124.854 1.262 . . . . 0.0 109.76 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.7 m -79.65 75.1 6.32 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 125.05 1.34 . . . . 0.0 107.989 179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -71.19 -7.19 45.05 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.659 -0.651 . . . . 0.0 111.115 179.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.24 178.45 6.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.396 1.878 . . . . 0.0 109.367 178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -121.62 155.28 35.42 Favored 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -45.29 120.5 2.5 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 125.75 1.62 . . . . 0.0 110.943 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 38.9 t -130.42 119.73 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.217 0 N-CA-C 105.637 -1.986 . . . . 0.0 105.637 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.24 159.94 5.52 Favored Pre-proline 0 CA--C 1.543 0.692 0 C-N-CA 125.52 1.528 . . . . 0.0 111.513 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.82 152.74 77.03 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 122.646 2.231 . . . . 0.0 111.034 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.9 p -127.01 -14.08 5.6 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.418 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 23.2 t30 -118.6 145.08 45.69 Favored 'General case' 0 CA--C 1.514 -0.415 0 N-CA-C 104.579 -2.378 . . . . 0.0 104.579 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.77 -29.52 54.32 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 122.84 0.456 . . . . 0.0 111.763 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 45.9 t -69.9 -45.0 78.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 -178.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.418 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 7.2 mt-10 -60.73 -42.13 96.7 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 -179.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -62.02 -49.34 76.42 Favored 'General case' 0 N--CA 1.447 -0.602 0 O-C-N 124.206 0.941 . . . . 0.0 111.021 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.5 mmtt -56.99 -54.48 46.2 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.876 0.87 . . . . 0.0 110.907 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.93 -37.58 87.59 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 117.273 -1.346 . . . . 0.0 112.21 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.28 -33.46 72.37 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 119.069 0.849 . . . . 0.0 109.755 178.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -62.86 -48.16 80.23 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 97.3 mt -55.27 -38.83 49.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -67.37 -44.98 77.62 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 118.23 -0.891 . . . . 0.0 109.062 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -55.38 -42.1 73.52 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.821 0.848 . . . . 0.0 110.295 -179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 48.1 mtm180 -71.62 -41.88 68.33 Favored 'General case' 0 CA--C 1.529 0.137 0 O-C-N 121.298 -0.876 . . . . 0.0 112.839 -179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 85.7 t -71.51 -45.16 69.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 C-N-CA 123.601 0.76 . . . . 0.0 110.997 -178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 80.7 mt -75.43 -32.15 60.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.92 0.888 . . . . 0.0 110.707 -179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.23 38.32 26.07 Favored Glycine 0 CA--C 1.525 0.667 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.7 m -134.04 171.91 17.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 C-N-CA 125.566 1.546 . . . . 0.0 108.087 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.3 t -143.92 127.94 17.5 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 120.39 40.1 0.6 Allowed Glycine 0 CA--C 1.527 0.821 0 C-N-CA 126.396 1.95 . . . . 0.0 110.961 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 35.2 mm -77.64 126.24 37.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 C-N-CA 123.842 0.857 . . . . 0.0 109.219 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -94.09 -179.07 38.72 Favored Glycine 0 C--N 1.334 0.454 0 CA-C-O 121.807 0.671 . . . . 0.0 111.71 178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 11.6 pt -78.41 -28.27 14.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 123.245 0.618 . . . . 0.0 111.687 -179.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.54 -4.1 20.08 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.421 1.489 . . . . 0.0 113.921 -179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.655 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.8 OUTLIER -61.62 123.19 17.22 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 -179.24 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -78.21 115.33 17.85 Favored 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 123.221 0.608 . . . . 0.0 110.833 -178.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.458 ' HA ' HD12 ' A' ' 41' ' ' ILE . 73.0 t80 -44.75 -46.5 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.502 1.121 . . . . 0.0 113.256 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -67.46 -29.78 69.32 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 112.981 0.734 . . . . 0.0 112.981 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -81.19 -31.19 34.1 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.921 0.888 . . . . 0.0 110.466 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 36' ' ' ASP . 24.2 mt -71.08 -21.43 22.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-N 118.172 0.442 . . . . 0.0 110.051 -179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 131.69 -5.21 5.48 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 124.74 1.162 . . . . 0.0 113.479 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -71.98 157.98 53.22 Favored Glycine 0 C--N 1.336 0.581 0 N-CA-C 110.096 -1.201 . . . . 0.0 110.096 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 26.0 p80 -146.18 176.93 9.37 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.31 6.6 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.157 1.783 . . . . 0.0 112.39 -179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.25 -37.2 76.98 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.1 mmtt -76.1 -37.93 57.53 Favored 'General case' 0 C--O 1.224 -0.261 0 O-C-N 120.215 -1.553 . . . . 0.0 110.984 179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.44 -41.46 72.87 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.415 1.486 . . . . 0.0 112.71 -178.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -62.43 -44.23 96.93 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 121.195 0.521 . . . . 0.0 110.33 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -59.82 -33.75 72.17 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 124.722 1.209 . . . . 0.0 110.741 -179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.8 t -63.45 -53.15 48.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 178.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.3 -35.09 71.31 Favored 'General case' 0 C--O 1.224 -0.276 0 C-N-CA 122.914 0.486 . . . . 0.0 110.952 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.63 -50.93 72.02 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.061 0.846 . . . . 0.0 112.043 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -72.38 -31.45 65.58 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 122.017 0.913 . . . . 0.0 111.442 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t -69.37 -42.78 81.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -59.42 -40.61 87.25 Favored 'General case' 0 N--CA 1.442 -0.842 0 O-C-N 121.758 -0.589 . . . . 0.0 110.086 -178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.95 -33.73 59.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -179.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -88.12 -39.61 14.43 Favored 'General case' 0 CA--C 1.511 -0.556 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 -177.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.448 ' HB2' HG12 ' A' ' 61' ' ' VAL . 14.1 m-85 -97.8 0.93 47.72 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 50.97 37.78 18.55 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.305 1.042 . . . . 0.0 110.437 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG11 HG13 ' A' ' 81' ' ' VAL . 14.1 p -138.48 129.23 35.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.278 0 C-N-CA 123.403 0.681 . . . . 0.0 112.785 -178.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.9 tt0 -80.82 116.61 20.89 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.0 tt -105.65 92.76 6.41 Favored Pre-proline 0 N--CA 1.451 -0.42 0 C-N-CA 127.197 2.199 . . . . 0.0 105.345 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.3 152.25 82.67 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.988 1.792 . . . . 0.0 110.524 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 20.4 tp -52.52 -28.84 22.23 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 125.701 1.6 . . . . 0.0 110.276 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 52.5 mtpt -52.28 -39.58 60.64 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 124.505 1.122 . . . . 0.0 112.133 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.64 -38.92 12.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.96 -50.68 72.55 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.972 0.909 . . . . 0.0 110.808 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -75.35 -41.35 56.8 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 125.628 1.571 . . . . 0.0 109.882 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -31.53 70.85 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.572 -178.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -139.36 73.99 35.76 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 125.185 1.394 . . . . 0.0 108.596 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.96 62.0 6.52 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 124.423 3.415 . . . . 0.0 109.869 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.61 146.95 36.85 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 mm -62.19 -42.35 94.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.347 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.0 ttmm -54.75 -42.89 72.2 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.061 0.846 . . . . 0.0 111.318 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.12 -44.47 88.62 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.5 mt -73.16 -38.76 66.09 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 125.367 1.467 . . . . 0.0 108.077 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.4 -51.32 69.97 Favored 'General case' 0 C--O 1.222 -0.389 0 C-N-CA 123.562 0.745 . . . . 0.0 109.348 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.4 pp0? -69.02 -38.93 79.47 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 118.241 0.473 . . . . 0.0 111.243 -179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 46.3 t80 -61.5 -48.27 81.83 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 -179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.449 HG13 HG11 ' A' ' 61' ' ' VAL . 54.3 t -72.21 -40.24 65.62 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.305 0 O-C-N 123.825 0.703 . . . . 0.0 110.033 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.17 -40.26 76.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 119.753 1.161 . . . . 0.0 114.034 -178.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.0 t -73.36 -24.41 60.33 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 122.322 0.249 . . . . 0.0 111.323 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.3 mtt-85 -87.95 -44.94 10.65 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 123.094 0.557 . . . . 0.0 109.732 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 46.0 m -83.1 38.73 0.61 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 127.028 2.131 . . . . 0.0 109.14 179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -60.88 146.67 45.7 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 120.937 -1.102 . . . . 0.0 112.635 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -75.6 9.45 2.24 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 127.673 2.389 . . . . 0.0 111.033 178.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -54.59 110.07 0.59 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 127.932 2.493 . . . . 0.0 109.145 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 30.9 m80 43.23 65.03 1.04 Allowed 'General case' 0 C--O 1.236 0.371 0 C-N-CA 125.944 1.698 . . . . 0.0 111.247 -179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -148.08 165.9 29.42 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.752 1.221 . . . . 0.0 108.58 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 C--O 1.242 0.675 0 C-N-CA 125.42 1.488 . . . . 0.0 108.352 -179.82 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 N--CA 1.479 0.626 0 CA-C-O 118.61 -0.662 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.3 m -67.31 166.04 1.84 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-N 119.58 1.082 . . . . 0.0 110.421 179.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.9 t -159.32 166.48 31.1 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -128.22 31.21 5.09 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 127.664 2.386 . . . . 0.0 106.752 178.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.18 159.92 30.14 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 125.84 1.656 . . . . 0.0 110.722 179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -59.91 154.24 19.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 126.499 1.919 . . . . 0.0 111.658 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -57.41 130.69 47.42 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 125.04 1.336 . . . . 0.0 109.202 178.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.3 t -145.22 117.52 2.28 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.91 160.67 19.05 Favored Pre-proline 0 CA--C 1.541 0.609 0 C-N-CA 124.869 1.268 . . . . 0.0 111.236 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -56.73 160.81 11.16 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.654 2.903 . . . . 0.0 114.222 179.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 74.0 p -127.96 -38.16 1.86 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 113.04 -1.891 . . . . 0.0 112.294 -179.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.402 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 1.4 t-20 -89.48 163.7 15.13 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 -178.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -64.2 -30.18 71.25 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.773 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.0 t -77.32 -49.96 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 C-N-CA 123.235 0.614 . . . . 0.0 109.558 -178.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.402 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 12.0 mt-10 -54.33 -41.58 69.21 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 123.863 0.865 . . . . 0.0 109.139 -179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -54.5 -37.7 65.6 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.607 1.563 . . . . 0.0 110.758 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.1 mmmt -76.93 -57.29 3.93 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 120.17 1.35 . . . . 0.0 111.302 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.5 mp -53.31 -41.96 66.2 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 124.518 1.127 . . . . 0.0 113.101 -178.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.58 -34.42 69.19 Favored 'General case' 0 C--O 1.223 -0.325 0 O-C-N 123.57 0.544 . . . . 0.0 110.378 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -77.74 -34.93 52.36 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.59 0.356 . . . . 0.0 110.215 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -63.36 -36.04 74.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 12.4 m0 -62.91 -33.98 76.47 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 124.833 1.253 . . . . 0.0 110.956 179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -63.59 -37.84 88.85 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.1 mtp85 -68.88 -15.97 63.64 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -178.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.563 HG21 HG22 ' A' ' 51' ' ' VAL . 0.4 OUTLIER -104.11 -54.45 6.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 119.201 0.909 . . . . 0.0 110.355 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.8 mt -70.55 -27.43 64.14 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 123.822 0.849 . . . . 0.0 111.983 -179.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.49 39.02 51.28 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 18.0 m -129.48 174.56 12.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 C-N-CA 124.918 1.287 . . . . 0.0 108.677 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.9 t -134.89 138.24 43.94 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 125.0 1.32 . . . . 0.0 109.42 179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.03 64.04 0.95 Allowed Glycine 0 C--O 1.228 -0.252 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.587 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 48.0 mm -91.18 141.37 14.53 Favored 'Isoleucine or valine' 0 C--O 1.24 0.557 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 178.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -113.3 -173.14 18.57 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 125.393 1.473 . . . . 0.0 111.025 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 25.4 pt -84.92 -28.85 6.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 114.931 1.456 . . . . 0.0 114.931 177.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.24 1.96 24.31 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -81.49 123.51 28.68 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 122.403 1.097 . . . . 0.0 110.8 -177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -69.93 122.52 19.47 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.585 -178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -48.58 -46.82 39.72 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.314 1.846 . . . . 0.0 111.98 -179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -70.36 -31.65 69.01 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 118.755 -0.64 . . . . 0.0 112.181 -179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -67.96 -33.06 73.94 Favored 'General case' 0 C--N 1.339 0.129 0 CA-C-N 119.14 0.882 . . . . 0.0 109.046 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mt -72.03 -11.64 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.834 0.854 . . . . 0.0 108.812 178.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 111.85 3.64 26.55 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 126.209 1.862 . . . . 0.0 114.206 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -63.98 152.91 48.32 Favored Glycine 0 CA--C 1.528 0.898 0 CA-C-N 119.297 1.549 . . . . 0.0 111.827 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 20.3 p80 -138.31 175.56 9.46 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.464 1.506 . . . . 0.0 108.144 178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -48.26 -49.23 34.31 Favored 'General case' 0 C--O 1.223 -0.327 0 C-N-CA 123.931 0.892 . . . . 0.0 112.92 -178.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -55.17 -51.11 67.54 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.568 1.077 . . . . 0.0 109.411 179.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.452 ' O ' HG23 ' A' ' 51' ' ' VAL . 63.6 mmtt -59.41 -48.09 82.96 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 119.044 -0.503 . . . . 0.0 110.01 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.15 -47.17 68.94 Favored 'General case' 0 C--O 1.235 0.29 0 C-N-CA 125.687 1.595 . . . . 0.0 110.542 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 3.7 mmt -66.09 -39.36 89.95 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.859 0.864 . . . . 0.0 109.683 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.67 -35.92 82.59 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-O 118.201 -0.905 . . . . 0.0 110.802 179.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.563 HG22 HG21 ' A' ' 26' ' ' VAL . 1.7 t -67.71 -50.78 57.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.01 -32.05 63.64 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.778 1.231 . . . . 0.0 112.808 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.57 -48.85 63.17 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.554 0.615 . . . . 0.0 109.366 179.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 15.1 mt-30 -69.44 -40.04 77.46 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 122.883 0.473 . . . . 0.0 111.184 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 7.7 t -63.64 -49.23 83.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.99 -39.98 91.74 Favored 'General case' 0 CA--C 1.505 -0.777 0 C-N-CA 119.492 -0.883 . . . . 0.0 111.306 -178.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.61 -30.95 59.73 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 113.892 1.071 . . . . 0.0 113.892 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.2 mt-10 -83.88 -48.22 10.25 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 119.029 0.831 . . . . 0.0 110.449 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -87.42 -3.58 59.01 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 123.592 0.557 . . . . 0.0 110.742 179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 59.02 38.02 24.27 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.52 1.055 . . . . 0.0 111.515 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.7 p -150.68 126.92 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 O-C-N 121.101 -0.999 . . . . 0.0 112.681 -177.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.87 142.0 58.58 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 114.805 1.409 . . . . 0.0 114.805 -177.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.97 78.61 74.61 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 178.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.74 152.99 79.48 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 121.734 1.623 . . . . 0.0 111.173 -179.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.72 -28.43 47.96 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.473 1.109 . . . . 0.0 110.905 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 26.1 pttt -54.27 -33.53 58.8 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 124.488 1.115 . . . . 0.0 111.417 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.408 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -88.17 -51.78 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 C-N-CA 125.354 1.462 . . . . 0.0 107.902 178.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -48.3 -48.9 35.62 Favored 'General case' 0 C--O 1.221 -0.427 0 C-N-CA 126.454 1.902 . . . . 0.0 111.41 -178.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -27.85 40.63 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 121.643 -0.66 . . . . 0.0 112.296 179.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -68.51 -41.85 79.4 Favored 'General case' 0 N--CA 1.449 -0.516 0 C-N-CA 119.818 -0.753 . . . . 0.0 109.223 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -138.33 79.63 30.19 Favored Pre-proline 0 CA--C 1.534 0.36 0 C-N-CA 124.519 1.128 . . . . 0.0 108.528 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -75.74 55.26 4.27 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 124.635 3.556 . . . . 0.0 112.651 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.26 147.8 38.84 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 119.549 1.068 . . . . 0.0 110.906 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.3 mm -54.94 -44.97 75.73 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 C-N-CA 124.527 1.131 . . . . 0.0 108.749 178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -54.19 -39.3 66.51 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.638 0.654 . . . . 0.0 111.913 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.88 -51.32 27.05 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 121.675 -0.641 . . . . 0.0 112.204 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.3 mt -65.4 -40.58 93.6 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 126.51 1.924 . . . . 0.0 109.726 -178.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.37 -51.29 68.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 118.913 0.778 . . . . 0.0 109.681 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 35.9 mt-30 -74.0 -35.7 64.44 Favored 'General case' 0 CA--C 1.52 -0.208 0 C-N-CA 123.745 0.818 . . . . 0.0 112.081 -178.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' CE2' HG21 ' A' ' 67' ' ' VAL . 13.9 t80 -66.07 -41.11 91.2 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 178.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -70.4 -43.12 78.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 119.131 -1.028 . . . . 0.0 108.305 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -58.69 -47.11 85.64 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.717 0.807 . . . . 0.0 112.539 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 15.3 t -63.49 -19.31 64.64 Favored 'General case' 0 C--O 1.238 0.471 0 O-C-N 121.348 -0.845 . . . . 0.0 111.386 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 59.3 mtt-85 -100.74 -25.51 14.11 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 112.76 0.652 . . . . 0.0 112.76 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 78.5 p -60.8 -35.6 76.9 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 118.514 0.597 . . . . 0.0 110.479 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -63.36 121.35 13.55 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 125.175 1.39 . . . . 0.0 108.578 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -68.68 139.54 55.42 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -142.73 127.51 18.18 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 123.722 0.809 . . . . 0.0 109.475 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -74.0 99.84 3.4 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 122.575 1.179 . . . . 0.0 108.898 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.5 m80 -139.0 97.21 3.26 Favored 'General case' 0 C--N 1.321 -0.643 1 N-CA-C 100.036 -4.061 . . . . 0.0 100.036 178.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 . . . . . 0 C--O 1.254 1.318 0 CA-C-O 117.367 -1.302 . . . . 0.0 108.244 -179.338 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo . . . . . 0 N--CA 1.476 0.485 0 CA-C-O 118.619 -0.659 . . . . 0.0 112.8 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.0 t -57.97 153.96 2.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -138.63 157.69 45.66 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 179.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -138.31 43.95 2.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.953 0.882 . . . . 0.0 110.089 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -108.33 164.24 12.49 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 125.461 1.504 . . . . 0.0 111.284 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 18.4 mm100 -86.6 179.54 6.79 Favored 'General case' 0 C--O 1.225 -0.194 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 177.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -54.31 123.12 11.92 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 123.463 0.705 . . . . 0.0 111.004 179.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.7 t -137.08 117.05 16.24 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 106.141 -1.8 . . . . 0.0 106.141 178.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.31 162.36 25.66 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.471 178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -59.25 137.32 78.12 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.528 2.152 . . . . 0.0 110.755 179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 63.8 p -106.05 -23.53 12.61 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 119.256 -0.402 . . . . 0.0 111.258 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -107.32 146.72 31.2 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -54.62 -31.9 57.99 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 31.2 t -69.4 -44.66 79.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -61.36 -36.39 80.07 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 123.504 0.721 . . . . 0.0 109.422 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.0 t -56.99 -52.43 65.3 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.102 0.961 . . . . 0.0 109.512 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -56.53 -54.75 42.25 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.723 0.409 . . . . 0.0 111.211 -179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.3 mp -57.95 -47.85 81.7 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 117.822 -1.085 . . . . 0.0 112.769 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.99 -32.92 62.09 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 118.738 0.699 . . . . 0.0 110.868 -179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -72.54 -38.91 67.86 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.184 -0.606 . . . . 0.0 111.518 -179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 16.4 mm -62.3 -34.98 66.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 CA-C-N 119.257 0.935 . . . . 0.0 109.98 -179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 10.9 m0 -62.62 -42.97 99.9 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 122.026 -0.421 . . . . 0.0 109.919 179.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -59.89 -32.06 70.39 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 124.135 0.974 . . . . 0.0 111.559 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -75.39 -40.42 57.99 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.882 0.873 . . . . 0.0 109.982 179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 58.1 t -76.34 -55.71 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.166 0 CA-C-N 119.109 0.868 . . . . 0.0 109.941 -179.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 96.3 mt -65.72 -35.94 82.17 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.018 0.927 . . . . 0.0 111.095 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.1 15.24 70.09 Favored Glycine 0 CA--C 1.528 0.875 0 CA-C-O 118.872 -0.96 . . . . 0.0 111.216 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.38 169.76 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 105.429 -2.063 . . . . 0.0 105.429 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 35.4 t -136.05 146.33 46.97 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 119.24 0.927 . . . . 0.0 108.876 -179.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.79 38.0 3.77 Favored Glycine 0 CA--C 1.522 0.482 0 C-N-CA 125.906 1.717 . . . . 0.0 111.324 179.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 HD12 HD13 ' A' ' 41' ' ' ILE . 20.1 mm -72.22 128.16 34.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 118.345 1.073 . . . . 0.0 109.493 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -103.45 175.96 23.95 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.965 1.269 . . . . 0.0 111.005 178.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.411 HG13 HD13 ' A' ' 35' ' ' LEU . 18.2 pt -70.8 -23.8 24.28 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 125.921 1.689 . . . . 0.0 112.73 -179.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 HG13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -108.35 0.2 21.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.872 1.669 . . . . 0.0 113.792 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -74.77 115.62 14.56 Favored 'General case' 0 CA--C 1.524 -0.052 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -73.4 122.97 22.93 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 122.829 0.452 . . . . 0.0 112.219 -177.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -45.98 -45.08 15.53 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.939 1.296 . . . . 0.0 113.352 -179.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -74.43 -32.63 62.71 Favored 'General case' 0 C--O 1.233 0.193 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.5 tp60 -72.26 -31.09 65.47 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.004 0.922 . . . . 0.0 111.59 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.48 HD13 HD12 ' A' ' 32' ' ' ILE . 23.4 mt -70.65 -21.23 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 -179.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 129.14 -4.55 6.37 Favored Glycine 0 CA--C 1.524 0.639 0 CA-C-O 118.664 -1.076 . . . . 0.0 111.548 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -68.18 162.91 48.85 Favored Glycine 0 C--N 1.339 0.711 0 CA-C-N 119.017 1.408 . . . . 0.0 109.821 179.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.1 p80 -152.32 174.55 13.68 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.52 -50.91 12.47 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 125.423 1.489 . . . . 0.0 112.242 -179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 tp -56.04 -46.06 79.01 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 117.702 0.228 . . . . 0.0 110.941 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -67.82 -37.89 82.53 Favored 'General case' 0 C--O 1.224 -0.251 0 CA-C-O 118.596 -0.716 . . . . 0.0 110.674 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.89 -40.02 72.42 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.014 0.926 . . . . 0.0 110.167 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . 0.439 ' HE3' ' HA ' ' A' ' 49' ' ' MET . 1.0 OUTLIER -58.66 -42.93 89.56 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.024 0.53 . . . . 0.0 109.856 179.022 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -66.66 -29.34 69.33 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 117.947 -1.025 . . . . 0.0 111.648 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 t -72.02 -51.55 30.2 Favored 'Isoleucine or valine' 0 C--N 1.341 0.238 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 178.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.56 -34.33 64.66 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.231 0.612 . . . . 0.0 111.66 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -64.03 -37.22 86.65 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.775 0.83 . . . . 0.0 110.713 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 6.0 mm-40 -77.77 -39.82 42.83 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.855 0.862 . . . . 0.0 110.47 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 38.7 t -65.0 -47.21 88.96 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -35.39 80.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.535 -178.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 8.5 ptm180 -76.68 -33.44 58.25 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -89.18 -48.77 7.16 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 118.375 0.534 . . . . 0.0 111.768 -178.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' HB2' HG12 ' A' ' 61' ' ' VAL . 39.8 m-85 -85.13 -3.0 58.65 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 122.981 0.512 . . . . 0.0 109.994 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 54.38 35.2 22.49 Favored 'General case' 0 C--N 1.344 0.332 0 C-N-CA 124.246 1.019 . . . . 0.0 110.395 179.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG12 ' HB2' ' A' ' 59' ' ' TYR . 7.3 p -141.75 131.61 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 CA-C-O 120.732 0.301 . . . . 0.0 111.3 -176.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 67.9 tt0 -70.46 140.93 52.06 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-O 121.723 0.773 . . . . 0.0 111.64 -178.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 21.0 tp -127.15 93.09 42.38 Favored Pre-proline 0 N--CA 1.452 -0.341 0 C-N-CA 127.507 2.323 . . . . 0.0 105.683 178.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -73.19 152.75 50.88 Favored 'Trans proline' 0 N--CA 1.448 -1.162 0 C-N-CA 122.072 1.848 . . . . 0.0 109.094 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.412 HD22 ' HA ' ' A' ' 65' ' ' LEU . 0.2 OUTLIER -56.1 -26.85 51.38 Favored 'General case' 0 C--O 1.221 -0.445 0 C-N-CA 123.755 0.822 . . . . 0.0 110.95 179.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 37.1 mtmt -54.26 -36.55 63.71 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 123.956 0.903 . . . . 0.0 112.908 178.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 72.6 t -85.87 -40.19 14.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.98 -49.96 75.04 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.963 1.305 . . . . 0.0 110.091 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -73.67 -39.06 64.7 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.663 0.785 . . . . 0.0 111.267 -179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.03 -34.13 71.0 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 119.034 -1.066 . . . . 0.0 112.655 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -137.08 67.79 55.95 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 123.533 0.733 . . . . 0.0 111.628 -178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -72.18 50.37 1.52 Allowed 'Trans proline' 0 CA--C 1.54 0.821 1 C-N-CA 126.394 4.73 . . . . 0.0 114.92 -179.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -137.91 147.05 44.02 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 178.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.6 mm -56.82 -46.23 83.39 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.719 0 C-N-CA 126.984 2.113 . . . . 0.0 108.099 -179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.8 ttmm -54.11 -41.63 68.54 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 119.957 -0.697 . . . . 0.0 111.898 179.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.35 -46.12 67.75 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 179.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -70.07 -36.84 75.23 Favored 'General case' 0 C--O 1.218 -0.563 0 C-N-CA 124.449 1.1 . . . . 0.0 108.758 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -64.83 -51.54 61.58 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 117.778 -1.106 . . . . 0.0 108.43 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -66.32 -37.76 86.11 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.552 1.069 . . . . 0.0 110.496 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -63.97 -53.84 43.81 Favored 'General case' 0 N--CA 1.458 -0.054 0 C-N-CA 123.66 0.784 . . . . 0.0 109.324 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 53.5 t -62.96 -40.83 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.47 -47.9 79.88 Favored 'General case' 0 C--O 1.225 -0.213 0 C-N-CA 124.536 1.134 . . . . 0.0 113.296 -179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.0 t -73.49 -25.0 60.26 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 118.258 0.481 . . . . 0.0 110.093 -179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.52 -15.89 29.89 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-O 117.96 -1.019 . . . . 0.0 113.031 -178.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 69.5 p -75.75 -4.81 42.58 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 119.319 0.963 . . . . 0.0 110.02 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -54.77 141.52 32.36 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.161 1.384 . . . . 0.0 109.404 178.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 16.4 t-80 -165.76 140.5 4.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -88.06 93.67 9.56 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 103.42 -2.807 . . . . 0.0 103.42 177.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 86.5 t60 -64.76 160.08 20.92 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 8.7 p-80 -161.24 168.21 24.54 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.159 0.984 . . . . 0.0 109.689 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.253 1.243 0 C-N-CA 127.514 2.326 . . . . 0.0 105.65 179.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo . . . . . 0 CA--C 1.541 0.868 0 N-CA-C 113.747 0.634 . . . . 0.0 113.747 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.7 p -67.16 168.99 1.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 127.762 2.425 . . . . 0.0 111.456 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 73.4 p -128.14 137.81 52.24 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 102.839 -3.023 . . . . 0.0 102.839 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.0 mm-40 -64.88 4.39 0.44 Allowed 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 115.138 1.533 . . . . 0.0 115.138 -178.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -95.82 -5.88 40.74 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 126.704 2.002 . . . . 0.0 112.836 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -60.92 145.99 48.33 Favored 'General case' 0 C--O 1.224 -0.27 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -59.57 122.44 14.06 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 118.78 0.718 . . . . 0.0 111.386 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.7 t -138.61 115.99 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 N-CA-C 103.521 -2.77 . . . . 0.0 103.521 176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.02 159.23 77.71 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 124.633 1.173 . . . . 0.0 110.558 179.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -52.86 129.36 32.5 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 124.466 3.444 . . . . 0.0 110.89 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.7 t -101.51 -21.34 14.78 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.671 1.188 . . . . 0.0 109.887 -178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.407 ' HB3' ' HG3' ' A' ' 16' ' ' GLU . 20.6 t-20 -109.52 148.69 30.79 Favored 'General case' 0 C--O 1.24 0.587 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.9 -23.83 67.54 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 117.25 -1.357 . . . . 0.0 112.108 -179.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 93.0 t -69.48 -44.38 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 CA-C-N 121.277 1.853 . . . . 0.0 107.542 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' HG3' ' HB3' ' A' ' 13' ' ' ASN . 16.8 mt-10 -57.84 -40.89 81.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 t -58.07 -51.2 70.67 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 124.555 1.142 . . . . 0.0 109.724 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -58.28 -52.7 64.51 Favored 'General case' 0 CA--C 1.519 -0.234 0 C-N-CA 123.196 0.598 . . . . 0.0 111.558 -179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.79 -42.87 99.89 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 118.868 0.758 . . . . 0.0 111.352 179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.04 -33.42 72.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 123.45 0.7 . . . . 0.0 110.128 179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -64.78 -47.39 78.29 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.8 mm -62.67 -34.85 67.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 118.76 -0.638 . . . . 0.0 110.468 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 16.1 m0 -59.81 -40.91 90.01 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 119.7 1.137 . . . . 0.0 109.321 178.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -64.94 -39.77 94.0 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -68.04 -32.04 72.12 Favored 'General case' 0 CA--C 1.517 -0.294 0 O-C-N 121.351 -0.843 . . . . 0.0 112.066 -179.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.8 t -85.57 -53.41 10.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 118.695 0.68 . . . . 0.0 109.855 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 83.3 mt -75.62 -25.57 57.03 Favored 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 -177.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.36 15.18 66.99 Favored Glycine 0 CA--C 1.535 1.288 0 C-N-CA 125.496 1.522 . . . . 0.0 112.229 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.439 ' CG2' HD11 ' A' ' 32' ' ' ILE . 21.3 m -94.91 175.25 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 125.811 1.644 . . . . 0.0 111.8 -178.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 27.6 t -144.83 119.35 9.7 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.889 0.876 . . . . 0.0 109.329 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.99 68.5 0.84 Allowed Glycine 0 C--N 1.335 0.496 0 C-N-CA 124.668 1.128 . . . . 0.0 110.772 179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.439 HD11 ' CG2' ' A' ' 29' ' ' VAL . 27.1 mm -90.72 125.06 43.54 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 C-N-CA 126.347 1.859 . . . . 0.0 107.874 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -95.03 164.98 25.15 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 33.6 pt -67.94 -28.09 40.05 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 121.771 -0.841 . . . . 0.0 111.49 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.603 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -99.68 -3.48 32.94 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 127.218 2.207 . . . . 0.0 116.147 -178.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -82.46 121.56 26.9 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 120.207 1.367 . . . . 0.0 108.823 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -68.33 127.64 33.69 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 122.576 0.35 . . . . 0.0 110.713 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' HA ' HD12 ' A' ' 41' ' ' ILE . 89.3 t80 -48.21 -44.22 32.68 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.479 1.912 . . . . 0.0 111.665 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 45.1 m-85 -69.36 -38.11 77.94 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.849 179.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -69.69 -28.16 65.6 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 119.028 -0.51 . . . . 0.0 110.781 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 38' ' ' PHE . 27.8 mt -71.03 -17.76 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 C-N-CA 123.661 0.784 . . . . 0.0 109.206 179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 124.46 2.69 8.15 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 124.935 1.255 . . . . 0.0 112.79 179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -76.0 164.62 53.82 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -146.77 174.92 11.03 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -44.15 -53.6 6.34 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.214 1.405 . . . . 0.0 112.779 -178.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.96 -43.76 94.84 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -66.17 -38.89 89.17 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 118.362 -0.828 . . . . 0.0 109.715 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.87 -41.64 74.68 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 123.5 0.72 . . . . 0.0 110.329 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 63.2 mtm -64.03 -40.49 96.44 Favored 'General case' 0 C--O 1.225 -0.209 0 C-N-CA 122.86 0.464 . . . . 0.0 110.276 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -60.59 -40.61 92.38 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 118.182 0.446 . . . . 0.0 110.234 179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 t -65.42 -52.96 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -56.56 -31.13 63.9 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 118.398 -0.81 . . . . 0.0 112.6 -179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.82 -43.1 69.28 Favored 'General case' 0 C--O 1.236 0.351 0 CA-C-N 118.912 0.778 . . . . 0.0 111.374 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 3.2 mm-40 -73.66 -42.7 61.02 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.264 0.625 . . . . 0.0 109.343 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.85 -33.91 66.77 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 O-C-N 120.672 -1.268 . . . . 0.0 108.195 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.65 -42.42 91.41 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 119.392 0.996 . . . . 0.0 109.18 -179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 2.7 ptp180 -75.27 -31.75 60.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -74.48 -48.92 24.44 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.466 ' HB2' HG12 ' A' ' 61' ' ' VAL . 68.5 m-85 -94.13 0.14 55.64 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 112.014 0.375 . . . . 0.0 112.014 -179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 54.15 37.85 27.95 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.46 1.504 . . . . 0.0 109.851 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.466 HG12 ' HB2' ' A' ' 59' ' ' TYR . 12.7 p -141.41 124.9 15.96 Favored 'Isoleucine or valine' 0 C--N 1.342 0.265 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 64.7 tt0 -67.37 130.74 44.02 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.565 -0.71 . . . . 0.0 110.521 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.9 tt -118.03 87.99 30.22 Favored Pre-proline 0 N--CA 1.452 -0.351 0 N-CA-C 103.398 -2.816 . . . . 0.0 103.398 177.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.14 159.2 54.15 Favored 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 122.475 2.116 . . . . 0.0 112.168 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.38 -40.93 51.07 Favored 'General case' 0 CA--C 1.514 -0.418 0 C-N-CA 126.724 2.01 . . . . 0.0 109.785 179.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 4.9 ptpp? -53.46 -32.18 48.9 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-O 117.713 -1.137 . . . . 0.0 112.393 -178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.448 HG21 ' CE2' ' A' ' 80' ' ' TYR . 88.8 t -87.28 -47.42 15.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 119.982 1.264 . . . . 0.0 109.328 179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.53 -47.31 76.5 Favored 'General case' 0 C--O 1.223 -0.334 0 C-N-CA 123.554 0.742 . . . . 0.0 111.749 -177.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -79.35 -31.74 43.07 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 117.95 -1.024 . . . . 0.0 111.974 -179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -71.42 -39.38 71.1 Favored 'General case' 0 CA--C 1.512 -0.495 0 C-N-CA 119.536 -0.865 . . . . 0.0 110.67 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -137.47 78.31 38.48 Favored Pre-proline 0 N--CA 1.453 -0.312 0 O-C-N 124.271 0.982 . . . . 0.0 109.39 -178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.03 52.69 3.52 Favored 'Trans proline' 0 N--CA 1.453 -0.892 0 C-N-CA 123.707 2.938 . . . . 0.0 111.756 -179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -135.85 147.78 48.39 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-N 120.224 1.375 . . . . 0.0 109.908 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 74' ' ' ILE . 8.4 mm -58.12 -40.68 78.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 32.7 ttpt -53.8 -46.21 71.02 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.229 0.468 . . . . 0.0 110.682 178.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.42 -51.42 44.04 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -179.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.4 mt -64.09 -38.12 89.92 Favored 'General case' 0 C--O 1.216 -0.668 0 C-N-CA 125.005 1.322 . . . . 0.0 109.86 -177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.01 -42.49 94.42 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 118.978 0.808 . . . . 0.0 109.385 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -74.54 -44.87 49.04 Favored 'General case' 0 CA--C 1.514 -0.421 0 C-N-CA 123.4 0.68 . . . . 0.0 111.395 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.448 ' CE2' HG21 ' A' ' 67' ' ' VAL . 27.7 t80 -62.22 -44.07 97.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 70.3 t -74.25 -43.2 50.68 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 C-N-CA 119.478 -0.889 . . . . 0.0 110.508 -178.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.56 -42.05 98.27 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 113.777 1.028 . . . . 0.0 113.777 -178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 t -67.73 -29.9 69.25 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 120.527 -0.469 . . . . 0.0 109.777 -179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 6.3 mtp85 -83.21 -43.99 15.5 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 119.074 0.852 . . . . 0.0 109.407 -179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 7.6 t -77.94 36.49 0.22 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.873 1.669 . . . . 0.0 109.395 178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 27.3 p-80 -69.11 133.21 47.76 Favored 'General case' 0 N--CA 1.442 -0.862 0 O-C-N 121.129 -0.982 . . . . 0.0 109.649 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -67.69 121.57 16.2 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 103.613 -2.736 . . . . 0.0 103.613 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -56.26 150.73 13.9 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-O 121.643 0.735 . . . . 0.0 110.953 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 28.1 p-80 -74.03 153.61 39.6 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 25.4 m-70 -136.59 144.32 44.07 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 127.851 2.46 . . . . 0.0 105.414 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 . . . . . 0 C--O 1.254 1.31 0 C-N-CA 127.644 2.378 . . . . 0.0 106.028 -178.669 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo . . . . . 0 N--CA 1.477 0.535 0 N-CA-C 110.518 -0.608 . . . . 0.0 110.518 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.6 t 58.05 75.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.216 0 CA-C-O 123.974 1.845 . . . . 0.0 108.719 179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.2 p -130.96 36.9 3.82 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 112.517 -2.129 . . . . 0.0 110.164 -178.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -73.25 -22.51 60.39 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 121.79 -0.569 . . . . 0.0 112.346 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -68.03 148.49 50.94 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 -179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mp0 -75.51 161.72 28.94 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.838 1.255 . . . . 0.0 110.709 -178.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 29.6 t80 -46.08 132.61 9.5 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 128.396 2.678 . . . . 0.0 113.174 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 81.5 t -140.05 117.62 10.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.303 0 N-CA-C 105.397 -2.075 . . . . 0.0 105.397 177.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.25 158.23 38.32 Favored Pre-proline 0 CA--C 1.55 0.964 0 O-C-N 124.116 0.885 . . . . 0.0 110.02 179.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -64.51 149.74 89.44 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 123.49 2.793 . . . . 0.0 112.023 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 19.2 p -123.61 -21.58 5.2 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.037 -0.983 . . . . 0.0 113.589 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -102.87 141.11 36.23 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.96 -18.66 0.82 Allowed 'General case' 0 C--O 1.225 -0.193 0 C-N-CA 124.713 1.205 . . . . 0.0 113.881 -178.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 96.7 t -79.78 -54.42 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.094 0.958 . . . . 0.0 109.636 179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -50.77 -42.77 58.14 Favored 'General case' 0 CA--C 1.516 -0.342 0 C-N-CA 126.893 2.077 . . . . 0.0 110.103 -177.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.2 t -60.86 -44.88 96.44 Favored 'General case' 0 N--CA 1.449 -0.492 0 O-C-N 123.837 0.711 . . . . 0.0 110.78 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 43.7 mtmt -61.25 -45.37 94.8 Favored 'General case' 0 N--CA 1.463 0.199 0 O-C-N 120.636 -1.29 . . . . 0.0 110.756 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.7 mp -65.89 -38.45 88.77 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 119.121 0.873 . . . . 0.0 111.452 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.19 -36.48 75.44 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.1 -37.53 75.42 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.4 -40.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 N-CA-C 107.678 -1.231 . . . . 0.0 107.678 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 11.1 m0 -60.45 -41.11 93.41 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -56.72 -38.88 72.96 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 118.547 0.612 . . . . 0.0 109.858 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.2 mtm-85 -68.45 -32.85 73.17 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.407 HG21 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -86.31 -46.25 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 123.022 1.391 . . . . 0.0 111.729 -179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 62.5 mt -70.14 -33.2 71.51 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 114.415 -1.266 . . . . 0.0 112.357 -179.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.13 38.82 54.44 Favored Glycine 0 CA--C 1.527 0.813 0 N-CA-C 108.224 -1.95 . . . . 0.0 108.224 -178.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 5.5 m -131.64 174.71 12.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 C-N-CA 126.015 1.726 . . . . 0.0 107.108 179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.2 p -136.72 138.85 41.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 125.122 1.369 . . . . 0.0 110.71 -178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 83.15 66.64 1.51 Allowed Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.21 1.386 . . . . 0.0 112.186 178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 47.7 mm -83.89 129.5 37.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 179.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.52 167.58 28.75 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 119.029 0.831 . . . . 0.0 111.326 179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 28.8 pt -74.62 -24.55 18.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 C-N-CA 123.987 0.915 . . . . 0.0 112.553 -178.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.23 -0.26 21.0 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.454 1.501 . . . . 0.0 114.911 -178.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -79.03 122.8 26.64 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 118.868 0.758 . . . . 0.0 109.557 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -67.23 123.73 21.12 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.331 1.052 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.2 t80 -46.36 -45.95 18.03 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.429 1.892 . . . . 0.0 112.876 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -70.72 -24.07 62.57 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 120.752 -1.218 . . . . 0.0 112.224 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 -74.28 -37.14 63.79 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.4 mt -78.46 29.36 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.27 0 C-N-CA 125.965 1.706 . . . . 0.0 109.981 179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.32 5.37 34.94 Favored Glycine 0 CA--C 1.535 1.316 0 O-C-N 119.159 -2.213 . . . . 0.0 113.936 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -65.64 142.19 43.47 Favored Glycine 0 C--N 1.338 0.675 0 N-CA-C 108.135 -1.986 . . . . 0.0 108.135 179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -132.81 173.18 11.64 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 117.847 0.823 . . . . 0.0 108.886 179.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -47.62 -47.48 28.94 Favored 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 123.347 0.659 . . . . 0.0 111.628 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.1 -48.26 73.83 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 117.91 0.323 . . . . 0.0 110.587 179.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -65.97 -39.59 90.51 Favored 'General case' 0 C--N 1.343 0.287 0 CA-C-O 118.191 -0.909 . . . . 0.0 110.026 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.72 -40.86 80.53 Favored 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.163 0.985 . . . . 0.0 110.427 -179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 53.5 mtm -65.78 -37.9 87.57 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.62 -33.56 75.23 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.222 178.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.407 HG22 HG21 ' A' ' 26' ' ' VAL . 70.9 t -63.08 -53.0 52.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 N-CA-C 106.246 -1.761 . . . . 0.0 106.246 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.65 69.62 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.064 0.946 . . . . 0.0 112.231 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -68.19 -47.48 67.82 Favored 'General case' 0 N--CA 1.457 -0.119 0 CA-C-O 121.651 0.739 . . . . 0.0 109.904 -179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.409 ' HA ' ' HG2' ' A' ' 57' ' ' ARG . 7.6 mm100 -67.16 -39.98 86.6 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.36 0.6 . . . . 0.0 109.987 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 8.0 t -64.59 -47.46 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.114 0 O-C-N 121.35 -0.844 . . . . 0.0 108.775 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.22 -37.65 86.16 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.529 -178.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . 0.409 ' HG2' ' HA ' ' A' ' 54' ' ' GLN . 10.6 ptm180 -75.85 -32.26 59.67 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -87.48 -48.14 8.18 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -176.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.512 ' HB2' HG12 ' A' ' 61' ' ' VAL . 80.1 m-85 -92.36 0.33 57.44 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 117.853 -1.07 . . . . 0.0 111.352 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 49.93 43.09 25.19 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 119.596 1.089 . . . . 0.0 109.199 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.526 HG11 HG13 ' A' ' 81' ' ' VAL . 8.2 p -136.1 128.43 45.58 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.155 0 C-N-CA 123.365 0.666 . . . . 0.0 110.657 -178.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -69.45 120.72 15.68 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 27.0 tp -114.76 78.71 5.33 Favored Pre-proline 0 N--CA 1.454 -0.238 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.42 158.15 42.26 Favored 'Trans proline' 0 N--CA 1.447 -1.22 0 C-N-CA 121.23 1.287 . . . . 0.0 111.503 178.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.72 -26.86 67.48 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.344 1.058 . . . . 0.0 110.579 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 15.6 ptpt -52.97 -41.59 64.7 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 117.586 -1.197 . . . . 0.0 111.262 -178.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.5 t -88.29 -37.23 10.19 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.442 0 CA-C-N 119.719 1.145 . . . . 0.0 109.021 -179.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.3 -50.08 60.05 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.549 0.69 . . . . 0.0 109.445 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -76.94 -30.7 56.18 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.399 0.888 . . . . 0.0 113.399 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.16 -31.43 49.69 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 119.119 0.872 . . . . 0.0 111.379 -178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -134.68 72.76 68.75 Favored Pre-proline 0 N--CA 1.449 -0.52 0 C-N-CA 125.468 1.507 . . . . 0.0 107.898 -179.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -74.18 53.28 2.92 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.892 3.061 . . . . 0.0 113.093 -179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -136.62 147.38 46.88 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 120.311 1.414 . . . . 0.0 110.455 179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.1 mm -58.12 -44.08 86.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.227 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 ttpm? -54.86 -46.68 74.74 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 122.576 0.35 . . . . 0.0 111.404 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.17 85.27 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.301 1.04 . . . . 0.0 113.233 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.9 mt -66.83 -42.97 84.91 Favored 'General case' 0 C--O 1.218 -0.586 0 C-N-CA 125.345 1.458 . . . . 0.0 107.246 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.46 97.76 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-O 118.405 -0.807 . . . . 0.0 109.749 179.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -76.24 -36.72 58.39 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 120.201 1.364 . . . . 0.0 111.159 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -60.99 -51.46 69.17 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG13 HG11 ' A' ' 61' ' ' VAL . 77.4 t -68.63 -47.32 77.39 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.466 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.692 -178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.13 -51.79 60.79 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 119.801 1.182 . . . . 0.0 113.304 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.4 t -64.41 -22.41 66.95 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -178.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 65.2 mtt-85 -100.58 -24.07 14.53 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.125 0.875 . . . . 0.0 112.98 -179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 27.8 t -73.15 -23.6 60.48 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.296 1.438 . . . . 0.0 111.295 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -63.38 116.34 5.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.278 -1.378 . . . . 0.0 107.278 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 18.2 t-80 -56.42 149.84 16.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 123.778 0.831 . . . . 0.0 108.94 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . 0.41 ' CE1' ' HB2' ' A' ' 90' ' ' HIS . 18.4 p80 -140.26 30.41 1.97 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.598 0.759 . . . . 0.0 111.757 -178.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 5.8 p80 46.06 33.97 1.88 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 128.674 2.79 . . . . 0.0 115.748 179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.41 ' HB2' ' CE1' ' A' ' 88' ' ' HIS . 48.6 t-80 -51.99 113.72 1.09 Allowed 'General case' 0 C--O 1.233 0.211 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.706 179.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 85.3 t60 . . . . . 0 C--O 1.253 1.24 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.412 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo . . . . . 0 N--CA 1.478 0.596 0 CA-C-O 118.247 -0.814 . . . . 0.0 113.639 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.1 m -60.3 140.97 17.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-N 119.622 1.101 . . . . 0.0 109.813 179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 71.9 p -84.12 149.79 25.96 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -130.83 17.48 5.18 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.242 1.017 . . . . 0.0 109.481 179.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.04 -10.49 22.31 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.596 1.558 . . . . 0.0 113.505 179.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -67.6 142.07 56.57 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 104.942 -2.244 . . . . 0.0 104.942 178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -47.33 131.03 13.48 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.105 0.962 . . . . 0.0 113.274 -178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 53.8 t -142.62 116.61 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 102.468 -3.16 . . . . 0.0 102.468 177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.01 161.19 65.08 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 123.883 0.873 . . . . 0.0 109.615 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.78 146.58 72.96 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 121.682 1.588 . . . . 0.0 110.056 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 p -132.24 -13.95 3.04 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 122.477 0.311 . . . . 0.0 111.283 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.64 141.95 28.53 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 104.506 -2.405 . . . . 0.0 104.506 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.55 -28.14 8.04 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 -178.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 94.5 t -82.4 -44.78 19.62 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.242 0 CA-C-N 119.086 0.857 . . . . 0.0 109.154 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -51.94 -42.51 62.89 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 124.269 1.027 . . . . 0.0 109.983 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.0 t -54.26 -50.54 66.98 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 124.331 1.019 . . . . 0.0 110.431 179.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -59.29 -50.12 75.22 Favored 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 125.397 1.479 . . . . 0.0 111.7 -179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 5.9 mp -67.25 -41.66 85.26 Favored 'General case' 0 N--CA 1.447 -0.61 0 O-C-N 119.99 -1.694 . . . . 0.0 112.724 179.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.77 -34.61 71.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 O-C-N 124.531 1.144 . . . . 0.0 111.024 -179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -72.7 -47.87 43.57 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.108 0.867 . . . . 0.0 111.23 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 94.9 mt -57.01 -37.89 57.27 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 C-N-CA 123.055 0.542 . . . . 0.0 109.743 179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . . . . . . . . . 9.4 m0 -59.68 -39.69 85.36 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 121.212 -0.93 . . . . 0.0 111.012 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -57.27 -43.18 82.85 Favored 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 123.276 0.63 . . . . 0.0 110.646 -179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 33.4 mtp180 -64.11 -31.73 73.04 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.726 0.81 . . . . 0.0 112.591 -178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 60.7 t -89.66 -44.44 15.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 118.899 0.772 . . . . 0.0 111.715 -178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 70.5 mt -80.27 -24.09 40.3 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.114 0.966 . . . . 0.0 112.728 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.79 23.93 68.42 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 124.901 1.239 . . . . 0.0 111.936 -179.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 3.8 t -116.0 175.03 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-N 119.467 1.633 . . . . 0.0 106.599 -179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.9 t -141.76 143.48 33.51 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 120.001 1.273 . . . . 0.0 107.859 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.31 69.15 1.41 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 108.875 -1.69 . . . . 0.0 108.875 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.402 HD12 HD13 ' A' ' 41' ' ' ILE . 49.7 mm -91.27 121.79 42.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.3 169.13 45.29 Favored Glycine 0 CA--C 1.531 1.071 0 CA-C-N 118.45 0.568 . . . . 0.0 112.67 179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 45.2 pt -68.54 -24.08 28.82 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 O-C-N 120.948 -1.325 . . . . 0.0 111.466 -179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.512 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -103.89 -3.37 24.89 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 128.12 2.568 . . . . 0.0 113.117 -179.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.71 ' HB3' HD11 ' A' ' 41' ' ' ILE . 0.9 OUTLIER -69.44 124.23 23.35 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -179.235 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -77.32 117.33 18.72 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.963 1.305 . . . . 0.0 108.777 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -45.09 -48.05 11.95 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.893 1.677 . . . . 0.0 113.223 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 64.4 m-85 -71.08 -33.64 70.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-O 118.941 -0.552 . . . . 0.0 111.876 -179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.7 tp60 -67.95 -29.54 68.62 Favored 'General case' 0 C--N 1.338 0.067 0 C-N-CA 123.61 0.764 . . . . 0.0 110.606 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.71 HD11 ' HB3' ' A' ' 36' ' ' ASP . 30.9 mt -72.01 -3.79 4.19 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 C-N-CA 123.985 0.914 . . . . 0.0 109.389 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.84 -0.56 33.96 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 126.033 1.778 . . . . 0.0 111.866 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.57 160.81 46.71 Favored Glycine 0 C--N 1.338 0.683 0 CA-C-N 118.618 1.209 . . . . 0.0 110.64 179.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -151.18 179.2 8.49 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.184 1.394 . . . . 0.0 108.316 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.26 -50.71 11.57 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.133 1.373 . . . . 0.0 113.251 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.63 -46.51 86.93 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 118.449 0.568 . . . . 0.0 110.324 179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' O ' HG23 ' A' ' 51' ' ' VAL . 27.7 mmtp -63.48 -39.2 93.83 Favored 'General case' 0 CA--C 1.514 -0.409 0 O-C-N 121.205 -0.934 . . . . 0.0 110.798 -179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.18 -42.39 69.61 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-N 118.662 0.665 . . . . 0.0 109.268 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 2.1 mmt -65.98 -41.52 91.03 Favored 'General case' 0 C--O 1.232 0.162 0 C-N-CA 123.164 0.586 . . . . 0.0 109.768 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -61.69 -37.28 83.53 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-O 118.377 -0.82 . . . . 0.0 112.1 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 47' ' ' LYS . 2.4 t -72.2 -52.3 25.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -52.83 -31.59 39.84 Favored 'General case' 0 C--N 1.343 0.303 0 C-N-CA 124.38 1.072 . . . . 0.0 111.095 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -61.18 -50.59 72.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 118.593 0.633 . . . . 0.0 111.447 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.09 -37.35 61.58 Favored 'General case' 0 C--O 1.224 -0.242 0 CA-C-O 121.574 0.702 . . . . 0.0 110.921 -178.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 9.1 t -64.63 -47.37 89.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 121.082 -1.011 . . . . 0.0 108.961 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -60.14 -40.7 90.71 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 120.208 -0.597 . . . . 0.0 110.344 -178.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 6.5 ptp180 -75.27 -29.1 60.04 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 -178.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -87.65 -48.09 8.16 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 118.065 0.393 . . . . 0.0 110.607 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -84.29 -3.7 58.4 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 -179.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 63.1 mt-30 51.49 39.17 24.01 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.268 1.827 . . . . 0.0 110.886 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.596 HG11 HG13 ' A' ' 81' ' ' VAL . 11.7 p -141.25 132.31 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-O 121.748 0.785 . . . . 0.0 112.085 -177.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -71.53 115.66 10.96 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.15 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 59.3 tp -110.19 83.72 3.26 Favored Pre-proline 0 CA--C 1.534 0.344 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -66.3 157.79 58.29 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.669 2.246 . . . . 0.0 112.439 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.52 -33.49 54.7 Favored 'General case' 0 C--O 1.226 -0.145 0 C-N-CA 125.436 1.494 . . . . 0.0 110.522 179.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.88 -30.85 47.69 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-O 118.052 -0.975 . . . . 0.0 112.146 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.1 t -86.92 -46.85 16.27 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.192 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.16 -49.72 60.33 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.277 1.431 . . . . 0.0 110.926 -178.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.2 -31.01 38.75 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 118.663 -0.684 . . . . 0.0 111.641 179.531 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -66.94 -37.11 83.7 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.076 0.853 . . . . 0.0 110.502 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 43.0 mt-30 -141.76 79.31 16.91 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.263 1.025 . . . . 0.0 110.939 -178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.3 52.56 3.58 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 123.951 3.101 . . . . 0.0 113.189 -179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.25 147.21 49.21 Favored 'General case' 0 N--CA 1.465 0.3 0 O-C-N 120.887 -1.133 . . . . 0.0 109.535 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.6 mm -56.47 -48.21 80.5 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp -52.32 -47.82 65.79 Favored 'General case' 0 CA--C 1.534 0.331 0 O-C-N 123.623 0.577 . . . . 0.0 111.508 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.47 98.98 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.1 mt -73.27 -41.48 63.57 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.62 -50.62 73.18 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.255 1.022 . . . . 0.0 109.315 179.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -69.42 -38.63 77.96 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.787 1.176 . . . . 0.0 111.552 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 38.9 t80 -67.16 -46.13 74.95 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 123.094 0.558 . . . . 0.0 110.627 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.596 HG13 HG11 ' A' ' 61' ' ' VAL . 78.0 t -73.78 -42.79 54.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 119.253 -0.403 . . . . 0.0 110.155 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.32 -44.99 84.65 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 118.86 0.754 . . . . 0.0 112.804 -178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.7 t -61.98 -32.71 73.19 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 118.349 0.522 . . . . 0.0 109.64 -179.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 -75.25 -37.93 60.76 Favored 'General case' 0 C--N 1.343 0.293 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 178.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.97 -33.5 64.85 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.299 1.04 . . . . 0.0 109.69 179.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 43.8 m170 -60.22 107.69 0.68 Allowed 'General case' 0 C--N 1.344 0.364 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -117.95 32.84 5.93 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 126.865 2.066 . . . . 0.0 110.591 -178.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.4 m-70 -59.42 105.3 0.34 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 124.018 0.927 . . . . 0.0 110.555 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 82.9 m-70 -139.02 41.62 2.11 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.34 1.856 . . . . 0.0 107.884 -179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.1 t60 -140.18 -15.44 0.99 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.055 0.942 . . . . 0.0 113.346 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 20.6 m80 . . . . . 0 C--O 1.246 0.886 0 N-CA-C 105.231 -2.137 . . . . 0.0 105.231 179.1 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 CA--C 1.538 0.722 0 N-CA-C 113.798 0.653 . . . . 0.0 113.798 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.5 m -58.91 161.44 1.04 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 122.25 1.024 . . . . 0.0 112.07 -179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.4 m -146.81 119.0 8.28 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.928 1.691 . . . . 0.0 107.445 -179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.7 mp0 -107.18 19.18 20.74 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 128.21 2.604 . . . . 0.0 109.006 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -77.16 164.31 25.78 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.884 1.273 . . . . 0.0 109.785 179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -120.59 160.26 23.58 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.635 1.574 . . . . 0.0 108.469 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -45.87 123.91 4.86 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.131 1.372 . . . . 0.0 114.138 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.3 t -146.33 117.6 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.555 0 N-CA-C 103.117 -2.92 . . . . 0.0 103.117 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' A' ' 11' ' ' PRO . . . -68.81 172.41 4.84 Favored Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 124.329 1.051 . . . . 0.0 112.008 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.762 ' HD2' ' HB1' ' A' ' 10' ' ' ALA . 52.9 Cg_endo -68.14 146.46 70.35 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 123.02 2.48 . . . . 0.0 111.111 -179.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.9 t -118.82 -13.51 9.53 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 123.607 0.763 . . . . 0.0 111.733 179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -120.31 147.11 45.43 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 106.538 -1.652 . . . . 0.0 106.538 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -53.29 -26.14 17.32 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-O 116.663 -1.636 . . . . 0.0 113.502 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 79.4 t -68.73 -55.1 17.06 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.366 0 CA-C-N 120.496 1.498 . . . . 0.0 107.792 -179.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.2 mt-10 -52.54 -44.08 65.57 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 126.618 1.967 . . . . 0.0 109.728 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -59.12 -40.32 85.04 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.305 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -61.37 -50.74 71.7 Favored 'General case' 0 CA--C 1.51 -0.568 0 CA-C-N 119.325 0.966 . . . . 0.0 110.237 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' H ' HD12 ' A' ' 19' ' ' LEU . 5.6 mp -63.45 -41.94 98.65 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 118.725 -1.19 . . . . 0.0 111.413 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.21 -36.16 68.13 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.977 0.911 . . . . 0.0 110.626 -179.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -76.29 -49.94 15.67 Favored 'General case' 0 CA--C 1.511 -0.557 0 CA-C-N 118.973 0.806 . . . . 0.0 110.409 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 98.0 mt -51.39 -40.94 24.92 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.958 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TRP . . . . . 0.401 ' CH2' ' HB2' ' A' ' 38' ' ' PHE . 8.2 m0 -64.95 -45.83 84.11 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.319 1.448 . . . . 0.0 110.223 178.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 83.0 mt-10 -59.33 -37.12 77.0 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.369 0.668 . . . . 0.0 109.923 179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.3 mtp180 -70.57 -29.08 65.42 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 118.647 -0.692 . . . . 0.0 112.04 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 66.2 t -81.49 -55.73 7.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 C-N-CA 123.764 0.826 . . . . 0.0 109.388 179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.9 mt -74.51 -20.51 59.95 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.631 1.172 . . . . 0.0 113.523 -177.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.29 32.93 68.49 Favored Glycine 0 CA--C 1.529 0.922 0 CA-C-N 119.034 0.834 . . . . 0.0 111.847 179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 17.3 m -117.14 175.21 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.4 1.88 . . . . 0.0 109.634 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.5 p -139.25 127.77 23.03 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 124.028 0.931 . . . . 0.0 112.945 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.76 69.27 1.16 Allowed Glycine 0 C--N 1.335 0.502 0 N-CA-C 109.196 -1.561 . . . . 0.0 109.196 178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 14.4 mm -87.02 123.39 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 C-N-CA 126.913 2.085 . . . . 0.0 107.383 179.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.5 174.32 44.82 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 32.8 pt -80.76 -26.83 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 CA-C-N 118.725 1.263 . . . . 0.0 110.628 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.776 HD13 ' H ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -96.71 4.84 51.6 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 128.013 2.525 . . . . 0.0 113.877 -179.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -62.99 123.35 18.31 Favored 'General case' 0 N--CA 1.444 -0.772 0 C-N-CA 125.651 1.581 . . . . 0.0 113.107 -178.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -79.73 105.3 10.92 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 120.226 -1.546 . . . . 0.0 107.09 179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.49 ' HA ' HD12 ' A' ' 41' ' ' ILE . 92.5 t80 -41.74 -47.55 4.07 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.208 1.403 . . . . 0.0 113.237 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -69.62 -33.19 72.31 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 -179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.6 tt0 -68.13 -31.07 70.39 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 119.277 0.944 . . . . 0.0 108.88 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.49 HD12 ' HA ' ' A' ' 38' ' ' PHE . 31.2 mt -71.29 -15.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.016 0.926 . . . . 0.0 109.587 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 114.16 -6.86 23.31 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 126.078 1.799 . . . . 0.0 112.541 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.76 157.77 33.91 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 118.675 1.237 . . . . 0.0 110.276 179.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' HIS . . . . . . . . . . . . . 23.9 p80 -143.33 171.45 14.1 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -45.04 -48.68 11.73 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.321 1.048 . . . . 0.0 112.475 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.1 -46.04 82.91 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.762 -0.586 . . . . 0.0 110.657 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.5 mttm -66.05 -42.17 89.85 Favored 'General case' 0 C--N 1.344 0.335 0 O-C-N 121.444 -0.785 . . . . 0.0 110.036 179.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.35 -43.71 67.94 Favored 'General case' 0 CA--C 1.529 0.147 0 C-N-CA 124.303 1.041 . . . . 0.0 110.187 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' MET . . . . . . . . . . . . . 40.5 mtm -63.72 -30.41 71.51 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 122.657 0.383 . . . . 0.0 111.811 179.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.52 -35.39 68.09 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 118.728 -0.653 . . . . 0.0 109.62 178.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 t -64.29 -48.28 86.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -55.22 -34.82 64.27 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.139 0.976 . . . . 0.0 111.337 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -63.9 -45.84 87.52 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.144 0.884 . . . . 0.0 110.442 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -73.25 -36.15 66.36 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-O 121.63 0.729 . . . . 0.0 110.385 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -64.04 -45.18 97.39 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 62' ' ' GLU . 1.2 t-80 -61.02 -36.73 80.29 Favored 'General case' 0 N--CA 1.444 -0.75 0 O-C-N 121.477 -0.765 . . . . 0.0 111.489 -178.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ARG . . . . . . . . . . . . . 24.9 ptt180 -76.79 -32.07 57.43 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -89.63 -44.86 9.76 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 122.04 0.924 . . . . 0.0 112.17 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -90.25 -0.62 57.71 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.883 1.273 . . . . 0.0 109.897 179.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 49.2 42.04 20.87 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.206 1.402 . . . . 0.0 111.002 -179.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.428 HG11 HG13 ' A' ' 81' ' ' VAL . 14.5 p -152.39 139.86 13.51 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.106 0 O-C-N 120.847 -1.158 . . . . 0.0 111.883 -177.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 56' ' ' HIS . 30.6 tt0 -66.8 143.77 56.7 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 122.193 -0.317 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -132.33 82.42 57.91 Favored Pre-proline 0 C--O 1.234 0.283 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 178.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.79 149.24 72.71 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 121.819 1.68 . . . . 0.0 111.147 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.8 -27.43 41.67 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 125.088 1.355 . . . . 0.0 111.294 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -53.19 -36.49 61.01 Favored 'General case' 0 C--N 1.337 0.059 0 CA-C-O 118.184 -0.912 . . . . 0.0 111.682 179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.4 t -87.57 -47.27 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.202 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -49.44 -48.9 47.13 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 126.007 1.723 . . . . 0.0 111.531 -178.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -80.35 -29.72 37.99 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.082 0.953 . . . . 0.0 112.848 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.69 -31.89 59.9 Favored 'General case' 0 CA--C 1.521 -0.169 0 O-C-N 123.256 0.347 . . . . 0.0 111.336 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -134.58 74.52 65.37 Favored Pre-proline 0 N--CA 1.451 -0.415 0 N-CA-C 106.218 -1.771 . . . . 0.0 106.218 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -73.88 56.32 3.55 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 124.346 3.364 . . . . 0.0 112.687 -178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.98 147.43 36.93 Favored 'General case' 0 CA--C 1.514 -0.417 0 CA-C-N 119.846 1.203 . . . . 0.0 110.677 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.2 mm -54.81 -49.26 70.79 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 C-N-CA 124.847 1.259 . . . . 0.0 108.876 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -52.38 -50.51 62.28 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.958 0.903 . . . . 0.0 111.28 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -60.2 -43.21 96.11 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.4 mt -73.59 -44.58 56.84 Favored 'General case' 0 N--CA 1.438 -1.031 0 C-N-CA 125.048 1.339 . . . . 0.0 107.559 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -55.18 -51.42 66.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.258 1.023 . . . . 0.0 109.678 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -70.33 -40.25 74.27 Favored 'General case' 0 CA--C 1.533 0.306 0 O-C-N 123.322 0.389 . . . . 0.0 111.099 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -61.55 -48.13 82.4 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 123.636 0.774 . . . . 0.0 110.077 -179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.428 HG13 HG11 ' A' ' 61' ' ' VAL . 71.3 t -72.24 -38.46 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 118.781 -0.628 . . . . 0.0 109.733 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -55.44 -48.71 74.04 Favored 'General case' 0 C--N 1.341 0.237 0 CA-C-N 119.258 0.935 . . . . 0.0 111.426 -179.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 8.8 t -63.51 -32.35 73.78 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 117.626 0.194 . . . . 0.0 111.379 -179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.3 mtt85 -75.8 -29.62 58.76 Favored 'General case' 0 N--CA 1.466 0.366 0 O-C-N 121.29 -0.881 . . . . 0.0 110.23 179.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' SER . . . . . . . . . . . . . 83.3 p -82.4 -10.75 58.93 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -126.88 86.25 2.48 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.027 0.931 . . . . 0.0 110.377 -178.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' HIS . . . . . . . . . . . . . 35.4 m80 -73.02 164.28 26.93 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.98 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -147.62 158.1 43.85 Favored 'General case' 0 C--O 1.231 0.093 0 C-N-CA 124.309 1.044 . . . . 0.0 109.841 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -74.79 46.01 0.27 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 127.507 2.323 . . . . 0.0 110.696 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.0 p80 -73.14 -11.05 60.39 Favored 'General case' 0 CA--C 1.529 0.166 0 O-C-N 120.278 -1.514 . . . . 0.0 112.796 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 44.2 t-80 . . . . . 0 C--O 1.252 1.202 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 -179.65 . . . . . . . . 0 0 . 1 stop_ save_